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Executive Summary
Skin sensitisation is a prime example with respect to the paradigm shift taking place in
regulatory toxicological risk assessment presently. The development of in vitro, in chemico,
and in silico methods is fuelled by the existence of a full adverse outcome pathway (AOP)
that relates the alternatives to animal testing to an overall framework. Within this frame this
thesis takes the approach of reanalysing available animal data based on a large evaluated
database of about 2000 substances and to use the information to develop in silico models,
which can aid risk assessors in the industry and administration by supporting their decisions.
In this regard, even before entering the model development stage, toxicologically interest-
ing results were achieved during a correlation analysis between the regulatory relevant skin
sensitisation tests, the local lymph node assays (LLNA) as well as guinea pig testing (GPT;
guinea pig maximisation test and Buehler test combined). Both are assumed to correlate to
a significant degree, which allows a mutual substitution as stipulated in the present european
chemicals regulation (REACH). This is not the case. Albeit the fact that both correlate barely
moderately (concordance, cc = 75%), the investigation showed that a mutual exchange of
the assays is not sensible from a regulators point of view. However, both possess an equal
predictive capacity towards high quality human data (cc = 84%), where the LLNA is biased
towards (false) positive and the GPT towards (false) negative read-outs. None of both is
superior for hazard prediction and their reliability depends on their domain of applicability. In
line with these results, an in silico approach was compared to the animal trials regarding the
predictivity of human data. The simple application of structural alerts encoding for reactivity
was able to discriminate between sensitisers and non-sensitisers and lead to a comparable
result as in the animal assays, which implies a mechanism-based in silico approach can be
utilised to support toxicological decision making. Likewise, combining structural alerts and
animal data yielded improved statistics of the latter, in particular with regard to their weak
points (predictivity of sensitisers in the LLNA and non-sensitisers in the GPT, both increased
by 10%-points). As last (brief) correlation analysis step, the relationship between toxicity
enhancement (in acute aquatic toxicity) and skin sensitisation was investigated. Indeed, a
correlation is observed between both endpoints (cc = 63-82%). Though, this emerges under
specific conditions, i.e. the exclusion of weak sensitisers in the LLNA as well as the exclu-
sion of substance for which the aquatic toxicity can be interpreted as equivocally (toxicity
enhancement between 0.5 and 1.5). Further analyses have to clarify if the last outcomes
are includable into e.g. consensus modelling.
After the correlation analysis was finished, the modelling started with the first key step of
the skin sensitisation AOP, the dermal bioavailability of a target substance. The idea was
to exclude poorly bioavailable compounds via physicochemical-based limit values already
successfully applied to the related endpoint of skin irritation. However, unfortunately no
such thresholds could be derived during several exploratory investigations. This is rooted
in differences between both endpoints as well as the animal protocols conducted to obtain
skin sensitisation data. The discrepancy is discussed referring to current literature and is
underlined by several recent findings. Furthermore, also the possible influence of physico-
chemical properties onto the skin sensitising potency is analysed, in particular with regard to
the molecular weight, hydrophobicity, as well as volatility. In conclusion, sensitisers should
be regarded as bioavailable in any case (at least for the applied animal models, but possibly
for humans the skin barrier is of greater importance). This knowledge should be included
into the current AOP. Risk assessor should assume bioavailibility to be the default case and,
thus, focus on the (electrophilic) reactivity of a chemical under assessment.
The focus on reactivity is driven by the fact that electrophilic interactions with nucleophilic
groups of proteins constitute the second key step in the skin sensitisation AOP. To improve
hazard assessment this parameter was investigated in the subsequent two-handed mod-
elling exercises, utilising an automated read-across based on atom-centered fragments
(ACF) and developing (new) structural alerts for skin sensitisation. The former in silico
method (read-across as interpolation between structurally similar neighbours) proved to give
proper estimates for the skin sensitising potential in the LLNA as well as the GPT, though
the overall statistics were lowly moderate (cc = 70/74%). Improvement measures comprise
a similarity threshold for the nearest neighbours or excluding uncertain predictions in a grey
area approach – both of which are associated with a loss of predictable compounds and
the latter lacks a mechanistic justification. In contrast to the moderate read-across, a better
moderate predictive performance is obtained with the developed structural alert model (cc
= 85/86%). A differentiation is made between a screening approach, which is searching
for reactive features in general, and a high resolution model, which is optimised towards
predicting a particular animal test. During the analysis of literature models it became appar-
ent that the domain of applicability of the model and the activation of chemical is important
for the prediction statistics. The structural alert model includes pre/pro-alerts (33% of the
sensitisers were found to be pre/pro-electrophiles) and was grounded in available literature
knowledge, but also applied additional 26 new alerts (meaning in public models not imple-
mented), most of which (18) are preliminary, together with 12 alerts for autoxidation, whereof
6 are preliminary. Moreover, 16 further preliminary alerts were applied, which are based on
individual compounds, but a sound mechanistic justification is available for them. The pre-
liminarity is discussed within the framework of a recently published alert reliability concept,
to evaluate not only the performance of the whole implementation but to assess how the
individual (preliminary) alerts perform. Importantly, as indicated, for all new alerts as well as
improvements of previous alerts it is discussed how they can be mechanistically justified.
Finally, a consensus modelling approach is applied to combine read-across and structural
alert predictions. Besides demonstrating the independence of both in silico methods, weight-
of-evidence (WoE) factors based on Bayesian statistics are exploited to shown that a com-
bination of the independent submodules leads to improved (good) statistics (cc = 89/92%).
This is achieved by excluding conflicting predictions of both in silico models, based on the
fact that those combinations do not lead to sufficiently high prediction probabilities or WoE
values, respectively. Further, to reach beyond the current assessment practice prior infor-
mation, i.e. the distribution of skin sensitisers in the respective animal tests, is taken into
evaluation. In addition, also intertwining in silico methods with existing animal test results
is discussed to explore the value of existing data. Eventually, the model was successfully
validated for the majority of the criteria of the OECD QSAR validation principles.
IV
Zusammenfassung
Entwicklungen im Bereich der Hautsensibilisierung (Hautallergie von Typ IV) sind ein Pa-
radebeispiel fu¨r den derzeit stattfindenden Wandel im Bereich der regulatorischen Toxikolo-
gie. Sie verfu¨gt u¨ber eine umfangreiche formalisierte Beschreibung des Weges zum ad-
versen Effekt (englisch adverse outcome pathway, AOP), was sie besonders geeignet fu¨r
die Entwicklung von in vitro, in chemico und in silico Alternativen zum Tierversuch macht.
Diesen Fakt greift auch diese Dissertation auf, indem sie auf Basis einer großen, evaluierten
Datenbank von circa 2000 Stoffen bisheriges Wissen zu Hautsensibilisierungs-Tierversuchen
reanalysiert und im Weiteren nutzt, um ein in silico (computerisiertes) toxikologisches Mod-
ell zur prognostischen Bewertung der Hautsensibilisierung zu entwerfen, welches regula-
torischen Risikobewertern in der Industrie und in Beho¨rden als Unterstu¨tzungsinstrument
fu¨r ihre Entscheidungen dienen soll.
In dieser Hinsicht ist zu erwa¨hnen, dass schon vor der eigentlichen Modellentwicklung im
Zuge einer breit gefa¨chterten Korrelationsanalyse zwischen den fu¨r die Regulation relevan-
ten Tiertestsystemen, LLNA (local lymph node assay an der Maus) und GPT (guinea pig
maximisation test und Buehler-test, beide im Meerschweinchen), aufschlussreiche Ergeb-
nisse erzielt werden konnten. Normalerweise wird angenommen, dass beide zu einem
großen Ausmaß miteinander korrelieren, was unter anderem die Grundlage dafu¨r ist, beide
Testsysteme in der europa¨ischen Chemikaliengesetzgebung (REACH) gleich zu behandeln.
Jedoch zeigte sich, dass dies nicht der Fall ist. Die beiden Tierversuche stimmen nur
mit moderater Gu¨te u¨berein (Konkordanz, cc = 75%) und eine Gleichbehandlung beider
Tests (sodass sie sich gegenseitig ersetzen ko¨nnen) ist nicht sinnvoll aus regulatorischer
Sicht. Allerdings sind beide Tierprotokolle in der Lage humane Daten mit der gleichen Gu¨te
(Konkordanz, cc = 84%) vorherzusagen, wobei der LLNA eine Neigung zu (falsch) posi-
tiven und die GPT zu (falsch) negativen Testergebnissen aufweisen. Keines der beiden
Tiertestsysteme scheint besser fu¨r die Humanprognose geeignet zu sein als das andere.
In diesem Zuge wurde auch ein erster in silico toxikologischer Ansatz mit den Korrela-
tionsanalyseergebnissen verglichen. Dabei handelt es sich um die Vorhersage des haut-
sensibilisierenden Effektes u¨ber Strukturalarme, welche diejenigen Struktureinheiten betr-
effen, die fu¨r die Reaktivita¨t von (organischen) Verbindungen ausschlaggebend sind. Mit
ihnen konnte eine vergleichbar gute Diskriminierung zwischen sensibilisierenden und nicht-
sensibilisierden Stoffen wie im Tierversuch getroffen werden. Außerdem konnten mit ihrer
Hilfe testsystemspezifische Unterschiede in der Bewertung von Hautsensibilisierern erkla¨rt
werden und sie waren in die Lage ein schon vorhandenes Tierversuchsergebnis signifikant
zu verbessern, insbesondere was die Schwachstellen der jeweiligen Tierversuche betrifft
(die Vorhersage von aktiven bzw. nicht-aktiven Stoffen im LLNA bzw. GPT konnte um
10%-Punkte erho¨ht werden). Diese Befunde deuten darauf hin, dass die Unterstu¨tzung reg-
ulatorischen Arbeitens durch dieses mechanismus-bezogene in silico Modell mo¨glich ist.
Als letzte (kurze) Korrelationsuntersuchung wurde der Zusammenhang zwischen der Haut-
sensibilisierung und der akuten aquatischen Toxizita¨t betrachtet. Zwischen beiden besteht
in der Tat eine U¨bereinstimmung (cc = 63-82%), allerdings nur wenn gewisse Bedingun-
gen beachtet werden, wie etwa das Ausblenden schwacher Sensibilisierer im LLNA sowie
das Auslassen von aquatisch-toxischen Ergebnissen, welche in einen Unsicherheitsbereich
fallen (Toxizita¨tserho¨hung von 0,5-1,5, d.h. nur Stoffe ab 1,5 werden als erho¨ht toxisch be-
trachtet). In diesem Bereich sind viele nachfolgende Untersuchungen denkbar, die kla¨ren
mu¨ssen, ob die Daten der aquatischen Toxizita¨t bei der Bewertung der Hautsensibilisierung
weiterhelfen ko¨nnen bspw. im Rahmen einer Konsensvorhersage.
U¨ber die Korrelationsanalysen hinausgehend wurde versucht den ersten mechanistischen
Schlu¨sselschritt des AOP, die dermale Bioverfu¨gbarkeit einer Zielverbindung, mit einfachen
Methoden zu erfassen. Zu Grunde gelegt wurde ein Verfahren basierend auf physiko-
chemischen Grenzwerten, u¨ber- oder unterhalb derer ein Sensibilisierungspotenzial aus-
geschlossen werden sollte, analog zu einem Ansatz, welcher bereits erfolgreich fu¨r den
verwandten Endpunkt der Hautreizung angewendet wurde. Leider konnten fu¨r die Hautsen-
sibilisierung keine solchen Regeln entworfen werden. Die Erkla¨rung dafu¨r sind markante
Unterschiede sowohl zwischen den beiden Endpunkten als auch zwischen den angewen-
deten Tierprotokollen, was im Hauptteil der Disseration aufbauend auf aktueller Literatur
und weiterer Untersuchungen diskutiert wird. Außerdem wird die Tatsache beleuchtet, dass
die Bioverfu¨gbarkeit zwar keinen Beitrag zur Diskriminierung zwischen Sensibilisierern und
Nicht-Sensibilisierern leistet, jedoch ein Einfluss auf die Wirkpotenz (stark vs. schwache
Sensibilisierer) durchaus denkbar ist. Dies wird anhand des Einflusses des Mokulargewichts,
der Hydrophobie und der Flu¨chtigkeit von Verbindungen dargestellt. Zusammenfassend ist
zu bemerken, dass dieses Wissen in den Hautsensibilisierungs-AOP Eingang finden sollte
und dass Regulatoren in jedem Fall von der Bioverfu¨gbarkeit eines Stoffes ausgehen sollten
(wobei zu sagen ist, dass dies insbesondere fu¨r die verwendeten Tiermodelle gilt und der
Beitrag der Bioverfu¨gbarkeit fu¨r eine sensibilisierende Wirkung im Menschen durchaus noch
gegeben sein kann, da sich dessen Hautbarriere stark von der von Tieren unterscheidet).
Auf Grund dieser Feststellung kommt natu¨rlich den weiteren Schritten im AOP, insbeson-
dere der der Hautsensibilisierung zu Grunde liegenden (reaktiven) Elektrophil-Nukleophil-
Interaktion zwischen einer Zielverbindung und Proteinseitenketten, welche als molekulares
auslo¨sendes Ereignis (molecular initiating event) gilt, eine besondere Bedeutung zu und
sollte dementsprechend im Fokus von Risikobewertern stehen. Dieser Interaktion wurde in
den nachfolgenden Modellierungsschritten der Dissertation in zweierlei Weise nachgegan-
gen und zwar einerseits mit einem automatisierten Read-across-Ansatz und andererseits
auf der Basis von (neuen) Strukturalarmen. Die zuerst genannte in silico Methode (die
eine Interpolation zwischen struktura¨hnlichen Verbindungen bezeichnet) war in der Lage
den hautsensibilisierenden Effekt von Stoffen im LLNA und den GPT vorherzusagen, wen-
ngleich zu erwa¨hnen ist, dass die Vorhersagestatistik nur ma¨ßige Ergebnisse bereit ha¨lt (cc
= 70/74%). Verbesserungen sind u¨ber etablierte Verfeinerungsansa¨tze mo¨glich, wie etwa
einer A¨hnlichkeitsschranke fu¨r die zur Extrapolation geeigneten Referenzstoffe (die diese
u¨berschreiten mu¨ssen, um zur Vorhersage herangezogen werden zu ko¨nnen) oder einer
Grauzone fu¨r das bina¨re Vorhersageinterval – wobei zweiteres eine Methode darstellt, fu¨r
die eine mechanistische Begru¨ndung fehlt.
Im Gegensatz zum ma¨ßigen Read-across waren die Strukturalarme in der Lage eine
moderate (statistische) Leistung zu erzielen (cc = 85/86%). Außerdem konnte reproduziert
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werden, dass die Anwendungsdoma¨ne eines Modells einen entscheidenen Einfluss auf
seine Vorhersagegu¨te hat und dass die Aktivierung von Stoff (pre oder pro) Alarme fu¨r
sinnvolle Vorhersagen beru¨cksichtigt werden muss. Daher wurde ein Ansatz gewa¨hlt der
pre/pro-Alarme einschließt (33% der Sensibilisierer im Datensatz sind pre/pro-Elektrophile)
und der zwischen einem Screening-Verfahren, welches reaktive Merkmale von Stoffen im
Allgemeinen erfasst, sowie einem hochauflo¨senden Modell (high-resolution), welches an
den jeweiligen Tierversuchsergebnissen ausgerichtet wurde, unterscheidet. Der erste Aus-
gangspunkt fu¨r die Strukturalarmentwicklung waren die Beschreibungen aus der bisherige
(mechanistische) Literatur, jedoch wurden auch 26 neue, bisher in o¨ffentlichen Modellen
nicht implementierte Alarme angewendet, von denen jedoch die meisten (18) vorla¨ufige
Alarme sind. Zudem wurden 12 Alarme zur Bestimmung von Autoxidationsprozessen (z.B.
abiotische Reaktion mit Luftsauerstoff) ermittelt, von denen 6 vorla¨ufig sind. Außerdem
liegen 16 weitere vorla¨ufige Alarme vor, die nur auf einer Verbindung beruhen, was ihnen
eine a¨ußerst schlechte statistische Grundlage gibt, jedoch sind alle mechanistisch fundiert,
sodass von ihrer (lokalen) Validita¨t auszugehen ist. Zur Bestimmung ob ein Alarm vorla¨ufig
ist, wurde das Modell der Alarm-Verla¨ssigkeit aus der aktuellen Literatur genommen und auf
jeden Einzelalarm angewendet, um nicht nur die Leistung des Gesamtmodells zu beurteilen,
sondern jeden (vorla¨ufigen) Alarm individuell zu evaluieren. Selbstversta¨ndlich werden fu¨r
alle neuen Alarme mechanistische U¨berlegungen vorgestellt und es wird diskutiert, wie die
assoziierten Stoffe reaktiv wirken ko¨nnen.
Abschließend wurden im Rahmen einer Konsens-Modellierung die methodischen Kom-
ponenten Read-across und Strukturalarme zu einem Gesamtmodell integriert. Dazu wur-
den Evidenzwichtungsfaktoren (weight-of-evidence factors) bestimmt, deren Anwendung in
der Tat dazu fu¨hrte, dass das Gesamtmodell eine bessere (gute) Statistik (cc = 89/92%)
als seine Einzelbestandteile erzielte. Dies wurde dadurch erreicht, dass – wie auf Grund
der Evidenzwichtungsfaktoren bzw. der assoziierten Wahrscheinlichkeit empfohlen – Stoffe
mit widerspru¨chlichen Prognosen in den beiden Submodellen von der Vorhersage aus-
geschlossen wurden. Weiterhin wurde im Vorhinein die Unabha¨ngigkeit der Read-across-
und Strukturalarmprognosen evaluiert. Nachfolgend wurde Vorwissen zur Verteilung der
Hautsensibilisierer in den jeweiligen Tierversuchsdatensa¨tzen angewendet, um dies in Form
eines “priors” in die Prognose miteinzubeziehen und so u¨ber die bisherige regulatorische
Risikobewertungspraxis hinaus zu gehen. Ebenfalls wurde gezeigt, was passiert, wenn
die Konsens-Vorhersage um die Informationen aus einem bereits vorliegen Tierversuch er-
weitert wird, um so die Ausnutzung von bereits vorhandenen Daten zu verbessern. Ab-
schließend wurde eine Validierung anhand der OECD-Kriterien zur Validierung von QSAR-
Modellen durchgefu¨hrt, welche in großen Teilen erfolgreich war.
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Revised Edition
The edition at hand of this dissertation is not the version submitted for evaluation of the doc-
toral thesis by the Technical University Bergakademie Freiberg, but a curated and updated
version. Herein, several small mistakes (e.g. spelling errors) were corrected. Furthermore,
due to discussions with colleagues after the submission of the original dissertation some
remarks had to be made for certain reaction mechanisms. Lastly, in comparison to the
original version some Annexes were adapted. In case any questions arise concerning the
modifications please contact the author or the working group of ecological chemistry of the
Helmholtz-Centre for Environmental Research (UFZ).
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1. Motivation and Scope of research
Skin sensitisation is a precondition for the development of an allergic contract dermatitis
(ACD). The latter of which is a very common disease in western civilisation with an estimated
prevalence of 20% in the whole population (Thyssen et al., 2007). Not only the general public
suffers from the effects of this currently incurable disease, but also in workplaces such as
the metal industry or hair dressing ACD is responsible for retreat, costs for the health care
system, and loss of quality of life (Peiser et al., 2012).
To overcome those health related issues it is not only important to regulate already known
contact allergens properly, but also to identify new ones even before they become problem-
atic. For this reason regulations such as the (new) European chemicals legislation REACH
(Registration, Evaluation, Authorisation and Restriction of Chemicals) or the Cosmetics Di-
rective foster the toxicological assessment of chemicals before they enter the market. How-
ever, there is a tension between the presently used regulatory toxicological animal protocols
and new testing approaches. On the one hand, the current regulatory framework stipulates
the assessment of skin sensitisation with animal trials (REACH Annex VII). On the other
hand, the assessment with alternatives to animal testing is encouraged within this regula-
tions (Annex XI in REACH) or even mandatory (Cosmetics Directive). Right now the regu-
latory acceptance of alternative testing systems is low and animal tests are still the method
of choice for most toxicological endpoints including skin sensitisation. This is a sensitive
matter as animal-based testing methods are subject to several ethical concerns1 as well as
economical and efficiency considerations.2 Therefore, animal-free alternatives are gaining
momentum. Overall, there is a controversial debate whether the complex processes under-
lying an adverse outcome require testing in adequately complex organisms or if animal trials
are not adequate at all because of interspecies differences, high doses applied, and artificial
testing conditions. Within this framework the purpose of this work is to solve the tension
between old and new testing to a certain degree with the development of a new in silico
model, which is applicable in the regulatory environment of legislation-based toxicological
risk assessment.
To this end it is important to mention the work of Teubner et al. (2013) and Verheyen
et al. (2017), who showed that most of the current in silico models are not sufficient for
the regulatory assessment of skin sensitisation. This is because they either perform just
moderate on data outside of their training set or they perform very well (e.g. TIMES-SS), but
their domain of applicability is severely limited (Teubner et al., 2013). One way to overcome
both of these problems is a model development based on a large data set, which encloses
a structurally diverse range of compounds and compound classes. As no such data set
is openly available,3 a comprehensive data collection is the starting point of this doctoral
thesis.
1See Zurlo et al. (1994) for a first overview of the issues.
2Efficiency: often animal tests are time and resource consuming which may render them as an inadequate
assessment strategy for the very large number of compounds to be assessed in the near future (over
50,000 substances registered under REACH – cf. echa.europa.eu/regulations/reach/registration/registration-
statistics); many alternatives on the contrary, are applicable in a much shorter time with less resources.
3At least not at the starting date of this thesis.
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After the data compilation, the scope of research includes the application and the devel-
opment of in silico methods onto this toxicological endpoint as well as a detailed (corre-
lation) analysis of the collected data to address open research questions, such as which
test system is best suited for skin sensitisation assessment. The modelling focusses on
two mechanistic key steps of the skin sensitisation adverse outcome pathway: (1) the der-
mal bioavailability and (2) the reaction of electrophilic (organic) compounds with nucleophilic
groups of skin proteins. To model the former step – which is the prerequisite for a skin sensi-
tisation to happen (if nothing enters the skin no reaction will be observed) – physicochemical
properties were explored to figure out if cut-off values can be derived estimating whether a
substances will penetrate the skin barrier or not.4 The latter key step, which also drives the
molecular initiation event of skin sensitisation (electrophile-nucleophile interactions with skin
proteins), is engaged two-fold: (1) by an automatic read-across (interpolation between sim-
ilar substances) based on atom centred fragments (ACF) to establish if similar compounds
can support the prediction of the sensitising effect of a target chemical as well as (2) by
structural alerts (substructural units that indicate a certain effect) which are a simple but,
nevertheless, effective modelling method. They will target electrophilic functional groups of
the compounds under prediction. Finally, all utilised methods and information shall be inte-
grated in one model using a consensus modelling approach grounded in weight-of-evidence
factors stemming from Bayesian statistics to enhance the reliability of the obtained predic-
tions and to ensure that an optimal use of the available data is made. The optimal use has
to be emphasised, because the overall goal of alternatives to animal testing should not be
to just replace animal methods, but to improve hazard assessment (Rovida et al., 2015).
The starting point for all predictions will be the binary classification (active vs. non-active
compounds). After that, if possible, a semi-quantitative or quantitative modelling approach
will be investigated.5 In the following sections the basic knowledge on skin sensitisation
including the currently applied animal assessment models as well as a short overview of
alternatives will be delineated for the sake of a comprehensive understanding. Thereafter,
the research results are reported.
4Though, no general physicochemical cut-off values for the discrimination between active and non-active com-
pounds were found.
5However, it turned out the global binary prediction was hard enough to obtain. Hence, no further development
was undertaken.
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2. General introduction to the process and regulatory
assessment of skin sensitisation
Skin sensitisation is the underlying precondition which is necessary for the development
of an allergic contact dermatitis (ACD). In other words skin sensitisation itself is not a full
disease, but the disposition for an adverse reaction of the immune system in susceptible
individuals. However, this does not mean that skin sensitisation is less relevant than other
toxicological endpoints. In sensitised individuals the exposure to compounds to which they
are sensitised leads to serious reactions in form of ACD (Basketter et al., 2008). This im-
mune system misfeature (i.e. an inappropriately strong reaction to a remotely harmful ex-
posure) can manifest as symptoms like rash (which can ooze, drain or crust), itching, and
inflammation, the last of which is associated with pain, warmth, swelling, and reddening of
the affected skin area (NIOSH, 2012). As outlined in the motivation, it occurs frequently with
a prevalence of 20% (Thyssen et al., 2007; Martin, 2016). Among the most common aller-
gens are nickel, fragrances, and preservatives (Peiser et al., 2012; Martin, 2016). Allergic
reactions to those and other compounds occur in women twice as frequently as in men and
often start already at a young age (Peiser et al., 2012). Furthermore, ACD is not only impor-
tant for the general population but also in the occupational setting, in which the associated
occupational contact dermatitis (OCD) is among the most prevalent occupational diseases
in many countries (Diepgen, 2003; NIOSH, 2012). Regarding OCD workers in the metal and
cement industry exposed to chromate as well as hair dressers exposed to para-phenylene-
diamine are the primary groups of concern (Peiser et al., 2012). Hence, because of their
potential to produce severe effects under specific circumstances, sensitiser are a possible
target for a SVHC classification (SVHC are substances of very high concern, ter Burg and
Jongeneel, 2012) from a regulatory perspective. Though, the majority of sensitisers should
not be regarded as SVHC (Basketter and Kimber, 2014).
It is important to differentiate between skin sensitisation/ACD and similar diseases, such
as other allergic reactions of the skin as well as skin irritation (Basketter et al., 2015). In
particular, ACD and skin irritation – also known as ICD (irritant contact dermatitis) – are
hard to differentiate clinically and their close connection in skin sensitisation testing6 will
be discussed on several occasions in this thesis. In contrast to ACD, ICD is an immediate
inflammatory response to a stimulus (e.g. an irritant chemical which causes damage to the
skin directly) and does not need the formation of an immunological memory, while signs
of ACD require the recruitment of the memory T-cells and usually appear one or two days
delayed after the exposure to a particular allergen. Moreover, other allergic reactions of the
skin can be differentiated from ACD by the time frame, too, wherefore ACD is called delayed-
type hypersensitivity (or type 4 skin allergy) to distinguish it from the immediate allergic
response (type 1-3, e.g. atopic dermatitis – in Germany colloquially called “neurodermitis”).7
For detailed information on skin sensitisation and other immunological diseases the reader is
referred to textbooks of toxicology and immunobiology (e.g. Marquardt and Scha¨fer, 2004, or
6For instance, a preliminary test for skin irritation is mandatory in skin sensitisation protocols and skin irritation
counts as important confounding factor.
7However, there may be positive associations between different types of allergy, cf. Thyssen et al. (2012a).
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Murphy and Weaver, 2016) or review articles (e.g. Rustemeyer et al., 2006; Basketter et al.,
2008; Kimber et al., 2002a, 2011; Thyssen et al., 2012b,c; McFadden et al., 2013). Still,
to understand the endpoint engaged in this thesis a basic understanding of the underlying
biological processes as well as assessment methods is necessary, which is delineated in
the next sections.
2.1. Adverse outcome pathway
Nowadays, the adverse outcome pathway (AOP) concept is used to describe the biological
underpinnings of a particular (toxicological) endpoint. An AOP is defined as “a concep-
tual construct that portrays existing knowledge concerning the pathway of causal linkages
between a molecular initiating event and a final adverse effect at a biological level of organ-
isation that is relevant to a regulatory decision” (Ankley et al., 2010; OECD, 2013). In other
words, a causal chain is laid through the different levels of natural organisation (molecule,
cell, tissue, organ, organ system, organism, population) starting with the lowest level (molec-
ular initiating event) followed by a number of key steps until ultimately the adverse outcome
emerges. Different references exist which lay down how this concept can be applied to sup-
port regulatory risk assessment (e.g. Vinken, 2013; MacKay et al., 2013; Maxwell et al.,
2014; Patlewicz et al., 2014b, 2015b; Tollefsen et al., 2014; Vinken et al., 2017).
Skin sensitisation was the first endpoint with a fully developed and published AOP (OECD,
2012a,b). A condensed version of this AOP is presented in the following paragraphs, high-
lighting the two key events most relevant for the understanding of this thesis. More details
concerning the further (sub)steps can be found in OECD (2012a,b) or Kimber et al. (2011).
Figure 1 shows a simplified representation of the skin and what happens if a sensitiser
is applied onto it. After its dermal application a chemical compound has to pass the outer
layers of the epidermis (in particular the stratum corneum) and is subsequently distributed
within the upper layers of the skin, e.g. into keratinocytes. Within those the compound –
given it is a sensitiser, i.e. a (pre/pro)electrophile – reacts with nucleophilic groups of skin
cell proteins to form a so-called protein-hapten complex.8 Notably, the exact target site of this
reaction remains unknown (Aptula and Roberts, 2006; OECD, 2012a). Representing a dan-
ger signal9 (Basketter et al., 2008; Kimber et al., 2011; McFadden et al., 2013; Martin, 2015),
this protein-hapten conjugate is incorporated by the dendritic cells of the immune system (in
the skin also called Langerhans cells), which migrate to the nearest lymph node to evoke
an immune reaction. During the migration the dendritic cells process the protein-hapten
complex and mature, e.g. they lose their ability to internalise new hapten-protein conju-
gates (OECD, 2012a). This enables them to present the processed protein-hapten complex
bound to MHC molecules10 to T-lymphocytes. Those recognize the covalently modified and
8The term ”‘hapten”’ was coined in a series by Landsteiner and Jacobs (1935) and derived from the Greek word
“hapten”, which means “to fasten” (Chipinda et al., 2011). Haptens can be considered as “half antigens”,
because they (the electrophilic chemicals) need another part (proteins with nucleophilic groups) to become
full antigens. Within this terminology the electrophile-nucleophile interaction is termed haptenation.
9In fact, sensitisers utilise the same signalling pathways that are usually triggered by other danger signals such
as infections (McFadden et al., 2013; Martin, 2015) or cytotoxic effects (Jaworska et al., 2015).
10MHCs (written out: major histocompatibility complexes) are major players of the immune system and important
in the representation of xenobiotics. More information can be found in Murphy and Weaver (2016).
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Figure 1: Adverse outcome pathway of skin sensitisation
MHC-bound peptides via their TCR (T-cell receptor) and form an immunologic memory of
the MHC-hapten-peptide complex (Kimber et al., 2011). Here the process of skin sensitisa-
tion stops and the prerequisite for ACD is acquired. In case a subsequent topical exposure
to the sensitisers takes place the immune system has already formed a memory for the
sensitising compound and upon presentation of the protein-hapten complex to (cutaneous)
T-lymphocytes (TH1 and TH17 are promoted in delayed type skin allergy, McFadden et al.,
2013) an ACD-reaction with release of inflammatory cytokines is elicited.
For this dissertation not the full AOP is relevant, but the two most important steps are
the penetration through/absorption into the skin barrier (leading to the bioavailability of the
substance) as well as the electrophile-nucleophile-interaction of the sensitiser with side
chains of the skin proteins (the molecular initiating event). Both steps are highlighted in
figure 2. More details regarding the dermal absorption of chemicals and the protein-hapten-
interaction (electrophilicity, domains of reactivity) will be given in subsequent introduction
sections of the biovailability and the structural alerts chapter. Beforehand, current assess-
ment methods for skin sensitisation have to be introduced starting with animal models.
2.2. Animal test systems
Animal test systems have a long history of use in (regulatory) toxicology. Their use was
promoted due to adverse reactions to pharmaceutical drugs and consumer products in the
early 20th century and they were introduced in order to prevent those reactions even before
the respective compounds are applied in humans (Zurlo et al., 1994). Historically guinea
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Figure 2: Key events of skin sensitisation important for this thesis
pigs have been the animal of choice for assessing skin sensitisation. Many different assays
exist (reviewed in Andersen and Maibach, 1985) and two of those – namely the Buehler test
and its further development the guinea pig maximisation test, short GPMT (Buehler, 1965;
Magnusson and Kligman, 1969; OECD, 1992) – have been in regulatory use for over 40
years now. Therefore, much experience with these tests is available and even 30 years after
their ﬁrst development updated assessment strategies were developed with suggestions
how to avoid false test interpretations (Robinson et al., 1990; Kligman and Basketter, 1995;
Schlede and Eppler, 1995; Frankild et al., 1996; Basketter et al., 2008). An overview of their
methodology is given in Annex A.1. In general, it is proposed that the GPMT offers a greater
sensitivity, whereas the Buehler test is more speciﬁc to putative non-sensitisers, but this has
not been proven in a formal review (Frankild et al., 2000; Basketter and Kimber, 2007, cf.
also Annex B.1). Moreover, although their usage is limited today old data will be likely the
target of new prediction techniques such as read-across (cf. section 6, Ball et al., 2016),
which underlines the importance of a (re)assessment concerning their reliability.
As many drawbacks of the GPTs (guinea pig tests) are inherent to their experimental
protocol11 (Cockshott et al., 2006), a novel test emerged in 1989, the local lymph node
assay (LLNA) in mice (Kimber and Weisenberger, 1989). It performed well in comparison to
the formerly used GPTs (see e.g. Kimber et al., 1990; Basketter and Scholes, 1992; van Och
et al., 2001) and also with respect to human data (Basketter et al., 1994, 2001b; Gerberick
et al., 2001; Dean et al., 2001; Schneider and Akkan, 2004). Eventually, it became the ﬁrst
fully validated animal testing system with a 89% accuracy in predicting the results of the
older GPTs (Loveless et al., 1996; Dean et al., 2001; Cockshott et al., 2006; Basketter et al.,
2007a, 2009b). Compared to the latter, the LLNA offers beneﬁts concerning animal welfare
and advances in the assessment of sensitisers, because it gives a quantitative outcome (in
contrast to the semi-quantitative expert judgements in GPTs), which can be related to the
potency of sensitisers that in turn correlates well with human data (Schneider and Akkan,
2004; Basketter et al., 2007a, 2008; ICCVAM, 2011; Api et al., 2014). Thus, the LLNA soon
became the hallmark of sensitisation testing and even today the LLNA is the gold standard or
reference test12 for sensitisation assessment (Kimber et al., 2002b; Cockshott et al., 2006;
11Such as uncertainties in determining appropriate induction and challenge doses, animal welfare concerns,
subjectivity of the read-out, as well as difﬁculties in assessing the relative potency of a substance with GPT
data leading to equivocal decision about the classiﬁcation of the test compound (Cockshott et al., 2006).
12The use of the word gold standard is discouraged in the modern toxicological literature, because data on
the predictive properties of the gold standard and its relevance to human health are often not available
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McGarry, 2007; Basketter et al., 2009b; ICCVAM, 2011; Angers-Loustau et al., 2011). For
details on the testing protocol the reader is referred to Annex A.1 or the OECD guidance
document (OECD, 2010). Also a reduced version of this popular test was conceived that
is using the highest available dose only (Kimber et al., 2006). The reduced LLNA can be
confidently applied to confirm negative assessments (Ezendam et al., 2013) and might even
be the basis for potency assessment (Roberts, 2015a). However, in recent years there has
been a keen eye on false predictions of the regulatory relevant test systems; in particular,
false positives in the LLNA are discussed controversially, a debate which will be engaged
further in the correlation analysis section of this thesis.
In comparison to the older GPT the LLNA focuses on the induction phase and no read-
out of the challenge is provided. In other words, the LLNA measures sensitisation more
closely, whereas the GPT are a more accurate representation of the whole process of ACD.
Typically, the LLNA gives a quantitative outcome in form of the 3H-methyl thymidine incor-
poration into lymph nodes for different dose groups (OECD, 2010).13 With this data a quan-
titative measure can be derived from a dose-response curve: the EC3 value14 (Basketter
et al., 1999a,c). As this thesis ultimately concerns the prediction of the binary (yes/no) clas-
sification of sensitisers and to a small degree semi-quantitative results (potency categories)
but not the quantitative outcomes, more information onto quantitative LLNA outputs are just
given in Annex A.1. For classification primarily the GHS classification scheme (Basketter
et al., 2005) as reported in table 1 was used, because it enables a coherent classification
for the LLNA as well as the GPT.15 Other classification schemes exists (cf. Loveless et al.,
2010) and some of those are discussed shortly in Annex A.1.
Table 1: GHS classification schemes
LLNA GPMT Buehler
EC3 [%] ind. conc. Incidence ind. conc. Incidence
30-60% >60% 15-60% >60%
> 2 M > 1 M M > 20 M M
> 0.2 – 6 2 S > 0.1 – 6 1 M S > 0.2 – < 20 M S
6 0.2 E 6 0.1 S E 6 0.2 S E
Category abbreviations: M = moderate, S = strong, E = extreme sensitiser; ind. conc. = applied induction
concentration in percentage (topical in the Buehler test, intradermal in GPMT), GHS classification scheme
as delineated in Basketter et al. (2005).
(Jaworska and Hoffmann, 2010). For animal models it is further suggested to use the term “traditional meth-
ods”, to ensure that the point of reference can evolve (and is likely better rooted in clinical human data,
mechanisms or composite knowledge on specific compounds; Hartung, 2010).
13References to other methods of measuring the lymph node cell proliferation are given in Annex A.1.
14The concentration at which the sensitiser would presumably induce a threefold lymph node cell proliferation.
15Furthermore, it will exhibit a lower number of discordant classification if more than one test is considered
(Dumont et al., 2016).
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2.3. AOP-based approaches
Alternatives to animal testing have been in discussion for a long time already (Russell et al.,
1959). For skin sensitisation several successful efforts have been made to develop in vitro,
in chemico, and in silico approaches even before the existence of the skin sensitisation AOP
(cf. Jowsey et al., 2006). However, the AOP concept brought a more robust framework as
well as a more sophisticated justification together with new ideas of testing and most present
alternative testing systems take credit to the skin sensitisation AOP. Without the knowledge
about AOP key steps (in particular the MIE) the development of alternatives would require
much more effort and rationales. In addition, not only reasoning for individual tests can
be given, but also combined approaches can be justified within the AOP framework. The
following paragraph shall introduce in vitro, in chemico, and in silico as well as combined
approaches briefly. For a broader overview of all mentioned methods the reader is referred
to the reviews of Mehling et al. (2012) or Ezendam et al. (2016).
In vitro (bio)assays estimate the outcome of complex endpoints such as skin sensitisa-
tion with the help of single or multi cell systems, nowadays with a focus on key steps of the
respective AOP. Currently, two validated (ECVAM, 2016)16 in vitro alternatives are at hand,
the KeratinoSensTM assay and the h-CLAT (human cell line activation test). In brief, the
first test focuses on the inference of sensitisation via the oxidative stress response pathway
of keratinocytes in which the binding of haptens to cysteine17 residues of Kelch-like ECH-
associated protein 1 (Keap1) is of major concern (Natsch and Emter, 2008; Emter et al.,
2010). The second assay evaluates the modulation of surface proteins (CD86 and CD54)
of dendritic-cell-like cell lines using flow cytometrie (Ashikaga et al., 2006; Sakaguchi et al.,
2006, 2009). Additional cell-based assays have been developed, e.g. the MUSST (myeloid
U937 skin sensitisation test), but they are either not validated yet or need further improve-
ments. Recent reviews of other current in vitro approaches and more information on the
validated tests can be found in Mehling et al. (2012), Reisinger et al. (2015), and Ezendam
et al. (2016). Although being promising alternatives, important present weaknesses of the
in vitro tests encompass the susceptibility to cytotoxic effects – which is a disturbing side
effect that the hinders the detection of skin sensitisation18 –, the inability to assess skin sen-
sitisation potency, a limited estimation of the bioavailability of substances,19 and the lower
metabolic competence of the cell systems in comparison the more complex organisms such
as animals (Mehling et al., 2012; Tollefsen et al., 2014; Patlewicz et al., 2015a). The latter
renders the detection of metabolically activated pro-haptens difficult – but not impossible
(Urbisch et al., 2016a; Otsubo et al., 2017), with a particular emphasis on the metabolic
capacity of the h-CLAT (Patlewicz et al., 2016; Roberts and Patlewicz, 2017). Lastly, the
16https://eurl-ecvam.jrc.ec.europa.eu/validation-regulatory-acceptance/topical-toxicity/skin-sensitisation
17Hence, lysine binding compounds are less detectable (Emter et al., 2013; Patlewicz et al., 2015a).
18However, at least some chemicals are cytotoxic as well as skin sensitising, because there is an intrinsic link
between cytotoxicity and reactivity (Jaworska et al., 2015). Moreover, to be fair it has to be recorded that
cytotoxicity is also a confounding factor in the LLNA.
19For instance, the permeability of the skin or the penetration of the stratum corneum are not taken into account.
Furthermore, the assays are primarily applicable to lowly volatile, water soluble substances and do not make
reliable predictions of compounds prone to hydrolysis (Tollefsen et al., 2014; Patlewicz et al., 2015a; Otsubo
et al., 2017).
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developed in vitro tests may add only limited information in case other results are available
such as in chemico/silico data (Benigni et al., 2016; Roberts and Patlewicz, 2017),20 which
should be subject to further discussions.
In chemico methods are the second approaching alternative to animal testing based on
standardised chemical tests (chemoassays). In those the (electrophilic) reactivity of a test
compound towards a model nucleophile is tested and the semi-quantitative depletion rate
or the quantitative kinetics of the reaction are measured (Bo¨hme et al., 2009; Roberts and
Natsch, 2009). Hence, they directly use the AOP knowledge about the MIE (the forma-
tion of the protein-hapten-complex) where electrophile-nucleophile-interactions play a major
role. These interactions take effect at nucleophilic amino acid side chains, primarily the thiol
group in cysteine and the amine function of lysine, which are the focus of current investi-
gations (Bo¨hme et al., 2009; Mehling et al., 2012). One example is the already validated
direct peptide reactivity assay (DPRA, ECVAM, 2016), in which the endogenous tripeptide
glutathione (GSH) or synthetic peptides are used as proxy for the skin proteins (Gerberick
et al., 2004).21 However, newer references also discuss the relevance of other peptides
which are much less researched (Natsch et al., 2015; Debeuckelaere et al., 2015, 2016). A
further topic for investigations (besides the occurrence of artificial peptide depletion due to
oxidation or cleavage, Urbisch et al., 2016a) is the focus of chemoassays on directly reactive
compounds. The assays do not represent the complex biological environment completely
and, typically, cannot assess pro-haptens/pro-electrophiles correctly. Therefore, it is aston-
ishing that Urbisch et al. (2016a) report the correct detection of several pre/pro-haptens22
in the unmodified DPRA, which can be explained by the fact the majority of their pre/pro-
sensitisers is susceptible to autoxidation and not metabolism (cf. also Patlewicz et al., 2016).
However, to overcome the metabolic limitation studies of biotic (enzymatic) and abiotic cat-
alysts are conducted to simulate the in vivo metabolism of the substances (e.g. by addition
of horseradish peroxidase, Mehling et al., 2012, or other substances as in current investiga-
tions of the UFZ working group of ecological chemistry). Furthermore, like the in vitro tests
chemoassays generate no information on bioavailabilitity (and chemoavailability, Mulliner
and Schu¨u¨rmann, 2013; Bo¨hme et al., 2016).
In silico approaches23 use the theoretical knowledge of the AOP to model the endpoint in
question. Several models have been developed for skin sensitisation (for overview and criti-
cal analyses consult Teubner et al., 2013 or Verheyen et al., 2017). It should be emphasised
that mechanistic models were found to be superior in the context of the OECD-principles
of (Q)SAR validation (Roberts et al., 2007a) and perform significantly better than statistical
approaches on data outside of their training set (Teubner et al., 2013; Verheyen et al., 2017).
20The latter authors even speculate that these in vitro protocols do not simulate their proposed key events of
the AOP, but model in fact the molecular initiating event (electrophil-nucleophile interactions with proteins)
to a certain degree and compensate for each other’s technical limitations if they are combined. This is line
with Otsubo et al. (2017), who note that the test systems (partly) provide redundant information regarding
the molecular initiating event.
21Notably, the DPRA may also be useful in the detection/exclusion of respiratory allergy (Basketter et al., 2017),
which is primarily based on the lysine reactivity of a target compound (Enoch et al., 2010; Mekenyan et al.,
2014).
22The prefix pro denotes metabolic activation whereas pre-haptens are activated via abiotic autoxidation; both
are not always differentiable (more information is given in the structural alert introduction section).
23Think of silicon valley to get the connection to computers instantly.
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As outlined in the motivation the common weakness of the present models is either a small
domain of applicability or a weak statistical performance for new compounds (Teubner et al.,
2013; Verheyen et al., 2017), indicating a small training data set.24 As this work primar-
ily concerns the development of in silico toxicological models, more details – also regarding
problems – on the applied approaches (bioavailability profiling, automatic read-across, struc-
tural alerts, consensus modelling) are given throughout this thesis.
Integrated testing strategies (ITS),25 or the broader integrated approaches to testing and
assessment (IATA), combine as meta-models several of the before mentioned assessment
methods. A large variety exists of how to possibly entangle the different assessment meth-
ods, ranging from binary (Otsubo et al., 2017) or simple 2 out of 3 approaches (Bauch et al.,
2012; Urbisch et al., 2015)26 to complex pipeline models (Patlewicz et al., 2014b), which
will not be discussed in full detail within this thesis. For more information and recent exam-
ples the reader is referred to the literature (for instance: Jowsey et al., 2006; Van Leeuwen
et al., 2007; Jaworska and Hoffmann, 2010; Hartung et al., 2013; Vermeire et al., 2013 – and
other papers of the OSIRIS project, cf. consensus modelling section; Nendza et al., 2013;
Roberts and Patlewicz, 2014; Tollefsen et al., 2014; van der Veen et al., 2014; Patlewicz
et al., 2014b; Urbisch et al., 2015; Jaworska et al., 2015 – and older papers concerning their
ITS; Rovida et al., 2015; Macmillan et al., 2016; Strickland et al., 2016; Casati, 2017; Fitz-
patrick and Patlewicz, 2017; Roberts and Patlewicz, 2017, and, in particular, the review of
Ezendam et al., 2016). Notably, the integrated approaches do not necessarily cover all key
events or have to be executed in the order of the AOP (Leontaridou et al., 2016). Current
critical issues comprise the assessment of potency (Ezendam et al., 2016; Fitzpatrick and
Patlewicz, 2017), the question of how they can be validated and still exhibit enough flexi-
bility to adapt to new knowledge and challenges ahead (Hartung et al., 2013), as well as
the development of performance standards and guidance (e.g. how to ensure their practical
applicability, how to set decision points, identification of reference substances, ensure suffi-
cient statistical power supporting the ITS) amongst several other issues (Rovida et al., 2015;
Ezendam et al., 2016). Rovida et al. (2015) point out further that little efforts were made to
really integrate information. This, however, may not be necessary for skin sensitisation if it is
verified that only the most important key event (protein binding) has to be covered and that
other parameters are negligible (Roberts and Aptula, 2008; Roberts and Patlewicz, 2017).
Eventually, because ITS and IATA both deal with the integration of data from different meth-
ods they need a decision theoretical component. One possibility is consensus modelling,
which will be explained in more detail later (section 8). However, before the actual modelling
starts it is important to envisage the compiled data base first as starting point for further
exercises. This is conducted in the next section.
24With the exception maybe of CADRE-SS (Kostal and Voutchkova Kostal, 2015). However, the model was
assessed (non-independently) after the original paper from Teubner et al. (2013) and further studies should
be conducted.
25Formerly intelligent testing strategies, but the use of intelligent was judged to be disadvantageous as it can
evoke pejorative connotations towards the traditional, animal-based testing paradigm, which may hinder the
implementation of new strategies (Van Leeuwen et al., 2009).
26The majority vote strategy therein is outperformed by sequential methods as recently shown in several publi-
cations (Leontaridou et al., 2016; Clouet et al., 2017; Roberts and Patlewicz, 2017).
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3. Building up an evaluated data base
A carefully compiled data set is the fundamental backbone of every in silico model. If insuffi-
cient measures are taken for data curation and evaluation, erroneous and misleading models
are developed. This process is summarised by the catchy phrase “garbage in, garbage out”
and can be potentiated by using inaccurate model development techniques (Hartung, 2016).
One important point is that errors in chemical structure translate directly to errors in the in
silico model (Ball et al., 2016), but also the biological test data should be collected and eval-
uated carefully. Further, the origin of the data has to be documented clearly. To ensure a
sufficient data quality the following points were regarded during the data compilation.
The assessed endpoint was the outcome in one of the already introduced regulatorily rel-
evant animal test systems for skin sensitisation: LLNA, GPMT and Buehler test. Starting
sources for the data collection were the data sets of Gerberick et al. (2005) and Kern et al.
(2010) for the LLNA and the GPMT data of Cronin and Basketter (1994). In addition to these
well-known publications, literature data included in the OECD QSAR Toolbox Version 3.3.5
(OECD, 2014) was analysed for suitable tests, which were incorporated into the data base
after checking the experimental and structural specifications. The same holds for the data
base of Interagency Coordinating Committee on the Validation of Alternative Methods (ICC-
VAM, 2011). Moreover, registry information of the ECHA dissemination site (until early 2014)
was utilised to find additional studies. Lastly, a general literature search was conducted to
extend the data base with other recent literature results (e.g. Roberts et al., 2007c; SCCS,
2011, 2013; SCCS is the Scientific Committee on Consumer Safety of the European Union)
and a data base extension with literature data took place throughout the time of this the-
sis (e.g. papers from the working group of university of Gothenburg – reviewed in Karlberg
et al., 2008 – and published data of the RIFM data base, RIFM means research institute for
fragrance materials).27
The data, in particular of the ECHA dissemination site, were evaluated (as far as reason-
able) for the soundness of their test results, i.e. it was assessed if the respective OECD
guidelines were followed (if applicable), if the studies were conducted according to GLP and
if e.g. positive and negative controls were used.28 Tests in animal systems comparable to the
LLNA, GPMT, and the Buehler protocol, which are regulatory accepted to a lesser degree
(ECHA, 2014a), such as the open epicutaneous test in guinea pigs (Andersen and Maibach,
1985) or cell-count-based LLNAs, were not investigated in this thesis. Additionally, tests with
unclear or uncertain outcomes were not deleted, but flagged as “equivocal” and excluded
from further analyses (but can be reincluded later). This concerns in particular LLNA mea-
surements in which a dose response relationship is observed, but the highest dose was not
enough to invoke a 3-fold lymph node proliferation (and is below 100%, obviously).
27The RIFM results are normally not publicly available but proprietary. However, data have been released partly
in an assessment series in the journal Food and Chemical Toxicology, such as Belsito et al. (2008, 2010b,a,
2012, 2013) and related papers.
28Primarily Klimisch classes 1 and 2 tests were utilised. However, it was recognised that some registrants rated
test results from well-established data sets (e.g. Gerberick et al., 2005) as only Klimisch 4 (= “not assignable”
data, e.g. reviews without study report). This is probably not adequate, because more data for the respective
compounds should be available, if the primary sources of the data set are consulted. This fits to Jaworska
and Hoffmann (2010), who stated that the Klimisch classification is prone to selection bias.
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In addition to evaluating the soundness the analysed animal tests also the collected
chemical structures – which are stored in form of SMILES (Weininger, 1988; Weininger
et al., 1989) and INCHI-strings (Heller et al., 2013) – were checked by using large estab-
lished structural data base, i.e. the ECHA dissemination site (echa.europa.eu), Pubchem
(pubchem.ncbi.nlm.nih.gov), ChemIDPlus (chem.sis.nlm.nih.govchemidplus), eMolecules
(www.emolecules.com) as well as the UFZ inhouse data base of ChemProp (v 6.5, 2016;
Schu¨u¨rmann et al., 1997). Moreover, the online tool OPSIN (opsin.ch.cam.ac.uk) was used
(where necessary and/or possible) to deduce the structure of a certain compound from its
systematic (IUPAC) name. In contrast to the defined structures of individual compounds,
substances for which the structure is certainly not clear (i.e. substances of unknown, vari-
able, complex or biological composition, short UVCB) or which are mixtures of two or more
unique compounds were excluded from further analyses. The remaining compounds were
desalted, if necessary, and the undissociated parent compounds were used for model devel-
opment. The results of substances with the same parent compound, but for which different
salts were tested, were grouped together.
With regard to multiple testing, every testing result for one particular compound was stored
and a consensus result was derived, if possible (see Annex G.1 for more information). If no
consensus could be obtained, e.g. when only two directly opposing tests were available,
the overall result was deemed unclear (0.5 on a “binary” scale). In case of the LLNA the
consensus for the EC3 value was calculated by utilising the median of all EC3 results (in
line with Hoffmann, 2015; in accordance with ICCVAM, 2011, also the geometric mean is
reported in the data base).
Overall a chemically structurally diverse data set was compiled (and brought into a Chem-
Prop structural data base) with results for 2002 chemicals, whereof 43 were tested in all
three regulatory relevant test systems (LLNA, GPMT, and Buehler test), 182 in the LLNA
and the GPMT, 21 in the LLNA and the Buehler test, 37 in the GPMT and the Buehler test,
934 in the LLNA, 660 in the GPMT and 123 in the Buehler test alone. In terms of activity
the data encompass 1023 non-sensitisers, 846 definite sensitisers, and 133 substances for
which the classification is equivocal. Notably, in particular data for the last mentioned class,
but also some of the other results, are not usable for all of the modelling exercises ahead due
to different reasons (e.g. if they are out of the applicability domain of the models, which es-
timate physicochemical properties). In addition, a comment is necessary on the distribution
of sensitisers in the LLNA and the GPT. In the former test system more sensitisers than non-
sensitisers are available (57% vs. 43%), whereas the latter animal assays (GPMT+Buehler
combined) offer a bias towards non-active compounds (35% vs. 65%). Information on the
distribution of GHS potency classes can be found in Annex E.4.
From a manufacturer perspective the data set comprises different fields of application,
such as pharmaceuticals and their intermediates, biocides, pesticides, preservatives, fra-
grances, and colors as well as several basic substances of the chemical industry. From
the perspective of an organic chemist the collected compounds are structurally diverse,
which will be delineated in the following paragraphs. The listed percentages denote the
percent of the different functional groups with respect to the overall data set and the per-
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centages do not sum up to 100%, because one compound can evidently exhibit two or
more structural features. Most of the compounds contain acyclic structures (99%), also with
olefinic components (21%), but aliphatic and aromatic rings (29% and 50%) are included,
too, with 9% condensed aromatic systems. Nearly all (94%) of the collected compounds
contain hetero atoms. 17% of the compounds in the data set have halogen atoms and even
some organometals (2% with silicon and tin atoms) can be located. A further investiga-
tion into the oxygen containing compounds reveals alcohols (14%), phenols (12%), acyclic
and non-aromatic cyclic ethers (15% and 4%), aldehydes (5%), ketones (11%), carboxylic
acids (8%), as well as esters (19%) in mentionable amounts. In addition, furanes (0.6%),
COX-groups (0.6%), and carbonates (0.8%) are included in smaller abundance. Next, the
nitrogen containing substances are listed. Among those, major groups are the amines (at
the non-aromatic carbon) with 9% as well as the anilines with 10%, but also more spe-
cial groups occur such as imines (5%), nitriles (3%), azones (3%), and azines as well as
azoles (aromatic six and five ring compounds, both approximately 4%). Additionally, some
more complex aromatic nitrogen compounds are available (3%). In case both of the before
mentioned hetero atoms are combined, i.e. compounds which contain nitrogen as well as
oxygen, acidic amides (9%) and nitro groups (5%) occur in most of these compounds. Fur-
thermore, the date sets comprises carbamates (1%), acylhydrazines (0.8%), carbamides
(0.7%), oximes (0.7%), and isocyanates (0.5%). Concerning the next hetero atom (sulphur),
important groups include thiols (0.6%), sulphides (1.3%), sulphonic acids (3.4%), sulphones
(1%), and aromatic sulphur compounds (1.5%), amongst several more special groups such
as sulphonamide (0.8%). Lastly, the data set exhibits some phosphorous compounds (3%),
whereof the phosphates with 0.7% (with respect to all data) constitute the main group.
A further representation of structural richness, which goes beyond this basic organic
chemistry knowledge, is the occurrence of different chemotypes29 in the data set. One
way to estimate those is given by Yang et al. (2015), who provide a software tool for cal-
culating chemotypes. According to their Chemotyper the data set contains 463 different
chemotypes which is approximately 2/3 of the chemotypes included in the whole EINECS
data set (689 chemotypes) or of all possible chemotypes (729) given by Yang et al. (2015).
Thus, a moderate structural diversity is contained within the data set.
In summary, a structurally and biologically diverse data set was compiled. It is the most
comprehensive evaluated skin sensitisation data base thus far30 and, therefore, can be used
as new reference in assessing alternatives to animal testing. To start with a further data base
centred investigation, the next section analyses the correlations between the different col-
lected regulatory animal testing protocols (and considers their relationship to acute aquatic
toxicity later on).
29 A chemotype is defined as a structural fragment encoded for connectivity (which may extend beyond a single
connected fragment) and the inclusion of additional representations of physicochemical properties of atoms,
bonds, fragments, and electron systems (Yang et al., 2015).
30The even larger data set of Luechtefeld et al. (2016a) has to be mentioned here. It comprises 1,470 sub-
stances with LLNA as well as 2,787 with GPMT outcomes, all of which were automatically extracted from the
ECHA dissemination data base by making the website information machine readable. However, no expert
evaluation took place thus far. In this regard a comparison of the Luechtefeld et al. (2016a) data set and
the data base of this work would be valuable to compare the rate of error of the automatic and the manual
extraction. Obviously, a merging of the data bases would be worthwhile, too.
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4. Correlation Analyses
4.1. Introduction
As outlined in the general introduction, with the large data base at hand a re-assessment of
the different animal assays and an analysis of their correlations become possible. These will
provide insights into the individual tests performances as well as the strengths and weak-
nesses of their use in a regulatory-toxicological environment. Several investigations with
respect to these issues exist already, making it necessary to introduce basic findings to set
the scene for the analysis. Most of recent references are concerned about false classifica-
tions of the LLNA, which can function as a starting point for this introduction.
The classic example of a false positive in the regulatory gold standard/reference of skin
sensitisation testing (the LLNA) is the irritant SDS/SLS (sodium dodecyl/lauryl sulphate;
Montelius et al., 1994; Loveless et al., 1996). Based on its erroneous activity and other irri-
tant measurements it was suggested that irritant substances in general lead to false positive
results in the LLNA (Montelius et al., 1994). Hence, in 2005 it was hypothesised the LLNA
might be even too sensitive in comparison to GPTs (Vohr and Ahr, 2005). However, the pub-
lication was lacking compelling examples for this hypothesis (Basketter and Kimber, 2011)
and analyses of the existing data could not find an elevated prevalence of sensitisers due
to the usage of the LLNA (Cockshott et al., 2006). In addition, several publications showed
that an unspecific lymph node proliferation via irritation is not a general confounder; the ma-
jority of non-sensitising irritants are negative in the LLNA (Basketter et al., 1998; Dearman
et al., 1999; Basketter and Kimber, 2011; for further in-depth information consult McGarry,
2007). Nevertheless, recent investigations suggest that irritation – in particular the release
of the cytokine interleukin 1α (IL-1α) – has still to be regarded as important confounding
factor for the LLNA (Ball et al., 2011). Likewise, a screening of the data included in the
confidential New Chemicals Database (NCD) at the Joint Research Centre (JRC) found a
higher prevalence in the labelling of the risk phrase “R43 may cause sensitisation by skin
contact” when using the LLNA only in comparison to the overall classification rate (GPT and
LLNA; Angers-Loustau et al., 2011). Thus, the claim that the LLNA is too sensitive might be
justified. However, it has to be pointed out that irritation is also a confounder for false positive
results in GPTs, where a re-challenge has been advocated for the purpose of clarification
(McGarry, 2007; Basketter and Kimber, 2007). Overall, the issue of irritation as confound-
ing factor for sensitisation may be more subtle and complex than an either-or-decision, as
irritants are an important cofactor for the enhancement of sensitisation processes (Kligman,
1966; Alenius et al., 2008; Martin, 2016; Basketter and Safford, 2016) and sensitisation may
be masked by an irritating potential of certain compounds (Basketter and Kimber, 2011). In
this regard, it remains presently unknown how much mechanistic overlap exists between the
irritant effect (i.e. the ability to provoke skin inflammation) of sensitisers and pure irritants
(Martin, 2015).
In coherence with the focus on false classifications, several substances and also sub-
stance classes were discovered during the recent years, which give likely (false) positive
signals in the LLNA, but are negative in other assays. Among those are siloxane derivates,
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long chain fatty alcohols, acids, and esters (Basketter et al., 2009a), such as oleic, unde-
cylenic, linoleic, and linolenic acid, alongside with fumaric, aleic, and succinic acid, squa-
lene, and octinol (Kreiling et al., 2008) as well as non-ionic sugar lipid surfactants (Garcia
et al., 2010) and other (non-ionic and anionic) surfactants (Ball et al., 2011). However, in
a very recent publication the question emerged whether several of these compounds are
truly false positive or if reactive impurities/autoxidation products are to blame (Roberts et al.,
2016b). Still, strategies to avoid false classifications are very important (Basketter et al.,
1998, 2009b) and if possible a weight-of-evidence approach should be applied in skin sen-
sitisation assessment (Weed, 2005; Basketter et al., 2006, 2009a; Linkov et al., 2009, 2015;
Rorije et al., 2013).
Turning the point of view, also false negative classifications in the LLNA have been re-
ported. Although they are more important from a regulatory perspective, the false negatives
are less frequently discussed, because of their comparatively rare incidence. One of the
historically first discovered false negative in the LLNA is nickel, which is one of the most
common human contact allergens due to its widespread occurrence (Basketter and Sc-
holes, 1992). Until recently, the cause for this misclassification was unknown, but extensive
research identified a subtle difference (missing histidine residues) in the toll-like-receptors
of mice in contrast to those of humans as responsible factor for the divergent allergenic-
ity (Peiser et al., 2012). Based on the experiences with nickel it was hypothesised that
metal salts in general are problematic for the LLNA, which was disproven by Basketter et al.
(1999b). However, the case of metal salts is more an academic than a regulatory issue,
because most of the sensitising metal salts are well known and regulated (Kimber et al.,
2002b) and may be even unimportant in comparison to the large number of low molecular
weight organic chemicals (Basketter et al., 1999b). For those, only isolated reports exist
with respect to false negative classifications. To the best knowledge of the author of this
thesis, there is no case where a false negative classification of an organic compound per-
sisted consistently and robustly throughout the literature. For instance, the early negative
results for benzocain (Basketter and Scholes, 1992) were falsified later on (Basketter et al.,
1995). Complementary, the false negative classification for neomycin is known since 1994
(Basketter et al., 1994), but none of the recent publications on false classifications (Basket-
ter et al., 2006; Basketter and Kimber, 2007; McGarry, 2007; Basketter and Kimber, 2011)
do mention false negatives – besides nickel.
But the LLNA is not the only test susceptible to classification errors. Likewise, reports
have been published listing erroneous negative classifications of GPTs, such as geraniol,
eugenol, abietic acid, parabens, methyldibromoglutaronitrile, benzalkonium chloride, and
benzocaine, but also false positives results are documented in case of glyceryl thioglycolate,
ethanol, and sulfanilic acid (Basketter et al., 2006; Basketter and Kimber, 2007; Basketter
et al., 2009a; Basketter and Kimber, 2010). However, there is no known systematic devia-
tion with respect to chemical classes and only these isolated substance misclassifications
are reported, possibly indicating handling or interpretative difficulties in the animal assays.
Even more important, while a huge focus is given to a possible positive bias of the LLNA,
the performance of the GPTs is discussed seldom in the recent years, in particular not with
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regard to selectivity and specificity (Basketter et al., 1998; McGarry, 2007). Strangely, less
attention is given to them despite the fact that they have never been formally validated (Bas-
ketter et al., 2008) and in spite of the fact that their data are still used for regulatory purpose,
which may even have a renaissance due to read-across with GPT data.
As a matter of fact, no test is perfect (Basketter et al., 2009b), which is also true for hu-
man data. All measurements incorporate advantages and disadvantages. Nonetheless,
statements about classes which perform worse in a particular test system are of high value,
as they contour the applicability domain (Ku¨hne et al., 2009) of the test and point out where
opportunities and challenges for new methods are. Eventually, defining a proper applicabil-
ity domain for a given (animal) assay may be more important than a focus of “false” positive
and negative outcomes (Roberts et al., 2016b). Thus, it is important to establish chemi-
cal classes that are incompatible in the LLNA (Ball et al., 2011) or other test systems. To
serve this end, this thesis compares not only the LLNA with guinea pig results, but also both
animal test systems with human findings. Because human data are not free from error, it
is important to note that high quality human data are often missing (Basketter et al., 2008;
ICCVAM, 2011). Therefore, to ensure a high level of assessment, only substantially evalu-
ated data from a recent analyses were included, which would even allow a semi-quantitative
evaluation (Basketter et al., 2014).
Independent of the concrete testing system wherein skin sensitisation is evaluated, the
last years unearthed a great amount of knowledge about the underlying sensitisation mech-
anisms, which culminated in the development of a fully mature AOP for this endpoint (OECD,
2012a,b, cf. general introduction). Based on this knowledge, a theoretical prediction of a
sensitising effect is possible, that additionally links skin sensitisation to other endpoints with
a common mechanism of action, such as aquatic toxicity (von der Ohe et al., 2005; Enoch
et al., 2011; Blaschke et al., 2012). Hence, also correlations between acute aquatic toxicity
and skin sensitisation have been investigated.
In conclusion, the scope of this part of this thesis is threefold. Firstly, to reassess the
correlation between the LLNA and GPTs on the basis of a broad evaluated database for skin
sensitisation. Secondly, to evaluate how both animal test systems perform in comparison to
human data. And finally, to map out how the well-known relationship between electrophilicity
and skin sensitisation can support the assessment of this toxicological endpoint and if this
relationship can be exploited for across endpoint predictions.
4.2. Methods
Animal Data. The data from the established data set were utilised (cf. section 3). For this
subpart of the overall thesis, only chemicals were considered which have results for more
than one animal test system and – important to emphasize – where a clear classification
in the respective animal trials is possible, i.e. there is no dissent between two tests of the
same animal testing system, if multiple tests are available. This yielded a data set of 220
compounds suitable for the correlation analysis LLNA vs. GPT.
Human Data. The data set of Basketter et al. (2014) was used as reference for the human
sensitisation potential of a compound. These data were thoroughly evaluated by a team of
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renowned experts, who assigned the compounds to six potency classes (with 1 the most
potent, 5 the least potent, and 6 non-sensitisers), solely based on human information.31 To
ensure a high quality standard it was decided to not include further data (e.g. those given
by ICCVAM, 2011 for which e.g. Roberts et al., 2016a noted quality flaws in the current form
of the data base), as those gave contradictory results to the Basketter data set or would
require further evaluation, which was not possible for several (confidential) studies. Based
on the six potency categories the data set is divided into sensitisers (human category 1 to 4)
and non-sensitisers (human category 5 and 6). This separation is not uncontroversial and
will be discussed later on. Due to the comparison with animal data of this thesis, 90 and 76
compounds were identified suitable for the correlation analysis human vs. LLNA and human
vs. GPT, respectively.
Statistics. The statistical evaluation is based on Cooper statistics (Yerushalmy, 1947;
Cooper et al., 1979). The values are calculated as followed (based on the respective contin-
gency table):
Negative sensitivity = TNF =
TN
TN + FP
(1)
Positive sensitivity = TPF =
TP
TP + FN
(2)
Negative predictivity = NPV =
TN
TN + FN
(3)
Positive predictivity = PPV =
TP
TP + FP
(4)
Concordance = cc =
TP + TN
TP + TN + FP + FN
(5)
Where TP are the true positive, TN the true negative, FP the false positive, and FN
the false negative test results leading to the calculation of the TNF (true negative frac-
tion),32 TPF (true positive fraction), NPV (negative predictive value), PPV (positive pre-
dictive value) and cc (concordance/agreement). The first two parameters describe the ability
of a model33 to detect (in)active compounds in a reference test while the next two values de-
scribe the capability of the model to make proper predictions towards (in)active compounds.
Thus, the former parameters (TNF , TPF ) ask the question: “is the model able to find
(non-)sensitisers, if present” while the latter values (NPV , PPV ) delineate the question:
“how reliable is a prediction of the model”. The last statistical measure (the concordance),
though, is an aggregated parameter measuring the overall model performance.
4.3. LLNA vs GPT vs SAR vs human data
GPT vs. LLNA. The results for the correlation analysis between the LLNA and GPT as well
as the respective statistics are depicted in table 2 and 3. The reasoning for grouping the two
GPT (the GMPT and the Buehler test) together instead of performing an individual analysis
31Note that very recently the data were extended by the same group of experts with a set of 89 fragrance
chemicals (Api et al., 2017), which are not included in this analysis.
32Instead of the term negative sensitivity very often the word specificity is used.
33Not necessarily an in silico model but this can also be animal test, which is a model, too.
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for each test is delineated in Annex B.1. In brief, treating the tests separately leads to the
same overall conclusions.
Given the good accuracy/agreement (= concordance) in previous publications of the GPTs
as predictor of the LLNA (0.89 accuracy, Dean et al., 2001) the observed concordance of
0.75 is unexpectedly low. Looking further into detail of this surprising result reveals that the
GPTs are able to detect non-sensitisers moderately (TNF ) and are able to predict most
sensitisers correctly (good PPV ) for the LLNA, whereas their ability to detect sensitisers
(TPF ) is barely moderate and their predictivity towards non-sensitisers (NPV ) shows even
a poor performance. Thus, the high number of 44 GPT false negatives (or LLNA false
positives), which influence in particular the two last mentioned parameters, lead to the only
moderate overall concordance.
Table 2: Contingency Table LLNA vs. GPT
LLNA (Reference)
Model Non-Sensitiser Sensitiser Total
GPT Non-Sensitiser 61 44 105
Sensitiser 11 104 115
Total 72 148 220
Table 3: Statistics of GPT as predictor for LLNA results
Model TNF TPF NPV PPV cc
GPT 0.85 0.70 0.58 0.90 0.75
TNF = true negative fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative pre-
dictive value, PPV = positive predictive value, cc = concordance.
One possible explanation for the low TPF and NPV would be a biased data set. Some
bias might have been introduced in comparison to previous analyses by the inclusion of data
from publications specifically targeting false positive compounds in the LLNA (e.g. Kreiling
et al., 2008; Ball et al., 2011), but this is only true for a fraction of the used data. Most
new data arise from the ECHA Dissemination database (for 117 of the 220 substances
entries were found there). However, to evaluate the impact of the great number of GPT false
negatives (or LLNA false positives, respectively) further, additional analyses were conducted
in which the potency of the sensitisers as well as borderline results were taken into account.
Still, this did not improve the results sufficiently. For instance, GPT were excluded in which
reactions in the tested animals were seen but which were below the GHS cut-off (30%
reacting animals), to envisage if the regulatory classification threshold is not conservative
enough and leads to false negatives. The purified data set had superior statistics, but the
correlation remained moderate (the number of GPT false negatives was reduced from 44 to
30 tests, which lead to values of 0.67 NPV , 0.78 TPF , and 0,80 cc).
Animal testing systems differ regarding several factors, among those are the tested species,
testing protocols, method of evaluation (quantitative measurement vs. expert judgement),
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and the assessed endpoint (lymph node proliferation as hallmark for the induction vs. skin
reaction after the elicitation phase). From this perspective a concordance of 0.75 might still
be regarded as acceptable. In contrast, for a reliable risk assessment using one of both tests
as possible standalone – as it is stipulated in REACH – a higher degree of agreement would
be required. It seems justified to use a weight-of-evidence approach instead (Basketter
et al., 2006, 2009a), if possible, or to switch to integrated testing strategies (cf. introduction)
in order to avoid bias arising from the usage of one animal test only. The usefulness of the
inclusion of non-animal data in this regard will be illustrated later on.
Anyhow, from a regulatory point of view it is of interest that a positive GPT is a good pre-
dictor (0.90 correct classification) for a positive LLNA result (but not vice versa). Turning the
view upside down – meaning the GPT are considered as experimental standard and, thus,
sensitivity and predictivity are exchanged –, a negative LLNA is a moderate predictor (0.85
correct classifications) for a negative GPT result (but not vice versa). These observations
are reflected in the whole data set by the fact that the GPTs were associated with more neg-
ative results (105 negative out of 220) in comparison to the LLNA which tended to give more
positive than negative outcomes (72 negative out of 220). A possible positive bias of the
LLNA has further implications for the development of new in silico and in vitro assessment
methods, since they are often validated against LLNA data only without regarding GPTs.
These thoughts will be picked up in the comparison against human data.
In addition to the statistically based evaluation, the discrepant data (opposing LLNA and
GPT results) were analysed with regard to their chemical classes and reactivity domains
(Annex B.4).34 There was no special reaction mechanism that gave positive results in the
one test, while being negative in the other. Although many Michael acceptors and pre/pro-
Michael acceptors were false negative in the GPTs (14 out of 22 reactive compounds of the
false negative GPT), this just reflects the fact that most of the included reactive compounds
belonged to this domain (65 out of 131 reactive compounds). Thus, if a target compound
has conflicting results in the animal assays than it is more likely from a statistical perspective
that it is a (pre/pro-)Michael acceptors. The same is true for concordant LLNA and GPT
classifications (e.g. sensitisers for which 43 out of 91 reactive compounds are (pre/pro-
)Michael acceptors). Similar findings have been observed in the other domains. Surprisingly,
also discrimination between reactive and non-reactive compounds brought no further insight,
as both classes are nearly equally distributed in the discrepant data (GPT false positive: 5
reactive vs. 6 non-reactive; GPT false negative: 22 reactive vs. 22 non-reactive).
It is known from literature that long chain fatty acids (e.g. oleic acid, linoleic acid, linolenic
acid, undecylenic acid) and some endogenous substances (i.e. fumaric, maleic and succinic
acid as well as squalene) are classified as positive by the LLNA (Kreiling et al., 2008), while
experiences in humans and GPMT data tend to question the relevance of these results.
There are two possible explanations: The first is the occurrence of autoxidation products
in the LLNA, which is conducted under air exposure, whereas the corresponding negative
GPMT results are obtained under occlusive conditions. The second is a hapten-unrelated
mechanism like an enhanced expression of pro-inflammatory cytokines such as IL-1α, which
34Note, individual substance data of this thesis will be distributed via ChemProp. Interested readers are advised
to please contact the UFZ working group of ecological chemistry for more information.
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stimulates the activation and migration of Langerhans cells and subsequently leads to a
cell proliferation of lymph node cells in the LLNA (Kreiling et al., 2008), but which may be
excluded as irritant effect via expert evaluation and rechallenge in the GPTs.
The first explanation is particularly put forward by Roberts et al. (2016b) for data of three
publications (Kreiling et al., 2008; Garcia et al., 2010; Ball et al., 2011). With regard to
their structure the analysed compounds should be readily autoxidised. However, while Kreil-
ing et al. (2008) and Garcia et al. (2010) did not include autoxidation considerations, Ball
et al. (2011) accounted for this and recorded that autoxidation is possible for their analysed
(non)-ionic surfactants (with reference to Karlberg et al., 2003), but the time of continual air
exposure has to be in the regime of months, which is much longer than the duration of their
experiments. Unfortunately, Roberts et al. (2016b) did not take into account this argument.
In this situation a measurement (or calculation) of the occurrence of autoxidation products
under experimental conditions of the LLNA seems reasonable to bring clarification. After Ball
et al. (2011) excluded autoxidation as explanation they focussed on inflammation processes
mediated by IL-1α. In fact, the occurrence of the pro-inflammatory cytokine coincided with
high stimulation indices in the LLNA and, thus, substantiates this line of reasoning.
As a consequence, it would be interesting to check whether an enhanced expression of
IL-1α also accounts for other reported false positive classes such as polyaminofunctional
siloxanes, long chain fatty alcohols, acids and esters (Kreiling et al., 2008; Basketter et al.,
2009a), as well as non-ionic sugar lipid surfactants (Garcia et al., 2010).35 Furthermore, it
would be valuable to evaluate if the irritants which are negative in the LLNA (Dearman et al.,
1999; McGarry, 2007) are not connected to IL-1α and if the IL-1α expression influences the
weak positive correlation between skin sensitisation and skin irritation potency (Auton et al.,
1995; Basketter et al., 2007b). However, this explanation is probably not universal and,
therefore, risk assessors should be still aware of the fact that there might be substances,
which are on the one hand skin irritants but on the other hand skin sensitisers (Basketter
and Kimber, 2011). In this regard, it would be useful to assess the domain of applicability of
the animal test systems critically (Roberts et al., 2016b).36
Not only the LLNA, also GPTs give false test results, as unsystematically observed for
several substances (Basketter et al., 2006, 2009a; Basketter and Kimber, 2007, 2010). Sim-
ilar to previous studies, the data of this thesis do not reveal systematic misclassifications, but
rather isolated substances tend to give discrepant results in the test systems. However, one
chemical class worth investigating might be (saturated) oximes. They are unsuspicious from
a reactivity point of view (in contrast to unsaturated oximes, see Bergstro¨m et al., 2008), but
lead to discordant results in the animals test systems. Of the oximes in the given data com-
pilation, two are negative in the LLNA, whereas positive guinea pig results (GPMT and/or
Buehler test) are available. On the other side, an additional third oxime is negative in a
reported Buehler test as well as the respective LLNA. More data have to be generated to
35Some of those data are missing in this analysis (and the respective data base), because they are chemically
not well-defined, e.g. one compound is listed as fatty alcohol 1 without any more structural information – in
GHS terminology: it could be an UVCB.
36As recently proposed this may include the vehicle stability to exclude that specific reaction products between
vehicle and test substance lead to false positive results (Watzek et al., 2017). However, more data are
needed to clarify the relevance and validity of this finding.
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reveal if this test system difference is verifiable for other (saturated) oximes and to clarify the
reasons for the deviations. One possible explanation would be the proposed low metabolic
activity of N-hydroxylation in mice of e.g. amid groups (Patlewicz et al., 2010). This offers
the possibility that guinea pigs are able to process the oximes (which are N-hydroxyl-imines)
and activate them in further metabolic phases that are not present in mice. One example
could be the acetylation via NAT (N-acetyl-transferases) that produce nitrenium radicals after
elimination of the acetyl-group from the central nitrogen. Additionally, aminoglycoside antibi-
otics (neomycin, streptomycin) exhibit negative LLNA results, while the respective GPTs are
positive. This is particularly interesting as they are also negative in current in vitro test sys-
tems (Urbisch et al., 2015), but positive human evidence is available. Because human data
are at hand, this compound class will be discussed in the next section.
Last, a brief summary of the potency analysis (Annex B.2-B.4) shall follow. It is concerned
with discerning sensitisers into subclasses with respect to the strength (potency) of the sen-
sitising effect,37 which should be possible for all analysed animal test systems according to
the GHS criteria (see introduction). It should be kept in mind that the GPT were not designed
for assessing potency and their classification is therefore associated with a significant de-
gree of uncertainty in comparison to the LLNA (Kimber et al., 2003; Basketter et al., 2005).
Overall, two important rules could be derived: strong sensitiser in the LLNA will also exhibit
a strong potential in the GPMT (LLNA 1A→ GMPT 1A), but not vice versa, and for moderate
sensitisers a GPMT 1B → LLNA 1B translation is possible, but not vice versa. Therefore,
the moderate sensitisation category (1B) seems to be of little use in the LLNA, which would
fit to the variability analysis of Dumont et al. (2016) and the results of Benigni et al. (2016)
– in both of which category 1A was judged to be more reliable. Moreover, a polarisation
towards extreme categories (Cronin and Basketter, 1994; Basketter et al., 2001a) indicates
that the GPMT is not able to discriminate precisely enough between strong and moderate
sensitisers. There are indications for more rules, but for those the data base was too small.
A more detailed summary is given in Annex B.3.
LLNA and GPT vs. human data. To put the previous findings further into perspective
– also regarding their implications for regulatory risk assessment of sensitisers – it was
subsequently analysed how both animal test systems perform in comparison to their ultimate
prediction goal (human skin sensitisation). Before discussing the test performances it should
be mentioned that the human data set is biased towards positive test results, whereas in
reality only 20-30% of all substances are considered to be sensitisers (Safford, 2008; Keller
et al., 2009; Angers-Loustau et al., 2011; Luechtefeld et al., 2016a).38 This is due the fact
that the absence of evidence of a sensitising effect is not a compelling argument for the
exclusion of a possible sensitisation and, therefore, the availability of robust negative human
data (human category 6) remains rare (Basketter et al., 2014).
Following this line of thought it has to be discussed that other recent publications (Urbisch
et al., 2015 and publications that use their data, e.g. Benigni et al., 2016; Urbisch et al.,
37This is not to be confused with the prevalence, e.g. allergy to nickel – a weak sensitiser – is common, because
of its widespread use (Kimber et al., 2003).
38However, this values are often based on animal results or mixed animal and human data. The data of Luechte-
feld et al. (2016a) offer a great potential regarding the skin sensitisers prevalence, because they include a
large amount of human patch tests.
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2016b) also treated compounds included in the human category 5 as sensitisers, because
some allergic reactions are observed for these chemicals, whereas this thesis considered
them to be non-sensitisers following the original publication of Basketter et al. (2014). The
definition of this class is: “Category 5: a rare cause of contact allergy except perhaps in
special circumstances, e.g. use in topical medicaments” (Basketter et al., 2014). Despite the
occurrence of reactions, the substances in category 5 (and 6) would not classify as human
sensitisers according to regulatory criteria (Basketter et al., 2014) and since this analysis has
the aim to check the regulatory applicability of the test systems, it was decided to classify
them as non-sensitisers. Furthermore, even for substances with the human category 6
occasionally positive human patch tests have been reported (Basketter et al., 2014). Another
piece of evidence pointing into the direction that these substances are not typical sensitisers
is the fact that 22 of the 28 compounds are not reactive according to reaction chemistry
principles, which would invoke further explanations if they were included as sensitisers.
The results as well as the respective statistics for the correlation analysis between the
LLNA, GPT, and human data are depicted in table 4 and 5. Both animal test systems showed
a similar overall performance towards the prediction of human data with a concordance
of 0.84. The similar performance is in good accordance with previous analyses, where
both, the LLNA and GPTs, obtained an accuracy of 0.72 when evaluated against human
data (Dean et al., 2001). The fact that the observed concordance in this thesis is even
higher illustrates the influence of the (high) quality of the utilised human data. However,
the systems differ regarding their predictive details: On the one hand, the LLNA proved to
have an astonishingly low detection capability towards non-sensitisers (low TNF and many
false positive classifications), whereas it was excellently able of detecting sensitisers (very
high TPT ). On the other hand, the predictivity (NPV and PPV ) of the LLNA was high for
both test results. Vice versa, the detection of both, non-sensitisers and sensitisers (TNF
and TPF ), was moderate in the GPTs and while these tests had a high predictivity towards
active compounds (PPV ), they were only moderately able to predict non-sensitisers (NPV ).
As the LLNA is excellently capable of identifying sensitisers (high TPF ) at the cost of mis-
classifying several non-sensitisers, claims in the literature (Vohr and Ahr, 2005) about the
LLNA being too sensitive seem justified. This is even more important, as publications specif-
ically targeting false positives (e.g. Kreiling et al., 2008; Garcia et al., 2010; Ball et al., 2011)
have not been included in this data set, because respective high quality human data are not
available in the publication of Basketter et al. (2014). Hence, this thesis strengthens the sug-
gestion that the GPT should stay available as assessment method for skin sensitisation.39
However, the LLNA is, of course, not always wrong when a negative GPT is available, which
is illustrate e.g. by R(-)-carvone, ethyl acrylate, 1,2-dibromo-2,4-dicyanobutane, or α-amyl
cinnamaldehyde. In contrast to its low TNF (capability of detecting non-sensitisers), from
the perspective of predictivity the LLNA is a moderate to nearly good choice with the pre-
diction of inactive substances (NPV ) being more reliable. This means although the LLNA
misclassifies several non-sensitisers as active compounds (low TNF ), its sensitiser predic-
tions (PPV ) are still valid to a moderate degree, a matter which is often not discussed in the
39As already stated by several authors (Kreiling et al., 2008; Garcia et al., 2010; Ball et al., 2011), who point out
the fact that the LLNA classification might be biased for different substance classes.
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Table 4: Contingency Table Human Data vs. (Animal) Test Predictions
Model Prediction Human results
Model Non-Sensitiser Sensitiser Total
LLNA Non-Sensitiser 16 2 18
Sensitiser 12 60 72
Total 28 62 90
GPT Non-Sensitiser 22 8 30
Sensitiser 4 42 46
Total 26 50 76
SAR Non-Sensitiser 42 7 49
Sensitiser 7 63 70
Total 49 70 119
SAR = structural alerts for reactivity.
Table 5: Statistics of Human Data vs. (Animal) Test Predictions
Modell TNF TPF NPV PPV cc
LLNA 0.57 0.97 0.89 0.83 0.84
GPT 0.84 0.84 0.73 0.91 0.84
SAR 0.86 0.90 0.86 0.90 0.88
SAR = structural alerts for reactivity, TNF = true negative fraction (specificity), TPF = true positive fraction
(sensitivity), NPV = negative predictive value, PPV = positive predictive value, cc = concordance.
literature. In fact, this is related to the distribution of active and non-active compounds in the
data sets, which influences the predictive values but not the sensitivity/true fractions (Pepe,
2003). For the GPTs it is the other way around. They are equally good at detecting sen-
sitisers and non-sensitisers (both, TPF and TNF , are 0.84), but their predictivity is more
reliable for active than non-active substances.
The regulatory consequences are the following: if a substance is positive in a GPT, it is
likely a sensitiser (0.91 PPV ). On the contrary, if a substance is negative in a LLNA, than it
is likely a non-sensitiser (0.89 NPV ).40 In brief:
1. GPMT+ → Sens+
2. LLNA− → Sens−
This is in good accordance with the GPT LLNA correlation analysis, since positive GPT
are usable to infer a positive LLNA result, while negative LLNA results are usable to in-
fer negative GPT. This fits further to the reported higher false positive than false negative
classification rates in the LLNA (Hoffmann, 2015). In addition, from a sensitivity (TNF )
perspective these results imply that the development of alternatives to animal testing solely
40In this regard it should be kept in mind that for several of the LLNA a repetition may lead to a positive outcome
as shown by Dumont et al. (2016).
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based on LLNA data might lead to oversensitive systems (also suggested by Urbisch et al.,
2016b), which mistake non-sensitisers as sensitisers. From a regulatory point of view this
kind of conservative approach is – to a certain degree – wanted. The inclusion of false pos-
itives can be avoided if structural insights or GPT results are taken into account (the latter
can, of course, stem from a read-across). In addition, the predictivity (NPV , PPV ) of the
LLNA is moderate to good and, thus, the LLNA can be taken for the development of new
assessment methods from this perspective.
With respect to GPT, their value in model development is different. On the one side, they
are equally good at identifying (human) sensitisers and non-sensitisers (a moderate 0.84
TNF and TPF ). Thus, it is a disappointing development that only few alternative methods
incorporate GPT data. This might be explained by the fact that the LLNA gives a more easy
to interpret outcome, while the GPTs need a sophisticated degree of expert knowledge for
interpretation. On the other side, their predictivity is barely moderate for non-sensitisers
(0.73 NPV ), which indicates a limited value of negative GPT data for model development.
On the contrary, their PPV is even higher than that of the LLNA and, therefore, positive
GPT data should be taken into account in any case, if available. This is exemplified by
aminoglycosides (see below), which are negative in other test systems (LLNA, in vitro), but
have been recognised human sensitisers for a long time.
At this point a discussion of the great amount of LLNA false positives is necessary. Most
of those (9 out of the 12) belong to the human category 5, which means that at least some
reactions are seen in humans and, thus, the prediction is not completely wrong. However, if
this view is broadened to all substances of category 5 – extremely weak human sensitisers
– only 8 of those (out of 17 available tests) were correctly predicted to be non-sensitisers
by the LLNA. The number of sensitisers and non-sensitisers would be balanced according
to the LLNA (8 sensitisers, 9 non-sensitisers) and this test seems to be not able to give firm
suggestions whether this category should be treated as active or not. The GPTs on the
other side classify only 4 substances as sensitiser (out of the 17 available tests) and only 6
substances have structural alerts (out of 28 predictions). Again this can be interpreted as
the LLNA being too sensitive. This means further that including the category 5 substances
as sensitisers (e.g. to be on the safe side in risk assessment and get all sensitisers) would
weaken the test results for the GPT and the structural alerts, while the results for the LLNA
are not really improved, because 8 additional false negatives arise.
Similar to the investigations in the previous section, additionally the compound classes
and their reactivity domains were analysed. In this regard, the high number of LLNA mis-
classifications for non-sensitisers goes together with the recent intense literature discussion
about false positives, which comprises compounds such as unsaturated lipids, surfactants,
and skin irritants (Basketter and Kimber, 2007; Kreiling et al., 2008; Garcia et al., 2010; Ball
et al., 2011; Roberts et al., 2016b) – further elaborated in the section LLNA vs GPT. Several
substances might be added to the list (Annex B.5).41 However, those do not belong to a cer-
tain chemical class or reaction mechanism. It is interesting to note that reaction chemistry
in form of structural alerts proved valuable in analysing these results, as 2/3 of the LLNA
41Cf. footnote 34.
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false positive substances are non-reactive compounds, showing that these predictions are
suspicious from a mechanistic point of view.
Investigating the false positives in detail a comment is necessary for R(+) limonene and
D,L-citronellol as well as the Michael acceptor α-hexylcinnamic aldehyde. The misclassifi-
cation of the latter (by both animal tests) will be discussed later – alongside with the other
structural alerts which correspond to negative human data. The other two compounds exhibit
an extremely weak or nearly negative human categorisation, whereas in the animal tests ac-
tivity for both compounds was found (LLNA and GPT results for R(+) limonene and LLNA
data for D,L-citronellol are positive). Furthermore, positive in vitro results for R(+)limonene
are available (Urbisch et al., 2015). These conflicting classifications between human and
other data are explainable via the occurrence of reactive autoxidation products, which are
reported for both substances (Karlberg et al., 1992; Rudba¨ck et al., 2014) and are excluded
for the human categorisation as it is based on lowly oxidised material.
Interestingly, both substances, which were classified false negative in the LLNA, are
aminoglycoside antibiotics (kanamycin and neomycin). Literature inquiries unearthed that
also another aminoglycoside antibiotic (streptomycin) is negative in the LLNA, while its re-
action chemistry suggests a skin sensitisation potential. In spite of their complex structure,
all three compounds incorporate structural features which make them capable of undergo-
ing a reaction forming a Schiff base with proteins due to the availability of a free aldehyde
group (streptomycin) or after metabolic activation of the primary amine function (neomycin
and kanamycin). As three aminoglycoside antibiotics are negative in the LLNA, while there
is a long history of human evidence for a skin sensitisation, this class of compounds may
constitute a specific group of false negatives, which is – according to the knowledge of the
author of this thesis – the only known systematic organic false negative classification in the
LLNA so far. It is important to note that two of those (streptomycin and kanamycin) would
have been also negative in modern in vitro approaches (Urbisch et al., 2015) and would
have been overlooked if these tests would be only compared to LLNA data. Their GPT data
on the other hand are positive, further strengthening the value of this test system.
Eventually, to finish the discussion about compound classes, no chemical systematic devi-
ation (neither positive nor negative) could be found for the GPT in relation to the human data.
In contrast to that, 7/8 of the false negative predictions of the GPTs are reactive compounds
and, thus, also for evaluating GPT results, reactivity can play a substantial supporting role.
To further value the chemical reactivity information, the next section analyses the predictive
capabilities of structural alerts encoding for electrophilicity alone and of simple combined
approaches of structural alerts and data from animal testing.
Structural alerts vs. human data. Although the replacement of an in vivo test is likely to
be consisting of a combined approach of different tests such as ITS (cf. general introduction),
it shall be demonstrated how powerful the information of reaction chemistry encoded as
structural alerts alone can be. To this end, all organic chemicals (this means also data where
no animal tests are available) of the human data set were envisaged from a reactivity point
of view,42 assigned to their respective reactivity domains, and the outcome was compared
42Also with the help of the structural alert models of Enoch et al., 2008a, 2011, both implemented in ChemProp
v 6.5, 2016.
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to human data in a binary matter (cf. table 4 and 5; beginning of the previous section).
It becomes apparent that the performance of structural features encoding for electrophilic-
ity obtains roughly the same or better results as the animal trials (with a slightly better con-
cordance). This means, in case of unknown human data structural alerts may be as reliable
as animal tests – at least for the substance classes represented in this data set – and, thus,
render an easy and robust way for an initial risk assessment. For example, if a structural
alert is found in a particular compound, than is likely to be a human (!) sensitiser with about
0.90 (PPV ), which is as good as the regulatory accepted GPTs (0.91 PPV ). Furthermore,
despite the fact that their sensitiser detection rate (TPF ) is lower than that of the LLNA
(0.90 vs. 0.97) it is still high and comes, unlike the LLNA, without the drawback of a poor
capability of detecting non-sensitiser (0.57 TNF in the LLNA). Hence, fewer false positives
can be expected. However, the close relationship between skin sensitisation and reaction
chemistry has been extensively studied (cf. Aptula et al., 2005; Aptula and Roberts, 2006;
Roberts and Aptula, 2008; Karlberg et al., 2008) and, therefore, these results may not be
transferable to other endpoints, where the role of reaction chemistry is less pivotal or less
knowledge is readily available. Furthermore, it cannot be excluded that this result is data set
specific, as all of the compounds with human data are regarded as well studied.
Figure 3: Substances which are non-sensitisers according to current structural alerts for re-
action chemistry, but have positive human data (human categories comprise: 1 =
extreme, 2 = strong, 3 = moderate, 4 = weak sensitisers). 1 = 3,3’,4’,5-tetrachloro-
salicylanilide, 2 = abietic acid, 3 = chlorpromazine, 4 = hexyl salicylate, 5 = linalool,
6 = benzocaine, 7 = aniline.
Seven compounds were misclassified as false negatives comparing human information
and structural alerts (cf. figure 3). All of these substances would have been classed as
sensitisers according to their animal data. Investigating in detail into the misclassifications
reveals current problems of structural alerts for skin sensitisation. Two of the compounds
(abietic acid and linalool) that are falsely predicted to be non-active are not sensitising by
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themselves, but their sensitising effect is mediated by reactive oxidation products (Sko¨ld
et al., 2004; Karlberg et al., 2008). Since the year 2000 several papers concerning the
influence of autoxidation have been released (Karlberg et al., 2008) and albeit current struc-
tural alert models for skin sensitisation (Enoch et al., 2008a) include features accounting for
pre/pro-haptens, autoxidation still is a weak spot. However, the underlying chemical sensi-
tisation mechanism of peroxides,43 is still not completely understood (Roberts et al., 2015).
The inclusion of these compounds via separate alerts for pre/pro-haptens without the need
to predict autoxidation beforehand (as it is conducted in TIMES-SS or modules of the OECD
QSAR Toolbox) is advised – given a sufficient database is available.
Two of the remaining substances, 3,3’,4’,5-tetrachlorosalicylanilide and chlorpromazine,
may be grouped together as they are structurally complex and are both able to induce pho-
tosensitisation via the formation of free radicals. In addition to the human tests, both com-
pounds are positive in the LLNA and 3,3’,4’,5-tetrachlorosalicylanilide is positive in GPTs,
too. The latter compound is structurally complex and hard to categorise according to re-
action chemistry (Roberts et al., 2015). Earlier models discussed an acylating mechanism
of N-aromatic amides in analogy to phenolic esters (Enoch et al., 2008a, 2011), which is
not realistic according to the investigations for this compound class made during this thesis.
3,3’,4’,5-tetrachlorosalicylanilide is a well-known photosensitiser since decades (Vinson and
Borselli, 1966; Roberts et al., 2007b), which raises the question if a comparable mechanism
is at work here, e.g. a radical formation via oxidation. The phenolic hydroxyl group is eas-
ily oxidised to a phenolic radical that is stabilised by the ortho and para chloride groups.
Nonetheless, more data are needed for a sophisticated evaluation (Roberts et al., 2015).
The same is true for chlorpromazine (alongside with other phenothiazines), for which pho-
tosensitisation mediated via radicals is well-known (Chignell et al., 1985). This mechanistic
observation drives the hypothesis that also for this compound the radical formation is possi-
ble without the need of UV-light activation, e.g. by oxidation. The hypothesis goes together
with the finding of liver toxic effects for phenothiazines, where UV-light certainly is not in-
volved. Although the exact mechanism is not known, the protein reactivity of cationic phe-
nothiazine radicals is discussed on the one side (Cruz et al., 2010; Hewitt et al., 2013). On
the other side, the formation of a Michael acceptor after metabolic activation (to 7-hydroxyl
metabolites) is suggested by other references (Wen and Zhou, 2009). Which of both mech-
anism is more likely for hepatotoxicity is presently not known. However, the latter authors
confirmed the occurrence of (pro)reactive hydroxyl metabolites and GSH-adduct-formation
via mass spectrometry, which fits well to existing knowledge on skin sensitisation – and
therefore, the mechanism is further delineated in section 7 (figure 26).
The next compounds to discuss are aniline and benzocaine, both of which are structurally
quite simple and possess an aromatic ring with an amine function attached. In animal testing
they give varying results with a positive tendency. Aniline is active in most LLNA (but also
negative tests have been reported) with a weak lymph node proliferation potential and gives
weak reactions in most GPMT (but also strong reactions have been reported). These data
result in the consensus that aniline is a weak sensitiser (cf. ICCVAM, 2011). For benzocaine
43These are discussed as active agents after autoxidation, but also epoxide formation is considered
(Bra˚red Christensson et al., 2006; Karlberg et al., 2008, 2013; Roberts et al., 2015).
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several positive as well as negative LLNA and GPT have been reported, which mark this
substance as more ambiguous, but overall it should be judged as sensitiser (cf. ICCVAM,
2011). The varying situation in animal trials already indicates that single NH2-substituted
aromatic amines are complex to assess. They are – in contrast to aromatic diamines and
aminophenols, which are definitely sensitisers (Aptula et al., 2009) – not sensitisers in gen-
eral. Examples included in this data set comprise 4-aminobenzoic acid, sulfanilic acid (false
positive in GPTs), 2-nitroaniline, and sulfanilamide, all of which have an additional electron
withdrawing group added to the aromatic system (what is true for benzocaine, too). This
observation fits to a recent investigation, wherein a radical formation or autoxidation mech-
anism has been proposed as sensitisation pathway for these compounds, based on the
observation that sensitising single NH2 substituted aromatic amines have a higher EHOMO44
than non-sensitising compounds of this class, where the EHOMO is lowered e.g. by the in-
troduction of electron withdrawing groups (Ouyang et al., 2014). However, more data on the
mechanism of these chemicals (especially on benzocain) should be generated for further
conclusions and during investigations of this thesis the results of Ouyang et al. (2014) could
not be verified for a large amount of further substances (cf. Annex E.6).
The last false negative misclassification is hexyl salicylate. This compound is discussed
in recent publications (Api et al., 2014; Safford et al., 2015; Roberts et al., 2015), where
it is stated that the LLNA result of hexyl salicylate appears to be anomalously strong and
despite the fact that salicylate esters are able to react as acyl transfer agents they only exhibit
weak reactivity. Likewise, other salicylate esters are considered to be non-sensitisers. For
instance, negative GPMTs are reported by Cronin and Basketter (1994) for amyl salicylate,
PG salicylate, and methyl salicylate (and contradictory observations were made for the latter
in several LLNAs). However, it was reported that no reactions were seen in humans for hexyl
salicylate (Api et al., 2014; Roberts et al., 2015), which is contradictory to the classification in
this human data set. Due to the fact that also negative GPT results are at hand, it is advised
to recheck the human classification of hexyl salicylate and decide if it should be grouped
together with benzyl and methyl salicylate in category 5. Lastly, a LLNA GPT difference
exists for this compound class, further discussed in the structural alert section.
Concerning false positive classifications (cf. figure 4), nearly all of them belong to the hu-
man category 5, which means that at least some reactions were seen in humans and, thus,
the categorisation is not totally wrong (as it would be for the human category 6). Two of the
seven substances (vanillin and benzaldehyde) are aromatic aldehydes (Schiff base form-
ers) and are negative in the LLNA. Both are in principle reactive, but for aromatic aldehydes
substitution patterns at the benzyl ring are very important for the actual reactivity (Patlewicz
et al., 2001; Roberts et al., 2006; Roberts and Aptula, 2015), which should be incorporated
into structural alerts (no specification is given e.g. in Enoch et al., 2008a) to increase their
performance and, thus, eliminate these misclassifications.
Two further compounds (benzyl benzoate and benzyl salicylate) are aromatic acetates
with a further aromatic ring attached to the acetate-oxygen via an intermediate aliphatic
carbon at which a SN2-like mechanism can induce a haptenation (Enoch et al., 2011). The
44EHOMO is the energy level of the highest occupied molecular orbital, i.e. the energetically highest orbital which
is occupied by electrons, a parameter from theoretical chemistry.
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Figure 4: Substances which are sensitisers according to current structural alerts for reaction
chemistry, but have negative human data (all are classified in the human category
5 = very weak sensitisers, except 7 which is a non-sensitiser with human category
6). 1 = benzyl benzoate, 2 = benzyl salicylate, 3 = α-hexylcinnamic aldehyde, 4 =
vanillin, 5 = benzaldehyde, 6 = pentachlorophenol, 7 = hexachlorophene.
alert is based on positive LLNAs (Gerberick et al., 2005; Kern et al., 2010) and additional
negative GPMT are available (for which the data for benzyl salicylate were excluded from this
analyses, because they are ambiguous). As the human data are negative from a regulatory
point of view, this borderline situation indicates that relying solely on the LLNA might have
led to the development of oversensitive alerts. Nevertheless, care should be taken as the
human category is 5, which means that some allergic reactions are observed and, thus, the
alert may be valid. To substantiate the respective alert and to improve its reliability, future
models should include further test data besides the LLNA (e.g. in chemico, GPT).
A little bit surprising are the negative classifications of pentachlorophenol and α-hexyl-
cinnamic aldehyde. The first is weakly reactive in a reported LLNA and principally able to
sensitise via a SNAr reaction. This reaction might be possible on paper looking on the parent
structure, but in situ the OH group of the phenolic compound should be dissociated. The
resulting negative charge on the oxygen atom of the phenolate anion should deactivate the
aromatic system, because it is able to give electron density into the aromatic unit (the anion
exhibits a positive mesomeric (+M) and positive inductive (+I) effect). Thus, the electrophilic-
ity of the compound decreases. The second compound gives a weak to moderate response
in the reported LLNAs, is additionally positive in both GPTs, and has the potential to react
as Michael acceptor. At least in the second case the weight-of-evidence clearly suggests
that this compound is a sensitiser and, hence, the human class should be rechecked.
The last substance, hexachlorophene, is categorised as clear non-sensitiser (human cat-
egory 6), has no additional animal data, and is in principle capable of reacting according to
a SNAr mechanism. However, the activation of the chlorine atom via an ortho and a para
chlorine is rather weak in comparison to other SNAr reactants, such as dinitrochlorobenzene
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(DNCB). Furthermore, the presence of the second substituted benzene ring in ortho-position
to the activated chlorine hinders the reaction sterically. In this case, further data on the re-
action chemistry would be necessary to clarify the misclassification.
Combined Assessments. As mentioned, information emerging from theoretical chem-
istry can not only be used as starting point for hazard assessments, but is in addition useful
to support already available evidence (also in vitro, as exemplified in Urbisch et al., 2015).
Because regulatory decision making depends not only on one test system, but more often
on a weight-of-evidence approach (Weed, 2005; Basketter et al., 2009a; Linkov et al., 2009,
2015), the following paragraphs present the results of a simple combined assessments of
the models towards human skin sensitisation. In these assessments data were excluded for
which the respective tests lead to conflicting results. Thus, only those data with a coherent
outcome in both prediction systems were evaluated. The results are shown in table 6 and 7.
Table 6: Contingency Table Human Data vs. Combined Test Predictions.
Model Predictiona Human resultsb
Model Non-Sensitiser Sensitiser Total
LLNA+GPT LLNA−/GPT− 10 0 10
LLNA−/GPT+ 1 1 2
LLNA+/GPT− 3 6 9
LLNA+/GPT+ 3 41 44
Total 17 48 65
LLNA+SAR LLNA−/SAR− 17 0 14
LLNA−/SAR+ 2 2 4
LLNA+/SAR− 8 7 15
LLNA+/SAR+ 4 53 57
Total 28 62 90
GPT+SAR GPT−/SAR− 21 1 22
GPT−/SAR+ 2 5 7
GPT+/SAR− 2 6 8
GPT+/SAR+ 1 38 39
Total 26 50 76
a = + predicted sensitiser in labelled tests, − predicted non-sensitiser in labelled tests.
b = grey data have been excluded from further analysis and are listed for the sake of completeness.
SAR = structural alerts for reactivity.
The simple combinations lead to improved results for every part of the statistics. Those
were good (over 0.90) for the predictive values (PPV and NPV ) and the detection of sen-
sitisers (TPF ) for each combination. However, while the combination of the LLNA with
another test only lead to moderate results for the detection of non-sensitisers (about 0.77
TNF ), because of the poor performance of the LLNA in this respect, intertwining GPT data
and structural alerts was also fruitful for this parameter.
30
Table 7: Statistics of Human Data vs. (Animal) Test Predictions
Modela TNF TPF NPV PPV cc
LLNA+GPT 0.77 1.00 1.00 0.83 0.94
LLNA+SAR 0.78 1.00 1.00 0.93 0.94
GPT+SAR 0.95 0.97 0.97 0.97 0.97
a = compounds with discrepancies between the test systems have been excluded from the statistics. SAR
= structural alerts for reactivity, TNF = true negative fraction (specificity), TPF = true positive fraction
(sensitivity), NPV = negative predictive value, PPV = positive predictive value, cc = concordance.
Therefore, care should be taken if only animal data are used in risk assessment, as the
LLNA GPT combination is only moderately able to detect non-sensitisers and is even worse
than the use of GPTs alone. Otherwise – similar to the LLNA SAR combination – sensitisers
are detected perfectly by this combination, which is more important from a regulatory point
of view. Likewise, both LLNA combinations make reliable predictions, especially they predict
a non-sensitiser (NPV ) – though the sensitiser prediction (PPV ) of the LLNA GPT com-
bination is moderate. Additionally, again the value of the GPT was demonstrated, as they
render the best way to detect non-sensitisers in case they are enhanced by easily obtainable
structural alerts. Hence, for a reliable identification of non-sensitisers a GPT should be con-
ducted, ideally taking into account reaction chemistry information. However, as only few very
robust data for human non-sensitisers are available (Basketter et al., 2014) this conclusion
should be considered as preliminary. Eventually, it is intriguing to point out that the inferior of
the both predictivity parameters (PPV for the LLNA and NPV for the GPT) is significantly
– over 10% – enhanced by the inclusion of the structural alerts, showing the great value of
reactivity information in compensating the weaknesses of the respective animal test.
From these observations the following regulatory heuristics can be inferred, given that
data from animal tests (GPT or LLNA) and an analysis concerning the reactivity of a target
compound are available: If a positive GPT is available (ideally with a structural alert), then
the respective compound should be considered a sensitiser. If a negative LLNA is at hand
(and no structural alert is found), then a compound should be classified as non-sensitiser. In
case, a negative GPT or positive LLNA is available and these are in accordance with reaction
chemistry, the assessed compound should be categorised as non-sensitiser or sensitiser,
respectively. But, if the reaction chemistry suggests a conflicting classification, further tests
should be conducted. A further test is in particular sensible, if a negative GPT is available in
combination with a structural alert and, thus, a potential sensitiser could be missed.
Concluding remarks. Surprisingly, when evaluated on a bigger data set, the regulatory
relevant test systems LLNA and GPT agree to a much lesser degree (cc = 0.75) than shown
in the original validation exercise. Hence, a regulatory one to one exchange of GPT and
LLNA is not sensible according to current data, which strengthens weight-of-evidence eval-
uations and should fuel further investigations into classification differences. Concerning the
discordant outcomes future research should focus on the role of the cytokine IL-1α or the
domain of applicability of the animal test systems.
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However, both animal test systems agree moderately (cc = 0.84) with the best available
human data, despite individual drawbacks. Overall, if a substance is positive in a GPT, it is
likely a human sensitiser; if a substance is negative in a LLNA, than it is likely a human non-
sensitiser. Regarding alternatives to animal testing, structural alerts for electrophilicity have
similar statistics as the animal trial and should support future risk assessments. Particular
problems at the moment seem to be the formation of autoxidation products45 and currently
insufficiently described reaction mechanisms involving radicals. Still, reaction chemistry en-
coded as structural alerts is notably valuable in analysing the animal results, as 2/3 of the
LLNA false positive substances are non-reactive compounds and 7/8 of the false negative
predictions of the GPTs are reactive compounds, showing that these predictions are suspi-
cious from a mechanistic point of view. Thus, intertwining structural alerts and animal data
lead to significantly improved statistics, in particular if GPT were used. Still, skin sensitisa-
tion is a field of intensive research and much knowledge about the underlying mechanisms
is readily available, which might not be true for other endpoints. Furthermore, high quality
human data compilations for other toxicological endpoints are often missing. Hence, the re-
sults of this correlation analysis should be further substantiated by additional investigations.
4.4. Sensitisation vs. aquatic toxicity
Besides the correlations between the different animal test systems for assessing skin sen-
sitisation it is interesting to analyse whether a correlation across different biological taxa
and toxicity endpoints is observed to facilitate a mutual information exchange. In partic-
ular, genotoxicity/mutagenicity and acute aquatic toxicity but also respiratory sensitisation,
hepatotoxicity, and irritation are (at least partly) based on similar mechanisms as skin sen-
sitisation (cf. Hulzebos et al., 2005; Schultz et al., 2006; Aptula and Roberts, 2006; Alenius
et al., 2008; Dearman et al., 2013; Enoch et al., 2010, 2011; Blaschke et al., 2012; Hewitt
et al., 2013; Patlewicz et al., 2013a; Mekenyan et al., 2014; Patlewicz et al., 2014b; Basket-
ter et al., 2017; amongst others), which means they concern the addition of an electrophile
to nucleophilic groups of molecules in the organism from a mechanistic point of view. Of
course, they differ regarding the specifications, e.g. the targets in genotoxicity are nucleid
acids (and thus primarily hard nucleophiles) or the environment in aquatic toxicity is water
while most chemicals in skin sensitisation testing are applied in more hydrophobic vehicles.
However, taking into account endpoint specific differences it should be possible to correlate
the different toxicity endpoints to a certain degree if they are really based on the same mech-
anism of action. This would allow the usage of information from one system (e.g. aquatic
toxicity) to derive a conclusion regarding the other (e.g. sensitisation) within the framework
of the respective testing protocols – meaning taking into account solubility issues etc.
The usefulness of utilising genotoxicity in the manner of an ITS for skin sensitisation was
already demonstrated (Wolfreys and Basketter, 2005; Patlewicz et al., 2010; Mekenyan
et al., 2010; Patlewicz et al., 2014b; and references therein). There is a marked overlap
between the underlying chemical mechanisms of both endpoints in form of several com-
45Although, in Roberts et al. (2016b) “autoxidation alerts” are stated, it is not known to the author of this thesis
in which (publicly available) structural alert model these autoxidation alerts are included.
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mon structural alerts for skin sensitisation and mutagenicity46 (Mekenyan et al., 2010) and a
concordance of 0.68 exists between the LLNA and in vitro mutagenicity tests47 without con-
sidering mechanistical underpinnings (Wolfreys and Basketter, 2005). With the same data
an enhancement of up to 0.88 can be obtained via excluding mechanistic outliers, adding
further literature information, and taking into account differences in skin and liver metabolism
(Patlewicz et al., 2010). Hence, sensitisation is likely if positive mutagenicity data are avail-
able, but negative mutagenicity results can not be used to infer that a particular compound
is a non-sensitiser, which is nevertheless a valuable addition for skin sensitisation assess-
ment (Patlewicz et al., 2010, 2014b). Eventually, Mekenyan et al. (2010) even propose to
use mutagenicity information (in an ITS) prior to any (!) initiation of in vivo skin sensitisation
tests.
As the knowledge on the before mentioned relationship is already advanced, the work
of this thesis is more concerned with the question if acute aquatic toxicity information can
be included in principle into skin sensitisation assessment, because of a shared mecha-
nistic basis (Aptula and Roberts, 2006; Enoch et al., 2011). Currently, three publications
are available which demonstrate the relatedness of both endpoints on the basis of concrete
experimental results (Koleva et al., 2008; Zhang, 2015; Ebbrell et al., 2017). All utilised
the 50% growth inhibitory concentration (IGC50) of Tetrahymena pyriformis as measure for
aquatic toxicity (either directly or as toxicity enhancement)48 and take LLNA EC3 values as
measure for skin sensitisation for different sets of compounds (Michael accceptors in Ebbrell
et al., 2017, Michael acceptors and Schiff bases in Koleva et al., 2008, and data from all do-
mains in Zhang, 2015). Except for Zhang (2015) the authors do not give suggestions for the
strength of the association between both toxicity endpoints. Although, notably this was not
the aim of those publications and the data sets are limited from a statistical perspective with
14 α,β-unsaturated compounds tested in both test systems in Koleva et al., 2008 and 4 in
Ebbrell et al., 2017. On the contrary, Zhang (2015) analysed 41 chemicals and obtained an
overall r2 of 0.6149 for his quantitative analysis, which could be further improved by including
reactivity domain information. Still, the discrimination between the 41 active and further 13
non-active compounds was problematic. Hence, there is a need for further investigations.
In contrast to skin sensitisation, which incorporates only one mode of action (sensitisa-
tion), in acute aquatic toxicity several modes of action occur (Aptula and Roberts, 2006).50
In general, three modes are differentiated. These are unpolar narcosis, polar narcosis,
and reactive toxicity. The first mode of action (and sometimes also the second) is based
on physicochemical non-specific interactions (approximatable by the Kow) between the tar-
get compound and membranes, albeit the exact site of action has not been determined
46In fact, only one alert for DNA reactivity – aliphatic nitro groups– was not applicable to skin sensitisation, while
22 are specific for the latter endpoint (Mekenyan et al., 2010).
47Concretely, the bacterial reverse mutation test (e.g. ames test) and the in vitro chromosome aberration assay
according to OECD Guidelines 471 and 473, respectively.
48With the addition of further data, e.g bacterial toxicity and reactivity of test chemicals towards glutathione in
Zhang (2015) and the latter also in Ebbrell et al. (2017).
49With a high standard error of estimate of about 0.69, primarily attributable to SNAr reactants.
50The same is true for skin irritation for which the details are yet to be unearthed (Worth et al., 2014), though
reactive toxicity seems to play a role in some cases (Lisby and Baadsgaard, 2006; Hulzebos et al., 2005;
Alenius et al., 2008; cf. section 5).
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yet (Aptula and Roberts, 2006; Verhaar et al., 1992; Russom et al., 1997). The last mode,
reactive toxicity, involves – like skin sensitisation – the covalent binding to proteins of the
aquatic target organism (Hermens, 1990; Lipnick, 1991; von der Ohe et al., 2005; Bo¨hme
et al., 2010; Blaschke et al., 2012) and leads to an enhancement of the hazardous effect.
Hence, in acute aquatic toxicity there is no direct differentiation into active (toxic) and non-
active (non-toxic) compounds, because each chemical can lead to an adverse effect in the
organism. Nonetheless, as narcotic (Kow-dependent) effects occur always and, thus, consti-
tute the minimal toxicity of an organic compound, they are considered as “baseline toxicity”.
Deviations from this expected mode of action, i.e. reactive toxicity, which add an additional
toxic effect – that moves the value of toxicity away from the Kow-calculated baseline – are
labelled as “toxicity enhancement” (difference to the baseline is quantified) or “excess tox-
icity” (everything beyond the baseline). To ensure up-to-date predictions the compound’s
chemoavailability should be included (Mulliner and Schu¨u¨rmann, 2013; Bo¨hme et al., 2016).
The following analysis made use of the large knowledge foundation on aquatic toxicity
within the UFZ working group of environment chemistry (Schu¨u¨rmann et al., 2011; Ku¨hne
et al., 2013; Ost, 2013). There, three aquatic toxicity data bases are available concern-
ing the toxic effects in fish (Pimephales promelas, fathead minnow), Daphia magna, and
Tetrahymena pyriformis. For all of those the correlations regarding the two sensitisation
test systems LLNA and GPT were analysed. This section lists the final statistics in table 8.
Some more details can be found in Annex B.6. The given statistics are based on two pre-
conditions: weak (EC3>10%) LLNA sensitisers were excluded as well as substances, for
which the toxicity enhancement was within a given uncertainty range (values between 0.5
and 1.5 – meaning substances with a toxicity enhancement above 1.5 were considered as
excess toxic and below 0.5 were treated as baseline toxic/narcotic).
Table 8: Concordances of skin sensitisation vs. toxicity enhancement
LLNA GPT
Model cc N % cc N %
Fish 0.74 57 53 0.77 93 72
D. magna 0.63 38 61 0.82 54 64
T. pyriformis 0.79 66 49 0.76 82 58
cc = condordance, N = number of compounds, % = percentage of the overall data set
Although the number of predicted compounds decreases substantially (up to 50%) in both
skin sensitisation testing systems, the overall concordance of the systems is moderate (typ-
ically 0.75) taking into consideration that two totally different endpoints and taxa are com-
pared. Moreover, under the given conditions it is even as good as the basic GPT LLNA
correlation. Thus, data from aquatic toxicity should be exploitable to support skin sensiti-
sation assessment – e.g. in a weight-of-evidence approach. Interestingly, despite the fact
that weak LLNA sensitisers were excluded as possibly hard to predict (because the LLNA is
judged as very – if not too – sensitive, see above) and, therefore, the LLNA predictions were
already improved, the less optimised GPT-prognosis still lead to more accurate predictions
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(higher concordance, except for T. pyriformis). Furthermore, in the GPT more substances
could be used for the evaluation with respect to the available data, because no GPT exclu-
sion took place.
With regard to this data, it has to be accentuated again that the GPT are useful tools in
risk assessment and may even be more useful than the LLNA in the context of forming a
coherent picture of the hazard profile of a chemical (with animal data). On the other side,
because the correlation of the LLNA with aquatic tests is weaker the question arises, if this
skin sensitisation test offers additional information not represented in the aquatic toxicity. To
investigate this, it is reasonable to establish reference points outside of the animal testing,
i.e. using predictions from alternative test systems (e.g. chemoassays as in Zhang, 2015).
Evidently, because the endpoints share the same mechanistic basis this should also be true
for the utilised alternative test system.
In contrast, it should be considered that the correlated toxicity enhancement is Kow-
dependent (Bo¨hme et al., 2016), whereas skin sensitisation offers a more complex rela-
tionship concerning the Kow – meaning some reactivity domains are not Kow-dependent
while for others domains its influence is inverted (different algebraic sign) in comparison to
toxicity enhancement/chemoavailibility (cf. discussion on hydrophobicity in section 5.4). This
fact questions the simple correlation between toxicity enhancement and skin sensitisation,
although there are still open question with respect to the influence of the Kow on the latter
endpoint. Hence, the influence of the Kow has to be investigated further. In this regard
the mechanistic domains should be taken into account in the follow-up correlation analysis,
because of the different Kow-influences in the domains (again cf. section 5.4.).51
This will also be helpful from another perspective. The present analysis is missing a de-
tailed investigation concerning the compound classes and chemical mechanisms due to time
constraints.52 It is likely that some of the remaining false negative predictions (concerning
the LLNA and the GPT) can be excluded via taking into account the reaction chemistry of
the substances (as seen for the mutagenicity-sensitisation-analysis in Patlewicz et al., 2010)
or figure in calculations on other effects such as hydrolysis, which is much more important in
aquatic toxicity (because skin sensitisation testing often takes place in organic solvents or is
conducted with pure substances) and can lead to a decrease in toxicity due to a minimised
availability of the active compounds. This would also go beyond the current protein binding
alerts (e.g. Enoch et al., 2011), which just regard the alerts both endpoints have in common,
but do not take into account the differences to a sufficient degree.
As varying testing conditions are important in general, an analysis shall follow concerning
the role of biovailability in skin sensitisation to map out the influences of the organism-based
(physicochemical and biological) environment, which is encountered during (animal) testing.
In other words, the role of toxicokinetics and exposure conditions is assessed in the following
chapter of this thesis.
51This was done by Zhang (2015). However, no significant influence of the Kow was observed in any of the
domains, which could improve the relationship between toxicity enhancement and skin sensitisation potency.
This was attributed to the high intercorrelation between hydrophobicity and the toxicity enhancement. More
research is required.
52This analyses took place on a short term base at the end of the doctoral thesis.
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5. Bioavailability
5.1. Introduction
The idea that the penetration of the skin barrier is an important hurdle for the development
of dermal toxicological effects and influences their severity has a long tradition. Without the
skin the human body would suffer a substantial loss of water (resulting in dehydration) and
it is considered a key barrier to minimise the impact of exposures to, for example, micro-
bial pathogens and chemicals (Hadgraft, 2001; WHO, 2006). Thus, it is not surprising that
dermal absorption53 makes up the first key step of the sensitisation AOP. Several models
exist to estimate the amount of a chemical that enters the body after passing the skin bar-
rier and is, therefore, able to evoke adverse or beneficial effects (overviews can be found
in Wilschut et al., 1995; Moss et al., 2002; Fitzpatrick et al., 2004; Geinoz et al., 2004; Lian
et al., 2008; Basketter et al., 2007c; Guy, 2010; Dumont et al., 2015; Tsakovska et al., 2017).
Most of those models focus on properties like hydrophobicity or water solubility to approxi-
mate the physicochemical distribution of the chemical under investigation between the cell
membranes, proteins, and cytoplasma of the skin cells as well as different skin layers (Moss
et al., 2002; Geinoz et al., 2004; Tsakovska et al., 2017).
The layered structure of the skin is important to understand in this context, because it de-
fines which hurdles a compound has to overcome to reach the deeper skin (dermis) or other
targets such as nucleophilic residues of skin proteins. As depicted in figure 5, above the
dermis rests the epidermis – the upper part of the skin – which is characterised by a state of
increased keratinisation54 (cornification) throughout its layers. To build this layered structure
the viable skin cells (also called keratinocytes) are released from the lowest single cell layer
(stratum basale) and migrate slowly through further distinct states/layers (stratum spinosum,
stratum granulosum, stratum lucidum) to the top (WHO, 2006). During this process the skin
cells lose their nuclei and cytoplasm (they shrink) and emit more and more cellular lipids to
the extra-/intercellular space. Hence, with ascending layer the content of water decreases
and the content of lipids increases. This creates a continual change in hydrophobicity un-
til finally the stratum corneum is reached. It is the outmost layer, which consists of 85%
dead, highly keratinised keratinocytes and 15% intercellular lipids (dry mass) that form a hy-
drophobic and mechanical barrier against adverse environmental influences (Schaefer et al.,
2006). Besides the keratinocytes several further structural features and cells are confined
within the skin such as hair follicles, sudoriparous (sweat) glands, melanocytes, Langerhans
cells, and Merkel cells (cf. textbooks of biology for their functions or in brief: WHO, 2006).
Lastly, the skin incorporates several extrahepatic metabolic enzymes (Smith Pease et al.,
2003; Schaefer et al., 2006; Gundert-Remy et al., 2014). The composition of the phase
I and II enzymes is different from those found in the liver with a stronger emphasis on the
phase II enzymes (with different levels expressed in the dermis and the epidermis – the latter
contains more metabolic enzymes), the skin enzymes exhibit generally a lower constitutive
activity as their hepatic counterparts, and it is controversially discussed whether the well-
53In medicine also the term resorption is used; chemically correct is absorption – an uptake into a volume.
54A term derived from keratin, the main protein of the skin. It is key for cornification and is included in the family
of fibrous structural proteins.
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Figure 5: Layers of the skin
regarded cytochrom P450 monooygenases (CYPs) contribute signiﬁcantly to the cutaneous
metabolic activity or not (Bergstro¨m et al., 2007b; Go¨tz et al., 2012a,b; Ja¨ckh et al., 2012;
Wiegand et al., 2014; Patlewicz et al., 2016).55
In general, entering the deeper skin layers is driven by different partition processes. A
brief overview on partitioning in the context of skin permeability – Fick’s ﬁrst law, the Potts
and Guy equation (Potts and Guy, 1992; Guy and Potts, 1993), Abraham parameters – is
given in Annex C.1.56 It is important to highlight that most models (e.g. Guy and Potts,
1993; Abraham and Martins, 2004; Guy, 2010) estimate the repeated partition and diffusion
across the epidermis by modelling the stratum corneum water partition coefﬁcient (this will
be discussed later, also noticed brieﬂy in Moss et al., 2002).
Overall, the step of a compound penetrating the ﬁrst layer, the stratum corneum, is con-
sidered as most important for its bioavailability (Hadgraft, 2001; Moss et al., 2002; WHO,
2006; Schaefer et al., 2006; Tsakovska et al., 2017). But also other effects have to be taken
into account such as volatility (estimated by e.g. the vapour pressure), which may prevent
the assessed compounds from even entering the outmost skin layers due to the competing
distribution into the air (Patlewicz et al., 2014c). However, this does not a priori mean that
more volatile chemicals are not able to penetrate to a signiﬁcant degree (Guy, 2010).
As a corollary to the fact that the amount of a chemical which is able to penetrate through
the skin layers is inﬂuenced by its physicochemical properties the concept of exclusion rules
was developed. Their general idea is straightforward: If a certain limit value is exceeded,
than a deﬁned effect does not occur, because the amount a particular compound entering
55In this regard it is relevant to note that CYPs deteriorate rapidly ex vivo and are not only contained within
keratinocytes but in particular in hair follicles and sebaceous glands (WHO, 2006) and depend on cell culture
conditions (Wiegand et al., 2014).
56However, it should be mentioned that the ﬂux over the skin barrier may not be the only determining factor for
bioavailability and also a high residence time in the skin is discussed to be an important parameter (Basketter
et al., 2007c).
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the target site would be too small (if it enters at all) to cause an effect. For example, if
a molecule is too big to pass the skin barriers (e.g. complex polymers or large proteins),
than it will not be able to pass into deeper skin layers and evoke effects there. So far it is
known that for skin and eye irritation and corrosion physicochemical limit values exist in the
form of exclusion rules developed by the BfR (Federal Institute for Risk Assessment), which
comprise a set of 30 limit values for different compound classes (Gerner et al., 2000b,a;
Zinke et al., 2000; Gerner et al., 2004b; Walker et al., 2005). They have been reviewed
and independently validated by the ECB (European Chemical Bureau), who confirmed their
soundness (Rorije and Hulzebos, 2005; Tsakovska et al., 2005). Their success story is
not only a scientific one, but they constitute an important decision support system (DSS) in
regulatory toxicology and they are implemented in integrated testing strategies (Hulzebos
and Gerner, 2010) or well-regarded computer programs like the OECD QSAR Toolbox (v
3.2, 2013) as well as ChemProp (v 6.5, 2016; Schu¨u¨rmann et al., 1997).
In case these limit values are general rules for penetration they should not only account for
the endpoint they were developed on, but also work for related ones like skin sensitisation or
dermal toxicity. To figure out if the physicochemical exclusion rules for skin irritation (Gerner
et al., 2004b; Walker et al., 2005) are merely endpoint specific or constitute general rules,
this thesis analysed the ability of the BfR rule system to discriminate between skin sensitis-
ers and non-sensitisers with the data at hand. Furthermore, because the original working
group was not able to improve or even verify their exclusion rules for skin sensitisation for
their data base (Gerner et al., 2004a) this thesis investigates further whether new rules can
be derived from the collected data and if new properties can be included, which had not been
analysed before, e.g. LSER (linear solvation energy relationship) or Abraham parameters,
respectively (Abraham and Martins, 2004) – which model the physicochemical distribution
properties between two phases more accurate than the log Kow. In this regard it has to
be taken into account that different limit values for skin penetration have been proposed
already.57 Widely known is the 500 Da rule for molecular weight as sensitisation cut-off cri-
terion (Bos and Meinardi, 2000; Smith Pease et al., 2003; Gerberick et al., 2004). Other
sources (Basketter et al., 2007c) proposed also a value of 800 Da. However, already Guy
(2010) pointed out that there is little proper information concerning the penetration of sub-
stances above 500 Da, which is not equal to the existence of a threshold and, thus, this limit
value was heavily criticised recently (Roberts et al., 2013; Fitzpatrick et al., 2016b). Further,
a proposal exists that sensitisers have to have a log Kow above 1 to be able to penetrate the
skin barrier (Smith Pease et al., 2003). Though, in case of the Kow-rule no firm evidence
is available that it is proposed as general exclusion. For instance, Basketter et al. (2007c)
simply state that the optimal log Kow is between 2 and 3, but do not give suggestions that
differing log Kow lead to a significant impairment of the penetration.
Eventually, differences between LLNA and GPTs have to be borne in mind with regard to
the dermal bioavailability. Not only are both tests conducted with different species, which
have differently constituted skin layers, also methodological details influence the amount of
penetrating compounds. First of all, in one of the GPTs (the GPMT) an additional intradermal
57Alongside with several rules of thumb for good and bad penetrants, e.g. by Lipinski et al. (2001) or Magnusson
et al. (2004).
38
induction phase is conducted and the skin barrier is circumvented in the first place. Second,
in both GPTs, the Buehler and the GPMT, the dermal induction and challenge are normally
carried out via closed patches, which make parameters like the vapour pressure unlikely to
influence the bioavailability. In contrast to that, the application in the LLNA is done onto the
dorsum of each ear without any further modifications. Therefore, it is useful to address not
only the overall categorisation of a chemical, but to have a look at the system it was tested
in, because the (physicochemical) applicability domains of the animal models differ.
This is also important, because the unsuccessful attempts to derive an exclusion rule
framework for skin sensitisation (Gerner et al., 2004a) are mainly based on GPTs, which
inherently and on purpose include methodological factors that strengthen bioavailability. A
further motivation for the following investigations is that – while on the one side reactivity is
a well-regarded key requirement for a sensitiser – bioavailability on the other side is subject
to controversial discussions in the literature (Basketter et al., 2007c; Roberts and Aptula,
2008; Roberts and Patlewicz, 2010; Roberts et al., 2013; Patlewicz et al., 2014c; Alves
et al., 2015; Basketter and Safford, 2016; Fitzpatrick et al., 2016b,a) and its (ostensible)
importance has be clarified further. For instance, Alves et al. (2015) report “no evidence that
high permeability implies high skin sensitisation potency and vice versa”, which contradicts
the present AOP and fuels the need for research.
5.2. Methods
Data. All data included in the data set were utilised for the bioavailability profiling starting
with the merged LLNA and GPT data and analysing each data set separately afterwards.
Classification into the respective GHS categories (see section 2.2) was also considered.
Calculation of physicochemical properties. All physicochemical properties were es-
timated using ChemProp (v 6.5, 2016; Schu¨u¨rmann et al., 1997) or the Epi Suite (v 4.11,
2012) with standard parameters. Annex C.2 lists the calculation details for the physicochem-
ical properties included, which function as bioavailability estimates in form of limit values in
the DSS (Gerner et al., 2004b; Walker et al., 2005). Details on further considered properties
can be found in Annex C.3. All calculations were computed using simple 2D-structures of
the undissociated parent structure of the respective substance, which is regarded a conser-
vative approach since ionic structures are assumed to penetrate even less than non-ionic
(Abraham and Martins, 2004; Kamal et al., 2005).58
Search for new exclusion rules. In order to possibly find new exclusion rules an ex-
ploratory data analysis was conducted. For this histograms of the analysed physicochemical
properties were constructed. In line with the former skin irritation rule investigations values
beyond the range of reliability of the calculation methods were excluded from the histogram
construction. In case of the histograms in the main section (figure 6) substances above 1000
Da (two) were left out in the molecular weight histogram for illustration reasons. Concern-
ing the log Kow values below -5 and above 8.2 were excluded. For the vapour pressure
P v (in log Pa) only values between a logarithmic range of -10 and 5 were considered and
58In fact, it was checked if limiting the analyses to just ionic or non-ionic substances influences the results, which
was deemed negative.
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the depicted data are for the LLNA only (because for GPT the occluded testing prohibits
evaporation). Furthermore, the portrayed histograms are stacked, meaning data of (moder-
ate or strong) sensitisers were added on top of the non-sensitiser columns and no data are
concealed (as opposed to other investigations, see Annex C.4).
5.3. Results
Skin irritation rules for estimating skin penetration. As first step it was analysed whether
the original exclusion rules developed for skin irritation can support skin sensitisation deci-
sion making – and, thus, function as general penetration rules. This was not the case, as
elaborated in Annex C.2. Either the NPV 59 was significantly below the ideal value of 100%
(i.e. only non-sensitisers are beyond a particular threshold) or the thresholds suffered from
the shortcoming of targeting few substances (often below 30), which renders them too uncer-
tain from a statistical perspective. The results took into account several model constellations
and also the suggested DSS-refinements of Rorije and Hulzebos (2005).
Exploratory investigations for new exclusion rules. As a simple application of the
BfR-DSS did not obtain confident results, it was investigated whether it is possible to derive
refined cut-offs. To this end, the efforts of this thesis were not limited to the original proper-
ties but also examined other parameters taken from mechanistic considerations. Particularly,
the LSER or Abraham parameters, respectively, were included (calculated by the method of
Platts et al., 1999) as well as further evaporation constants such as the log Koa and the
log Kaw (Henry’s law constant, cf. Annex C.3 or Schu¨u¨rmann et al. 2016 for an application
example). Figure 6 shows three examples further explained in the discussion section. The
histogram’s distributions demonstrate that all properties span over the whole range of rea-
sonable results. This is true for the non-sensitisers as well as strong and moderate sensitis-
ers and no new exclusion rules emerge. In all cases the calculated physicochemical values
distribute around a maximum and the curves have the shape of a (log) normal distribution.
To broaden the scope of research additional parameters were explored for their ability
to function as discriminating factors regarding the sensitisation potential of organic com-
pounds. Furthermore, it was checked if an influence is observable regarding different sub-
stance classes suggested by Gerner et al. (2004b) or with respect to the skin sensitisation
reactivity domains (Aptula et al., 2005; Aptula and Roberts, 2006). The latter of which were
taken into account, because they are more mechanistically sound than the arbitrary DSS
classes (as criticised by Rorije and Hulzebos, 2005). In addition, the different test systems
were separated and it was investigated, whether a test system specific threshold could be
derived. None of these trials were successful.60 Afterwards, combinations of two properties
to derive more complex exclusion rules were tested, but had to be rejected due to statisti-
cal performance problems – only few compounds (normally below 20) could be excluded.
59The negative predictive value (cf. equation 4); the NPV is the most meaningful statistical parameter for this
investigation as also suggested by Rorije and Hulzebos (2005).
60It was particularly interesting to investigate whether the non-sensitisers which belong to the domains of reac-
tivity (i.e. they are reactive and should sensitise) are in the range of extreme physicochemical values, which
would render bioavailability an explanation for the occurrence of reactive, albeit non-sensitising compounds.
However, even though some physicochemical properties are discussed as appropriate tools in potency as-
sessment for specific reactivity domains, they are not strong enough to rule out a sensitisation.
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Figure 6: Distribution of MW, Kow, and P v (merged LLNA and GPT data; modified SPSS
output; raw output is listed in Annex C.3)
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Finally, also a multivariate discrimination analysis obtained no confident results, either. Ex-
amples for these exercises are documented in Annex C.3-C.5.
5.4. Discussion
Skin irritation rules for estimating skin penetration. In accordance with the literature the
application of the skin irritation rules for this data set obtained a low discriminatory power.
This can be endpoint specific, but also the DSS itself should be subject to a critical analysis.
Recent investigations (Mehmed et al., 2014, poster presentation) observed a high number
of false negative classifications due to the application of the DSS exclusion rules to a new
data set, which suggests that the derived exclusion rules might be data specific. This is
interesting, because most of the compounds used for the derivation of the DSS exclusion
rules were non-active substances (only 14% are positive in skin irritation testing) and, there-
fore, the data set was biased towards negative results. In contrast, the newer data collection
contains mainly positive substances (just 6% were negative). However, neither the original
working group of the BfR nor the validation report by the ECB nor the recent investigations
pointed out that the associated (negative) predictive values depend strongly on the rate of
positive and negative results included in the data sets (cf. Pepe, 2003) and for this reason
the latter should be taken into account (either by defining stricter criteria for the acceptance
of predictive values or applying further statistical measures).
Exploratory investigations for new exclusion rules. To investigate whether the failure
of the old rules is endpoint specific and, thus, can be substituted by new limit values, the
distributions of the calculated properties were inspected. As shown in the histograms (fig-
ure 6 and Annex C.3) all GHS potency categories (strong, moderate, and non-sensitisers)
are distributed similarly over the complete range of the respective physicochemical prop-
erties. For instance, in case of the log Kow the maximum frequency is (almost) the same
for all potency categories at approximately 2 and the shape of the histograms is similar (cf.
Annex C.4 for a more clear comparison). This means that the observed increased amounts
of non-sensitisers at extreme log Kow values is primarily due to the larger overall amount
of non-sensitisers in the data base (967 in the merged data compilation) and does not indi-
cate a threshold, which cannot be crossed by sensitisers. If enough data for sensitisers are
collected some would reside beyond that threshold. In fact, the analysed distributions are
almost identical if they are normalised with the amount of included substances (e.g. in form
of density functions, Annex C.4).
For this reason no clear cut-off value can be drawn to discriminate confidently between
sensitisers and non-sensitisers. The lack of limit values for skin sensitisation is supported by
publications of Davies et al. (2011) and Alves et al. (2015), who both did not find any corre-
lation between (predicted) epidermal kinetics or skin permeability coefficients and the EC3
of the LLNA.61 Furthermore, this is in line with recent investigations, which could not achieve
61Davies et al. (2011) explain these findings with the differences between mice and human skin – they used an
in vitro assay based on human skin permeation. This also applies to the data of Alves et al. (2015) – which
likewise took human skin permeability data – but was not discussed sufficiently by the authors. However,
Alves et al. (2015) observed important examples, which are weak penetrants but are still strong sensitisers,
such as the well-known p-phenylenediamine (PPD), and, thus, contradict the notion that strong sensitisers
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improvements by introducing phsysicochemical parameters into a discriminant analysis (Be-
nigni et al., 2016) or which heavily criticised the widely accepted physicochemical cut-off
value at 500 Da for molecular weight (Guy, 2010; Roberts et al., 2013; Fitzpatrick et al.,
2016b) or which still found sensitisers within the range of ‘extreme’ physicochemical param-
eters (Patlewicz et al., 2014c). Moreover, also a cut-off value at 800 Da is not enough to
exclude a sensitisation potential. In this regard N,N’,N”,N”’-tetrakis(4,6-bis(butyl-(N-methyl-
2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine, found in
the ECHA data, is interesting. The complex compound has a molecular weight >2000 Da
and is a sensitiser in the LLNA and GPTs. Existing structural alert models predict no directly
reactive features. Thus either a breakdown product (e.g. glyoxal as suggested by Fitzpatrick
et al., 2016b) or an impurity is responsible for its sensitising effect or it is activated in the
body. Whatever the cause is, this substance demonstrates that even in case of high cut-off
values further factors such as degradation have to be taken into account and a sensitisation
is still possible.
Reasons against physicochemical exclusion rules for skin sensitisation. As all in-
vestigations failed, a general applicability of the physicochemical exclusion rule approach as
discrimination factor between active and non-active compounds is to be questioned. One
preliminary point to consider is that the development of the DSS rules was based on ex-
perimental physicochemical results whereas the current investigations were utilising QSAR
methods62 to approximate these experiments. This introduces an additional source for un-
certainty and/or bias. However, besides the melting point calculations, which are known to
be associated with significant uncertainty, most of the physicochemical properties can be
modelled readily with a high degree of accuracy (e.g. reviewed in Schu¨u¨rmann et al., 2007).
Furthermore, the robustness of this argument is decreased by the fact that also the BfR-
working group, who developed the DSS, tried to derive limit values for skin sensitisation and
their investigations were not QSAR-based (Gerner et al., 2004a). Thus, further arguments
are needed to explain the negligible importance of bioavailability in animal-based skin sen-
sitisation testing in contrast to skin irritation. For this several lines of argumentation can be
reasoned. These will be elaborated in the following paragraphs and comprise:
1. Differences between animal testing protocols for irritation and sensitisation.
2. The concentration necessary to evoke a sensitising effect.
3. The influence of the vehicle (and hydrophobicity).
4. The existence of zones of high permeability (e.g. shunt pathways).
(1) Assuming that the skin irritation exclusion rules are true, differences in the skin irri-
tation and sensitisation in vivo testing protocols (OECD Guideline 404, 406 and 429) as
well as the endpoints itself are able to rationalise the findings. First of all, the GPMT und
have to be readily (bio)available. As both publications are not concerned with qualitative (limit values) but
quantitative predictions, their results could imply that bioavailability is not relevant for those either. This will
be addressed in one of the subsequent sections, because for specific substance groups e.g. Kow-based
quantitative prediction models exist.
62QSAR denotes qualitative or quantitative structure activity relationsships.
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the Buehler test are conducted occlusively to enhance the bioavailability of the substance,
whereas the irritation testing is carried out in a non-occlusive manner. Therefore, parame-
ters like Henry’s law constant or the vapour pressure are less likely to play a significant role.
In addition, occlusion enhances the penetration of substances by various factors (Schaefer
et al., 2006; Basketter and Safford, 2016). However, the LLNA is conducted non-occlusively,
which suggests that the patched testing alone cannot explain all results. A further point to
consider is the often applied pretreatment with SLS or other irritants in both sensitisation
animal systems. The irritant substances weaken the barrier function of the skin by perturba-
tion (Kligman, 1966; Lisby and Baadsgaard, 2006; Fluhr et al., 2008) and, thus, increase the
amount of a compound that is able to penetrate through the skin barrier. This is executed
intentionally to enhance the bioavailability of a test substance and leads to conservative skin
sensitisation estimates – also regarding the fact that the barrier function of the skin may not
always be intact (e.g. after irritant exposure or due to skin diseases such as psoriasis). Obvi-
ously, such measures are not applied in skin irritation testing. In addition, skin irritation may
enhance the detectability of weak sensitisers via the recruitment of further (inflammatory)
cellular signalling pathways (Kligman, 1966; Martin, 2016). Still, the exact amount of mech-
anistic overlap between both endpoints remains unknown (Martin, 2015). A last difference
is the time scale of testing: in skin irritation the duration of a test is 4 hours, whereas the re-
peated application in skin sensitisation testing lasts for several days. Evidently, a longer time
period leads to an enhanced bioavailability of substances, which need time to overcome the
hurdles of the skin barrier (for example because of a slow penetration) and reach the deeper
skin layers only after the prolonged testing. To investigate if this testing protocol variations
are responsible for the observed differences a prolonged, occlusive skin irritation test would
be necessary, which is likely to be subject to ethical concerns.
(2) Concerning the underlying mechanisms, skin sensitisation is more comprehensively
described than skin irritation (Worth et al., 2014). Complex interactions of inflammatory
mediators play a significant role in the pathogenesis of the latter endpoint, which depends
on multiple factors (Fluhr et al., 2008) with no single mechanism (Lisby and Baadsgaard,
2006) and is not fully understood presently, whereas for skin sensitisation a fully developed
AOP is available (OECD, 2012a,b). Fuelled by these circumstances an explanation arises,
which targets the concentration threshold that has to be reached in the deeper skin layers to
evoke the respective effect. Provided this threshold is normally lower for skin sensitisation
than for skin irritation, a smaller amount of substance needs to be bioavailable to give a
sensitising response than to evoke an irritation effect. This in turn leads to higher (or lower)
physicochemical cut-offs for skin sensitisation, which in fact may lie beyond the range of
reasonable or observable values for the respective properties.
(3) With respect to mechanistic considerations, an interesting mechanistic domain in the
context of skin sensitisation bioavailability are acylating agents (cf. chapter structural alerts
for a description of their electrophilic mechanism of action). Basic knowledge in organic
chemistry (Bruice, 2007) ranks their reactive potency along the increasing stability of the
leaving group, where e.g. acid chlorides and anhydrides are among the higher (more re-
active) ranks, which means their reactivity towards nucleophiles is substantially. In fact, it
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is that high that they react very rapidly with water. However, if they react with water (which
makes them hard to handle in alternatives to animal testing that rely on watery mediums)
how can they be sensitisers? The human body consists to a high degree (70%) of water and
even though the outer layers of the epidermis are hydrophobic, an aqueous environment is
found in the lower parts of the epidermis and if the ultimate target protein of sensitisation
rests within the cytoplasm, then the contact to water is unavoidable. Thus, acylating agents
should be hydrolysed before they reach their target according to the current skin sensitisa-
tion AOP.63 Two explanations are possible to rationalise their reactivity against the odds:
• at least one possible target protein, which is engaged during haptenation, has to be in
a hydrophobic environment. This could be either proteins contained within the stratum
corneum, which constitutes a rather hydrophobic zone, or cell membranes in general
(the latter is also proposed in different references, cf. potency influence of the log
Kow), which have to be monitored by (or be part of) dendritic cells to make the further
induction of immune responses possible, or
• the vehicles used in animal testing could incorporate the sensitisers within micelles
that migrate into the deeper skin layers, where they ultimately release the sensitiser
close to their nucleophilic target (in that way the vehicle function as a Trojan horse).
Of course, also a combination of both is imaginable, where the micelles protect the acylating
agents from hydrolysis and where the target protein rests in a hydrophobic environment.
Overall, recent literature on bioavailability in the context of skin sensitisation gives few de-
tailed considerations regarding the influence of what type of vehicle is used. However, the
latter might be important, because typically hydrophobic substances, such as acetone-olive-
oil (AOO), dimethyl sulfoxide (DMSO) or dimethylformamide (DMF) are applied, wherein the
assessed compounds should be soluble to a maximum extend. As the major barrier (the
stratum corneum) composes a hydrophobic environment the vehicle can partition into the
upper skin layers readily, which should also apply to a chemical that is soluble in the vehi-
cle. With time the vehicle will diffuse deeper into the skin along the gradient of continuously
decreasing hydrophobicity until the latter reaches a point, where the vehicle forms micelles
which contain the sensitisers. This in turn is a very different situation from the classical
skin permeability models, which primarily work by estimating the stratum corneum water (!)
partition coefficient for human skin (as noted briefly in Moss et al., 2002) and explains why
sophisticated permeability models can coexist with the fact that only a negligible influence of
the penetration/bioavailability is observed for skin sensitisation. Likewise, newer skin perme-
ability models include the vehicle, because it is considered “as important as the penetrant
itself” (Tsakovska et al., 2017).
Following these considerations aqueous vehicles should lead to weaker sensitisation reac-
tions than lipophilic vehicles64 – leaving out other proposed mechanism of action for vehicle
effects such as irritant effects, dendritic cell activation, modulation of the metabolism, and
63Wherein the sensitiser has to reach the keratinocytes of the epidermis to react with nucleophilc groups of
proteins to form a protein hapten-complex, which leads to sensitisation or an allergic reaction, respectively.
64Which is already reported in Elias and Friend (1975), where the authors noted an increased penetration depth
of tracer substances in case the skin was treated with organic solvents beforehand.
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pK a influences (Basketter et al., 2001a; McGarry, 2007) as well as thermodynamic con-
siderations65 (Schaefer et al., 2006). However, although vehicle effects are reported in the
literature – primarily for the LLNA but also for GPT (e.g. Warbrick et al., 1999; Wright et al.,
2001; Ryan et al., 2002; Lalko et al., 2004, amongst others, reviewed in McGarry, 2007
and Jowsey et al., 2008) – they do not compromise hazard identification (Basketter et al.,
2001a). Further, they are normally not sufficient enough to change the classification of a
strong sensitiser to a weak potential and differences are supposed to be within the range of
variability of EC3 values (Roberts and Aptula, 2008). Albeit, newer investigations showed a
significant increase in EC3 variability due to the use of different vehicles (Hoffmann, 2015;
Dumont et al., 2016). Another publication even reports that although most of the reported
vehicle effects are within the variation of the observed EC3 (5-fold), some chemicals differ by
a factor of more than 10-fold between different vehicles, predominantly in propylene glycol or
aqueous vehicles (Jowsey et al., 2008).66 For example, Ryan et al. (2002) showed that the
potency of formaldehyde and dinitrobenzene sulphonate changed from strong sensitisers in
DMSO and DMF to weak sensitisers in (the not recommended vehicle) water. If this is due
to bulk properties (high surface tension of water) or a modified penetration, was not shown.
Overall, specific investigations regarding vehicle effects in the Kow-dependent domains such
as acylation do (still) not exist and could clarify whether the vehicle is actually relevant as
well as if its hydrophobicity is of importance.
(4) The last consideration was proposed in Roberts and Aptula (2008). The authors stated
that the fact of skin penetration being only important under specific circumstances for skin
sensitisation can be rationalised via a fixed proportion of a compound reaching the deeper
skin layers rapidly (which is in line with (2); if a small fixed proportion enters the skin easily,
than the surpassing of a low(er) concentration threshold for the respective effect is facil-
itated). Therefore, they conceptualised a modified version of the frequently used “bricks
and mortar” representation (cf. Schaefer et al., 2006; Dumont et al., 2015) of the stratum
corneum. In their model the stratum corneum consists not of a regular pattern of dead cells
(bricks) which are embedded in hydrophobic lamellar lipid phases (mortar), but these two
structural features are much more disorganised forming “a bed of coarse gravel (represent-
ing dead cells) in which discontinuous layers of greased sheeting (representing the lamellar
phase lipid) have been interspersed” (Roberts and Aptula, 2008). In the latter model the
lamellar phase lipid do not form a continuous barrier and, thus, allow liquids to penetrate into
the stratum corneum. However, it gives means to retard the passage through the stratum
corneum, by providing a hydrophobic phase into which compounds can partition. Roberts
and Aptula (2008) point out that even if this model does not apply to all areas of the skin,
65In case the solubility limit in the vehicle is approached the thermodynamic potential is increasing in favour of
a diffusion out of the vehicle (Schaefer et al., 2006).
66A recent publication (Watzek et al., 2017) discussed further that the choice of vehicle can also lead to false
positive results if the assessed compound is unstable in the chosen vehicle (e.g. a Schiff base formation
between the assessed compound and actone occurs). However, which chemical classes are concerned and
how frequent this is needs further clarification and verification. This is particularly true as their comparison
concerns AOO and propylene glycol. The latter of which exhibits a great variability in comparison to other
vehicles (Jowsey et al., 2008). Moreover, Watzek et al. (2017) based their results on two LLNA experiments
only, which might be not enough considering the variability of LLNA results in general (Hoffmann, 2015;
Dumont et al., 2016).
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it should be an adequate representation of some regions – in particular if the skin is dam-
aged, irritated, or inflamed (which fits nicely to (1)). In addition to this idea attention should
be given to the existence of shunt pathways within the skin, which facilitate a rapid intrusion
of small proportions of a test chemical into the deeper skin layers (Roberts and Aptula, 2008;
Schaefer et al., 2006). Examples for shunts are hair follicles or sweat glands that interlink
different skin layers (from the dermis to stratum corneum).
Final limit value considerations. Going beyond the difference of irritation and sensiti-
sation testing, the last consideration is in general important for assessing skin sensitisation
based on animal tests, because in comparison with humans most of the used test species
have much more hair – as sensitisation testing is not conducted in animals with few hairs
such as pigs. Hence, the animal skin offers more shunt pathways than found in the organism
they model,67 which leads conservative estimations from a bioavailability perspective. This
is strengthened by the fact that the skin of e.g. mice is much more permeable in comparison
to humans (Griem et al., 2003), which can be illustrated by the fact that humans in con-
strast to mice have a 3 times thicker the stratum corneum (cf. Bronaugh et al., 1982). The
different permeability of human and rodent skin manifests itself further as low coefficient of
correlation (r2 = 0.44) between both (Alves et al., 2015). Hence, the proposed negligible
influence of bioavailability in the animal test systems could prohibit animal skin sensitisers
from being positive in human testing, because humans have a more advanced skin barrier.
This would even weaken the argument against alternative tests that those do not model skin
penetration properly. Still, also with regard to humans Basketter and Safford (2016) suggest
that penetration across the stratum corneum is unlikely to be a rate-determining factor. For
this they cite Kligman (1966), who demonstrated that compromising the skin barrier via tape
stripping does not lead to a significantly increased induction of skin sensitisation. Lastly, it
has to be considered that the permeability of damaged and diseased skin is higher and the
permeability of the human skin is body location dependent (Griem et al., 2003).
In conclusion, compounds that are brought onto the skin in the context of assessing sen-
sitisation via OECD animal testing protocols will lead to a sensitisation in the respective an-
imals given the compound is a sensitiser. In other words, a substance entering the deeper
skin layers is the normal case in skin sensitisation testing and there is no example that a
reduced bioavailability can overrule reaction chemistry. However, the problem is not the
bioavailability itself but the derivation of cut-off values. For this reason, the above given
rationalisation for the failure of establishing limit values for skin sensitisation challenges by
no means that physicochemical properties are important factors for bioavailability, which is
also suggested by several experience with human skin models (Moss et al., 2002). The
rationalisations particularly explain why bioavailability is of lesser importance for the specific
endpoint of skin sensitisation assessed by current animal models. Still, identifying com-
pounds with extreme physicochemical values is valuable, because they indicate whether
substances will lead to technical difficulties for experimental sensitisation measurements
(as stated by Patlewicz et al., 2014b for low Kow). Furthermore, physicochemical properties
may be important in potency considerations as explained in the following paragraphs.
67In the human skin shunts concern only 0.1-1% of the surface (Hadgraft, 2001; WHO, 2006; Dumont et al.,
2015) and are, thus, considered insignificant for skin sensitisation (NIOSH, 2012).
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Bioavailability as influence on potency. In spite of the fact that skin sensitisation can-
not be excluded by taking into account bioavailability, it can still be important e.g. for the
potency of the sensitising effect. This is driven by the idea that the physicochemistry may
not govern whether a sensitiser reaches the lower skin layers or not, but can determine the
amount which is able to pass in a certain time-frame. In this respect, three physicochemical
properties have to be reflected:
1. Molecular weight as proxy for molecular size.
2. Partition coefficients to approximate permeability into deeper skin layers.
3. Evaporation coefficients to estimate substance loss to the air.
(1) Although other properties can be used as more accurate measure for molecular size
(such as the hexadecane air partition coefficient or the characteristic volume; cf. Annex C.3),
molecular weight is the easiest size proxy to obtain (Potts and Guy, 1992; Tsakovska et al.,
2017).68 Even though it is not usable to discriminate confidently between sensitisers and
non-sensitisers, molecular weight can be nonetheless helpful in characterising potency. This
is illustrated in table 9 for a limit value of 400 Da. This threshold was selected with respect
to an analysis of the molecular weight density function (Annex C.4).
Table 9: GHS potency categorisation for compounds above/below 400 Da
GHS Class MW > 400 MW < 400
No. of compounds % of compounds No. of compounds % of compounds
Cat 1A 4 2% 292 18%
Cat 1B 26 14% 463 28%
Unclassified 152 84% 879 54%
All 182 1634
Albeit sensitisers crossing the selected cut-off, it is evident from the data that a significantly
higher percentage of strong sensitisers (GHS Category 1A) is found below 400 Da than
above. The same is true for moderate sensitisers (GHS Category 1B) and is also observed in
case the animal test systems are evaluated separately (Annex C.7). Therefore, an influence
of a molecular weight above 400 Da is to be expected based on the current data, which is an
indication of a decreased bioavailability – or a decreased reactivity, in case the increase in
molecular weight is paralleled with an increase in the structural complexity, which can lead
to sterically challenging molecules with masked reactive centres.
The addition that this is based on the current data compilation is critical. First of all, the
number of 4 compounds is very low from a statistical perspective and should, hence, be
68Moreover, the other methods require an approximation via e.g. fragment models, which introduce additional
uncertainty. Thus, two source of uncertainty (how good do they approximate the real molecular size + how
certainly can they be modelled) have to be considered. It is subject to debate whether the first type of
uncertainty – which is the prime uncertainty source for the approximation via molecular weight – is larger
in comparison to the both uncertainties of other models. All together, all approaches give a similar picture
(Annex C.3).
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taken with care. This might be a general problem of regulatory data sets, given the low
number of compounds with a molecular weight above 400 Da stems from the fact that just
few complex chemical structures are part of chemical testing programs. Furthermore, Fitz-
patrick et al. (2016b) and Luechtefeld et al. (2016a) analysed a newer data set of the ECHA
dissemination site, wherein additional sensitisers with a molecular weight above 500 Da are
incorporated.69,70 Nevertheless, also with the inclusion of the additional strong sensitisers
their percentage in the higher molecular weight fraction is lower than in the fraction of com-
pounds below 400 Da.
This observation stands at first in contrast to Roberts and Aptula (2008), who showed
that their QSAR model developed for Schiff bases (Roberts et al., 2006) is not improved
significantly by the inclusion of molecular weight into their equation. However, for their QSAR
they used just low molecular weight compounds with the heaviest compound having 220 Da.
For those a much smaller influence on potency is to be expected. As shown in table 10 the
percentages of strong and moderate sensitisers of compounds below and above 220 Da
are much closer together than for the 400 Da cut-off and, therefore, a smaller influence on
the potency can be observed. A reinvestigation with higher molecular weight compounds
is necessary to prove whether the inclusion of this property is important for this and other
QSAR; in the best case the new compounds used should be heavier than 400 Da.
Table 10: GHS potency categorisation for compounds above/below 220 Da
GHS Class MW > 220 MW < 220
No. of compounds % of compounds No. of compounds % of compounds
Cat 1A 114 15% 182 17%
Cat 1B 188 25% 301 29%
Unclassified 464 60% 567 54%
All 766 1050
(2) Hydrophobicity is an often used proxy for the partition behaviour of substances be-
tween different phases, e.g. a liquid vehicle and the different skin layers. It is known to
influence the permeability of a substance to a significant degree (equation of Potts and Guy,
1992; Basketter et al., 2007c) and is, furthermore, part of QMMs (quantitative mechanistic
models) or QSARs for Schiff base formers (Roberts et al., 2006, 2017b). Moreover, its influ-
ence is also suggested for other hard eletrophiles (cf. Annex E.2) such as acylating agents
(Patlewicz et al., 2015a, see above for a discussion of acylation agents in the context of
bioavailability) and SN2 reactants, e.g. epoxides (Roberts et al., 2017a), sulphonate esters
(Roberts and Basketter, 2000), as well as halogenated (long chain) alkanes (Roberts et al.,
2007b). However, in case of the latter newer references (Siegel et al., 2009) propose the
69However, the authors did not take into account the concentration tested in the GPT, wherefore a suggestion
of the potency cannot be given.
70At this point, a comment is necessary concerning the classification of the 641.70 Da substance 1,2,5,6,9,10-
hexabromocyclododecane which is considered a strong sensitiser the molecular weight analysis of Roberts
et al. (2013). Checking the presumable raw data (Nakamura et al., 1994) for this data entry it was found
that the compound elicited reactions in 4 out of 10 guinea pigs at an induction concentration of 0.5%, which
means it has to be (re)classified as moderate sensitiser according to GHS criteria.
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observed changes in potency for this group can also be explained by volatility of light short-
chain compounds as well as decreased solubility of heavier long-chain molecules. Thus, at
least for one substance group other factors than hydrophobicity play a significant role. For
other QSARs/QMMs a critical re-evaluation with regard to volatility should be conducted to
ensure the robustness of the hydrophobicity parameter.
However, at the present state of research hydrophobicity is expected to modify the potency
of specific substance classes or domains. Bioavailability in form of skin penetration is typi-
cally excluded as explanation for this finding (Roberts et al., 2007b; Roberts and Patlewicz,
2010; as well as the work in this thesis) and two hypothesis are suggested for rationalisa-
tion: (a) a competing partitioning into other compartments of the skin occurs or (b) the nu-
cleophilic targets are localised within a hydrophobic environment (which do not necessarily
exclude each other). In detail, the former hypothesis (a) includes the removal of a sensi-
tiser by partitioning into aqueous compartments of the epidermis (lymphatic fluid) and, thus,
“models bioavailability at the location where the protein-binding reaction leading to sensiti-
sation occurs” (Aptula et al., 2005; Roberts et al., 2008; Roberts and Patlewicz, 2010). This
is also true for models based on the relative alkylation index (RAI, Roberts and Williams,
1982). Roberts et al. (2007b,c) clarify that the original findings for the RAI do not take into
account bioavailability, because they were developed for guinea pig tests in which the skin
barrier is circumvented by a intradermal induction. Therefore, the hydrophobicity term in the
RAI equation models according to Roberts and Aptula (2008) “the partitioning into lymphatic
fluid (leading to elimination) in competition with reaction with lipid-bound nucleophiles (lead-
ing to sensitisation).” This is very similar to the concept of chemoavailability (Mulliner and
Schu¨u¨rmann, 2013; Bo¨hme et al., 2016), which models a competing partitioning of reactive
compounds between the (hydrophobic) membrane and aquaeous sites of attack.
Comparing both processes it is noted that in the regression equation for chemoavailabil-
ity in aquatic toxicity (Bo¨hme et al., 2016) the algebraic sign for the log Kow is negative,
whereas in skin sensitisation QSARs/QMMs (Roberts and Williams, 1982; Roberts et al.,
2006, 2007b, 2017b,a) the algebraic sign of the log Kow is typically71 positive. This means
in the chemoavailability concept with an increasing hydrophobicity of compounds a lesser
quantity of them reaches the target site – because they are trapped in the membrane. In
skin sensitisation on the contrary more compounds reach their target in the hydrophobic
environment with increasing hydrophobicity.72,73 This is important, because it stands in con-
trast to the idea that a partitioning of the compounds into other compartments occurs (than
71The exception are the sulfonate esters in Roberts and Basketter (2000) for which the algebraic sign is negative.
However, as Roberts et al. (2017a) note the log Kow of the analysed compounds are high (>5). In high
hydrophobicity ranges the influence log Kow is inverted, which is also seen for haloalkanes, and explained
by the fact the residence time in the hydrophobic phase (primarily the stratum corneum) is longer (Roberts
et al., 2007b). Ultimately, at very high values passage through the stratum corneum can becoming rate
determining and fewer compounds reach their target site (Aptula et al., 2005; Roberts et al., 2017a). Still, as
observed above this does not mean that beyond a certain Kow threshold the decreased bioavailability leads
an exclusion of sensitisation.
72Of course, these relationships are only true within certain limits of hydrophobicity. For instance, if a compound
is very hydrophibic (e.g a Kow above 6) the Kow may lose its quality as modelling parameter for the parti-
tion into the membrane (chemoavailability) or the hydrophibic target site (skin sensitisation). Furthermore,
extreme Kow values suffer from larger measuring uncertainties.
73This is a further argument why the simple correlation between toxicity enhancement and skin sensitisation
(section 4.4) is to be questioned.
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the algebraic sign would be negative!) and, thus, the second explanation (b) is more likely.
Likewise, other publications rationalise the importance of hydrophobicity for QSARs/QMMs
of hard electrophiles (cf. Annex E.2) by the hypothesis (b) that their biological target nucle-
ophiles rests within an hydrophobic environment, probably in the membrane, which stabilises
the hard electrophile-nucleophile transition states via medium effects (Aptula and Roberts,
2006; Roberts and Aptula, 2008; Roberts et al., 2017b). This fits to the positive algebraic
sign of the QSARs/QMMs given above and is complemented by soft electrophiles such as
Michael acceptors or SNAr electrophiles for which QSARs/QMMs without the addition of the
log Kow have been proposed (Roberts and Natsch, 2009; Roberts et al., 2011; Enoch and
Roberts, 2013; Roberts and Aptula, 2014). Their target proteins are proposed to be located
in the cytosol rather than in the membrane (Roberts and Natsch, 2009). This is supported
by the fact that the cytosol offers a reducing environment and, hence, the amount of avail-
able free thiol groups, which are the primary soft target nucleophiles, is higher than in other
(subcellular) parts of the skin (Roberts and Natsch, 2009). Given these considerations it
seems plausible that there are two environments where the target proteins are located an
aqueous and a hydrophobic (Roberts and Patlewicz, 2010), whereof the former needs no
hydrophobicity information and the latter does.
Nevertheless, the precise target protein(s) of sensitisers remain unknown and present
theories propose either any protein encountered in the epidermis or specifically designed
membrane bound proteins as suitable targets (Aptula and Roberts, 2006). Albeit the latter
authors propose that this is not important, further investigations should clarify if this is signif-
icant for the differences between soft and hard electrophiles. Within this context considering
the concept of chemoavailability is helpful, as shown above, and it should be of further value
because it has already been proven to be an useful tool in aquatic toxicity for predictively
discriminating between narcotic and excess-toxic α,β-unsaturated (Michael acceptor) esters
(Mulliner and Schu¨u¨rmann, 2013; Bo¨hme et al., 2016).
(3) Not only partitioning processes within the skin are (possibly) important for determin-
ing the potency of a chemical under assessment, also eliminating the amount of available
substance due to partitioning into the air (volatility) is relevant. In this context a recent anal-
ysis (Patlewicz et al., 2014c) discussed the volatility in form of the vapour pressure P v as
explanation for the lower potency of substances in the LLNA compared to other tests with a
pragmatically chosen cut-off at P v > 100 Pa (or log P v > 2) at 25°C. Their rule accounts for
31 substances with 7 reasonably explainable outliers due to reactivity. In the publication it
is not clear for every substance which test gives different results than the LLNA. During this
thesis the pragmatic cut-off was re-analysed to check whether differences in volatility are an
explanation for discrepancies between the GPMT and the LLNA (see also Annex C.8).74 The
cut-off could not be verified – with 6 substances supporting the potency limit value and 12
against it. Furthermore, given that volatility is a good explanation for the differences between
the test systems, one would expect a great amount of these compounds to be highly volatile,
but as many as 19 out of 22 substances had a log P v below 2. Following this evidence the
compiled data of this thesis suggest that at least for the discordant results between the LLNA
74Cf. footnote 34.
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and the GPMT the vapour pressure P v is not a robust general explanation. This may still be
conclusive with regard to the results of Patlewicz et al. (2014c), because their discrepancies
seem to be based primarily on in vitro tests.75
Further measures of the volatility of a particular compound are Henry’s law constant (e.g.
as Kaw), which models the volatility out of water, or the octanol-air partition coefficient Koa
(already usefully applied for a categorical discrimination in Schu¨u¨rmann et al., 2016). While
the utility of the former is restricted to special cases, because most chemicals are applied in
non-aqueous vehicles regarding the OECD test guidelines, investigations with respect to the
latter might be worthwhile. Overall, from a theoretical perspective the Koa should be applied
to chemicals tested in low concentrations within a hydrophobic vehicle and with increasing
concentration the P v of the respective testing compound should become more important.76
That not only P v (see above) but also Koa is a useful parameter is demonstrated by findings
of the UFZ working group of ecological chemistry that include Koa into predictions of the
pEC3 (cf. Annex A.1) of Michael acceptors (Bo¨hme, 2016, personal communication). With
their data it is possible to show that the LLNA underestimates the reactivity of volatile com-
pounds (which is important, as the LLNA is often judged as most sensitive animal test; see
also section 4 on correlation analyses) and, therefore, these are more accurately assessed
by GPTs or, even better, newer approaches of chemical testing. Further research in this
area is indicated with a particular focus on the LLNA and not GPT, which are conducted in
an occlusive manner.
Concluding remarks. All of the above given contemplations concerning bioavailability
pathways are summarised in figure ??. As the in-depth analysis demonstrated that physic-
ochemical cut-off values for skin sensitisation are rather “urban legends” than reality (cf.
also Roberts et al., 2013), it is conservative for regulatory toxicologists to assume that a
chemical is able to access the lower skin layers in the first place, unless proven otherwise.
Nevertheless, bioavailability is by no means obsolete, since it can still influence the sensi-
tising potency of a substance and, thus, should to be taken into consideration in future risk
assessments. It is suggested to investigate further, whether the observed drop in potency
beyond 400 Da is a general finding or an artefact of the present data (this can e.g. be
conducted by including the new data of the ECHA dissemination site). The same applies
for the literature findings concerning hydrophobicity (QSARs/QMMs for hard electrophiles,
maybe also explainable by evaporation of the compounds) and volatility (pragmatically cho-
sen cut-off at P v > 100 Pa as well as reactivity-driven QSAR for Michael acceptors including
the Koa). In addition to the bioavailibility profiling of substances, a detailed analysis of the
electrophilic reactivity and structural resemblances of the investigated compounds is sensi-
ble, because this connects them to the next key step in the skin sensitisation AOP that even
constitutes the MIE (the molecular initiating event). This is done in the following chapters
of this thesis starting with an automated read-across analyses of the compiled animal test
results to assess the (local structural) similarity of the data.
75Furthermore, they suspected the discrepancies between GPMT and LLNA to be metabolic differences in mice
and guinea pig, a topic for which more research is necessary.
76Of course, the performance of the Koa-corrections will depend on the quality of octanol as substitute for the
actual vehicle used.
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Figure 7: Summary on Bioavailability pathways.
As stated in the main text the exact target proteins of skin sensitisation and their location remain
unknown, wherefore the following explanations are hypothetical. However, four possible pathways are
differentiated for sensitisers (red dots) leaving their vehicle (blue) and entering the skin (increasing
hydrophobicity towards the outer barrier is symbolised by the decreasing transparency). (a) primarily
concerns hard electrophiles, which react with amine (NH2) groups of proteins supposedly contained
within the membrane of keratinocytes or dendritic cells and the vehicle functions as “trojan horse”
by protecting the electrophiles within micelles. Mind that the reaction in the membrane could also
take place in hydrophobic regions of other (non-membrane) proteins, in case the substance is able
to reach those. (b) is a proposal that the substances (with a suitable hydrophobicity) partition into
the dendritic cells after leaving the vehicle and lead to further reactions in the immune cells (soft and
hard electrophiles). (c) and (d) target primarily soft electrophiles that react with thiol (SH) groups
of proteins within the cytoplasma of keratinocytes. They differ in the fact that for (c) the compound
has to have a suitable hydrophobicity to permeate into the keratinocytes, whereas in case of (d) the
shunt pathway next to or within the hair follicle can also lead to the bioavailability of compounds with
disadvantageous hydrophobicity. Additionally, it is conceivable that also the vehicle can be distributed
using the shunt pathway. Thus, for hard electrophiles (d) can also function a special case of (a) –
with the target proteins residing in the membrane. Finally, volatility parameters such as Koa or P v
can lead to substance loss due to partitioning into the air (if no patch is applied).
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6. Read-across
6.1. Introduction
Read-across is the local deduction of properties and potentials of a target compound on
the basis of data from similar compounds (Schu¨u¨rmann et al., 2011). The development
of read-across models has been done in the UFZ working group of ecological chemistry
since the 1990s with a first publication in 1996 (Ku¨hne et al., 1996). This thesis utilises
the software programs (in ChemProp), the expertise, and the knowledge gained by the UFZ
working group to a large extent. Parallel to the independent developments and advances
of this working group also other references have been published, which will be presented in
the introduction section in order to give a broad overview of the state of knowledge.
In general, read-across is expected to be a comprehensive method for reducing the large
amount of necessary animal test to be conducted under REACH in an effective manner
and on a short-term basis. The realisation of its prime importance is paralleled by the use of
strong metaphors, such as “Big Sense” and “Holy Grail” (Hartung, 2016) or “the ugly duckling
growing up” (Teubner and Landsiedel, 2015). The latter term indicates there is still consider-
able work to do to move read-across from a rapid (and low-cost) generation of information to
a sophisticated tool for hazard assessment. In particular, the regulatory acceptance remains
a major challenge for read-across due to the high degree of subjectivity in the current often
expert judgement driven approaches as well as a lack of means that address uncertainty
properly (Gini et al., 2014; Shah et al., 2016).77 Also, a consensus is needed about what
kind of evidence is necessary to what extent (Patlewicz et al., 2015a; Ball et al., 2016). This
stands in contrast to the fact that within a representative subset of the ECHA dissemina-
tion data base78 up to 75% of the registration dossiers contained a read-across proposal
for at least one endpoint (ECHA, 2014b). The latter fact fits to the analysis of Luechte-
feld et al. (2016b), who showed that a substantial amount of the study documents used for
REACH registrations refer to read-across and grouping approaches. To handle the large
amount of read-across proposals and facilitate regulatory risk assessment suggestions for a
good read-across practice (GRAP) as well as a read-across assessment framework (RAAF)
have been distributed recently (Ball et al., 2016; ECHA, 2015; for further literature see also
Cronin, 2013). Moreover, several case studies were published in the recent years (e.g. Vink
et al., 2010; Blackburn et al., 2011; Ball et al., 2014) together with different assessment
frameworks (e.g. Wu et al., 2010; Blackburn and Stuard, 2014; Patlewicz et al., 2015a) and
strategic proposals to include strengthening evidence from additional (novel) non-guideline
approaches (Berggren et al., 2015; Schultz et al., 2015; Zhu et al., 2016), which would effec-
77Uncertainty is inherent to read-across (Patlewicz et al., 2014a). One reason is that all uncertainty associated
with the data of reference compounds is transferred to the target compound (Dimitrov and Mekenyan, 2010;
Vink et al., 2010). But there are additional areas of uncertainty (e.g. toxicokinetics, chemical similarity; Ball
et al., 2016), which have been extensively discussed in two recent papers: Patlewicz et al. (2015a) and
Schultz et al. (2015). While being of prime importance – illustrated by the fact that regulatory authorities
accept only very low levels of uncertainty (Ball et al., 2016) – ideas how to address uncertainty in read-
across are in their infancy. Most promising for regulatory purpose is the introduction of assessment factors
(Vink et al., 2010; Blackburn and Stuard, 2014), which are pragmatic and well-known to risk assessors; but
primarily applicable to the uncertainty associated with potency according to Patlewicz et al. (2015a).
783662 phase-in substances with 100 t/a or more (ECHA, 2014b).
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tively expand the read-across to a weight-of-evidence assessment (Teubner and Landsiedel,
2015). Overall, it is a challenge to correctly justify a regulatory read-across (Patlewicz et al.,
2013a, 2014a; Shah et al., 2016), and unforeseen practical hurdles can occur (Ball et al.,
2014, 2016).
In this respect, there is no cardinal way to read across different substances in a regulatory
context. Several strategies exist. For example, Van Leeuwen et al. (2009) and Patlewicz
et al. (2013b) differentiate between an analogue and a group/category approach (where
the former uses one carefully chosen properly similar substance and the latter denotes the
interpolation – or possibly extrapolation – of the target properties of one compound from
a group of related molecules). Other examples include Berggren et al. (2015) and Ball
et al. (2016), who consider four or six read-across scenarios, respectively, which include
factors such as the mode of action and metabolism, which are not covered in detail in this
thesis. Discussions about the strengths and weaknesses of read-across and (mechanistic)
category approaches can be found on several occasions (cf. Cronin et al., 2011; Cronin,
2013; Patlewicz et al., 2013a,b; Raies and Bajic, 2016) and are, thus, not contemplated
further. The crucial point about similarity between two or more substances is that similarity
itself represents no observable. Hence, it can be expressed in different ways. Furthermore,
from a philosophical perspective similarity is not an absolute but a relative concept, which
means that two chemicals are only related to each other with respect to certain key features,
i.e. their similarity is context-dependent (Nikolova and Jaworska, 2003; Van Leeuwen et al.,
2009). Therefore, first the metric in which similarity is measured has to be defined, which is
basically structural resemblance in this thesis (utilising the atom-centered fragment method
of UFZ working group of ecological chemistry).
Deriving properties of a target substance by using structure as similarity metric is a rather
old idea connected to e.g. homologue series of substances (where quantitative read-across
works best, Van Leeuwen et al., 2009).79 It is further a routine practice in chemical engineer-
ing and physical chemistry (Dimitrov and Mekenyan, 2010) and, therefore, the notion that
also toxicological endpoints can be assessed via considering structural or chemical resem-
blance is a straightforward extension of these considerations. However, besides their struc-
ture – the current regulatory starting point for read-across (ECHA, 2015; Ball et al., 2016) –
two or more compounds can also be similar with regard to their physicochemical or biolog-
ical properties (Dimitrov and Mekenyan, 2010; Wu et al., 2010; Ball et al., 2014; Berggren
et al., 2015; Zhu et al., 2016), which can also be used for assessing their relatedness, for
example in form of metabolome patterns (e.g. Van Ravenzwaay et al., 2012). In line with this
broadening of the similarity concept, Schultz et al. (2015) gave a detailed overview of differ-
ent (toxicological important) key similarities and criteria. In this regard it is interesting that
the possibility of biological read-across (Zhu et al., 2016), which is very close to the idea of
test-across (Hartung, 2007),80 is discussed intensely in the recent literature alongside with
the combination of structural and biological similarity (Low et al., 2013; Shah et al., 2016).
79Dimitrov and Mekenyan (2010) and Nikolova and Jaworska (2003) give two further examples for “ancient”
read-across: the periodic table of elements (discovered by Dmitri Mendeleyev and independently by Lothar
Meyer in the same year) and the theoretical investigations in organic chemistry of Butlerov.
80Test-across means using data from in vitro tests in a mini-validated manner in case the respective test was
shown to assess related compounds correctly (Hartung, 2007).
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Finally, whether structural features alone are sufficient for an assessment will likely depend
on the endpoint under consideration (Patlewicz et al., 2013a; Teubner and Landsiedel, 2015;
Shah et al., 2016). As the chemical structure based ACF-method developed in the UFZ has
proven to be useful for several different endpoint already (see end of the introduction), it
seems promising to apply this approach also to skin sensitisation.
However, there is not only a differentiation between structural similarity and other mea-
sures of resemblance. Additionally, various methods exist for the way of assessing how
structurally similar two or more compounds are to each other. First of all, this can be done
manually in an expert-driven manner (Roberts et al., 2008; Enoch et al., 2008b; Koleva et al.,
2008; Schultz et al., 2009; Patlewicz et al., 2015a), where reference should be given to the
mechanistic basis of the assessed endpoint optimally in the context of an AOP (Patlewicz
et al., 2014a; Teubner and Landsiedel, 2015).81 For this approach several supplemental
software tools are available such as the OECD QSAR toolbox (Diderichs, 2010; OECD,
2014), ToxRead (Gini et al., 2014), Toxmatch (Patlewicz et al., 2008a), or Toxtrack (also
called REACH-across, Hartung, 2016)82 amongst others, reviewed in Madden (2013) and
recently in Patlewicz et al. (2017). Moreover, fully automatic methods can be applied. For
those the exact definition of the provided algorithms is of prime importance, which can be
decomposed into two to three steps:
1. The definition of the chemical similarity metric, i.e. what structural features are taken
into account to what extend together with the level of structural detail (from simple
connectivity to adding details such as isomerism and finally calculating the molecular
density functions via quantum chemistry methods; Nikolova and Jaworska, 2003).
2. The mathematical procedure (also called statistical similarity, Raies and Bajic, 2016)
with which the relatedness of the selected features is quantified. For this different
similarity coefficients are available (reviewed in Willett et al., 1998).
3. A third step within this frame would be how to combine the information of the similar
compounds to predict properties of a target compound. This includes e.g. determining
the median, averaging etc. (Dimitrov and Mekenyan, 2010).
Overviews of the multitudes of approaches for approximating chemical resemblance that
follow these steps can be found in the reviews of Willett et al. (1998) or Nikolova and Ja-
worska (2003). One very interesting and chemically intuitive approach to represent struc-
tural relatedness was developed by the UFZ working group of ecological chemistry (already
in the 1990s, Ku¨hne et al., 1996) and continually improved until today. It concerns the atom-
centered fragments (ACF) of a molecule. In brief, the ACF are based on two fundamentals
of (organic) chemistry: atoms and bonds (or hybridisation state) in form of a centre atom and
its neighbours. The ACF construction constitutes the first step of the similarity algorithm and
is subsequently followed by applying the Dice coefficient as mathematical similarity measure
(further explained in the methods section).
81As a side note, for justifying the validity of this approach the concept of local validity was proposed (Patlewicz
et al., 2014a; Hartung, 2016; Shah et al., 2016).
82Currently under development, http://toxtrack.com.
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The ACF-based procedure has been successfully utilised to develop a diverse range of
automatic read-across applications. Published examples include the similarity-based error
correction of QSAR predictions (Ku¨hne et al., 1996), the selection of the best available QSAR
models with respect to particular structures (e.g. for water solubility; Ku¨hne et al., 2006), the
(semi-quantitative) estimation of physicochemical properties (compartment half-live, Ku¨hne
et al., 2007) as well as the quantitative prediction of environmental endpoints, such as acute
fish toxicity (Schu¨u¨rmann et al., 2011) and acute toxicity towards Daphnia magna (Ku¨hne
et al., 2013). Additionally, categorical prediction models for mutagenicity and carcinogenicity
are already implemented in ChemProp (v 6.5, 2016) and – interestingly – perform better than
a prominent structural alert model (data not published, yet). Moreover, in a recent publication
concerning inhalation repeated-dose thresholds of toxicological (TTC) the ACF-approach
was exploited to enhance the structural analysis of the data and lead to the development
of structural alerts for discriminating between high- and low-toxic compounds (Schu¨u¨rmann
et al., 2016). Eventually, an important application, which is independent of the examined
endpoint, is the ACF-based estimation of the structural applicability domain of a given set of
data and to decide if a particular target compound belongs to it (Ku¨hne et al., 2009).
As read-across should take part on an endpoint-to-endpoint basis (Patlewicz et al., 2013a;
Schultz et al., 2015; Teubner and Landsiedel, 2015; Shah et al., 2016), the aim of this the-
sis is to analyse if the application of the successful generic ACF-based automatic method
(also as proxy for other structure-based approaches) is possible for skin sensitisation in a
regulatory toxicological context over a broad range of data and how it can support regulatory
decision making. In particular, this approach seems promising for the research in this thesis
because skin sensitisation, mutagenicity, and acute aquatic toxicity are based on a similar
toxicological mechanism (electrophile-nucleohile-interactions of toxic compounds with sub-
cellular targets – proteins or DNA) and the generic ACF-method already demonstrated its
efficiency in analysing the latter endpoints – and in case of the aquatic toxicity even for two
different species (Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013).
6.2. Methods
Atom-centered fragments (ACF) are an automated method for analysing the 2D-structure
and connectivity of a molecule. The following paragraphs delineate their construction and
usage for read-across as given by the literature (Ku¨hne et al., 2007, 2009; Schu¨u¨rmann
et al., 2011; Ku¨hne et al., 2013). Basically, the molecule is decomposed into the different
substructural units, consisting of a non-hydrogen centre atom and its neighbours. Neigh-
bours are atoms (primarily non-hydrogen) attached directly to the centre atom via covalent
bonding (first-order ACF) or attached to the first-order neighbours (second-order ACF) and
so forth. The UFZ experience from other model development exercises with this approach
has shown that extending the ACF over the second-order path length has only limited impact
on model performance, while drastically decreasing the applicability domain. A graphical
representation for the decomposition of a molecule of the skin sensitisation data set into its
different first-order ACF is shown in figure 8.
As mentioned in the introduction there is no cardinal way of assessing the (structural)
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Figure 8: ACF decomposition example (HC Red no 7). The figure presents the first or-
der ACF of the compound. As can been seen several of the ACF account for
more than one individual central atom. The shown code for chemical struc-
ture are the in chemical computer sciences commonly used SMILES (Weininger,
1988; Weininger et al., 1989) of the respective fragments with the centre fragment
marked in bold and explicitly using hydrogen atoms for clarification purpose. Within
ChemProp a more advanced language is utilised.
similarity of compounds. This is also true within the ACF approach, because the definition of
the fragments can differ (cf. ChemProp ACF instructions). With a given definition of the ACF
the first part of an algorithm for the structural similarity sim(A,B) between two molecules
A and B is completed. The subsequent quantification of the ACF-based similarity takes
place via counting the identical and differing ACF of the target molecules and applying the
Dice coefficient (Dice, 1945),83 which generally is the fraction of the doubled shared features
divided by the non-shared features (Schu¨u¨rmann et al., 2011):
simD(A,B) =
2
∑
i#ACFi(A,B)∑
j #ACFj(A) +
∑
k#ACFk(B)
(6)
With following meanings: #ACFj(A) is the number of ACF of the type j occurring in com-
pound A, #ACFk(B) stands for the number of ACF of the type k included in compound B,
and #ACFi(A,B) represents the number of ACF of the type i which occur in both com-
pounds. This formula is applied to all of the previously defined ACF.
One drawback of the utilisation of the Dice similarity measure (and also other coefficients)
is that in case of large molecules the weight of e.g. alkyl fragments increases linearly with
increasing chain length and, hence, the influence of other fragment such as relevant toxi-
cophores decreases (Schu¨u¨rmann et al., 2011). However, typically toxicophores, i.e. sub-
structures which contribute critically to the toxicity of a compound, should have a higher
83Typically, the Jaccard-Tanimoto-coefficient is preferred in chemical similarity analysis among several available
coefficients/distances (Willett et al., 1998). However, as the Dice coefficient (according to Willett et al., 1998,
also known as Sørensen coefficient, Sørensen, 1948, or Czekanowski binary coefficient) weights shared
features to a higher degree it was taken by UFZ working group of ecological chemistry (Schu¨u¨rmann et al.,
2011) for the quantification of the statistical resemblance. In the end, both coefficients correlate closely
(Willett et al., 1998).
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impact than basically unreactive alkyl chains. The influence of the latter can be reduced via
logarithmic ACF counting as given in equation 7 (Schu¨u¨rmann et al., 2011; Ku¨hne et al.,
2013):
f(#ACFm) = 1 +
log(#ACFm)
log(2)
(7)
The respective modified similarity simDm(A,B) can now be obtained by replacing all
previous ACF-occurrences #ACF () from equation 6 with the corresponding f(#ACFm())
(Schu¨u¨rmann et al., 2011):
simDm(A,B) =
2
∑
i#ACFim(A,B)∑
j #ACFjm(A) +
∑
k#ACFkm(B)
(8)
The calculated value simD(A,B) or its modified version simDm(A,B) are numerical sug-
gestions for the structural similarity between both compounds A and B. To move from this
similarity measure to a read-across, which interpolates the activity of a compound from its
k (typically 3 or 5) nearest structural neighbours (kNN), a similarity-weighted average is ap-
plied (Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2007, 2013):
RX =
∑
i(sim(A,Bi) · act(Bi)∑
i sim(A,Bi)
(9)
Where sim(A,Bi) denotes the similarity between the target compound A and the respec-
tive nearest structural neighbours Bi. Further, act(B)i is the activity of the compound Bi in
its respective toxicity test with the associated outcome (i.e. binary classification or quanti-
tative measurement). In other words a similarity-selected local reference set is constructed
and analysed.84
As the following analyses primarily concern binary read-across models for the collected
skin sensitisation data, an example shall be given how a dichotomous conclusion is reached
(applying knowledge of the UFZ working group of ecological chemistry). If three compounds
are available which have a Dice similarity of 0.6, 0.8, and 0.9 and which are inactive, active,
and active (computerised 0, 1, and 1) in the respective assay, than the activity of each
compound is multiplied with the respective similarity, all values are summed up, and the
sum is divided by the sum of the similarities (in this case 2.3). This result will take a value
between zero and one in case of a binary classification. In order to move from the continuous
scale between zero (inactive) and one (active) to a real binary classification the value is
dichotomised afterwards. This is done by interpreting values above 0.5 as active (1) and
values below 0.5 as inactive (0). In case of our example the calculated value of 0.74 would
indicate an active (sensitising) compound.
With this example at hand further strategies for the modification of the read-across can
be discussed. First of all, the read-across depends on the number of molecules taken into
account for the similarity-selected local reference set. Normally, the interpolation is done
with 3 to 5 most similar molecules, as including more compounds does seldom lead to
84This formulation is important, because kNN-approaches are ideal for calculating properties with strong locality,
meaning a single neighbour with a high similarity weights more than a dozenth neighbours with a low value
(Mitchell, 2014), which fits to experiences of the UFZ working group of ecological chemistry.
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a significantly increase the statistical performance according to previous experiences (e.g.
Ku¨hne et al., 2007; Schu¨u¨rmann et al., 2011). However, the more compounds are included
the higher the probability gets to find outliers, i.e. compounds which are not very similar,
but influence the calculation (of course weighted by their low similarity, but they still have
an influence).85 To cope with this problem a similarity threshold can be applied during the
calculation of the read-across result to ensure that only compounds with a defined mini-
mum similarity are taken into account (Ku¨hne et al., 2006; Schu¨u¨rmann et al., 2011; Ku¨hne
et al., 2013). This means that all compounds with a similarity below a certain threshold (e.g.
0.7) are excluded from the analysis, possibly reducing the accounted neighbours below the
original number. In the example given above this would concern the first compound, which
is non-active and, thus, the calculated activity would be 1.86 This additional theoretical in-
strument is not only applicable to categorical but also to quantitative data (cf. introduction
section; e.g. Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013) and resembles a measure which
is rarely used in practice by other working groups.
In addition to the minimum similarity the interpretation of the continuous calculation out-
come can be changed for binary and categorical classifications (but not for quantitative pre-
dictions). In the dichotomous interpretation example every value above 0.5 is regarded as
active. However, a value of 0.511 might already indicate that the read-across prediction is
not completely reliable. Take for example a setting with the nearest neighbours consisting of
2 active and 2 inactive compounds. In this scenario a deduction of the activity of the target
compound via a read-across with these structurally most similar compounds is not sensi-
ble given all neighbours have a sufficiently high similarity to the target molecule. For this
reason, a grey area can be introduced, meaning only values above e.g. 0.7 are interpreted
as positive and only similarity weighted averages below e.g. 0.3 are counted as negative
predictions. This approach was conducted in the UFZ working group of ecological chem-
istry internally beforehand, but has only been used in a limited manner in published models
(Ku¨hne et al., 2013). It is termed “binary (or dichotomisable) prediction interval” or simply
“grey area” in this thesis.
Figure 9: Binary prediction interval with grey area
For the statistical evaluation concordance or Cooper statistics, respectively, were used
as explained in section 4 (correlation analysis). However, it has to be considered that the
statistics cannot be applied directly to a set of given data, because the target compound
itself has to be excluded from the analysis or otherwise it will be included as perfect read-
across result. For this reason all of the statistics below are subject to a leave-1-out procedure
(Ku¨hne et al., 2013).
85This is a problem of the generic automatic approach, as an expert would probably not group substances with
low similarity together. Thus, the minimum similarity reintroduces expert judgement in a computerised form.
86(0.8 · 1 + 0.9 · 1) / (0.8 + 0.9)
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6.3. Results
Principle investigations – ACF definition. Atom centered fragments were created as de-
scribed in the main section (see also Annex D.1 or the documentation given in ChemProp;
for an illustrative example see Annex D.2). Various model parameters were tested system-
atically with respect to their influence on the skin sensitisation prediction statistics, which is
illustrated in table 11 for the four best performing models of first and second-order ACF with
3 and 5 nearest neighbours.
Table 11: Used options for the ACF-decomposition of molecules (best models)
ACF definition parametersa
Model nameb D A H HN N R RF Ex X O/S N/P
1A5 1 1 1 0 2 0 0 0 1 1 1
1M5 1 1 1 0 2 0 0 0 0 0 0
1A3 1 1 1 0 2 0 0 0 1 1 1
1N3 1 2 1 0 2 0 0 3 1 1 1
2L5 2 2 1 0 3 0 0 3 1 1 1
2U5 2 2 1 2 3 0 0 3 1 1 1
2A3 2 1 1 0 3 0 0 0 1 1 1
2M3 2 2 1 0 3 0 0 0 1 1 1
a = Used parameters in the ACF definition are depth (1st or 2nd order), level of aromaticity, inclusion of
hydrogen at centre fragment, consideration of hydrogen at neighbours, consideration of exact number of
neighbours, ring membership, fused rings, use of specific extensions, distinguishing different halogens as
well as oxygen and sulphur atoms as well as nitrogen and phosphor atoms. For details on these parameters
and their implementation please consult the ChemProp read-across manual.
b = Model name: first number = depth (1st or 2nd order), letter = ACF definition, last number = nearest
neighbours used (3 or 5).
The models in table 11 were part of a larger testing series, fully documented in the An-
nexes of this thesis.87 All of the listed ACF definitions (using the different parameters in
table 11) were used to conduct a subsequent read-across according to the above given
formula to find out if a particular definition fits best to the skin sensitisation data (e.g. a sep-
aration of halogens seems sensible, because fluorine undergoes no SN2 reaction, whereas
the rest of the halogens do – with a varying degree of likelihood). For all of the read-across
trials logarithmic counting was applied. The selected best performing models in table 11
represent the standard approach A as well as the best modified ACF-definitions L, M, N,
and U for first or second-order ACF. Their statistics for merged data88 are listed in table 12.
Note that the statistical performance of the modified ACF compositions L, M, N, and U are
only marginally better, if all, than the standard fragmentation approach A.89 In addition, read-
ing across 3 or 5 compounds as well as using first or second-order ACF had only negligible
effects, too. Overall, the (slightly) superior models were 1A5 and 1M5, whereof 1A5 was
87Cf. footnote 34.
88Test system specific principal investigations (Annex D.5) lead to the same conclusion. The merged data were
chosen for the sake simplicity of the initial overview.
89The same is true for other ACF definitions for which the variation of the concordance was small (5%-points,
0.66-0.71) for the different definitions applied (Annex D.4).
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Table 12: Read-across results for the best performing models (merged data)
Model name TNF TPF NPV PPV cc
1A5 0.75 0.67 0.73 0.7 0.71
1M5 0.75 0.67 0.73 0.7 0.71
1A3 0.74 0.65 0.71 0.68 0.7
1N3 0.74 0.65 0.71 0.68 0.7
2L5 0.74 0.65 0.71 0.68 0.7
2U5 0.74 0.66 0.72 0.68 0.7
2A3 0.73 0.67 0.72 0.68 0.7
2M3 0.74 0.65 0.71 0.68 0.7
1A5 + 2A3 0.73 0.76 0.68 0.70 0.72
1A5 + 2M3 0.73 0.76 0.67 0.71 0.72
TNF = true negative fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative pre-
dictive value, PPV = positive predictive value, cc = concordance.
Model name: first number = depth (1st or 2nd order), letter = ACF-definition, last number = nearest neigh-
bours used (3 or 5).
chosen for further investigations for the sake of simplicity. With this knowledge available,
efforts were undertaken to deduce a combined model for first and second-order ACF, which
has been proven to be a successful improvement in comparison to the individual applica-
tions (Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013). The obtained outcomes are presented
exemplary in table 12 and the combinations show only a slightly increased statistical perfor-
mance compared to the non-combined ACF-based read-across models. The statistics for
other combinations (Annex D.4) did not differ substantially from the exemplified outcomes.
In summary, it became clear that the standard approach with 5 similar compounds is statis-
tically as robust as all other applied definitions and no substantial improvement is obtained
due to a combination of first and second-order ACF without the usage of additional modifica-
tions (such as a similarity threshold or a grey area). Hence, the standard ACF decomposition
was deemed well-suited for the follow-up read-across investigations.
Test system discrimination, similarity threshold, and grey area. The before men-
tioned results were generated using a merged data set of LLNA and GPT in which both
test systems were evaluated jointly (with a consensus in case results for more than one test
system were available). This is sensible, because a larger data set makes it more likely
for the automated read-across to find similar compounds. However, considering the corre-
lation analysis as well as the bioavailability results90 LLNA and GPT differ to a substantial
degree. Therefore, a read-across with the data of one test system only is a more accurate
representation of the discrepancies and, thus, might obtain better results. Following this line
of thought the key read-across modelling steps were repeated for both animal test systems
separately (executed in detail in Annex D.5). In summary the development of data set spe-
cific models lead to similar conclusion regarding the ACF definition: the default (generic)
ACF decomposition is robust.
90The first of which was conducted after the first read-across modelling approaches, because of data limitations
regarding substances tested in both animal species.
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In addition to the principal ACF decomposition investigations further parameters were
modulated. Both, the threshold of similarity as well as the grey area for the binary prediction
interval, provided significant improvements in the subsequent read-across exercises (with
the drawback of decreasing the applicability domain, cf. also Annex D.3). The statistics for
selected examples of these exercises are depicted in table 13 (and a further summary of
the results is given in Annex D.4 and D.5 with a comparison of the merged, LLNA, and GPT
results in the end of Annex D.5).
The general trends are the same for both animal test system.91 Overall, a barely moderate
statistical performance (concordance 0.70 LLNA, 0.74 GPT) is obtained without the applica-
tion of further read-across modifications. The main weakness in the LLNA was the low TNF
(ability to detect non-sensitisers), while the primary problem in the GTP was the prediction
and detection of sensitisers. The performance can be increased to moderate statistics with
the application of the similarity threshold (concordance 0.83 LLNA, 0.84 GPT) or the grey
area for the binary prediction interval (concordance 0.83 LLNA, 0.88 GPT), but the drawback
of both approaches is a drastic decrease in the number of predictable compounds. In this
regard the grey area lead to a lower overall substance loss for the strictest applications (83%
vs 73% in the LLNA, 83% vs 64% in the GPT).
Surprisingly, a combination of both approaches – a moderate similarity threshold of 0.7
with different grey areas – was not significantly better than one method alone. To see this
the statistics of different approaches with similar numbers of excluded compounds have to
be compared. For example, in the LLNA a grey area from 0.2 to 0.8 with a threshold of 0.7
did exclude the same percentage of compounds as the same grey area without threshold
or the similarity threshold of 0.8 (about 50% in all approaches). However, this particular
combined approach was not more successful regarding its statistics than the corresponding
non-combined approaches. An explanation for this is given in the discussion section. In
addition, the grey area was not able to further improve the statistics after its initial application.
The values for grey area of 0.3-0.7 are nearly the same as for 0.1-0.9 in both animal test
systems and even showed decreasing values for the TPF , i.e. the detection of sensitisers,
in the GPT. This is a further indication that it adds no value beyond the minimum similarity.
Finally, in line with the previous results of this thesis for the LLNA the positive statistical
parameters (TPF , PPV ) and for the GPT the negative ones (TNF , NPV ) performed better
with increasing rigorousness of the parameters applied. In particular the detection of sen-
sitisers in the LLNA (TPF ) by the non-combined approaches is good with values of about
0.9. In the GPT in turn the detection of non-sensitisers (TNF ) by all improvement methods
reaches good to very good values (0.88-0.96 in the most rigorous applications). This will be
taken up in the discussion section.
Further read-across investigations. During this thesis further ACF-related read-across
ideas were investigated with respect to the skin sensitisation data and shall be summarised
briefly. In addition to the standardised read-across modelling parameters, also ACF ap-
proaches were tested which were aligned to structural features of sensitisers to differentiate
between fragments with active (chemically reactive) and non-active (non-reactive) substruc-
91They are also in line with the assessment of the merged data set, cf. end of Annex D.5.
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Table 13: Read-across results for the skin sensitisation data with similarity threshold and
grey area
LLNA data
Applied measures TNF TPF NPV PPV cc N %
Similarity threshold
none 0.59 0.79 0.68 0.72 0.70 1081 100
0.7 0.61 0.81 0.67 0.77 0.73 769 71
0.8 0.66 0.84 0.70 0.81 0.77 505 47
0.9 0.74 0.88 0.76 0.86 0.83 187 17
Grey area without sim. threshold
none 0.59 0.79 0.68 0.72 0.70 1081 100
0.3-0.7 0.63 0.86 0.77 0.77 0.77 660 61
0.2-0.8 0.65 0.91 0.83 0.79 0.80 532 49
0.1-0.9 0.64 0.94 0.86 0.81 0.83 293 27
Grey area with 0.7 sim. threshold
0.3-0.7 0.64 0.84 0.71 0.79 0.76 595 55
0.2-0.8 0.65 0.85 0.73 0.79 0.77 525 49
0.1-0.9 0.65 0.83 0.72 0.78 0.76 450 42
GPT data
Applied measures TNF TPF NPV PPV cc N %
Similarity threshold
none 0.84 0.57 0.78 0.65 0.74 1000 100
0.7 0.86 0.67 0.82 0.72 0.79 728 73
0.8 0.84 0.77 0.85 0.75 0.81 487 49
0.9 0.88 0.77 0.87 0.79 0.84 166 17
Grey area without sim. threshold
none 0.84 0.57 0.78 0.65 0.74 1000 100
0.3-0.7 0.90 0.61 0.83 0.74 0.81 687 69
0.2-0.8 0.92 0.63 0.86 0.78 0.84 557 56
0.1-0.9 0.96 0.65 0.89 0.83 0.88 362 36
Grey area with 0.7 sim. threshold
0.3-0.7 0.88 0.71 0.86 0.74 0.82 573 57
0.2-0.8 0.89 0.69 0.86 0.74 0.82 525 53
0.1-0.9 0.89 0.67 0.86 0.74 0.83 465 47
TNF = true negative fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative predic-
tive value, PPV = positive predictive value, cc = concordance, N = number of compounds, % = percentage
of the overall data set
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tures. In other words, the ACF-construction was calibrated with knowledge gained from the
structural alert exercise. This is equal to a (manual) mechanistic interpretation of the created
ACF. However, the implemented weighting of the ACF did not obtain a significant improve-
ment over the standard ACF read-across (the reader is referred to Annex D.6 for the details),
which is agnostic with regard to reactive substructures.
Other investigations targeted non-binary predictions such as the semiquantitative classi-
fication as stipulated by the globally harmonised system (GHS), which is poorly predictable
(a maximum Spearman’s rank r2 of 0.65 was reached with a similarity threshold of 0.9; sum-
marised in Annex D.7), suffers from a substantial loss of predictable substances (over 85%),
and is, thus, not regulatory applicable. Finally, quantitative LLNA read-across models were
investigated (pEC3 prediction; Annex D.8). However, all quantitative prediction attempts (in-
cluding a separation into reactivity domains) obtained only a low statistical performance and
are primarily summarised for the sake of documentation in Annex D.8.
6.4. Discussion
Results at hand. The obtained statistics in table 13 span from barely moderate to moderate
concordances. This has always to be related to the number of predictable compounds and,
hence, the expected applicability domain. A model which has supreme statistics but is appli-
cable to 5% of the whole data set has limited use in predictive toxicological risk assessment.
Yet, there are no fixed rules which number of compounds is still viable. Concerning the re-
sults of this thesis it is suggested to take the read-across models with a similarity threshold
of 0.8 for sensitisation predictions as they offer the best trade-off between applicability (both
can be applied to about 50% of the respective data set) and statistical performance (which
is moderate in both cases with a concordance of about 0.8). Nonetheless, it should be re-
garded that the read-across models are better for positive data in the LLNA and better for
negative data in the GPT (values over 0.8 are obtained).
In contrast to the similarity threshold the use of the grey area alone is discouraged. This is
not due to the statistics (which are superior in comparison to similarity threshold for particular
scenarios), but due to mechanistic considerations. The grey area method without similarity
threshold allows the read-across with structurally very different compounds. Although these
are the closest neighbours to the target compound – due to a lack of sufficiently similar
compounds in the whole data set – they may not represent the mechanism of the assessed
compound properly. Even compounds with a similarity of 0.1 may be included in the read-
across even though a chemical expert would not relate these to the target compound. For
this reason is the application of a grey area without the usage of any similarity threshold not
as mechanistically sound as the similarity threshold alone. Likely, the similar performance of
both is coincidental. More research is needed to clarify if this still occurs with different data
on a large scale (which would fuel the need for further explanation).
A last issue concerning the data at hand is the combined approach. Surprisingly, it did not
obtain significantly better results than non-combined methods – which would be expected
because both individual approaches lead to an improvement in statistics. An explanation for
this is that even a similarity threshold of 0.7 excludes predominantly compounds which re-
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side within the grey area. This is to be expected as the threshold is conceptualised to remove
insufficiently similar compounds from the prediction. Without a threshold at least some of
the neighbours are not sufficiently structurally related to the target compound from a struc-
tural and, thus, mechanistic perspective. Assuming an equal distribution between active
and non-active closest neighbours, which do not surpass the similarity threshold, the pre-
diction is driven towards equivocal results (0.5 in the binary prediction interval). Removing
the structurally “detrimental” neighbours will result in more clear predictions by the closest
neighbour (whereof all now surpass the threshold), meaning the values in the prediction in-
terval is polarised towards 1 or 0.92 One indication for this visible in table 13. Comparing
the grey area approaches which stretch from 0.1-0.9 with and without similarity threshold
reveals that applying a threshold results in a much lower loss of compounds. With threshold
42% and 47% of the compound remain in the LLNA and GPT data set, respectively, whereas
without a minimum similarity only 27% and 36% of the compounds are predictable. This is
only possible if compounds, which resided in the grey area before, are located outside of the
grey area after application of the threshold. Likewise, this means the grey area is another
(structurally unjustified) measure for structural similarity, as it removes primarily compounds
with “detrimental” (non-similar) neighbours. This becomes also apparent in the fact that the
grey area and similarity threshold combination does not exhibit improved statistics with in-
creasing rigorousness of the grey area, meaning it is not capable to improve the predictions
for compounds for which only sufficiently similar neighors are taken into account.
Variability in data of chemical structures. One common issue93 of all analysed data
sets (LLNA, GPT, merged) is that the number of analysed compounds decreases drastically
with increasing similarity threshold. This means many compounds do not have structurally
close neighbours and, hence, the barely moderate performance of the generic ACF-based
read-across can be explained – at least partly – with the structural heterogeneity of the data
compilation (further analysed in Annex D.9 utilising ChemProp to estimate heterogeneity).
It has to be critically stated that the structurally heterogeneous data base of this thesis
may be an artefact of a misguided data compilation. More care should have been given to
collect data which can lead to a more useful model from a statistical point of view.94 How-
ever, in the practice of regulatory toxicology unfortunately and typically no homologue series
are available either. This is rooted in the fact that modern chemical and pharmaceutical
companies do not develop a battery of structurally similar substances, which are tested in
subsequent animal toxicological studies, but they focus on lead candidate structures, which
are most promising for the task at hand – also for the sake of cost reduction and efficiency.
The rigorous selection process leads eventually to structurally fragmented data submitted to
regulatory authorities. Of course, this is not an inevitable law of nature and does not have to
be the case, but explains at least for particular substances, why no or only few structurally
close neighbours can be found. For this reason, a model which should be applied to regu-
latory problems and is based only on structurally similar compounds, will face the problem
92For an illustrative example see also Annex D.2.
93Which is also known for other data sets the UFZ working group of ecological chemistry has build models upon,
cf. Schu¨u¨rmann et al. (2011).
94Also with less preliminary structural alerts or alerts based on single substances, cf. next chapter.
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of a limited domain of applicability (as exemplified for TIMES-SS in Teubner et al., 2013).
Strategies have to be found to make confident predictions also for structurally isolated sub-
stances. In this regard it is important that the recent read-across assessment strategies
(ECHA, 2015; Ball et al., 2016) not only address structural similarity, but for a sophisticated
read-across also further considerations have to be given, e.g. on common toxicokinetics
including metabolism, physicochemistry, and mechanistic reasoning. The reference to other
similarities will be particularly important if the (structural) similarity-selected local reference
set is small, e.g. in analogue approaches (read-across with one similar substance).
In the context of a regulatory read-across implementation and with respect to the ACF
model of this thesis it should be mentioned further that the decreased applicability domain
is primarily driven by the data at hand and (administrative and industrial) users will be able
to read across different (proprietary) data sets, wherein sufficiently similar reference com-
pounds may be found. Furthermore, the performance statistics are often more important
from a regulators point of view. Their interest is usually not reading across a large data
base, but finding suitable analogues to support a decision. In this respect and with regard to
the concept of local validity (Patlewicz et al., 2014a; Hartung, 2016; Shah et al., 2016) it is
not important how many analogues can be found, but that the similarity-selected reference
set leads to reliable conclusions. If there is no sufficiently reliable similar substance, than it
is not there. Or colloquially: better no read-across than a worse one. Still, it has to be made
clear that in this thesis a generic read-across was applied, because the generic approach
already proved surprisingly useful for mechanistically related endpoints (aquatic toxicity and
mutagenicity; cf. Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013, and ChemProp) and a more
specific mechanism-based read-across will achieve superior results.
Mentioning the mechanism leads to the several manual read-across exercises for skin
sensitisation (Roberts et al., 2008; Enoch et al., 2008b; Schultz et al., 2009) that have al-
ready been executed – alongside with an automated approach for category formation (Ja-
worska and Nikolova-Jeliazkova, 2007). These expert-driven analyses make use of the
notion that the creation of global assessment models covering the whole chemical universe
is probably a naive idea (Patlewicz et al., 2014a) and that local mechanism-based models
are expected to work generally better than informatics-based similarity measures (Schultz
et al., 2015) – while having the drawback of a time and labour intensive development (Cronin
et al., 2011). Still, a performance improvement is not excluded by default in case a compu-
tational algorithm is applied, if the latter is mechanism-related. For instance, Schu¨u¨rmann
et al. (2011) presented a good global and generic ACF-based read-across model for aquatic
toxicity, which is mechanistically sound and automatic. In fact, whether local models are
better than global ones is endpoint driven. As the generic approach lead to only moderate
results for skin sensitisation, the question arises if further measures have to be applied for
which more research is necessary.95
95Some of those further measures/ideas such as the differentiation into reactivity domains have been investi-
gated and are summarised in Annex D.6-D.8. In this regard it was unexpected that automatically reading
across the reactivity domains with ACF did not improve the quantitative model performance (cf. Annex D.8),
albeit this should be in line with the above (manual) literature exercises for Michael acceptors on smaller
data sets as well as several mechanistic studies. The reason for the failure is probably that the expert-driven
literature methods (Enoch et al., 2008b; Schultz et al., 2009) are methodically too different and that the de-
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Discrimination between animal test systems. With respect to the test system specific
statistics, in the LLNA model the positive statistical parameters performed markedly better
than their negative counterparts, while in the GPT models the inverse was observed – i.e. an
enhanced detection and prediction of negative test results. This is in line with the correlation
analysis results96 and based on the amount of positive and negative animal test results in
the different data sets. As to be expected, the balance for the GPT is shifted towards non-
sensitisers (350 active vs 651 non-active compounds) and, therefore, the initial probability
to find a negative test result is larger than the probability of identifying an active compound.
The contrary is true for the LLNA data. They exhibit more positive than negative test results
(613 active vs 468 non-active compounds), making it less likely to identify non-sensitisers
within this data set. These given imbalances influence the read-across towards the direction
of more often occurring test result, because it is more likely to find similar compounds for
this than for the contrary test result. However, this is wanted to a certain degree because
the tests are not balanced and, for instance, negative tests are in fact occurring more often
in GPTs. Thus, the read-across accounts for the test system specific biases.
In this regard it has to be mentioned that the aggregated LLNA data may not represent the
overall universe of LLNA data accurately. It was noticed during the data collection that the
data in the open literature focus on sensitisers and, thus, introduce a positive (publication)
bias to the data compilation. Despite the fact that this should not occur with other public
data, such as the ECHA dissemination database, the other data were not enough to dilute
the positive bias accordingly. For this reason more negative LLNA data should be collected
to improve the representativeness of these data. One opportunity is the further usage of
the ECHA database, in which more substances will be included in the future. The additional
compounds will likely consist of more non-sensitisers, a fact that can be extrapolated from
the newer automatic extraction exercise of Luechtefeld et al. (2016b), where the authors
calculated a skin sensitisation prevalence among industrial chemicals of 21% (but a dis-
crimination between GPT and LLNA took not place). However, if this goes together with an
imbalance towards non-sensitisers solutions have to be found to cope with this imbalance.
This is even more true for the before mentioned GPT, where an imbalanced data set is at
hand. One possible solution that is quite specific for this context (ACF-based read-across
with imbalanced data) is introducing an asymmetrical grey area adjusted to the data set.97
Other read-across approaches. Another totally different issue emerging in the recent
discussion is the possibility of biological read-across (Zhu et al., 2016). There, data are
used from the nearest neighbour(s) in bioassays, for example high-throughput screening
methods (Zhu et al., 2016; Shah et al., 2016). Despite the fact that these neighbours may
be completely different from a structural perspective they have shown to be a good proxy for
the activity of the target compound and may outperform nearest neighbours from structural
read-across as well as a combination of structural and biological read-across for certain
endpoints (Zhu et al., 2016; Shah et al., 2016). This is surprising as typically the structural
rived domain-based data sets were generally to small for an automatic ACF-analysis (Annex D.8; therein
also a discussion regarding the global quantitative read-across is given and why this failed in contrast to the
successfully applied approaches for aquatic toxicity – Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013).
96The GPT tend to give (false) negative results, whereas the LLNA is biased towards (false) positive results.
97In fact, this has been tried, with moderate improvements, see Annex D.5.
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similarity is pivotal for mechanistic similarity. This has not been respected in the respective
publications and should be taken into account further, to analyse for which endpoints the
structural similarity is inferior to the bioassay activity and for which reasons. In addition, the
mechanistic reasoning behind the biological read-across has to be checked individually, i.e.
the utilised bioassay has to be based on the relevant mechanism of action for the evaluated
endpoint (which it normally does), otherwise mere correlations between two test systems
are exploited instead of generating further insights. The same applies to other test-across
approaches (Hartung, 2007) such as a chemical read-across using data of reactivity-based
chemoassays – which are optimally part of an integrated testing strategy. Mentioning these
assays it should be emphasised that their assessed mechanism (electrophile-nucleophile
interaction) is not only important in skin sensitisation. Hence, also a range of other end-
points (aquatic toxicity, mutagenicity, cf. correlation analysis) can be assessed using the
nearest chemoassay neighbour and, therefore, data of one animal-free test system could be
utilised to assess several endpoints – taking into account the domain of applicability and the
characteristics (e.g. hard and soft target molecules/atoms) of the endpoints.
Concluding remarks. Speaking of other endpoints, for some of those already remarkable
generic structural ACF-based read-across approaches are available even with quantitative
predictions. This concern effects in different aquatic organisms (Schu¨u¨rmann et al., 2011;
Ku¨hne et al., 2013) as well as physicochemical properties (Ku¨hne et al., 2006, 2007) and
human endpoints (available in the public version of ChemProp). In this regard the current
work shows that the ACF-based read-across is moderately possible for skin sensitisation98
in a binary matter; although the statistics are not robust enough for a regulatory applica-
tion. To overcome this weakness a larger data set should be compiled, because this will
lead to higher likelihood of finding similar compounds (in particular if a similarity threshold
is applied). The extended data set should comprise more negative LLNA data in the ideal
case, as the current LLNA compilation is likely imbalanced towards sensitisers. Moreover,
refinements have to be done to conceive either a categorical or quantitative approach (cf.
Annex D.7 and D.8 for summaries of basic investigations). Albeit increasing the size of
the data set is certainly not a panacea99, also in case of the categorical and the quantita-
tive investigations, it likely leads to model improvements. Eventually, read-across was the
first applied model of this thesis which engages the skin sensitisation MIE. In the following
chapter the second MIE-related approach, the structural alerts, will be presented.
98Which should still be regarded as most promising candidate for the development of alternative methods –
maybe together with mutagenicity – because in comparison to other human endpoints (1) its mechanistic
basis is well-researched, (2) its animal test system is validated (which is not true for many other animal
tests), and (3) it considers one specific outcome, instead of summarising a diverse set of effects as in
repeated dose toxicity. In this regard further difficulties should be expected for more complex multi-factorial
endpoints (Patlewicz et al., 2014a).
99A universal cure.
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7. Structural Alerts
7.1. Introduction
Structural alerts (also known as toxicophores) are a straightforward incarnation of the struc-
tural similarity principle: if substances can be grouped together, because they evoke a com-
mon (toxicological) effect in an organism and this is inherent to specific structural elements
of compounds, then it should be possible to identify the shared parts of their structure, which
are responsible for the effect. So to speak, structural alerts are common substructural fea-
tures, which function as indicators for a certain effect. In general, structural alerts constitute
rule-based models, which take the following form (Raies and Bajic, 2016):
IF Substructure A is present in Compound X THEN Compound X is active
Importantly, this accounts just for the presence and not (!) the absence of substructural
elements, meaning the absence of a structural alert cannot be used to inferred that a com-
pound is non-active. This is because other structural features can exist which indicate e.g.
a reactive-toxic chemical, but are not known by current knowledge bases. Hence, treating
substances without an alert not automatically as inactive, is a (very) conservative approach
of risk assessment.100 An approach to circumvent this problem is to derive the applicability
domain of a structural alert model (e.g. with the model of Ku¨hne et al., 2009). Given it is de-
rived properly, compounds with unknown structural features should be outside of the domain
and all compounds within the domain and without structural alerts should be inactive.
Two cardinal ways can be differentiated for the development of structural alerts (Raies and
Bajic, 2016): firstly, expert-based and, secondly, algorithm-based rules. While the former is
based on the formalisation of the knowledge of human experts, the latter is driven by an
automatic and statistic-based correlation of structural features with given toxicological end-
points. Both approaches have distinct drawbacks and benefits, discussed in greater detail in
Annex E.1. Of course, the differentiation is not completely strict and combined approaches
exist, i.e. human experts can utilise the algorithm-based methods to support their knowledge
about particular endpoints or derive preliminary rules which they can generalise according
to their expertise (as e.g. done in Estrada et al., 2003 or Schu¨u¨rmann et al., 2016).
Figure 10: Examples for the importance of the concrete substructure (R = aliphatic carbon).
The depicted structures are 1 aldehydes, 2 ketones, 3 Michael acceptor ketones
(a Michael acceptor is an α-β-unsaturated carbonyl), 4 Michael acceptor esters
(acrylates), 5 methacrylates.
100Otherwise, if the knowledge or data base is large enough it should be possible to identify features which, if
present, do not contribute to a sensitising or other toxicological effect such as in the group of simple aliphatic
alcohols without additional functional groups or which even mask structural alerts, meaning, if present, they
overrule the structural alert for various reasons such as the suppression of immunological processes. In this
regard two rules could be derived, presented in the end of the discussion.
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A further very important issue concerning the alerts is the definition of the relevant sub-
structure. For this figure 10 can be consulted. Therein, five substructures are shown. The
first depicts an aldehyde function, which is part of many sensitisers and a good alarm per
se.101 Though, replacing the hydrogen atom at the carbonyl moiety by a methyl group leads
to the second substructure, which is a ketone. The latter compounds are significantly less
reactive – and typically non-sensitisers in case no further reactive substructures are present.
Notably, the only difference is one adjacent group. However, adding a double bond in the
α-β-position leads to a substructure called Michael acceptor, which is reactive/sensitising
again.102 The next compound is also a Michael acceptor, but the carbonyl function was re-
placed by an ester group (the resulting structure is also called acrylate). This class should be
less reactive (observed e.g. in Bo¨hme et al., 2009, 2010; Wondrousch et al., 2010; Mulliner
et al., 2011) than the ketones according to their electron withdrawing properties, because
the second oxygen of the ester is able to compensate the polarisation of the carbonyl oxygen
mesomerically (Bruice, 2007).103 They are moderate sensitisers. Eventually, for the latter
compound class the reactivity can be significantly lowered if a carbon is introduced in the
α-position as exemplified in compound five (a methacrylate), which is explained by a positive
inductive (+I) effect of the α-alkyl substituent (which lowers the electro-positive character of
the double bond’s β-position) as well as the steric hindrance introduced by that substituent
(Schultz et al., 2009; Blaschke et al., 2012; this also accounts for other Michael acceptors,
Bo¨hme et al., 2010). Further references for structure activity relationships of Michael accep-
tors are given in Annex E.8. In conclusion, the substructural configuration has a significant
influence on the question whether a compound is reactive or not (as well as its sensitising
potency, which can be encoded as electrophilic reactivity of the compounds). Therefore, it is
of pivotal importance to define exactly, which substructural elements should be included for
a structural alert and at which position a structural variation is not significant.
Concerning general strengths and weaknesses of structural alerts several (dis)advantages
are reported in Raies and Bajic (2016) and Alves et al. (2016). Some of the proposed draw-
backs should be subject to a critical discussion, which is conducted in-depth in Annex E.1.
In brief, it is just partly true that structural alerts do not provide insights into biological path-
ways of toxicity (stated by Raies and Bajic, 2016). This may account for insights into the
whole AOP cascade, but structural alerts can at least define a priori what exact key event
will be observed (if they are mechanism-based), which will likely affect further downstream
events. Furthermore, the notion that structural alerts exhibit a positive bias leading to over-
101Except for aromatic aldehydes, for which the R is an aromatic system (cf. Annex E.8 and E.9 or structural alert
discussion section on Schiff base formers as well as several references e.g. Patlewicz et al., 2001; Natsch
et al., 2012; Roberts et al., 2006; Roberts and Aptula, 2015; Roberts et al., 2017b).
102But this time not at the carbonyl function, but at the β-carbon an. Furthermore, Michael acceptors are typically
soft electrophiles while aldehydes are hard electrophiles, cf. Annex E.2. However, this strict differentiation
is questioned by recent literature (Slawik et al., 2017). Furthermore, the hardness differs between Michael
acceptors as demonstrated by calculations of Wondrousch et al. (2010).
103Additionally, esters exhibit an increased hardness (cf. Wondrousch et al., 2010) that consequently leads to
an even lower reactivity towards soft thiol groups, which are the primary target for Michael reactions in skin
sensitisation. Still, also reactions with hard nucleophiles are possible in skin (amine function of lysine), which
underlines the importance of the work of Slawik et al. (2017). Lastly, effects such as a high volatility and
polymerisation have been reported as confounding factors for an unexpectedly lower acrylate sensitisation
potency (Enoch and Roberts, 2013).
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sensitivity (Alves et al., 2016) is (at least partly) based on the fact that Alves et al. (2016)
did not take into account the domain of applicability of structural alert models (while they
did this for QSARs) – e.g. by using the method of Ku¨hne et al. (2009). Furthermore, they
were not aware that proposals for assessing individual alerts performance exist – e.g. alert
reliability (Mekenyan et al., 2014; Patlewicz et al., 2014c). Also, the criticism that structural
alerts are affected by further structural elements in complex molecules (Alves et al., 2016)
is basically correct, but far from being a universal limitation in case chemical knowledge is
applied. Finally, to criticise the “blind” reliance of structural alerts (Alves et al., 2016) seems
trivial. Blind reliance can never be a rationale in science even for long-established tests,
such as the Ames mutagenicity assay.
Nonetheless, because of their simplicity and easy application as well as interpretation
(Raies and Bajic, 2016; Alves et al., 2016), structural alert models have already been de-
veloped for an extensive amount of endpoints, such as mutagenicity and carcinogenicity
(several references starting with Ashby, 1978, 1985; among the most recent are Benigni
and Bossa, 2008; Enoch and Cronin, 2010, 2012; Benigni and Bossa, 2011; Benigni et al.,
2013), acute aquatic toxicity to various species (Lipnick, 1991; Verhaar et al., 1992; Russom
et al., 1997; von der Ohe et al., 2005; Blaschke et al., 2012; Ost, 2013; amongst others),
mitochondrial toxicity (Naven et al., 2012; Nelms et al., 2015), hepatotoxicity (Hewitt et al.,
2013), developmental toxicity (Hewitt et al., 2010), oral and inhalation threshold of toxicolog-
ical concern (Munro et al., 1996; Schu¨u¨rmann et al., 2016), skin and eye irritation/corrosion
(Gerner et al., 2000b; Hulzebos et al., 2005; Gallegos Saliner et al., 2007; Tsakovska et al.,
2007), respiratory sensitisation (Enoch et al., 2010, 2012b; Mekenyan et al., 2014), and pho-
toallergenicity (Barratt et al., 2000). Their usage varies from detailed structural descriptions
with highly reliable predictions to the application as screening tool or for grouping purpose
only. Of course, structural alert models for skin sensitisation exist in the literature (e.g. Bar-
ratt et al., 1994; Zinke et al., 2002; Gerner et al., 2004a; Enoch et al., 2008a), which are
implemented in commercial (DEREK) as well as non-commercial software (ToxTree, OECD
QSAR Toolbox, ChemProp) either exactly as shown in the papers or in derived forms. In
addition, structural alerts have been developed for electrophilic features that enable com-
pounds to bind covalently to nucleophilic groups of proteins (Enoch et al., 2011) – which is
the underlying molecular initiating event of skin sensitisation.
An important point for structural considerations regarding skin sensitisation is that the part
of the chemical universe which contains skin sensitisers is divided into five domains, which
constitute the basic reaction chemistry principles by which an electrophile-nucleophile inter-
action between skin proteins and putative sensitisers can take place. Namely, the possible
domains of reactivity (Aptula et al., 2005; Aptula and Roberts, 2006) comprise:
1. Acylation: nucleophilic substitution at an acyl-group,
2. Michael acceptors: α,β-unsaturated compounds activated by an electron withdrawing
groups able to react via Michael addition,
3. Schiff base formers: formation of imines with NH2-group of e.g. lysine-residues,
4. SN2 reactants: a heterogeneous set of reactions involving a leaving group at an
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aliphatic carbon probably adjacent to activating electron withdrawing groups, and
5. SNAr reactants: a leaving group attached to an activated aromatic system (primarily
with electron withdrawing substituents in the ortho and para-positiv with respect to the
leaving group).
In addition to the five canonical domains further domains are sometimes discussed, which
involve the first order nucleophilic substitution (SN1) or a free radical route. Also, the forma-
tion of disulfides is proposed as possible separate domain (Chipinda et al., 2011), but other
authors rank them among the SN2-like reactions (Enoch et al., 2011). Anyhow, the listed
domains are not only important for skin sensitisation but link this effect to other toxicologi-
cal endpoints as pointed out in the correlation analyses between contact allergy and acute
aquatic toxicity (and mutagenicity, Mekenyan et al., 2010; Patlewicz et al., 2010). However,
differences between specific features of the domains may exist across the various endpoints
depending the particular nucleophilic target sites encountered as well as the environment of
the reaction. One example for an endpoint specific difference are hard and soft electrophile-
nucleophile-interactions, discussed further in Annex E.2.104
A major issue for the development of mechanism-based structural alerts is the activation
of pre/pro-haptens due to (in cutaneo) metabolism or via (aut)oxidation during air contact,
both of which can transform seemingly harmless molecules into potent electrophiles. The
pre/pro-haptens are often differentiated via the prefix “pre” (autoxidation with air) and “pro”
(metabolism), but in many cases it is not clear which of both activation steps takes place
and there is a controversial debate in literature whether this differentiation is useful or not
(Lepoittevin, 2006; Aptula et al., 2007; Patlewicz et al., 2016; Urbisch et al., 2016a). As in
this thesis the focus is on alert development in general and not pre/pro-alerts per se, the
combined prefix is used as convention.105
In general, taking (bio)activation into account significantly increases the model perfor-
mance (Mekenyan et al., 2012). Two principal ways can be differentiated. The first is the sep-
arate modelling of the metabolic and abiotic activation of particular compounds such as in
TIMES-SS (Dimitrov et al., 2005b; Roberts et al., 2007c; Patlewicz et al., 2008b; Mekenyan
et al., 2012; Patlewicz et al., 2014c). This offers the advantage of being transparent and
applying a mechanistically sound modelling, but introduces additional uncertainty into the
model in case errors in the metabolic step occur, e.g. due to interspecies differences. In
other words, modelling metabolism separately leads paradoxically to an increased preci-
sion by adding additional uncertainty at the same time. Moreover, calculating all possible
metabolites can lead to the drawback of disproportionally increasing the sensitivity (TPF )
104In short, hard electrophiles react preferably with hard nucleophiles and soft ones with soft counterparts. This
becomes important for the differentiation between skin sensitisation, genotoxicity, and respiratory sensitisa-
tion, as the last two endpoints primarily include hard nucleophilic target sites, while contact allergens also
attack soft nucleophilic protein residues. Moreover, hard skin sensitisers seem to be influenced by bioavail-
ability which is not the case for soft ones (cf. discussion section in the bioavailability chapter). However, the
strict differentiation in soft and hard nucleophiles is questioned in recent investigations (Slawik et al., 2017).
105A further, very recent subcategorisation of pre-haptens targets rapidly and slowly activated compounds
(Roberts and Patlewicz, 2017). The former typically exhibit a strong sensitising potential whereas the lat-
ter show a very wide variation in potency after multiple testing of the same substance (depending on the
amount of oxidised compounds, e.g. after different storage times with air contact).
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of a model (oversensitivity) and, thus, mistaking non-sensitisers as sensitising compounds,
in case the active metabolites have a low occurrence. Oversensitivity can be avoided by the
second approach – as pursued in this thesis – which involves the prediction on a theoreti-
cal level directly from the structure at hand. In this regard the modelling considers just the
initial structure for which a certain key reactive metabolite is proposed and postulates it as
pre/pro-alert. Due to the missing metabolic simulation, it must be ensured that the assumed
reactive metabolite is supported by literature (which also reduces the black box character of
the direct prediction). On the one side, this approach will be, of course, not as precise as
a separate metabolism module and is less transparent. Further, it remains an open ques-
tion whether the theoretically conceived metabolism pathways take place in reality. On the
other side, also current metabolism modules use theoretical metabolism knowledge for their
metabolite prediction (e.g. Dimitrov et al., 2005b, used a hierarchically ordered list of prin-
cipal molecular transformations). Additionally, because of its direct character the second
approach is faster,106 does not come with the expense to buy or use additional software
(which may not be readily available), and can take into account possibly disregarded or un-
noticed processes such as the release of formaldehyde from particular structures. Overall,
with enough resources available and a good metabolism model, the metabolism-simulation
approach should be superior, whereas with limited resources the second approach should
be preferred.107
7.2. Methods
From a methodological point of view the investigation conducted in this thesis is an expert-
knowledge driven approach combined with a semi-automatic (ACF) derivation of structural
alerts. Firstly, the previous knowledge was implemented and refined step by step (or alert
by alert) taking into account findings of the recent literature. Secondly, the ACF-approach
(cf. read-across section) was used to derive (further) structural fragments associated with
skin sensitisation. Thirdly, the remaining substances were sorted by chemical classes and
screened manually for the visual derivation of new alerts either grounded on a statistical or
mechanistic basis, i.e. a sufficient number of compounds was available that indicates the
inspected feature is associated with sensitisation or few compounds were available, but a
mechanistic justification can be given. This procedure was conducted for the LLNA data
first. Afterwards, the structural alert model was applied to the GPT outcomes and adjusted
for this animal test system (which does not completely correlate with the LLNA as shown
in the correlation analysis). Thereafter, step three of the alert development (sorting and
manual screening) was repeated for the remaining GPT results.
Eventually, the developed model was split into two parts. Firstly, a screening model which
is applicable to a maximum range of (theoretically) possible structures, and, secondly, a
high resolution model which is optimised towards the training set. Within this framework
106This was also an argument for its usage in this thesis, because the development of a metabolic model was
not possible due to time constraints.
107There is also the last possibility to simply exclude the substances which can subject to metabolism as being
not predictable. However, this was rejected as it would have born no additional insights and would severely
limit the applicability domain of the ultimate model.
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the structural alerts are not only able to indicate a certain effect, but also make predictions
possible for structures where further tests should be conducted. The latter would be the
case, if a screening alert is triggered, but the structure is not included in the high resolution
model. Obviously, this indicates that the performance of the alert is not sufficient for a reliable
prediction – otherwise it would be part of the high resolution model. However, exclusion of
activity (i.e. classifying the compound as non-sensitiser) is also not advised as at least some
structures show activity – otherwise the alert would not occur in the screening model. The
reasons for this may differ, e.g. it is possible that currently information is missing for reliable
classification, such as chemotype considerations, or the current test results were influenced
by impurities and thus the screening alert is not justified – which can be a result of further
investigations.
During the discussion about screening and high resolution model one question was ne-
glected: How do we measure how well individual structural alerts perform? No measure like
r2 or q2 exist. Internally, in the UFZ working group of ecological chemistry criteria for the
performance of structural alerts and preliminary alerts have been used already (e.g. tenta-
tive alerts in Ost, 2013, with differentiation between mechanistically and statistically justified
tentative alerts). However, formal criteria for alert evaluation have not been published, yet,
and are, thus, not included in this thesis. With no published criteria available the alert reliabil-
ity scheme for assessing structural alerts outlined by Mekenyan et al. (2014) and Patlewicz
et al. (2014c) was consulted. It consists of reliability classes for structural alerts which are
based on the number of compounds, which hit a specific alert, as well as the statistical
performance, which is equal to the positive predictive value (PPV ) and calculated as:
alert performance =
correctly predicted compounds
total number of compounds [meaning: hits] in training set
(10)
A prerequisite for this measure is that a mechanistic justification can be given. Statistically
justified alerts are not regarded. “The specific reliability thresholds applied [. . . ] are as
followed:
1. high performance alerts based on performance ≥60%, n ≥ 5, mechanistic justifica-
tion available;
2. low performance alerts based on performance ≤60%, n ≥ 5, mechanistic justification
available;
3. undetermined alerts based on n < 5 mechanistic justification availability but does not
take into account the performance, and
4. undetermined theoretical alerts based on mechanistic justification of the toxic end-
point.”
However, to be critical these are working definitions and whether an alert with a predictivity
of ≥60% gives already a high (!) performances is to be questioned. Therefore, the term
elevated performance is used in this thesis instead with reference to the reliability class
1 is given. Further, in this work the term undetermined alert is substituted with the word
preliminary alert, because this better reflects the not fully developed nature of these alerts.
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7.3. Results
State of research with respect to literature models. Since structural alert models for skin
sensitisation have been developed before, it is reasonable to use their knowledge as starting
point and clarify their strengths and weaknesses. Most of the publicly available former skin
sensitisation models (Barratt et al. 1994 or Zinke et al. 2002 as well as Gerner et al. 2004a
and Enoch et al. 2008a) have been incorporated into the protein binding alerts of Enoch
et al. (2011). Hence, a separate analysis of all previous structural alert models seems not
sensible and the most recent model (Enoch et al., 2011) was taken as research starting
point. This model is implemented in ChemProp (v 6.5, 2016) as well as the OECD QSAR
Toolbox (as OECD Protein binding alerts). The latter of which offers a further recent model
(OASIS protein binding alerts)108 that includes some improvements in comparison to the
OECD protein binding alerts. Both models of the QSAR Toolbox focus on alerts without (!)
abiotic and biotic activation, because autoxidation and metabolism of a target compound can
be simulated separately. However, pre/pro-alerts have been given by Enoch et al. (2011),
which is taken into account in the ChemProp implementation. Due to this computational
difference it is possible to compare the two methodological approaches – direct prediction
from structure (as pre/pro-alert) as well as the separated simulation of metabolic and air-
oxygen activation. The results for the mentioned models are depicted in table 14 for the
LLNA and the GPT, respectively.
Table 14: Statistics of literature structural alert models
LLNA data
Model name TNF TPF NPV PPV cc N %
Enoch et al., 2011 (ChemProp) 0.73 0.54 0.55 0.72 0.62 1090 100%
Toolbox OECD 0.65 0.50 0.50 0.65 0.57 1090 100%
Toolbox OECD + pre/pro 0.45 0.79 0.62 0.65 0.64 1090 100%
Toolbox OASIS 0.80 0.50 0.56 0.77 0.63 1090 100%
Toolbox OASIS + pre/pro 0.48 0.84 0.70 0.68 0.68 1090 100%
GPT data
Model name TNF TPF NPV PPV cc N %
Enoch et al., 2011 (ChemProp) 0.83 0.62 0.81 0.65 0.76 974 100%
Toolbox OECD 0.77 0.52 0.76 0.54 0.69 974 100%
Toolbox OECD + pre/pro 0.54 0.81 0.85 0.47 0.63 974 100%
Toolbox OASIS 0.84 0.54 0.79 0.63 0.74 974 100%
Toolbox OASIS + pre/pro 0.56 0.87 0.89 0.50 0.66 974 100%
TNF = true negative fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative predic-
tive value, PPV = positive predictive value, cc = concordance, N = number of compounds, % = percentage
of the overall data set; Toolbox Version 3.3.5 and ChemProp 6.5 were used for the calculations. +pre/pro =
inclusion of autoxidation/metabolism.
108Which seems to be congruent with the OASIS skin sensitisation alerts.
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Firstly, the animal test are compared. One influence besides the unequal test system pro-
tocols is the different balance of active and non-active compounds in the utilised data sets.
This has an impact onto the statistical performance. In general, the alerts perform better for
the GPT, which is likely to depend on the higher number of the non-active compounds (up to
651) that uplifts the negative predictivity (NPV , which is most dependent on the negatives
incorporated in the data set) by 20-25%-points. This fits to the fact that the positive predictiv-
ity (PPV ) in turn is approximately 10% larger for the LLNA. Again this shows the bias of the
LLNA/GPT to give predominantly (false) positive/negative results. The true fractions (TNF
and TPF ), resembling the detection of non-sensitisers and sensitisers, in turn archive higher
values for the GPT, resulting eventually in a higher concordances for the GPT.109 This means
the development of the structural alerts should primarily target LLNA data. They offer not
only more potential for improvement from a statistical perspective but also comprise more
sensitisers due to the (over)sensitivity of the LLNA and, thus, have the greater potential for
new alerts. Still, for GPT higher statistical values have to be achieved, either, to apply the
reactivity-based alerts in risk assessment.
A weakness of most models is the low TPF , signalling that several sensitisers cannot be
detected by those implementations. At least in the QSAR Toolbox models the pre/pro-alerts
are excluded by default and, hence, the prediction was repeated with the inclusion of the
autoxidation and metabolism simulator. This raised the detection rate of sensitisers (TPF )
by up to 30%-points (together with the predictivity of non-sensitisers, NPV ), while at the
same time decreasing the counter values (TNF , PPV ) substantially by up to 20%-points.
The latter two statistical parameters are connected to the false positive predictions, while
the former are influenced significantly by the false negatives. Therefore, the inclusion of
the autoxidation and metabolism lead to an increased detection of sensitisers (less false
negatives) at the cost of misclassifying several non-sensitisers (as false positives). The
inaccuracy is partly due to the fact that the prediction was made for all possible products of
metabolism and with increasing number of metabolites the likelihood of finding compounds
with structural alerts rises. A more accurate treatment of metabolites (just take the most
likely) can circumvent this problem, but is not readily available.
In contrast, the ChemProp implementation of Enoch et al. (2011) takes the way of directly
including pre/pro-alerts without further computerisation of the metabolism/autoxidation. In
general, this is better than not including the biotic and abiotic activation of chemicals at all,
demonstrated by the fact that the ChemProp implementation surpasses the directly corre-
sponding Toolbox calculations (OECD method) without the inclusion of metabolism/autoxi-
dation for most of the statistical quality criteria. In comparison to the separate simulations the
ChemProp implementation leads to a higher TNF /PPV and a lower TPF /NPV reflecting
an increased detection of non-sensitisers at the cost of misclassifying several sensitisers.
109This is odd since at least the models of Enoch et al. 2008 and 2011 – and likely the Toolbox models, either –
rely to a greater extent on LLNA than GPT data. A possible explanation for the superior GPT performance is
the lesser number of sensitisers in the GPT; fewer alerts will suffice to describe the data properly and fewer
sensitisers are overlooked due missing alerts. However, a higher false positive number and, thus, lower
TNF should be observed (it is more likely that an alert targets also non-sensitisers, in particular in the test
with the lesser sensitivity), which is not the case. It can not be excluded that this is an artefact of the data
collected. Furthermore, the LLNA performance increases markedly if the applicability domain is regarded
(cf. discussion section).
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Thus, some reactive metabolites are missed by the direct ChemProp implementation but
also overpredictions (resulting from to many metabolites) are prevented. Overall, the con-
cordance is nearly equal for both approaches in the LLNA (excluding the improvements of
the OASIS method). On the contrary, for the GPT the ChemProp implementation is even
more successful than the Toolbox with (!) metabolism/autoxidation, underpinned by the
larger concordance.
In conclusion, for both, LLNA and GPT, poor to (barely) moderate results are obtained by
the used publicly available models with a worse performance of the models on the LLNA data
in comparison to the GPT (disregarding the applicability domain, cf. below). Therefore, the
LLNA should be the prime focus of model development. Beyond that was the incorporation
of the autoxidation and skin metabolism as separate simulation (as given in the OECD-
Toolbox) ambivalent. It lead to an enhanced detection of sensitisers (increase in TPF )
on the one hand while on the other hand the predictive power towards sensitisers (PPV ) is
decreased (and vice versa for non-sensitisers). This is in accordance with the direct pre/pro-
alert implementation of Enoch et al. (2011) in ChemProp, which – despite having different
detailed statistics – obtained nearly the same concordance in the LLNA as the separate
simulation approach taken in the OECD-Toolbox. In contrast, the ChemProp implementation
was more successful for the GPT. Thus, it seems justified to not consult a separate autoxida-
tion/metabolism simulator, but make the predictions directly from structure – accepting the
limitations as outlined in the introduction. Finally, both approaches were distinctively better
than not considering metabolism at all.
Statistical performance of the new structural alert model. Based on the previous
structural alert models (Barratt et al., 1994; Zinke et al., 2002; Gerner et al., 2004a; Enoch
et al., 2008a, 2011) as well as several additional literature sources (cf. table in Annex E.8)
an updated structural alert model was developed. It includes knowledge from endpoints
which are mechanistically related to skin sensitisation e.g. mutagenicity and acute aquatic
toxicity (cf. section 4.4 and table in Annex E.8 for the used references). An overview of
the new alerts, which have not been implemented in public models, is given in figure 11.
Their proposed mechanism of (re)action is delineated in the discussion section. Older alerts
already implemented can be found in Annex E.8 and are also included in the developed
model. The following paragraphs summarise the overall alert statistics for the whole model
(new and old alerts including performance optimisations for the latter).
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Figure 11: Overview of newly implemented alerts
Not all totally new; also included are structures already known in literature but not implemented before. Not
incorporated are small improvements and low performance, screening only alerts. More information, e.g. spec-
ification of variable compound parts and reaction mechanism, are given in the respective figures of the discus-
sion section, as listed below. The used abbreviations for the reactivity domains are: Ac = acylating agent, MA =
Michael acceptor, SB = Schiff base former, SN2 = SN2 reactant, SNAr = SNAr reactant, sp = special case, p be-
fore abbreviation denotes pre/pro-alerts. The alerts for formaldehyde releasers (figure 46) and pre/pro-epoxides
(figure 54) have not been included for the sake of illustration.
NA1 fig 29 (pMA)
NA2 fig 19 (pMA)
NA3 fig 31 (pMA)
NA4 fig 35 (pMA)
NA5 fig 51 (SN2)
NA6 fig 53 (SN2)
NA7 fig 65 (sp)
NA8 fig 64 (sp)
NPA1 fig 14 (Ac)
NPA2 fig 19 (pAc)
NPA3 fig 26 (pMA)
NPA4 fig 30 (pMA)
NPA5 fig 36 (pMA)
NPA6 fig 38 (SB)
NPA7 fig 41 (SB)
NPA8 fig 40 (SB)
NPA9 fig 52 (SN2)
NPA10 fig 50 (SN2)
NPA11 fig 53 (SN2)
NPA12 fig 53 (SN2)
NPA13 fig 59 (sp)
NPA14 fig 60 (sp)
NPA15 fig 63 (sp)
NPA16 fig 61 (sp)
NPA17 fig 66 (psp)
NPA18 fig 66 (psp)
NSA1 fig 17 (Ac)
NSA2 fig 18 (Ac)
NSA3 fig 16 (Ac)
NSA4 fig 20 (pAc)
NSA5 fig 24 (pMA)
NSA6 fig 24 (pMA)
NSA7 fig 27 (pMA)
NSA8 fig 33 (pMA)
NSA9 fig 43 (pSB)
NSA10 fig 44 (pSB)
NSA11 fig 49 (SN2)
NSA12 fig 58 (SNAr)
NSA13 fig 55 (pSN2)
NSA14 fig 55 (pSN2)
NSA15 fig 60 (sp)
NSA16 fig 62 (sp)
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Table 15 contrasts the results of the structural alert compilation of Enoch et al. (2011)
(as point of reference) and the model developed during this thesis. As already explained
in the methods sections the model of this thesis is separated into three submodels: (1) a
screening approach including all possible reactive features, (2) a high resolution approach in
which the screening alerts are fitted to the respective animal test system, and (3) a combined
model that excludes substances with discordant results in the screening and high resolution
submodels (i.e. compounds which have a screening alert, but no alert in the high resolution
submodel; hence, usually the low performance alerts are excluded).
Table 15: Statistics of the developed structural alert model
LLNA data
Model name TNF TPF NPV PPV cc N %
Enoch et al., 2011 0.73 0.54 0.55 0.72 0.62 1090 100%
New model screening 0.70 0.88 0.82 0.79 0.80 1090 100%
New model high resolution 0.84 0.85 0.82 0.88 0.85 1090 100%
New model combination 0.82 0.88 0.82 0.88 0.85 1004 92%
GPT data
Model name TNF TPF NPV PPV cc N %
Enoch et al., 2011 0.83 0.62 0.81 0.65 0.76 974 100%
New model screening 0.72 0.92 0.95 0.62 0.79 974 100%
New model high resolution 0.86 0.81 0.90 0.75 0.84 974 100%
New model combination 0.84 0.91 0.95 0.75 0.86 850 87%
TNF = true negative fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative predic-
tive value, PPV = positive predictive value, cc = concordance, N = number of compounds, % = percentage
of the overall data set.
As can be seen from table 15 the updated structural alert model, which includes several
improvements and new alerts, outperformed the previous model for the LLNA as well the
GPT with a higher concordance in all cases.110 The conducted changes and additions in
comparison to the literature knowledge are delineated in the discussion section with a focus
on reactivity mechanisms. As expected, the parameters connected to false negatives (TPF ,
NPV ; detection of sensitisers, prediction of non-sensitisers) were best in the screening
approach, which is optimised for finding reactive features – rejecting the question of their
actual relevance –, while the parameters connected to false positives (TNF , PPV ; detection
of non-sensitisers, prediction of sensitisers) exhibited larger values in the high resolution
model, which is calibrated to the respective animal test system (including the question if the
structural fragment indicates a high enough reactivity). Considering that both submodels
have complementary weaknesses and strengths it is reasonable to combine them, which
indeed lead to the best overall performing model – in particular for GPT results, the LLNA
110As for the other parameters the TNF of the screening model in the GPT is worse than the literature method.
This can be explained by the fact that data set is biased towards negative data (which is test system inherent,
cf. correlation analysis), whereas the screening model was optimised towards finding active compounds.
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results differ only marginally. This, however, comes with the drawback of excluding some
substances as “unclear predictions” (contradictory predictions in the submodels), albeit the
substance loss is small with 8-13%. Otherwise this rejection is also interesting as it marks
the substance classes for which more research or more accurate data are necessary.
A further note should be given on the alert reliabilities. The high resolution model includes
alerts with elevated reliability as well as preliminary alerts. Obviously, the latter of both
are supported by mechanistic reasoning but not by proper statistics (and, thus, remain at
least to some degree speculative). Setting aside the 34 preliminary alerts would result in
a loss of substances of approximately 4% and 2% in the LLNA and GPT, respectively, with
an associated loss in TPF (the main affected parameter) of approximately 1% and 2% in
comparison to the high resolution models. For details the reader is referred to Annex E.9.
However, as the impact of the preliminary alerts onto the statistics of this data set seemed
small, it was decided to include also the preliminary alerts in the final model, but indicate in
the output that their reliability is reduced – for the sake of a broadened domain of applicability
and to prevent the loss of specificity for new substances (and, thus, prevent misclassifying
potential sensitisers).
7.4. Discussion
Domain of applicability. One point to consider regarding the analysed literature models
is a restricted domain of applicability. This parameter has to be regarded to give a more
fair comparison and to derive more precisely what advances have been made during this
thesis.111 However, the present reference model (Enoch et al., 2011) can not be taken
directly for this exercise, because its training set is not available.112 Fortunately, the domain
of applicability can be calculated for the SMARTS string method of Enoch et al. (2008a) as
the complete training set is available. The author used the data of Gerberick et al. (2005),
which can be targeted to derive the (structural) domain of applicability by applying method
of Ku¨hne et al. (2009). Subsequently, the differentiation of compounds inside and outside
of the applicability domain of the model of Enoch et al. (2008a) can be used for a more
sophisticated comparison to the model developed in this thesis as well as the related model
of Enoch et al. (2011).113 The results of this exercise are illustrated in table 16.
As to be expected, a substantial increase in statistical performance can be obtained for
the SMARTS strings of Enoch et al. (2008a) due to considering the structural applicability
domain (about 19% and 13%-points for the concordance in the LLNA and GPT, respectively).
It even equilibrates the LLNA-GPT-differences mentioned beforehand.114 In contrast to the
111As side note, this is relevant with respect to the critical structural alert review of Alves et al. (2016). They
compared structural alert models to QSARs without calculating a possible domain of applicability for the
alerts (but did so for QSAR models) leading to a biased comparison of both.
112And might be not be available in principle, because the model relies on literature knowledge (of different
endpoints) with refer partly to theoretical considerations for which no specific data set can be given. Still,
there are (unpublished) ways to calculate the applicability domain of models for which no training set data
are at hand (Schu¨u¨rmann, 2017, personal communication).
113Which includes additional alerts, can be seen as extension and improvement of the 2008 method, and should
be able to operate within the applicability domain of the 2008 model, which was one source for the 2011
developments.
114Also observed for this method, cf table 16. The differences are equilibrated at least for the concordance. The
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Table 16: Statistics of the structural alert models with applicability domain
LLNA data
Model name TNF TPF NPV PPV cc N %
Without applicability domain
Enoch et al., 2008 0.53 0.69 0.57 0.66 0.62 1090 100%
Enoch et al., 2011 0.73 0.54 0.55 0.72 0.62 1090 100%
New model combination 0.82 0.88 0.82 0.88 0.85 1004 92%
Inside the applicability domain of Enoch et al., 2008
Enoch et al., 2008 0.50 0.91 0.63 0.86 0.81 258 24%
Enoch et al., 2011 0.72 0.65 0.38 0.88 0.66 258 24%
New model combination 0.65 0.95 0.77 0.92 0.90 239 22%
Outside the applicability domain of Enoch et al., 2008
Enoch et al., 2008 0.54 0.58 0.56 0.56 0.56 832 76%
Enoch et al., 2011 0.65 0.43 0.53 0.55 0.54 832 76%
New model combination 0.84 0.84 0.83 0.85 0.84 765 70%
GPT data
Model name TNF TPF NPV PPV cc N %
Without applicability domain
Enoch et al., 2008 0.66 0.79 0.86 0.54 0.70 974 100%
Enoch et al., 2011 0.83 0.62 0.81 0.65 0.76 974 100%
New model combination 0.84 0.91 0.95 0.75 0.86 850 87%
Inside the applicability domain of Enoch et al., 2008
Enoch et al., 2008 0.73 0.92 0.90 0.78 0.83 166 17%
Enoch et al., 2011 0.83 0.56 0.65 0.77 0.69 166 17%
New model combination 0.84 0.95 0.93 0.87 0.90 145 15%
Outside the applicability domain of Enoch et al., 2008
Enoch et al., 2008 0.65 0.74 0.85 0.48 0.68 808 83%
Enoch et al., 2011 0.77 0.51 0.78 0.48 0.69 808 83%
New model combination 0.84 0.90 0.95 0.71 0.86 699 72%
TNF = true negative fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative predic-
tive value, PPV = positive predictive value, cc = concordance, N = number of compounds, % = percentage
of the overall data set, All applicability domain calculations were executed using the respective ChemProp
(version 6.5) module.
increase in performance the number of predicted compounds dropped to 24% and 17%
of the whole data set, indicating that a significant degree of the compounds are residing
negative statistical parameters are still better in the GPT and positive ones are still better in the LLNA –
as to be expected from the distribution of active and non-active compounds in the data sets as well as the
trends/bias observed in the correlation analysis.
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outside the domain of applicability. The latter of which exhibit a significantly lower statistical
performance in both animal tests (cf. table 16). Further developments have to consider
these compounds (outside the domain) particularly, which was done in this thesis. Still, as
explained beforehand the focus should be the LLNA data, because they have an inferior
overall performance for data outside of the applicability domain, are based on the more
sensitive test system, and offer more positive data to derive new alerts.
To underpin the advances made during this thesis it was analysed how the model devel-
oped in this thesis as well as one further literature model behave in contrast to the approach
of Enoch et al. (2008a). The literature comparison with Enoch et al. (2011) is interesting for
clarifying, if the broader 2011 approach, which includes the 2008 alerts plus several (the-
oretical) considerations and improvements, can compete with the more skin sensitisation
specific 2008 method. However, concerning the protein bind alerts of Enoch et al. (2011) it
is important to note that they were not developed for such an analysis and, thus, this com-
parison is not completely fair. Their domain of applicability is most likely not equal to the
domain of the 2008 model, they target other protein binding related endpoints as well (e.g.
aquatic toxicity), and they are primarily intended as classification support instead of being
a precise prediction tool.115 This is reflected by the statical performance parameters which
were normally better for the 2008 SMARTS strings than the 2011 alerts for compounds in-
side the domain of applicability of the 2008 model. The exception is the TNF in both animal
models. This can be explained by the fact that the 2008 alerts were optimised towards the
detection of sensitisers and, thus, accepting that the detection of non-sensitisers is worse.
Interestingly, the models of Enoch et al., 2008a, and 2011 showed a similar performance
outside of the applicability domain of the 2008 data set.116 This indicates further that the
applicability domain of the model of Enoch et al. (2011) is not much wider than the domain
of Enoch et al. (2008a) at least with respect to the data analysed in this thesis. This is
supported by the fact that at least for the LLNA the performance of the 2011 alerts is better
inside the domain of the 2008 approach than outside of it. However, its overall performance
(without considering the applicability domain) is better than Enoch et al. (2008a).
Finally, although the model developed in this thesis bears a greater substance loss117 it of-
fers several improvements for both, compounds inside as well as outside of the applicability
domain of the model of Enoch et al. (2008a). As expected, the made advances are signifi-
cantly larger outside of the domain of applicability with a focus on the LLNA improvements
(10% and 7%-points, inside, vs 28% and 17%-points, outside the applicability domain, on
115Strictly, the latter is also true for the 2008 model.
116In detail, the TNF was better in the 2011 model, whereas the 2008 model had a better TPF . The concor-
dance as well as the predictive values (PPV , NPV ) are nearly identical for both with the exception of the
higher NPV of the 2008 method with respect to the GPT data outside of its domain.
117Due to the exclusion of alerts with significant performance differences in the screening and the high resolution
model. In detail, it is bigger for the compounds outside the domain of applicability of Enoch et al. (2008a) than
for the compounds inside, which can be explained by the fact that the compounds (or compound classes)
inside this domain are better known in literature and have been discussed intensively. Furthermore, the
larger loss in the GPT in comparison to the LLNA is related to the fact that more alarms are equivocal for the
former animal test system. This is an indication that the alert development in the GPT is more complicated,
e.g. because the GPT are harder to assess (and, thus, their data offer a greater uncertainty) and are less
sensitive – as shown in the correlation analysis – meaning they are less suited for detecting weakly reactive
compounds.
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average in the LLNA and GPT, respectively).118 Only the TNF in the LLNA is the same or
better in the model of Enoch et al. (2011) – at the cost of the other statistical parameters.
Overall, a moderate to good performance was reached by utilising the combined model of
this thesis for the known (inside the domain of Enoch et al., 2008a) and, in particular, for the
new compounds (outside the domain of Enoch et al., 2008a).
In summary, in accordance with literature knowledge (e.g. Ku¨hne et al., 2009; Teubner
et al., 2013) the statistical performance of literature structural alerts can be increased sig-
nificantly on the one hand, if they are restricted to their respective domain of applicability.
This was demonstrated for Enoch et al. (2008a), for which the training set was available. On
the other hand – also in accordance with Teubner et al. (2013) –, the applicability domain of
literature models is substantially limited, which stems from the small data sets on which the
models were developed. This in turn means the collected data offered a significant amount
of the compounds that reside without the domain of applicability, which fuelled the devel-
opment of new alerts. In the end, the model developed in this thesis exhibits significant
improvements inside as well as outside the applicability domain of Enoch et al. (2008a) and
obtained moderate to good overall statistics for both domains. Obviously the model devel-
oped here constitutes a new, larger domain of applicability based on the data set collected
for this thesis – which has to be regarded for its application. Ultimately, the made advances
shall be discussed in the next sections.
New alerts and their mechanisms. It is of little value to reiterate the vast body of already
available literature (cf. Annex E.8) on reactivity-driven structure-activity relationships in skin
sensitisation, which would be a suitable task for a review article. Instead it is reasonable to
focus on the differences to previous structural alert models and what advances were made
during the course of this thesis. This includes on the one hand previously unimplemented
literature knowledge and on the other hand completely new alerts. The discussion of both
will be delineated with respect to the well-known reactivity domain. For the complete struc-
tural alert model with several literature references as well as the performance of already
proposed alerts, the reader is referred to Annex E.8 and E.9.
Acylating agents. An acylation is a nucleophilic substitution at an acyl group with an ad-
jacent leaving group as depicted in figure 12. The lone pair of electrons of a nucleophile (for
example of sulphur in cysteine or nitrogen in lysine) attacks the positively polarised carbonyl
carbon and a tetrahedral anionic intermediate is formed. Afterwards, the leaving group –
which should have a sufficiently stable/acidic corresponding anion – dissociates from the in-
termediate and the carbonyl function is restored. Thus, an exchange of the nucleophile and
the leaving group has occurred. The latter is not necessarily separated from the attacked
compound but can stay attached, e.g. in ring opening acylations. This mechanistic domain
also includes similar reactions at thioacyl, sulphonyl, and phosphoryl compounds (Aptula
and Roberts, 2006). In general, the quality of the leaving group (i.e. how acidic is the cor-
responding expelled anion or how good is it stabilised, respectively) dictates how readily
the acylation reactions occurs and, hence, how strong the sensitising effect of a chemical
is (cf. for example Aptula et al., 2005; Aptula and Roberts, 2006; Enoch et al., 2011). For
118As analysed beforehand the LLNA was the main focus for improvements due to the lesser statistical perfor-
mance in the older structural alert models and, thus, it is suitable that more advances were made here.
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an overview of already proposed acylation alerts such as acid halogenides, anhydrides,
thioesters, iso(thio)cyanates, β-lactams, and azlactones, amonst others, the reader is re-
ferred to Annex E.8 and the literature cited therein.
Figure 12: General acylation reaction mechanism. X = good leaving group (e.g. those of
figure 48.
New alerts and improvements have been visually derived from the data at hand for the
acylation domain. Those comprise two new alerts for the “simple” (=non-ring opening) acy-
lation reactions, namely (a) (activated) salicylates esters as well as (b) succinimidyl es-
ters and carbonates, which are depicted in figure 13 and will be explained further below.
Alongside, small modifications have been introduced to include substances, which should
be identified according to previous structural knowledge, but for which the alerts were not
implemented broad enough. For instance, phosgen reacts like other acid halogenides with
attached chloride leaving group, but was not detected by former models, because they spec-
ify acid halogenides as a RC(=O)X-structure (with R = an aliphatic or aromatic carbon and X
= any halogen atom). For this reason phosgen with XC(=O)X is not incorporated. The same
is true for cyanamide, which has a potentially reactive diimine tautomere (which is a known
literature alert, cf. Annex E.8).
Figure 13: New simple acylation alerts. 1 (activated) salicylates esters, 2 succinimidyl esters
and carbonates (R = C or O), 3 phosgen, 4 cyanamide and its diimine tautomere.
(a) During the alert development several lines of evidence pointed towards a positive sen-
sitising effect of salicylate esters. This is interesting, because this alert seems to be specific
for the LLNA in which it is positive for 4 substances, but none of the 8 tested salicylates was
positive in the GPT (cf. Annex E.9).119 A direct example is hexyl salicylate which is positive
in the LLNA but negative in the GPMT. Its human data are borderline positive (cf. correlation
analysis). One possible explanation is a very weak reactivity of the salicylate esters due to
an acylation at the ester function as in figure 14. There the ortho hydroxy-group is key to
the activation of the ester attached to the aromatic system, since it stabilises the interme-
diary negative charge at the carbonyl oxygen via hydrogen bonding (in analogy to aromatic
aldehydes and ketones, Roberts and Aptula, 2015).
119Thus, this alert is an example for a derivation solely based on positive LLNA data. As seen in the correlation
analysis further mechanistic considerations are needed to exclude a false positive.
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Figure 14: Putative acylation reaction of salicylates esters with nucleophilic groups of pro-
teins. R = carbon.
However, phenyl esters are typically not reactive (cf. Roberts et al., 2007c), because
alkoxides are bad leaving groups.120 Therefore, a depiction of the salicylate esters found
positive in the LLNA is given in figure 15.
Figure 15: Salicylate esters found positive in the LLNA. 1 atraric acid methyl ester, 2 methyl
salicylate, 3 hexyl salicylate, 4 benzyl salicylate, 5 (4Z)-hept-4-en-2-yl salicylate.
Further inspection reveals that for three of the substances other reactions are possible.
Atraric acid methyl ester (1) can react via a quinone methide formation (a quinone in which
one carbonyl group is replaced by a terminal C-C double bond, cf. number 9 in figure 23)
after metabolic activation. Benzyl salicylate (4) can undergo a SN2 reaction (cf. figure 47)
at the benzoylic carbon with salicylate acid as (good) leaving group. For (4Z)-hept-4-en-
2-yl salicylate (5) an autoxidation of the double bond is conceiveable leading to a reactive
epoxide compound (which is not found for every double bond, cf. discussion on pre/pro-
SN2 compounds below). Finally, we are left with methyl121 (2) and hexyl salicylate (3) which
are both sensitising and can be only be explained by this mechanism, in case they are
true positives. However, at least for methyl salicylate it is reported that an irritating effect
is confounding the LLNA results (Montelius et al., 1998). This should be checked for hexyl
salicylate, either, to exclude a false positive.122
120In contrast to the phenolate anion which is a good leaving group included in phenyl benzoates/salicylates.
The latter compounds are well-known sensitisers and fall under the long-established alert for phenyl esters
(Barratt et al., 1994; Zinke et al., 2002).
121Strictly methyl salicylate is not counted among the 4 positive salicylate esters above, because there are also
several negative LLNA results for this compounds. It is not fully clear if the 6 positive test results (primarily
reported by Montelius et al., 1998) are correct, which all show a weak sensitisation, or if the 12 negative
results are right, which do not always reach high enough concentrations.
122Recent investigations (Api et al., 2014; Safford et al., 2015; Roberts et al., 2015) highlight the anomalously
high EC3 value of this compound in its LLNA, which could be explained by confounding via irritation or a
reactive impurity. A retesting or reanalysis is advised.
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As further confounding factor salicylates are well-known modulators of inflammatory reac-
tions (with acetylsalicylic acid, short ASA or Aspirin, being the most prominent). They bind
covalently to cyclooxygenases (cf. textbooks of pharmacology, e.g. Aktories et al., 2005)
and inhibit the arachidonic acid metabolism as well as the prostaglandin synthesis. There-
fore, it should be checked whether the reaction in the LLNA is due to the modification of the
inflammation reaction (e.g. an modified IL-1α-release, which is connected to several LLNA
false positive reactions, cf. correlation analysis section or Ball et al., 2011). However, the
alert is still included in the final model, because it can be applied for flagging the group as
LLNA false positive, in particular if this is verified for further salicylate esters.
(b) The second new simple (non-ring opening) acylation alert is not described in any skin
sensitisation literature before. Even though it is based on just one substance it should be
regarded as well-founded, because succinimidyl esters are regularly used to modify primary
amines (Kalkhof and Sinz, 2008; ThermoFisher, 2010, therein also tetrafluorophenyl (TFP)
esters and sulfodichlorophenol (SDP) esters – for which no sensitisation data are available –
are mentioned as suitable amine modifying agent), which are represented by lysine residues
in a biological environment. The associated reaction is shown in the figures 16. The N-
oxysuccinimidyl anion is considered a very good leaving group due to its highly delocalised
electron density.
Figure 16: Acylation reaction of succinimidyl esters and carbonates (R = C or O) with nucle-
ophilic groups of proteins (ThermoFisher, 2010).
In addition to the simple acylation alerts, also two ring acylation alerts are newly included.
These are benzoxazinones and 5,6-dihydrocoumarines for both of which the respective re-
actions with proteins are shown in figure 17 and 18. The latter substances were reported
in the early literature on reactivity domains (Aptula et al., 2005; Roberts et al., 2007b), but
did not find its way into previous structural alert models. Also, benzoxazinones were already
described (in Patlewicz et al., 2008b) and are related to acylating azlactones, but have not
been implemented in openly available structural alert models. Both alerts are preliminary
with one active substance in the LLNA (cf. Annex E.9 alert 13D and 13E), but fit well into
the mechanistic scheme of ring-opening acylating reactions and, thus, a generalisation is
plausible.
pre/pro-acylating agents. Seven pre/pro-acylating alerts have been included in the
model (shown in figure 19). Six of those are not based on skin sensitisation data, but con-
siderations concerning the metabolism of pro-mutagens (e.g. Kalgutkar et al., 2005; Enoch
and Cronin, 2010; Benigni and Bossa, 2011). In principle, the same rules should apply
to pre/pro-protein reactive sensitisers. Mekenyan et al. (2010) and others already showed
that knowledge of reactivity-based mutagenicity alerts is usable to infer a skin sensitisation
potential (but not vice versa), albeit the author demonstrated this for directly reactive com-
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Figure 17: Acylation reaction of benzoxazinones (a 6-ring azlactone fused with an aromatic
system) with nucleophilic groups of proteins.123
Figure 18: Acylation reaction of Dihydrocoumarines with nucleophilic groups of proteins.
pounds and not for pre/pro-alerts. Differences between skin and other metabolism pathways
will play an important role (Go¨tz et al., 2012a; Ja¨ckh et al., 2012; Wiegand et al., 2014). In
this regard, the suggested new alerts compose an important area of further research as only
few alerts are backed up by data. Most alerts remain theoretical (cf. Annex E.8 and E.9).
Figure 19: Alerts for pre/pro-acylating compounds (X = halogen, R = aliphatic carbon). 1
1,1-dihaloalkanes, 2 1,1,1-tri- (R = C) and tetra-haloalkanes (if R = X), 3 thiazo-
lidinedione, 4 formamide, 5 sulfonylurea, 6 benzylamines, 7 isonitriles.
For the alerts which have data the performance is preliminary. For example, formamides
identify 2 sensitisers (1 LLNA, 1 GPT), but also mark 3 non-sensitisers (1 LLNA, 2 GPT). An-
other non-theoretical alert are the 1,1,1-tri- and tetra-halogen compounds.124 Benigni and
Bossa (2011) discuss the emergence of reactive radicals during the metabolism of tetra-
chloromethane, which ultimately result in the formation phosgen and is a plausible way for
123Theoretically, also compounds for which the carbonyl O is replaced by a S (thioacyl) as well as compounds
where the N in the azlacton is replaced by a C (and the double bond stays intact; including smaller ring
systems e.g. 5,6-dehydropyrones) should react in the same manner. Strictly, for thioacyl compounds the
reaction would be a thioacylation.
124These react not with an SN2 mechanism, because of “adverse non-bonding interaction between the lone pairs
of the halogen and the incoming nucleophile” (Aptula and Roberts, 2006).
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1,1,1-tri-halogen compounds, too. Overall the alert for these compounds is preliminary, as
sensitising reactions are observed only occasionally (1 sensitiser in the LLNA and 1 sensi-
tiser in the GPT amongst 2 non-sensitisers in the latter test system).
Finally, a new pre/pro-acylation alert is proposed within this thesis for which no refer-
ence regarding its metabolism was found. Within the data set one compound was detected,
which bears an isonitrile function that can be metabolised to an isocyanate as portrayed in
figure 20. Alternative also a direct reaction with nucleophilic groups is possible.
Figure 20: Activation isonitriles and subsequent acylation reaction with nucleophilic groups
of proteins. [O] denotes the insertion of an oxygen typically mediated by cy-
tochrom P450 enzymes.
Michael acceptors. In the domain of Michael acceptors a great body of existing literature
describes several direct alerts for skin sensitisation (cf. Annex E.8). In general, a Michael
acceptor consists of an electron withdrawing (activating) group (e.g. a carbonyl, nitro, es-
ter) with an adjacent unsaturated bond (i.e. a double or tripple bond) in α,β-position, for
instance C(=O)Cα=Cβ. Due to the electron withdrawing effect the β-position is positively
polarised as shown in the example of α,β-unsaturated ketones in figure 21. Therefore, a
nucleophile is able to attack at this position leading to the formation of an enolate anion. The
initial carbonyl function is restored if a proton is added and a tautomerisation of the resulting
enol to the more stable ketone takes place. The strength of the reaction primarily depends
on the strength of the electron withdrawing group (e.g. nitro groups offer a stronger elec-
tron withdrawal than ketones or esters) and the fact if the unsaturated bond is substituted
with electron donating substituents or not (which leads to unfavorable steric and electronic
effects, cf. structural alert introduction or e.g. Schultz et al., 2009; Bo¨hme et al., 2010;
Wondrousch et al., 2010; Blaschke et al., 2012).
Some advances for the Michael acceptor alerts have been introduced by the differentia-
tion between screening and high resolution model, i.e. low performance alerts have been
removed from the latter. The respective removed structures are depicted in figure 22. All
of these compounds exhibit a low reactivity from a chemists perspective. Hence, they are
hard to detect, are prone to (false) negative results, and are considered just as screening
alerts (which is reflected by their statistics, cf. Annex E.9 alert 21A). Firstly, it is known that
the Michael reactivity of molecules is significantly reduced by carbon substituents in the α-
position such as in methacrylates and their related ketones (Schultz et al., 2009; Bo¨hme
et al., 2010; Blaschke et al., 2012). Several of these compounds give (false) negative out-
125As mentioned in the structural alert introduction the often made assumption that a Michael reaction only occurs
with soft nucleophiles (such as thiols) is questioned by recent investigations, e.g. Slawik et al. (2017).
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Figure 21: (a) General Michael addition mechanism (Q = electron withdrawing group) and
(b) concrete example for Michael acceptor ketones.125
comes particularly in GPT126 and, thus, have been excluded from the high resolution mod-
els.127 Also the weakly reactive Michael acceptor amides or acids lead to low performing
results (amides: 2 out of 8 compounds sensitise in the LLNA and 2 out of 3 in the GPT;
acids: 1 out of 5 in the LLNA and 2 out of 4 in the GPT). The reactivity of the former is de-
creased by a reduced polarisation of the carbonyl C (and the β-C) due to the lone pair of the
amine, which can shift electron density towards the carbonyl by a positive mesomeric effect.
The same is true for the Michael acceptor acids, particularly in case they are deprotonated
(which will depend on the concrete pK a and the vehicle applied), because the electron with-
drawing effect of the carbonyl O can be compensated by redistributing electron density from
the charged O (Bruice, 2007).
Figure 22: Weakly reactive Michael acceptors excluded in the high resolution models: 1
methacrylate-like ketones (excluded just for GPT not the LLNA), 2 methacrylates,
3 α,β-unsaturated amides (+ mesomerism), 4 α,β-unsaturated carbonic acids (+
mesomerism after deprotonation).
Furthermore, some small improvements have been added. These concern the addition of
thiadiazoldioxides as alert, which is supported by one compound (3-Methyl-4-Phenyl-1,2,5-
thiadiazol 1,1-dioxide, cf. Annex E.10) and has been discussed in literature (Patlewicz et al.,
2008b), but was not implemented in public structural alert models, yet. Moreover, it is clari-
126Which seem to be less sensitive than the (oversensitive) LLNA. The reader is referred to Kimber and Pember-
ton (2014) for a discussion of this particular compound class.
127Both classes for GPT and only the less reactive methacrylates for the LLNA.
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fied that the activation of Michael acceptor double bonds with (hetero)aromatic groups, which
is a very broad description in the model of Enoch et al. (2011), is more accurately described
as activation by 2-pyridino, 4-pyridino,128 pyrimidino, and triazine (most of them are theo-
retical, though).129 Finally, two additional theoretical electron-withdrawing groups (nitroso
and alkyl-sulfone) have been added for polarised alkenes and alkynes. The structures are
illustrated in figure 23.
Figure 23: Small (mostly theoretical) improvements in the Michael acceptor domain. 1 thia-
diazoldioxides, 2 α,β-unsaturated nitroso compound, 3 α,β-unsaturated alkyl-
sulfones, 4+5 α,β-unsaturated pyridines, 6+7 α,β-unsaturated pyrimidines, 8
α,β-unsaturated triazines, 9 quinone methides, 10 pyranones. For 9 and 10 also
the respective ortho variants are conceivable and new alerts concern compounds
with O to N substitution. Analogous compounds of 2-8 are possible for alkynes.
Lastly, theoretical additions have been made concerning pyranones and quinone methides
in which the O is replaced by a N-atom (different variations, documented in Annex E.8, alert
23A+23B). Of those the pyranones with a O-to-N-substitution in the ring (= pyridinone) have
also been described in a publication by Rodriguez-Sanchez et al. (2013), but the authors
categorise this alert into the domain of acylating agents. However, this is not based on data
such as actual adduct formation patterns, but the observation that the compounds do not
react with cysteine. The latter is taken as indication that no classical soft Michael reaction
takes place, but according to recent investigations in the working group of ecological chem-
istry (Slawik et al., 2017) Michael acceptors can also form adducts with hard nucleophiles,
e.g. lysine, and, thus, the compounds can still be Michael acceptors.
pre/pro-Michael acceptors. Several advances have been derived from animal sensiti-
sation data in the pre-/pro-Michael acceptor domain. Firstly, additions have been made to
the known pre/pro-Michael acceptor alcohols alert for which the alcohol function in princi-
ple can be substituted with (a) amines, (b) methoxy ethers, or (c) sulphurous acid esters
(figure 24). That these groups can be similarly treated as the α,β-unsaturated alcohols is
derived from (a) the metabolisation of amines to aldehydes (well-know metabolic step in the
pre/pro-Schiff base domain),130 (b) from the transformation of methoxy groups to alcohols
128Both of which also listed in Aptula and Roberts (2006).
129The latter four compound classes can also be regarded as pre/pro-SN2 compounds via an epoxidation of the
double bond, cf. pre/pro-SN2 section).
130This is substantiated by calculations with the skin metabolism simulator of the OECD toolbox, which lists an
alert for α,β-unsaturated aldehydes after application of the simulator for an example compound. Unfortu-
nately, the concrete structure is not depicted by the OECD toolbox.
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(e.g. dealkylation of (iso)eugenol, cf. Bertrand et al., 1997), and (c) from the possible hy-
drolysis of sulphurous acid esters next to a double or tripple bond, which would result in a
allyl/propargyl alcohol. Nevertheless, these alerts remain preliminary (or theoretical). The
primary source for their derivation are two substances: 8-methoxy-1,6-octadiene for the allyl
methoxy ethers and 2-(4-tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite for the propargyl
sulphurous acid esters (depicted in Annex E.10).
Figure 24: Activation and subsequent Michael reaction of several pre/pro-Michael acceptors
(allyl alcohol type; a propargyl tripple bond is also possible) with nucleophilic
groups of proteins. For the catalysis with MOA a cofactor (NADPH) is required,
which is not shown (also in the following schemes).
A further group of alerts for pre/pro-Michael alkenes, for which more research is needed,
are furans and thiophens (1 in figure 25). They can be metabolically activated to α,β-
unsaturated compounds according to investigations with mutagens (Kalgutkar et al., 2005;
Enoch and Cronin, 2010), but a verification for skin sensitisation is lacking compelling ev-
idence. For furans only 2 out of 4 compounds are sensitising in the LLNA. Furthermore,
1 GPT negative substances is available. For the thiophens only 1 out of 2 compounds is
positive in the LLNA and 1 further sensitiser is observed in GPTs. With this data available,
both should be treated as (preliminary) screening alerts, until further evidence emerges.
Moreover, various additions (as well as some clarifications) have been made to the well-
described alerts for ortho and para pre/pro-quinone molecules.131 These are shown in fig-
ure 25 and comprise (a) phenothiazines, (b) methylene-dioxyphenyl as well as tetrahydro-
quinoxaline, (c) ortho or para N-diaromatic diamines, (d) N-N-alkyl-anilines with a free para
position, (e) ortho and para nitrophenols, (f) ortho and para-nitro-(N-alkyl)-anilines. It should
be mentioned here that also two further individual sensitising phenols, i.e. 4-Phenylphenol
and 4-Hydroxystilbene, have been added due to a possible quinone formation after hydrox-
ylation and oxidation (depicted in Annex E.10).
(a) Firstly, the photosensitising potential and liver toxicity of phenothiazines (2 in figure 25)
was already discussed in the correlation analysis section, but the concrete mechanism was
not shown. A proposal for the reactivity towards nucleophilc groups after metabolic activation
is given in figure 26 (taken from hepatotoxicity investigations in which GSH-adduct-formation
131Which have detailed alerts in Enoch et al., 2008a and are treated astonishingly brief in Enoch et al., 2011; for
the skin sensitisation mechanism cf. in particular Aptula et al., 2009).
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Figure 25: New pre/pro-Michael acceptor alerts. 1 furans and thiophens (Y = O or S), 2
phenothiazines, 3 methylene-dioxyphenyl, 4 tetrahydro-quinoxaline, 5 ortho or
para N-diaromatic diamines (only para depicted), 6 N-N-alkyl-anilines with a free
para position, 7 ortho and para nitrophenols (only para depicted), 8 ortho and
para nitro-(N-alkyl)-anilines (only ortho depicted).
was demonstrated; Wen and Zhou, 2009). As in several of the other (subsequent) alerts, a
free para position and an opposing nitrogen are required for this alert. Though, the statistics
mark this compound class as an preliminary alert with 1 LLNA and 1 GPT sensitiser only.
No data on compounds with a blocked para position (and, thus, inhibited initial metabolic
step) are available, which would make interesting subjects of further research.
Figure 26: Reaction of Phenothiazines with nucleophilic groups of proteins (according to
Wen and Zhou, 2009). Ox denotes an (aut)oxidation of the compound, often
catalysed by cytochrom P450 reductase (cf. Schu¨u¨rmann et al., 2016 for an
example of quinone redox behaviour).
(b) Secondly, an additional metabolic alert not yet considered in skin sensitisation – but
in mutagenicity (cf. Kalgutkar et al., 2005; Enoch and Cronin, 2010) – is available, i.e
methylene-dioxyphenyls (3 in figure 25) that can metabolised to an ortho quinone after
dealkylation of the bridged carbon. However, this alert should be consulted for screening
purpose only, as most of the found sensitisers (4 out of 6 compounds in the LLNA and 1
out of 2 in the GPT) contained also other alerts (portrayed in Annex E.10). For a similar
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substance (namely tetrahydro-quinoxaline, 4 in figure 25) a completely new metabolic alert
is proposed, which is on a preliminary level with just one substance available. The probable
metabolism for this substance group is shown in figure 27.132
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Figure 27: Metabolic activation of tetrahydro quinoxaline. The further fate of the oxidised
and detached C-C-bridge (which is a 1,2-diketone) is neglected at this point. Also
other metabolic mechanisms are conceivable, e.g. hydroxylation in the ortho or
para position of the emerging NH2.
(c) Thirdly, the proposed reactivity after metabolism of ortho or para N-diaromatic diamines
(5 in figure 25) is backed up by findings in the literature (but was not included in previous
structural alert models). Naisbitt et al. (2007) suggested this metabolic activation for the
allergenicity of Diclofenac (figure 28, next page). The addition of an amine function in ortho
or para position to the secondary amine group, which is located between both aromatic sys-
tems, should facilitate the formation of reactive metabolites due to predetermined oxidation
at the additional amine group (cf. figure 29, next page).133 Overall, this alert has an elevated
performance, with 5 LLNA positive compounds, 6 GPT sensitisers and 2 counterexamples
(non-sensitisers).
(d) Fourthly, from a mechanistical point of view also N-N-alkyl-anilines with a free para
position (6 in figure 25) will have a similiar underlying sensitisation reaction as Diclofenac,
which is illustrated in figure 30 (page after the next page). They are activated via a hydroxy-
lation of the aromatic ring system in the para position (which has to bear no substituents for
this reason, cf. also Roberts et al., 2007c). As indicated, for this alert literature knowledge
is available, but was not properly implemented in previous structural alert models. However,
with 2 sensitisers available in the LLNA and 1 in the GPT the alert is on a preliminary alert
reliability level.
(e) Fifthly, nitro groups in para and ortho position to a hydroxy group (7 in figure 25) have
been added as already described in Roberts et al. (2007c); Ost (2013). Again more use
132The respective metabolism is not found in literature, but can be derived by the skin metabolism simulator of
the OECD toolbox, which lists an alert for 1,2-dicarbonyls after calculating the transformations of tetrahydro-
quinoxaline. This is likely the detached C-C-bridge, which should be glyoxal (C2H2O2); the correspond-
ing ortho phenyl-diamine is not detected by the toolbox skin sensitisation alerts, because it needs to be
(metabolically) oxidised to become a sensitiser and, thus, follow-up metabolic calculations beyond the pri-
mary metabolites would be necessary. Unfortunately, the concrete structures are not depicted by the OECD
toolbox.
133Several variants were tested for this alert. However, the performance of a simple N-diaromatic amine alert
without the opposing amine function was not sufficient and is used for screening only.
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Figure 28: Michael reaction of Diclofenac with nucleophilic groups of proteins after metabolic
activation (taken from Naisbitt et al., 2007). A similar reaction is possible for other
N-diaromatic amines, see figure 29. Mind that also a SN2-like reaction with the
chlorines at the double bond is conceivable (cf. Mbiya et al., 2016).
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Figure 29: Michael reactivity of para N-diaromatic diamines with nucleophilic groups of pro-
teins after metabolic activation (a similar pathway is likely for ortho N-diaromatic
diamines; R = C or H). For compounds with an para/ortho NH2-group also the for-
mation of a Wu¨ster-type radical (see Sto¨rle and Eyer, 1991; Aptula et al., 2009)
should be considered. Further, a reaction involving a hydroxylamine formation
is conceivable (Ji and Schu¨u¨rmann, 2013). Studies with concrete adducts are
missing currently.
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Figure 30: Michael reaction of N-N-alkyl-anilines after metabolic activation (according to
Roberts et al., 2007c; R = C).
could have been made of available literature knowledge – this time on the keto-aci tau-
tomerism of nitrophenols (cf. Roberts et al., 2007c; Ost, 2013, for the reaction mechanism).
With both alerts (ortho + para) 8 sensitisers (and 1 non-sensitiser) have been detected (cf.
Annex E.9). Thus, taken together both alerts have a elevated performance while their indi-
vidual performance is at a preliminary state.
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Figure 31: Activation of ortho nitro-(N-alkyl)-anilines and subsequent reaction with nucle-
ophilic groups of proteins (R = C or H). Mind the stabilisation due to hydrogen
bonding, which is not able for the (theoretical) para alert.134
(f) Lastly, a similar mechanism explains the sensitising potential of ortho and para-nitro-
(N-alkyl)-anilines (8 in figure 25; also the respective non-alkylated annilines are included,
but most have additional alerts) as shown in figure 31. The ortho nitro compound should be
more reactive, because the intermediary quinone structure can be stabilised via hydrogen
bonding. This is only possible for monoalkylated or unalkylated amines and it is surprising
that positive data are reported for one N-N-dialkyl-aniline with an ortho nitro function (Tri-
fluralin EC, positive in several LLNA, but GPT negative). A quinone formation seems not
plausible, because of an unfavorable steric constellation (figure 32). An alternative expla-
nation was put forward by Roberts et al. (2016a) recently. The authors point out that the
variability in the stimulation indices of the reported LLNA is large and the observed very
high values with an SI>75 are only matched by one other sensitiser (1-methyl-3-nitro-1-
nitroso-guanidine). The latter compound is similar to a proposed nitroso impurity stemming
from the production process of Trifluralin EC. Therefore, Roberts et al. (2016a) suggest that
plausibly the nitroso (or another) impurity are responsible for the sensitising effect. How-
ever, with only 1 ortho-nitro-N-N-dialkyl-aniline compound available and more data required,
this substance class is (preliminary) kept within the screening model – also to account for
134However, the last step (oxidation and loss of a hydrid ion) is unusual and, despite being in line with literature
(Roberts et al., 2007c), adduct formation data are missing. Evidently, these would be very helpful to verify the
proposed scheme or if other mechanisms take place, e.g. enzymatic hydroxylation as in N-N-alkyl-anilines
(figure 30).
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other substances which are target of the same production associated impurities. The ortho-
nitro-(N-alkyl)-anilines, though, detect 8 sensitisers (three with additional other alerts) and 3
non-sensitisers, while the para alert remains primarily theoretical (compounds with this alert
also bear other reactive features).
Figure 32: Unfavorable steric in the activation of Trifluralin EC. Roberts et al. (2016a) suggest
a nitroso impurity from the production process as sensitising agent.
In addition to these advances for pre/pro-quinones, two deactivating structures for the
pre/pro-quinone compounds have been implemented in the developed structural alert model.
The first concerns diazo-phenyls in ortho position to hydroxy groups, which both are attached
to a naphthyl-ring in position 1 and 2 (as shown in figure 34, next page). Interestingly, despite
the fact that this alert is positive for compounds with phenyl rings (e.g. 2,2-azobis-phenol, cf.
Roberts et al., 2007c), attachment to a naphthyl-ring seems to diminish the metabolisation.
10 out of 12 compounds with this structure were negative in animal sensitisation testing,
despite the fact that the diazo-bond can undergo metabolic cleavage that should produce
an 1-amino-2-naphthol, which would be a pre/pro-quinone. The reason for this remains
yet to be unearthed and at least one of the two sensitisers carries an additional alert (cf.
Annex E.10).135 Secondly, pre/pro-quinone alerts that additionally carry aromatic aldehydes
were excluded. Probably the aldehyde group is preferably metabolised (by ALDH, aldehyde
dehydrogenase, as e.g. proposed in Zhang, 2015) and no quinone-like structure is formed
as the compound is already well excretable. An example would be the very weakly, if all,
sensitising vanillin (cf. figure 34, next page).
Finally, further advances concern the additional alerts for (a) 1-naphthylamines, (b) 2-
naphthols and 2-naphthylamines, as well as (c) 6-alkoxy/hydoxyindoles, 5-alkoxyindoles,
and 3-methylindoles as presented in figure 33 below.
Figure 33: New pre/pro-Michael acceptor alerts. 1 1-naphthylamines, 2 2-naphthols and 2-
naphthylamines (Y = OH, NH2), 3 6-alkoxy/hydoxyindoles (Y = OCH3, OH), 4
5-alkoxyindoles (Y = OCH3), 5 3-methylindoles.
135Possibly the bond cleavage is hindered by the naphthol-ring. However, the 12 compounds comprise several
compounds with sulfonic acids group (SO3H), which would make them readily excretable already. Addition-
ally, the compounds are often more complex structures, for which further metabolism is expected.
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Figure 34: 1 Diazo-phenyls in ortho position to hydroxy groups, which are both attached to
a naphthyl-ring in position 1 and 2 as shown. They seem to be inactive in the
current skin sensitisation animal assays, albeit a metabolic activation is conceiv-
able (cleavage of the diazo-bond gives rise to an 1-amino-2-naphthol). Note the
stabilisation of the diazo-bond via hydrogen bonding with the hydroxy-group. 2
Vanillin as example of a possible pre/pro-ortho quinone (the methoxy group can
be dealkylated via cytochrom P450 and the hydroxyl groups subsequently ox-
idated), which has a very weak sensitising effect, if all, because the aldehyde
function is (likely) preferably metabolised (with ALDH, aldehyde dehydrogenase;
the resulting benzoic acid is very hydrophilic and, thus, readily excretable).
All compounds of figure 33 can be activated to quinone-like structures by metabolic pro-
cesses. The respective proposed transformations are delineated in the subsequent lines.
For most of the proposed pre/pro-quinones – 1-naphthylamines (a corollary of 1-naphthols),
2-naphthols and 2-naphthylamines, as well as 6-alkoxy/hydoxyindoles – no literature refer-
ences are available. However, most should follow the same relationship as ortho/para hy-
droquinones, aminophenols, as well as benzenediamines (Aptula et al., 2009; Enoch et al.,
2011), but are separated from the well established alerts for phenyl compounds. This is
because the additional ring system leads either to a stabilisation of a certain position at the
ring that has the hydroxy/amine group attached or an attack at the additional ring is indi-
cated. For the naphthylamines, also a hydroxylamine formation with further metabolism to
reactive nitrenium-ions is conceivable (e.g. Ji and Schu¨u¨rmann, 2013). However, it should
be noted that the activity of the necessary cytochrome P450 enzymes is discussed contro-
versially for skin metabolism (cf. discussion of aromatic amines below, Go¨tz et al., 2012a;
Ja¨ckh et al., 2012) and it is suspected that metabolic activity of N-hydroxylation in mice is
low (Roberts et al., 2007b; Patlewicz et al., 2010) – although the latter is primarily reported
for the N-hydroxylation of amide and nitro groups; more data are required.
As indicated, (a) 1-naphthylamines can be metabolised to 1-naphthols, which are an es-
tablished skin sensitisation alert (Enoch et al., 2008a). The 1-naphthylamines compose a
preliminary alert with 1 GPT positive substance. Although (b) 2-naphthols and 2-naphthyl-
amines have not been discussed in previous publications (because no data were available)
their metabolic activation is likely the reason of their sensitising potential. The respec-
tive reactions leading to sensitisation are shown in figure 35. Despite the fact that the
2-naphthylamines-alert is purely theoretical at the moment, the related 2-naphthol alert is
supported by 2 sensitisers in the LLNA and 4 active compounds (out of 5 substances hit
by this alert) in GPT, which makes it an elevated performance alert according to the alert
reliability scheme. (c) The pathway for 5-alkoxyindole and 3-methylindoles can be found in
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Kalgutkar et al. (2005) (and Enoch and Cronin, 2010), which discussed their transformation
as pro-mutagens. However, the proposed metabolic conversion into reactive electrophiles
can be applied for skin sensitisation, too. Though, for the latter endpoint both alerts are
theoretical currently and these substance groups should be target of further research. 6-alk-
oxy/hydoxyindols will behave similar to 5-alkoxyindoles, which is depicted in figure 36. The
skin sensitisation data base provides 2 positive 6-hydoxyindol examples in the LLNA and 1
in the GPT (with an additional GPT-negative compound) marking it a preliminary alert.
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Figure 35: Michael reaction of 2-naphthols and 2-naphthylamines with nucleophilic groups of
proteins. For the first step cf. Aptula et al. (2009); alternatively a direct hydroxyla-
tion of the 1-position and, thus, 1-amino-2-naphthol formation is possible. In case
of 2-naphthols the depicted H can also be an methyl group leading ultimately to
a (quinone-)methide-like naphtalene. Notably, the attacked position at the naph-
talene ring can be stabilised via resonance by the attached benzene ring. Also,
a hydroxylamine-formation and subsequent transformation to a nitrenium-ion is
conceivable (e.g. Ji and Schu¨u¨rmann, 2013).
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Figure 36: Activation and subsequent Michael reaction of 6-alkoxy/hydoxyindols with nucle-
ophilic groups of proteins.
Schiff base formers. Schiff base is another name for imines in which the nitrogen carries
an organic carbon substituent. They can be formed if carbonyl functions react with primary
amines of biological molecules, primarily the amine function of lysine. The prototypical re-
action with aldehydes is shown in figure 37 and is initilised by a nucleophilic addition of the
lone pair of the amine onto the carbonyl.136 In the presence of catalytic amounts of pro-
136At which no suitable leaving group is attached, which is an important difference to the acylation mechanism
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tones a tetrahedral hemiaminal is formed. With a further protonation of the hydroxy group
an oxonium ion (H2O+R, not shown in figure 37) is formed, which offers an excellent leaving
group. Thus, the formed leaving group (water) is expelled and after this dehydration a Schiff
base is obtained. Typical compounds that can undergo Schiff base formation are (aliphatic)
aldehydes and activated carbonyl groups, for instance 1,2- and 1,3-diketones,137 but not
simple monoketones (Aptula et al., 2005; Aptula and Roberts, 2006; Enoch et al., 2011; for
structures of established alerts, cf. Annex E.8).
Figure 37: General Schiff base formation mechanism (R = C or H).
Firstly, at a very fine level of refinement aromatic aldehydes were engaged. It is well-
known that their sensitising potential is heavily influenced by the ortho, meta, and para sub-
stituents of the aldehyde group (Patlewicz et al., 2001; Natsch et al., 2012; Roberts et al.,
2006; Roberts and Aptula, 2015). The activity of a particular combination of substituents
in relation to other substituent patterns can be estimated via the respective Hammett con-
stants (cf. textbooks of organic chemistry e.g. Lu¨ning, 2010) of the substituents in question.
However, as already observed by Natsch et al. (2012) this is not the whole story, because
e.g. the supposedly very reactive para nitro benzaldehyde is negative in their conducted
LLNA. No solution for this riddle is available, yet – besides a flawed animal test. Likewise,
aromatic aldehydes are significantly less potent in the LLNA and human patch testing (cf.
also correlation analysis) than expected by quantitative mechanistic modelling (QMM) for
reasons that are not unequivocally clear (Roberts et al., 2017b). One particular important
point not included in the Hammett constants, which apply for the meta and para substituents
only, is the significant influence of the occurrence of hydroxy groups in the ortho position with
respect to the aldehyde (cf. figure 43 some pages below for a visualisation). As already dis-
cussed this activates the respective aldehyde/ketone function – e.g. sufficiently to transform
the barely reactive benzaldehydes into protein-reactive sensitisers (cf. also Roberts et al.,
2006; Roberts and Aptula, 2015). For the sake of the precautionary principle all aromatic
aldehydes are included in the screening model, which lead to a low performing alert (9 out
of 20 compounds positive in the LLNA and 2 out of 6 in the GPT) in contrast to the better
performing optimised Hammett based alert rules.138 Still, also the latter only had a moderate
performance with 6 positive and 3 negative compounds found in the LLNA.
Next, a completely new alert in this domain concerns imines. They have not yet been pro-
posed as sensitising in literature, but imines with an hydrogen attached to the imine-carbon
(called “aldimines”) should have a comparable reactivity as the respective aldehydes and
lead to a “reimination” (exchange of one imine group with another) with amine groups of
discussed above (Enoch et al., 2011).
137In both of which the electron density of one carbonyl group is decreased due to the electron withdrawing effect
of the adjacent α- or β-carbonyl group (Aptula et al., 2005).
138This has been hard-coded into the structural alert model with compounds with a value below σ = -0.17 ac-
cording to the data given in Lu¨ning, 2010 as being likely non-active.
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proteins such as in lysin. The proposed reaction is shown in figure 38. A second possi-
ble reaction mechanism not shown is hydrolysis of the imine group (already under slightly
acidic conditions, cf. Binauld and Stenzel, 2013) and a subsequent reaction of the emerg-
ing aldehydes with nucleophilic protein residues. If this happens will depend on the applied
vehicle, which does normally not contain water. Furthermore, if the target substance enters
an aqueous skin compartment, e.g. the cytosol of keratinocytes, this reaction can occur.
However, it is not known in which skin compartment skin sensitisation takes place and also
reactions in hydrophobic environments should be considered (cf. bioavailability section of
this thesis). Thus, hydrolysis is a possible explanation, but further investigations are needed
– e.g. (ald)imines in water-free chemoassays. Overall, the alert is backed up by 3 sensitisers
in the LLNA which makes it preliminary.139
Figure 38: Reimination (Re-Schiff base-formation) of aldimines (R = C or H) and nucleophilic
groups of proteins (lysine). Also hydrolysis to sensitising aldehydes (reaction in
figure 37) is conceivable, if contact to water occurs (cf. main text).
Figure 39: Additional activating groups for alerts related to 1,2-diketones, ketone with adja-
cent 1 ester, 2 amide, 3 carboxylic acid, 4 nitro group, 5 nitroso group, 6 quater-
nary amine, 7 sulfinyl, 8 sulfones, 9 sulfonate esters, 10 cyano, 11 phosphoryl.
Strength of the activation depends on the strength of the electron withdrawing
effect of the adjacent group (R = C or H and for 11 also O).
In addition to (ald)imines, a group of new alerts targets 1,2-diketones. Typically, ketones
are not sensitising in skin sensitisation assays, but the addition of a further carbonyl group
in α- or β-position increases the reactivity drastically due the electron withdrawing effect of
the adjacent carbonyl group.140 However, not only carbonyl groups are capable of decreas-
ing the electron density at the further carbonyl group and, thus, activating it by facilitating
the initial attack of the amine at the carbonyl. Also other activating groups (typically neg-
ative inductive, −I) at the α-carbon can be considered, such as given in figure 39. Most
139This alert is also interesting as Watzek et al. (2017) suggested that their analysed secondary amine (methyl
cyclohexyldiamine, MCDA) can react with the vehicle acetone (e.g. in acetone olive oil) to produce different
imine compounds. On the contrary, the imines observed by Watzek et al. (2017) comprise ketimines instead
of aldimines, which should be significantly less reactive, which is exemplified by 1 LLNA non-sensitiser
available in the collected data of this thesis. Further, the respective hydrolysis product would be acetone,
which is a non-sensitiser.
140And the stabilisation due to hydrogen bonding in case of tautomeres 1,3-diketones, cf. figure 41.
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are theoretical, but for esters141 in the α-position or phosphoryl (P=O) as α-neighbour data
are available. Both groups are supported by 2 sensitisers (for esters 1 in the LLNA and 1
in the GPT; for phosphoryl 2 LLNA-active compounds) and the respective reaction mecha-
nism is illustrated in figure 40. Notably, for the α-phosphoryl compounds also an acylating
reaction seems plausible with the phosphoryl group leaving the carbonyl, but no publica-
tions were found (e.g. chemoassays) which investigate this. Positive sensitisation data are
also observed for attached amide groups and carboxylic acids in the α-position, both of
which should be less activated than the respective diketones, but are found still sensitising
(amides: 1 LLNA and 1 GPT sensitiser, carboxylic acids: 2 LLNA and 1 GPT sensitiser).
Figure 40: Formation of Schiff bases for two α-activated ketones (R = typically C, but also O
is possible for (b)) reacting with nucleophilic groups of proteins (lysine only, the
two structural elements are actually found sensitising in the data base).
Besides the well-known alerts for Schiff base formation, an additional alert for tautomers
of 1,3-diketones was added. The latter compounds are not only available in their diketone
form, but at least some substances have a stable (keto-)enol tautomer due to hydrogen
bonding between the two oxygen atoms. For this reason, this form may also be reported in
skin sensitisation data bases such as in this thesis (examples given in Annex E.10). This
features together with the sensitisation mechanism is depicted in figure 41. Interestingly,
the tautomeres shown offer a suitable site for a Michael attack at the β-unsaturated carbon
(from the perspective of the remaining carbonyl group) which is a conceivable reaction not
considered so far. The alert accounts for 3 GPT sensitisers and is, thus, preliminary.
pre/pro-Schiff bases. Notably, there is a test system difference in the fraction of pre/pro-
sensitising Schiff base formers between LLNA and GPT (cf. Annex E.3) with a higher
occurrence of these compounds in the latter test system. This may indicate a metabolic
difference between both. However, this can also be data set specific as the fraction of non-
pre/pro-alerts was biased toward fewer compounds for the GPT, in particular half as much
141Again a compound class which is known in literature (Aptula and Roberts, 2006), but not implemented properly
in publicly available alert models – strictly, only diketones are included in those.
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Figure 41: Formation of Schiff bases for tautomers of 1,3-diketones with nucleophilic groups
of proteins (amino only).
aldehydes are included in comparison to the LLNA data (where this compound class was
the predominant Schiff base former alert). Beyond the know pre/pro-Schiff base formers
new alerts and refinements of existing alerts have been derived. The respective structures
(except for formaldehyde releasers) are given in figure 42.
Figure 42: New and refined pre/pro-Schiff base alerts (R = C or H). 1 thiazoles, 2 morpho-
lines, 3 piperizines, 4 benzylamines (cf. also figure 19 in the pre/pro-acylation
section), 5 ortho hydroxy benzylalcohols, 6 1,2-diamines (together with the not
depicted 1,3-diamines).
Again one of those (thiazoles, 1 in figure 42) has been described for mutagenicity (Kalgutkar
et al., 2005; Enoch and Cronin, 2010), but has not been introduced to skin sensitisation so
far – for the metabolic transformation (epoxidation and 1,2-diketone formation) the reader
is referred to the respective publications. However, due to its very low performance (only 1
positive substance out of 4 with an alert in the LLNA and 1 out of 5 in the GPT ) it should be
considered as preliminary and for screening purpose only. At least one of the two positive
compounds (disperse blue 106) does not bear other proven features indicating reactivity,142
albeit it has to be said that its structure is complex whereas the other positive (4-nitrophenyl
1,3-thiazol-5-ylmethylcarbonate) is also an acylating carbonate (all substances with thiazole
alert are depicted in Annex E.10). The poor performance can be taken as indication that the
skin metabolism of this substance group is different from the mutagenicity metabolism.143
Furthermore, the pre/pro-alerts concerning morpholines and piperizines (2 and 3 in fig-
ure 42) of Enoch et al. (2011) were extended. The respective publication lists a metabolic
decomposition for the parent compounds (R = H) to 1,2-diketones, which can possibly be
142Though, an aromatic substitution SNAr of the diazo-group at the nitro activated thiazol ring seems possible,
but more data on e.g. adduct formation patterns are needed to substantiate this.
143However, most of the structures are quite complex (cf. Annex E.10) which make an evaluation difficult and it
is likely that this will influence the metabolism of the compounds.
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enriched with further substituents for R that result in similar decomposition products. How-
ever, quite specific rules were derived for both (cf. Annex E.8 and E.9 Alert P31Af) and at
least the modified morpholine alert should be used for screening only due to a low statistical
performance. For piperizines a differentiation was made between screening (R = any) and a
high resolution model with exclusion rules,144 but also this is considered preliminary.145
Two further new alerts target benzylamines (4 in figure 42) and the closely related ortho-
hydroxy-benzylalcohols (5 in figure 42). The first alert is theoretical at the moment, but a
metabolic activation is reported (Kalgutkar et al., 2005; Enoch and Cronin, 2010), which
lead either to a reactive isocyanate or an aromatic aldehyde, which may function as Schiff
base (the latter is also discussed in Patlewicz et al., 2014b). The activation to an isocyanate,
though, is the preferred explanation, because aromatic aldehydes are typically not reactive
enough on their own, but other groups at the benzene ring influence the concrete reactivity.
The same is true for benzylalcohols. However, for those an additional restriction has been
made, meaning they should carry a hydroxy group in the ortho position, which is strongly
activating (as reported by Roberts et al., 2006; Roberts and Aptula, 2015). Their activation
including the reactivity-enhancing hydrogen bonding is illustrated in figure 43. For this alert
1 positive substance and 1 negative counterexample are available rendering it preliminary
in requirement of more data. An extension to other benzylalcohols with suitable activating
groups is possible but needs further data, too.
Figure 43: Metabolic activation of ortho hydroxy benzylalcohols to an aromatic aldehyde and
the important stabilisation via hydrogen bonding.
The last two new alerts are related to 1,2-diamines (6 in figure 42) and their theoretical
collorary the 1,3-diamines. As indicated for the latter no substances are available, but 1 sen-
sitiser (1,2-diaminocyclohexane) was observed for the former pre/pro-diketone alert. The
proposed metabolic activation is shown in figure 44. Albeit no concrete literature source is
available, its metabolism should be very similar to the other amines, which are frequently
listed as pre/pro-aldehydes (cf. below or Edmondson et al., 2009 for MAO, monoamine oxi-
dase, metabolism). Another explanation is put forward recently by Watzek et al. (2017) who
reported the formation of (di)imines, if secondary (di)amines (in their case methyl cyclohexyl-
diamine, MCDA) are applied in vehicles containing acetone, though a reaction mechanism
and a proof of reactivity of those compounds is missing. According to the data base also for
the observed sensitiser, which was the base for the alert derivation, acetone was the used
vehicle and further studies should be conducted.
144Exclusion of directly attached aromatic systems and carbonyl function to the ring nitrogen, which probably
influence the metabolic decomposition; performance 5 out of 6 positive compounds in GPT and 1 LLNA
sensitiser, listed in Annex E.10.
145In particular the structure for piperazines are quite complex, which suggest that simple metabolic considera-
tions cannot be applied for those. However, with two simple rules (cf. footnote 144) most negative substances
could be excluded.
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Figure 44: Metabolic activation of 1,2-diamines to Schiff base forming diketones. The
metabolic reactions shown are speculative as no actual metabolic data were
found for this compound class.
Two further improvements of existing alerts have been established. The first concerns
the reactivity of primary, secondary, and tertiary amines in the LLNA and the GPT. It was
observed that only the primary amines are sensitising in both animal test systems and at
least the tertiary amines lead to frequent sensitisation reactions in mice only pointing to-
wards metabolic differences between both animal species (see statistics in Annex E.9, alert
P31Ac; unfortunately for secondary amines only one LLNA sensitiser was available). For this
reason the latter alerts were excluded from the GPT high resolution model. The difference
is probably a dissimilar efficiency in the metabolic dealkylation (e.g. via cytochrom P450) of
the secondary and tertiary amines in mice and guinea pigs, which does not affect the fur-
ther transformation of the primary amines to sensitising aldehydes – which is also possible
via MAO. The steps are displayed in figure 45. Regarding the dealkylation it was noticed
that this reaction is much more likely for amines with methyl and ethyl residues at the nitro-
gen, but for longer substituents, such as propyl and higher alkyl, a competing metabolism
becomes more prominent. This is an oxygen transfer at an aliphatic carbon, which is not
adjacent to the amine group and, thus, does not lead to dealkylation.
Figure 45: Dealkylation of tertiary and secondary amines and subsequent formation of alde-
hyds from primary amines. Instead of the P450 route shown, also a metaboli-
sation via MAO is conceivable, in particular for the primary amines (Edmondson
et al., 2009).
105
Figure 46: Alerts for formaldehyde releasers in the developed skin sensitisation model.
Specifications of R, X, and Y can be found in Annex E.8, alert P34. 1 benzylhemi-
formal and related, 2 halo nitro dioxanes and halo nitro diols, 3 poly-tert-amine
ring systems, 4 cyanuric acid, 5 cyclic urea derivates, such as imidazolidinyl urea
and hydantoin, 6 N-methylol derivatives and related, such as α-hydroxy ureas, 7
lactonitrile, anilinoacetonitrile, cyanomethyl acetate.
Although the sensitising potential of formaldehyde releasers is known for a while (already
Barratt et al., 1994 had alerts included for those), the inspection of the data of De Groot
et al. (2009, 2010) revealed weaknesses of present models, which had to be refined. The
alerts are for substances which can release formaldehyde under usage conditions (or after
metabolisation). The refined alerts are listed in detail in Annex E.8 (alert P34) and are de-
picted in figure 46 (similar to the figure given by Enoch et al., 2011). Moreover, structures
related to formaldehyde release in acute aquatic toxic and discussed in Lipnick (1991) (lac-
tonitriles, anilinoacetonitriles, cyanomethyl acetates) were added. In contrast to their known
aquatic toxicity, the performance of the latter alerts for skin sensitisation is on an preliminary
level. They should be considered for screening purpose only, until further evidence becomes
available. However, also the performance of at least one other formaldehyde releaser alert is
low (cyclic urea derivates) with 0 positives out of 3 hit compounds. On the contrary, positive
human data are reported for at least one of those substances (2-imidazolidinone) and sev-
eral similar compounds (De Groot et al., 2009). Additionally, one halo nitro diol (2-bromo-2-
nitropropane-1,3-diol, bronopol) with with positive human data (according to De Groot et al.,
2009) is GPT negative, too. Therefore, this may indicate a limitation of the animal data (LLNA
and GPT). Another explanation would be that at least some of the sensitising potential relies
on the occurrence of formaldehyde impurities in the tested substances, which may not occur
if very pure solutions are applied. The remaining alerts are preliminary with 1-3 positive and
few negative compounds (Annex E.9 , alert P34). The alert with the highest performance
concerns the N-methylol derivatives which comprise 4 sensitisers and no non-sensitisers.
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SN2 reactants. In bimolecular nucleophilic substitutions (SN2) a nucleophile attacks a
target atom, usually an aliphatic carbon, at which a good leaving group is attached. The
latter is subsequently expelled after going through a transition state (figure 47). The speed
of the reaction depends on the quality of the leaving group – i.e. its acidicity or stability of
the corresponding anion, respectively – as well as the structural neighbourhood. The latter
is important, since SN2 reactions at primary carbons occur more readily than reactions at
secondary or tertiary carbons (at the last a SN1 reaction is more prominent). Furthermore,
allylic and benzylic compounds are more reactive (in particular for open chain compounds)
and, moreover, adjacent electron withdrawing groups increase the reactivity, in particular for
secondary carbons (cf. also “reactivity SAR principles for SN2” in Roberts et al., 2017a). As
mentioned for acylation reactions, the leaving group can stay attached to the molecule as in
case of ring opening SN2 reactions for strained ring systems such as epoxides. Well-known
SN2 alerts, e.g. primary haloalkanes, activated secondary haloalkanes, alkyl sulphonates
and sulphates, N-nitroso compounds, isothiazolones, thiols, and disulfides, are listed in An-
nex E.8.
Figure 47: General SN2 reaction mechanism (R = C or H). The transition state is normally
used as explanation for the inversion of the chirality, which is not important in the
shown scheme as two hydrogen atoms are attached to the carbon and, thus, it
bears no relevant stereochemical (enantiomeric) centre.
Figure 48: Prominent SN2 leaving-groups (R = C): chloride, bromide, iodide, azide, alkyl
sulphate, alkyl sulphonate.
One new instalment for the SN(2) domain is the introduction of alkynes with halogen and
other (theoretical) leaving groups (cf. figure 48) in addition to the already established SN-
vinyl146 alerts. The substitution of a suitable leaving group should be possible not only at
double bonds (SN-vinyl) but also at tripple bonds (corresponding to double and tripple bond
Michael acceptors both capable of undergoing Michael reactions). The related reaction is
depicted in figure 49. Because of the rare occurrence of tripple bonds in the data base, this
alert is preliminary with 1 substance supporting it – which is not surprising since the alert
targets a quite unique group of structures.
Figure 49: SN-Reaction of alkynes with a halogen (or other leaving group) attached with
nucleophilic groups of proteins.
146Which is actually a reaction in between SN2 and SNAr, cf. Rappoport (1992) and Ferna´ndez et al. (2013). This
should account for the “SN-propargyl”, either. Some leaving groups (all non-halogen) of figure 48 have been
added to the SN-vinyl alert, too.
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Next, updates were made for the known SN2 alert of α-activated haloalkanes, for which
the respective alert is displayed in figure 50. Normally, a leaving group at a secondary car-
bon does not undergo a SN2 reaction. However, this changes if an activating group is added
in α-position, which leads to a positive polarisation of the carbon atom at which the leaving
group is located. Not only haloalkanes with already implemented activating groups in α-
position (carbonyl, ether, alkene, alkyne, aromatic system, cf. Enoch et al., 2011) should be
able to undergo this reaction, but further groups are plausible for this alert. Hence, additional
leaving groups as well as further activating groups were added in comparison to previous
models (leaving: azides, sulphate, and sulphonate; activating: ester, acids, amids, carbon-
ate, thiocarbonyls, thionesters, thionamides, nitro, and cyano).147 Most of the additions are
theoretical (cf. Annex E.9), but for nitro and cyano activation of halogens some sensitisers
are detected (nitro: 1 out of 2 substances found in the GPT; cyano: 1 positive in the LLNA
and 1 GPT negative).
Figure 50: SN2 Reaction of α-activated haloalkanes with nucleophilic groups of proteins
(Q = activating group, such as double and tripple bonds, phenyl, carbonyl,
carboxylic acids, esters, amides, carbonates, thiocarbonyls, thionesters, thion-
amides, ethers, nitro, and cyano, X = leaving group as in figure 48).
The new SN2 alert for phenoxyacetic acids and their esters belongs to the α-activated
compounds, too, but is listed separately due to its rather uncommon SN2 leaving group. The
proposed reaction (cf. figure 51) is rooted in the fact that phenoxyacetic acids and their
esters have an α-activated (primary) carbon next to the acid/ester group with a moderately
good adjacent leaving group (phenol or phenolate, respectively, pK a = 9.99 according to
wikipedia). The attack is not possible at the carbonyl carbon, because the attached hydroxy
or ether groups of the acids or esters, respectively, are bad leaving groups in general (pK a
= 15 for alkohols according to wikipedia). However, despite the well-known sensitising po-
tential (e.g. Fukuyama et al., 2009 or ICCVAM, 2011) phenoxyacetic acids and their esters
have never been mechanistically discussed in the literature before and protein binding data
are missing. In chemico assays would be very helpful to verify the proposed mechanism.
In those also other α-activated carbons with a phenolate leaving group could be tested to
broaden the substance spectrum of this alert. Overall, the alert is embedded into the ele-
vated performance level with 5 positive LLNA and 1 positive GPT (alongside with another
negative GPT). The structures of those compounds are depicted in Annex E.10.
Another new set of alerts targets organometal compounds. This molecules were ignored
in previous structural alert models, because metal-containing substances are often excluded
in the data curation step of the model development. However, the reactivity of organometal
compounds is well-known in acute aquatic toxicity (Hermens, 1990) and, thus, the respective
147For a reasoning of cyano as additional alert see also Patlewicz et al., 2008b. For esters, acids and amides
it is not clear, if they were already summed under the α-halocarbonyls in Enoch et al., 2011 or not. At least
they are depicted in Gerner et al., 2004a. If they are not included they offer a useful addition with several
sensitisers found: esters: 1 positive GPT and 1 negative LLNA; acids: 1 positive and 1 negative LLNA;
amides: 2 positive LLNA and 1 positive out of 2 substances found in the GPT.
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Figure 51: SN2 reaction of phenoxyacetic acids and esters with nucleophilic protein groups.
organometals were added to the structural alert model of this thesis.148 The alerts concern
firstly compounds (a) with a leaving group attached, which are not necessarily the classical
leaving groups shown in figure 48, but can also include thioorganometal compounds. In
those an exchange of an already attached thioether group with other thio groups (such as
proteins containing cystein) can occur. Secondly, also organometals (b) with a positively
charged metal ion should be regarded, because electron rich nucleophilic groups of pro-
teins can easily react with them in a reaction termed nucleophilic addition.149 This group is
important as at least for two compounds that should not be reactive (tetrabutyl and -octyl
tin, in which the alkanes would be very bad leaving groups) sensitisation reactions in the
LLNA are observed. According to the data source impurities of the production process are
present, where the metal ion is not fully saturated (i.e. tributyl/octyl tin). Thus, a nucleophilic
addition at the positively charged metal ion is plausible. Applying both alerts to the data base
revealed 5 positive out of 5 compounds in the LLNA and 0 out of 1 in the GPT. All structures
were organo-tin compounds. In conclusion, the two related alerts should be considered at
the border to an elevated performance according to the alert reliability scheme.
Figure 52: SN-Reaction of organo-metal-compounds with nucleophilic groups of proteins.
The restriction to particular metals is derived from acute aquatic toxicity alerts
(Hermens, 1990). The actual valences will depend on the metal (ion).
Furthermore, the alerts for sulphur SN2 compounds have been enlarged and refined (cf.
figure 53). Refinements were conducted, because previous models150 described thiol or
disulphide compounds as well as related substances, which are able to form disulphide
bonds with cysteine residues of proteins, as e.g. R-SH or R-S-X (with R = C and X =
148But not metal ions themselves such as nickel, because new metal allergens will be seldom in comparison to
new organic structures and most metal allergens are well-known; cf. also correlation analysis section.
149Therefore, those are not strictly SN2 electrophiles, but have been added here for the comparison with the
organometals with leaving group.
150Enoch et al. (2011), which is more advanced for sulphur-SN2 than Enoch et al. (2008a). Furthermore, the
work of Richarz et al. (2014) should be mentioned in this regard.
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various structures). However, this classification can imply that just simple aliphatic thiols and
disulphides (R = C) are able to undergo this reaction, in spite of the fact that other compound
classes with free thiol functions are capable of disulphide formation, too – for instance, thiol
acids (R = C(=O)C) and phosphothiol (R = P) molecules (see Annex E.8 for the concrete
alerts). Even though, at least the first is possibly included in R = C, it was decided to form
a more explicit classification to avoid this ambiguity. Further, one preliminary alert, i.e. thio-
phthalimines, has been added (1 LLNA and 1 GPT positive). The exact statistics can be
found in Annex E.9. In general, for the thiols, 5 LLNA- and 2 GPT-sensitisers were added
and 1 additional positive disulphide compound was found (cf. Annex E.9 for details).
Figure 53: (SN2 )Reactions of several sulphur containing alerts with nucleophilic groups of
proteins. See text for further explanations on the different pathways for thionyl
(C=S) compounds. 1 disulfids (X = SC), thiocyanates (X = CN) and other (e.g.
X = halogen or other good leaving group cf. Annex E.8 Alert 46C), 2 thiols, 3
thiol151acids (Y1 = C, Y2 = O), dithiocarbonates (Y1 = O, Y2 = S), dithiocarbamates
(thioacids, Y1 = N, Y2 = S) and further theoretical alerts (cf. Annex E.8 Alert 46C),
4 thions with adjacent H-donor such as thiourea (Y1 = NHR, Y2 = NR, mechanism
with SOxH explained in Kalgutkar et al., 2005), dithiocarbamates (Y1 = NHR, Y2
= SR) and dithioesters (Y1 = C, Y2 = SR only middle reaction path), 5 mercap-
tobenzothiazols (X = H, S, N), 6 thio-phthalimine (X = leaving group; however,
depending on X also another mechanism is plausible, because thio-phthalimines
have highly delocalised electron systems and are good leaving groups, too).
151As a note of caution, commonly just the term thio-acid (or thio-esters, respectively) would be used. However,
the oxygen substitution can refer to two different compounds, if just the syllable thio is added. The first is
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One of the newly added alerts concerns compounds with a thionyl group (C=S) and a
closely connected neighbour which is a hydrogen donor (4 in figure 53). The hydrogen (in
NHR-groups) enables these molecules to tautomerise into a free thiol containing structure
(cf. wikipedia or Ost, 2013), which can react with proteins via disulphide formation. The
thionyl alert is particularly assisted by thioureas and dithiocarbamates, whereof 4 out of 6
targeted molecules are positive in the LLNA and additional 4 out of 5 sensitising in the GPT,
which locates the alert at an elevated performance level. Nonetheless, this sulphur SN2 alert
can also be explained by other mechanisms as discussed in the literature (Kalgutkar et al.,
2005; Enoch and Cronin, 2010). Therein, the thionyl-sulphur is oxidised to a sulphoxide
group. The subsequent nucleophilic attack of the protein residue takes place at the thionyl-
carbon, and the sulphur(di)oxide is eliminated (cf. figure 53 bottom right path). As second
confounding mechanism a thioacylation is possible (cf. also Ost, 2013), if a leaving group
is attached to the thionyl-carbon (mechanism shown in figure 53 bottom middle path). In
particular for (di)thio esters (Y1 = C, Y2 = SC) a thioacylation mechanism is likely,152 because
thiolat anions are moderately good leaving groups (with e.g. a pK a of 10.5 for butanethiol
according to wikipedia). 3 positive substances in GPT were found. Eventually, mechanistic
investigations (in e.g. chemoassays with detection of the adducts formed) are necessary to
clarify which mechanism is actually at work for a particular compound.
Thioacylation has also been discussed by Roberts et al. (2007b) as explanation for a sen-
sitisation towards benzothiazol (cf. figure 53 number 5 and bottom left path). Though, other
benzothiazols are available for which the tautomerisation to the thion-form is hindered by the
occurrence of substituents at the -SH/=S-group outside of the ring system (depicted in An-
nex E.10). In their case a disulphide formation (with exchange of the attached substituent)
seems much more likely and also for benzothiazol itself a disulphide formation has been
reported as underlying sensitisation mechanism (Chipinda et al., 2008). For mercaptoben-
zothiazols 2 sensitisers in the LLNA, 3 sensitisers in the GPT and 2 GPT non-sensitisers,
but with positive human evidence, were found. Thus, the latter alert resides at a preliminary
or moderate performance level.
As final small addition, for some substance classes in this domain an influence of the
hydrophobicity in form of the log Kow partition coefficient has been described in the liter-
ature. Among those compounds are H-polar SN2 reactants (Roberts et al., 2007b), like
primary and secondary haloalkanes. On the one side, although the derivation of Kow rules
for discriminating between active and non-active compounds failed in general,153 a cut-off
value specific for each halogen atom could be observed in follow-up investigations (CH-X
= sensitising if Kow > Y, with X = Cl, Br, I, and Y = 2.5, 3.5, 3.5 respectively, more details
given in Annex E.5). On the other side, this limit values should be judged as preliminary
as well as subject to further research, because no other Kow-based bioavailability exclusion
rules are available and there are uncertainties concerning the role of the Kow in bioavail-
ability. Furthermore, Siegel et al. (2009) demonstrated that the observed trend – at least
an substitution of a =O (carbonyl) group with an =S (referred here commonly as thion) and the second a
replacement of -OR (e.g. ether bond, alcohol) with an -SR (referred here commonly as thiol). This was
chosen for the sake of a precise language and following a proposal given in wikipedia.
152Already given in Barratt et al., 1994; Zinke et al., 2002.
153Also for other groups with a proposed Kow influence such as aldehydes or acid halogenids.
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for 1-bromoalkanes – can be explained alternatively with the short-chain compounds being
prone to volatility loss and the long-chain compounds exhibiting solubility problems. How-
ever, derived limit values based on volatility parameters (Koa, P v) were slightly inferior for
this substance group154 (cf. Annex E.5) and had more inconsistent results. For this reason
further investigations regarding the reactivity and bioavailability of primary and secondary
haloalkanes are necessary.
pre/pro-SN2 reactants. Within the domain of pre/pro-SN2 reactants only polycyclic aro-
matic hydrocarbons have been included so far.155 However, concerning the vulnerability of
double bonds and their possible autoxidation or metabolisation to reactive epoxides as well
as hydroperoxides156 a large body of literature is available (even a recent epoxide QMM in
Roberts et al., 2017a), primarily from a working group of the university of Gothenburg (re-
viewed in Karlberg et al., 2008, 2013). Despite being distributed this knowledge never found
its way into public structural alert models. Partly, this is due to the fact that autoxidation is
often modelled separately and, thus, no pre/pro-SN2 alerts are needed. Furthermore, the
compounds are challenging for assays to identify (Patlewicz et al., 2016) as usually the pre-
compounds themselves are not sensitising, but their oxidation products which are contained
as impurities in varying quantities in the principal component.157 Therefore, the derivation of
alerts can seem counter-intuitive, because the alerts for the respective sensitising oxidation
products/impurities (epoxides and hydroperoxides) already exist and a good model should
not be fuelled with too much information to avoid overfitting (and to obey Occam’s Razor).
However, the argument about the principal component not being sensitising seems not ro-
bust because a) already other alerts for compounds with sensitising structures emerging in
varying quantities from a parent compound were introduced in literature (e.g. formaldehyde-
releasers) and b) even though the principal component is not a sensitiser an information
about the occurrence of possible impurities can be very valuable for sensitisation testing. In
addition to the impurity issue, the analysed pre/pro-SN2 compounds in the previous publica-
tion comprise a set of structurally diverse molecules, which are hard to condense into few
alerts if viewed in isolation. Still, with the large data set available it was possible to visually
derive a set of pre/pro-SN2 alerts for these substances (cf. figure 54).158
In principle all double bonds can be target of autoxidation processes. However, the vulner-
ability of them to air-oxygen is increased if they are attached to an activating function such
as (hetero)aromatic systems, (pre/pro-)Michael acceptors with double-substituted β-carbon
or α,β-unsaturated oximes. Together with cyclic terpenes containing double bonds (often in
conjugation with a second allylic function) these were among the prime target compounds of
the Gothenburg working group and other references (Sko¨ld et al. 2004, 2008; Nilsson et al.
2005a,b; Bergstro¨m et al. 2006, 2007a, 2008; Hagvall et al. 2007, 2008; Rudba¨ck et al. 2012,
154But not for Michael acceptors in recent investigations of the UFZ working group of organic chemistry.
155Enoch et al., 2008a; also Enoch et al., 2011, but therein they are counted as pre/pro-Michael acceptors.
156While epoxides are able to perform ring opening SN2 like reactions, hydroperoxides function via radical for-
mation as sensitisers, discussed more deeply in the special cases section.
157This is different from metabolically activated pro-sensitisers, because there the principle component is trans-
formed after the uptake and, thus, is completely responsible for the observed effects (and not small impure
parts of a mixture).
158Notably, the alert development based on ACF-fragments additionally pointed into the direction that carbon-
carbon double bonds indicate a sensitising effect and were also a starting point for these alerts.
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Figure 54: pre/pro-SN2 reactants with an (activated) double bond oxidisable to epoxides or
hydroperoxides. The ring denotes a ring composed of aliphatic carbons with more
than seven atoms. (Y = N and, theoretically, also O or S).
2014; Delaine et al. 2013, 2014). As pointed out by Roberts et al. (2017a) the autoxidation
potential is enhanced by conjugation with a second double bond (in comparison to isolated
double bonds they are more readily oxidised due to their higher EHOMO – the energy of the
highest occupied molecular orbital) as well as the inclusion in a ring system (which disables
bond rotation and leads to a permanently coplanar delocalization of the π-electrons). The
latter fact can be transferred to other new pre/pro-SN2 alerts, in which the double bonds are
contained within complex or long-chain (more than 7 atoms) aliphatic ring systems, which
are sensitising according to the data of this thesis.
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These alerts constitute four major groups as depicted in figure 54. Twelve of the shown
alerts are preliminary and six obtained an elevated performance (cf. Annex E.9 for the exact
numbers). Taken together the alerts offer an elevated performance in the LLNA (57 out of
66 compounds found are sensitising), but only a moderate in the GPT (9 out of 18 com-
pounds are sensitisers).159 This is attributable to the different testing protocols. The GPT
are conducted occlusively and, hence, no or less air-oxygen is available for the activation of
the compounds.
As last autoxidation related issue, two LLNA positive compound classes – long chain
fatty acids and (polyethoxylated) (non)-ionic surfactants – are discussed in literature (Kreil-
ing et al., 2008; Ball et al., 2011) as being falsely positive in the LLNA, which was rebutted
for structural considerations recently (Roberts et al., 2016b). Due to the unfinished state
of discussion the double bond within fatty acids and the polyethoxylated compounds160 are
not included within this alert systems, but compose separate alerts which flag a substance
belonging to these compound groups as false positives. Notably, at least for the polyethoxy-
lates not only autoxidation is discussed as reason for the LLNA GPT discrepancy, but also
the release of IL-1α is reported as cause for the false classification (Ball et al., 2011), which
was discussed already in correlation analysis of this thesis (cf. section 4).
Figure 55: Activation of thiophosphate ester (Y = O, S, R = C) and silyl thioethers (R = C, or
OC if located at Si) via hydrolysis to thiols capable of disulphide formation..
In addition to the double-bond-related alerts two new single substance alerts based on
sensitisers with quite unique structural elements have been derived from the data. Their
pathway to sensitisation is given in figure 55 and they comprise thiophosphate ester as
well as silyl thioethers. For the former it has to be pointed out that they reintroduce the
alkyl-(thio)phosphate alert of Enoch et al. (2011), which was excluded beforehand in this
thesis. Alkyl-(thio)phosphates are not generally sensitising within this data set, which is in
line with observations of Patlewicz et al. (2014b) for phosphates in the OECD toolbox data.
It is well-known that alkyl phosphates readily react with OH-groups of serin residues and, in
contrast to lysine and cystein, these are not commonly discussed as being connected to skin
sensitisation. However, in case of the alkyl thiophosphates (alongside with silyl thioethers)
an alternative pathway is possible, because if they are hydrolysed at the Si/P-S-bond a free
thiol group as hydrolysation product emerges, which can react via disulphide formation.
159This became also visible in the calculation of the percentage of pre/pro-alerts in this domain, cf. Annex E.3.
160Additionally, also for one sensitiser (LLNA positive, GPT negative) with an ether bond bridged via an aliphatic
carbon to an aromatic system at both sides of the ether (dibenzyl ether, depicted in Annex E.8) autoxidation
should be considered as likely explanation for sensitisation. The carbon between ether O and aromatic
system should be able to undergo a stable peroxide formation at this position.
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SNAr reactants. SNAr reactions are nucleophilic substitutions at aromatic systems (cf. fig-
ure 56). They typically concern good leaving groups such as halogen atoms attached to an
activated aromatic system. Activating electron withdrawing groups (with –M- and –I-effects)
stand in ortho and para position to the leaving group and typically at least two activating
groups are necessary to enable the reaction. They facilitate the formation of an intermedi-
ary Meisenheimer complex after the initial attack of a nucleophile. This complex is resolved
by expelling the leaving group. The strength of the reaction depends (a) on the quality of
the leaving group161 and (b) the strength of the activation of the aromatic system (e.g. ni-
tro groups are strong activators whereas halogen atoms only lead to a weak activation). In
addition to the external activating groups also hetero atoms in the ring in ortho and para
position to the leaving group are activating, because they constitute electron poor aromatic
systems (for example pyrimidines).
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Figure 56: General SNAr reaction mechanism. Q denotes (activating) electron withdraw-
ing groups, ideally capable of forming the resonance structures shown (Meisen-
heimer complexes, prominent examples for Q are nitro groups).
Few effective changes have been made in the domain of the SNAr reactants in compari-
son to previous models (cf. Annex E.8). The primary modifications comprise the introduction
of new theoretical leaving and activating groups at the aromatic system (leaving: diazo, me-
sylates, and tosylates, activating: nitroso, quaternary alkylamines, sulphonamides, as well
as (alkyl)sulphones). Additionally, exclusion rules have been defined for the high resolu-
tion model. These target aromatic systems at which no strong activating group is attached
(strong denotes non-halogen electron withdrawing groups, halogens are weakly activating)
and pyridines with a leaving group ortho or para to the aromatic nitrogen as well as an addi-
tional activating group. All are depicted in figure 57 and provide an activation of the aromatic
system, which is usually not strong enough to result in a sensitisation as expressed by the
low statistical performance of those alerts (cf. Annex E.9). Presently, those are artificial
exclusion rules. In the optimal case the strength of activation is underpinned by (quantum
chemical) calculations (e.g. Roberts et al., 2011; Promkatkaew et al., 2014; Roberts and
Aptula, 2014) or chemoassay data (e.g. Enoch et al., 2012a, 2013), which in turn can be
used to exclude the weakest activated systems.
Besides the optimisation of the existing alerts, two additional preliminary alerts have been
added that concern para activated aromatic systems without an ortho activating group as
161Where interestingly the normal order of the quality of halogen atoms (I > Br > Cl > F, with > meaning is
a better leaving group than) is reversed. This is, because the first step (Meisenheimer complex formation)
of the addition substitution mechanism is slow and, thus, rate determining (Bruice, 2007) and is easier at
e.g. fluoro substituted aromatic systems (fluor is the smallest of the halogen atoms and leads to the hightest
polarisation because of its electronegativity).
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Figure 57: SNAr compounds with weak activation. X = leaving group, Y = halogen, Q =
activating group as defined in Annex E.8 (alarm 51A-F), though, usually halogens
for the depicted compounds and no data for strong groups are available.
well as halo imidazoles (including halo-purines, 1 sensitiser available). While the latter is
a straightforward extension of the halo-pyrimidine and halo-triazine alert (cf. figure 58 for
the sensitisation mechanism; also reported in Ost, 2013), the former alert seems to fit not
completely into this scheme, because only one activating group in the para position should
result in a weak sensitising potential only if at all. However, this heavily depends on the con-
crete leaving and activating groups. It was tried to derive which combinations could serve as
good alerts, but too few substances were available and further research (e.g. chemoassays,
quantumchemical calculations) is indicated. For this reason, the conceived alerts for para
activated aromatic systems (Annex E.8) are kept at screening level, until further data are
available.
Figure 58: SNAr Reaction of halo imidazoles (and related) with nucleophilic groups of pro-
teins.
Special cases. Finally, further alerts shall be discussed which are not part of the five
“cannonical” reactivity domains. The alerts within this section are concerned with a sensi-
tisation via a radical162 formation, SN1 reaction (unimolecular nucleophilic substitution) or
metabolism to hydroxylamines.
The first radical alert is composed of a different set of peroxides. Peroxides in general
are able to sensitise animals and humans directly as demonstrated by Bra˚red Christensson
et al. (2006) and in recent literature there was an intense discussion regarding this class of
sensitisers (Karlberg et al., 2008, 2013; Natsch et al., 2015; Karlberg et al., 2015; Roberts,
2015b). Concerning their reactivity domain classification, Enoch et al. (2008a) included
some peroxide structures in the SN2 domain, while others, such as acyl peroxides, are
counted as acylating agents – because they are analogues of anhydrides of mixed acids
and peroxy acids163 (Gerner et al., 2004a). On the contrary, recent literature (Roberts et al.,
2015) also considers the possibility that peroxide structures form a separate domain.
162Very reactive molecules with unpaired electrons.
163As a side note: this fits to the fact that organic peroxy acids themselves are negative in the collected skin
sensitisation data, mostly with confounding irritant effects observed.
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Interestingly, not all compounds which incorporate a peroxide function are sensitising as
observed in the skin sensitisation data base. For this reason the peroxide alerts have been
restricted to 3-4 substance classes for which the respective reaction pathways are portrayed
in figure 59 and 60. Not for all of them a sensitisation via radicals is the only possibility.
Concretely, although unstable peroxides are contained within mixed anhydrides of acids and
peroxyacids (or peroxycarbonates), e.g. diacyl peroxides, an acylating reaction is also plau-
sible for this substance group (as depicted in figure 59 (a)).164 Still, a reaction with radical
formation is another possibility (figure 59 (b)) and no protein binding data are available to
prove what mechanism is at work. This is also true for tert-butyl peroxyacid esters (figure 59
(c)),165 but for those a radical formation seems more likely. Note that the carboxyl radical
can decompose into a alkane radical and carbon dioxide (figure 59 (d)). Overall the anhy-
drides of acids and peroxyacids (or peroxycarbonates) and tert-butyl peroxyacid esters (all
implemented as one alert as depicted in figure 59) are at the border of a elevated perfor-
mance alert with 4 out of 5 compounds positive in the LLNA as well as 4 sensitiser and 2
non-sensitiser observed in the GPT. Finally, it is noted that many of those substances are
also irritants which makes them hard to assess (particular in GPT) and which is an important
confounding factor.
Figure 59: Reactions of mixed anhydrides of acids and peroxyacids (or peroxycarbonates,
R1,2 = C or O) and tert-butyl peroxyacid esters with nucleophilic groups of pro-
teins. All implemented as one alert in the model, as depicted (with R1,2 = C).
In the next two alerts the peroxy-group is attached to a group which will stabilise a po-
tential radical if the peroxy-group leaves the molecule after homolytic bond cleavage. In
figure 60 both group neighbour groups can stabilise the formed unpaired electrons, either
via hyperconjugation (t-butyl hydroperoxides)166 or resonance stabilisation (benzylic perox-
ides). From an alert reliability perspective the alerts are both preliminary with 2 (t-butyl
hydroperoxides; 1 LLNA, 1 GPT) and 1 GPT (namely, benzyl peroxide) sensitisers found.
Lastly, peroxides in ring systems have been included as screening alert (they can be un-
164This alert is not entirely new and was included in Gerner et al. (2004a) as well as Enoch et al. (2008a).
165Also discussed in Dimitrov et al. (2005b), but not included in e.g. Enoch et al. (2011).
166Cf. footnote 165.
117
Figure 60: Radical reaction of peroxides, e.g. tert-butyl hydroperoxides (a) or dibenzyl per-
oxide (b) (R = benzyl), with nucleophilic groups of proteins.
stable if the ring strain of the particular compound is high). However, the 3 found sensitisers
are very different from each other (details in Annex E.10) and more compounds should be
added to increase the reliability of this alert beyond its current preliminary level.
Also 1,1,1-trihalogen carbons attached to an aromatic system, e.g. benzylic chlorides,
do not fit into the existing five canonical domains. They react by a SN1 mechanism as
schematically expressed in figure 61, where the benzyl group is excellently able to sta-
bilise the intermediary planar (sp2) carbo-cation via conjugation (Hauptmann, 1991; Lu¨ning,
2010; Schu¨u¨rmann et al., 2016). The same should be true for analogous 1,1-dihalogen-
compounds, but those are not found within the skin sensitisation data base. For the 1,1,1-
trihalogen compounds 3 sensitisers in the LLNA are available, rendering this alert prelimi-
nary.
Figure 61: Reaction of 1,1,1-trihalogen benzyls with nucleophilic groups of proteins.
Further, two substances with quite unique structures have been included due to mech-
anistic reasoning, i.e. 1-[bis(dimethylamino)methylene]-1H-benzotriazol-1-ium 3-oxide and
clotrimazole (depicted in Annex E.10). For the latter a SN1 mechanism is discussed in lit-
erature (Roberts et al., 2007d) and the reader is referred to the respective publication for a
depiction of the mechanism. For the other compound with a quite remarkable structure no
references are available, but a nucleophilic attack of proteins according to a SN mechanism
(at the central carbon of the bis(dimethyl-amino)methylene substructure) seems plausible as
given in figure 62. Evidently, both alerts are preliminary with only one compound available.
Figure 62: Reaction of bis(dimethyl-amino)methylenes with nucleophilic groups of proteins.
R = 1H-benzotriazol, cf. Annex E.10.
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The last directly reactive alert to discuss targets trivalent organo-phosphorous compounds.
For their sensitising potential no explanation was found in a recent publications (cf. Kostal
and Voutchkova Kostal, 2015). One conceivable pathway towards reactivity would be the
oxidation to phosphates, but those are not sensitising in general. Therefore, another mech-
anism seems to be more likely. In fact, since they are trigonal planar compounds with an
empty π-orbital they can function as Lewis acids (as proposed briefly in Fitzpatrick et al.,
2016b). The latter compounds are electrophilic because they miss electrons to fulfil the
octet-rule and, thus, are prone to react with lone pairs of electrons. The corresponding re-
action is shown in figure 63. The performance of this alert is preliminary with 4 compounds
positive in the LLNA and 2 in the GPT, while 4 compounds are non-sensitising in the animal
testings (1 in the LLNA and 3 in the GPT) partly due to sterically challenging substituents.
Figure 63: Reaction of trivalent organo-phosphorous compound with nucleophilic groups of
proteins.
pre/pro-special cases. Three alerts that are pre/pro-special cases have been developed.
The first concern nitroxide radicals and their precursors, which are mentioned as hydroxy-
lamine precursors in a recent publication (Kostal and Voutchkova Kostal, 2015).167 Likewise,
two alerts were derived from the collected skin sensitisation data: 2,2,6,6-tetramethylpiperi-
dines as well as 8-azabicyclo[3.2.1]octanes. The suspected nitro SN1-like mechanism is
elaborated in figure 64. An (enzymatic) oxygen transfer and/or oxidation of the compounds
is proposed. Alternatively, in case the nitrogen is substituted with a methyl-group enzymic N-
dealkylation (via cytochrom P450) is possible (cf. Kalgutkar et al., 2005). As there are no in
chemico data on protein binding of those substances, chemoassays would be a good start-
ing point for further research concerning their mechanism. The two closely related alerts
are backed up by 4 sensitisers in the LLNA and 3 sensitisers in the GPT constituting an
alert reliability at the margin to an elevated performance alert. However, for the GPT also
5 non-sensitisers are available, which indicates an organism or testing protocol based dif-
ference between the two animal tests systems. One explanation is a different metabolism
in both animal species, which is in line with the proposed low metabolic efficiency of N-
dealkylation in guinea pigs as suggested for tertiary amines (cf. figure 45). Alternatively,
a second explanation would be the formation of nitroxide radicals via autoxidation with air
oxygen, if possible. This is hindered in the GPT due to the occluded testing (in analogy to
the many pre/pro-alerts of the pre/pro-SN2 domain) and would also explain why some GPT
are positive, i.e. were nitroxide impurities were already formed, while other are not.
Similar considerations are important for phenols and anilines, which have been discussed
by Ouyang et al. (2014) as being able to sensitise via a radical formation reaction – an idea
which emerged from their observation that the EHOMO (determined by quantum chemical
calculations) is higher in sensitisers than in non-sensitisers. However, despite the fact that
167Unfortunately, the authors could offer further insights into their in-house SMARTS patterns encoding for reac-
tive and they did not discuss the associated mechanism in detail (e.g. schematically).
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Figure 64: Activation of aliphatic nitroxide and hydroxylamine precursors (Y = H, OH, CH3)
and subsequent (SN1) reaction with nucleophilic groups of proteins (alert sug-
gested by Kostal and Voutchkova Kostal, 2015, without mechanistic scheme). For
dealkylation cf. Kalgutkar et al. (2005). Instead of a protonation and leaving of
H2O also a metabolism with Phase II enzymes is possible, e.g. sulfotransferases
(SULT, SO4 leaving group) or N-acetyltransferases (NAT, acetate leaving group).
Finally, it is also conceivable that the nitroxide radical reacts directly with protein
residues, in particular thionyl radicals of cysteine. However, in discussions with
colleagues about this reaction after the submission of the dissertation, it was re-
marked that the depicted mechanism is not likely due to the missing stabilisation
of the positive charge at the nitrogen atom. Otherwise, it was also pointed out
that with the intermediate TEMPO radical reactions are possible, which would be
another pathway for adduct formation.
a reproduction of their quantum chemical calculations was possible, the application of their
model to other substances did not obtained a sufficient discrimination between active and
non-active compounds (cf. Annex E.6). Nevertheless, also Roberts et al. (2015) proposed
for one particular substance (3,3’,4’,5-tetrachlorosalicylanilide, cf. section correlation anal-
ysis) the possibility of a radical formation at a phenolic oxygen – which is stabilised by two
attached chlorine substituents – as cause for the sensitising potential. In addition, for or-
tho, meta, and para aromatic diamino-, dihydroxy-, and amino-hydroxy compounds a radical
formation of the Wurster-type is discussed in the literature (Aptula et al., 2009).
Considering these results, the aniline and phenol groups of the data set at hand were
screened for common substituents, which could influence a radical formation. After exclud-
ing substances with already known alerts it was observed that particularly chlorine groups
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Figure 65: Possible activation and reactions of anilines, phenols and toluenes (Y1 = NH2,
OH, CH3) which have a para (Y2) halogen with nucleophilic groups of proteins.
in the para position seem to support a sensitising effect – which is interestingly also true
for a para chlorine in toluene. Theoretically, other halogens in para position should be able
to evoke the same and the supposed (radical) reactions for the derived alert are depicted
in figure 65. The alert reliability is preliminary at the edge to elevated performance (Y1 =
NH2, CH3) or at elevated performance (Y1 = OH) – the concrete statistics can be found in
Annex E.9. Furthermore, addition of a strong electron withdrawing group such as NO2, SO3
or CF3 seemed to eliminate the possibility that the molecule in question is a sensitiser. This
goes together with further considerations:
For the anilines a second mechanism has been discussed, i.e. their possible metabolism
to aromatic N-hydroxyl-amines (e.g. Mekenyan et al., 2010; Ji and Schu¨u¨rmann, 2013;
Schu¨u¨rmann et al., 2016). The subsequent formation of the reactive nitrenium-ion de-
pends on the presence of further phase-II enzymatic systems such as N-acetyl-transferases
(Watanabe et al., 1994). The formation of N-hydroxyl-amines though is influenced by the
substituents attached to the ring system (Ji and Schu¨u¨rmann, 2013) in two ways as dis-
cussed for mutagens (Enoch and Cronin, 2010): firstly, an addition of an ortho substituent
leads to sterical hindrance and, thus, prevents metabolism. This can explain why ortho
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chlorine substituent in anilines and phenols are not sensitising in contrast to the para chlo-
rine.168 Secondly, e.g. SO3-groups enhance the solubility of the compounds significantly
and, therefore, a metabolism (functionalisation to more water soluble variants) is not nec-
essary. This fits to the fact that the presence of a SO3 (alongside other strong electron
withdrawing groups) lowers and even eliminates the sensitisation potential.
Both of the discussed mechanistic paths – radical reaction (a) as well as the hydroxyl-
amine-formation (b) – are shown in figure 65. Mind that either a nucleophilic attack at the
substituent or at the aromatic ring system is possible leading to two different adducts, which
are similar for both pathways. However, more research into the sensitisation mechanism of
this compounds is still advised and more knowledge needs to be gained. Ultimately, it will
be important how the controversial discussion about the actual activity of cytochrom P450 in
skin (WHO, 2006; Bergstro¨m et al., 2007b; Go¨tz et al., 2012a,b; Ja¨ckh et al., 2012; Wiegand
et al., 2014) turns out and whether the hypothesised low metabolic activity of N-hydroxylation
in mice is true (Roberts et al., 2007b; Patlewicz et al., 2010).169
In addition to the para halo phenols, annilines, and toluenes, also compounds with an
amine function and aromatic nitrogen atoms in ortho and meta position (meta/ortho NH2
pyridines, cf. figur 66) are prone to sensitisation and should function by an analogue mech-
anism (Mekenyan et al., 2010).170 However, it is strange that ortho as well as meta sub-
stitution lead to skin sensitisation because both positions often have opposing effects (e.g.
the meta position is much less activating in the SNAr domain). Nonetheless, both were kept
in the developed alert system as preliminary alerts (ortho: 2 LLNA and 1 GPT sensitisers
as well as 1 LLNA and 1 GPT non-sensitiser, meta: 3 LLNA sensitisers). It is noted that at
least some compounds detected by this alert have an additional amine or hydroxy group at-
tached, rendering them as possible pre/pro-quinones with N-heteroaromatic rings (depicted
in Annex E.10)
Figure 66: Ortho and meta aminopyridines
Structural exclusion rules. Besides the given structural alerts also two exclusion rules
were derived from the data at hand. These comprise perfluorinated compounds as well as
substances with a steroid structure. For both classes several compounds are available which
bear an structural alert, but are not sensitising (cf. figure 67). This can be rationalised the
following way: the first group (perfluorinated compounds) have the special characteristic that
they are neither hydrophilic nor lipophilic and cause lots of different experimental problems
(e.g. Shafique et al., 2016). Therefore, it seems likely that either a reduced bioavailability
168Additionally, if a ortho carboxylate group is present it can induce “the formation of a six-membered intramolec-
ular hydrogen bonded ring, which inhibits the initial metabolic transformation” (Enoch and Cronin, 2010).
169Although the latter is primarily stated for the N-hydroxylation of amide and nitro groups and not yet for aromatic
amines.
170Laqua (2013) cites Mekenyan et al. (2010) for this. Though – to be very precise – the hydroxylation of NH2 is
discussed therein only for normal aromatic and not for heteraromatic systems.
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or solubility problems lead to negative sensitisation testing. The second compound class
(steroids) is a well-known regulator of immune functions. The compounds are readily ex-
creted during stress situations, which downregulate immune functions, but are also used
iatrogenically to suppress immune reactions, e.g. of autoimmune diseases (Aktories et al.,
2005). It is proposed that their intrinsic endocrine activity and immunologic suppression
interferes with the sensitising reaction and, thus, prevents the development of a contact al-
lergy. Possibly, their anti-inflammatory properties diminish the danger signalling discussed
in the newer literature (Martin, 2015, 2016). Of cause, the hypothesis for both substances
classes have to be tested further by specifically targeting those compounds which should
be reactive, but show no sensitisation in animal models. Examples of compounds, which
should be reactive, but carry these deactivating features, are presented in Annex E.10.
Figure 67: Exclusion rules: 1 perfluorinated compounds and 2 steroids
Final considerations. Evidently, besides the delineated alerts a plethora of other ideas
was tested. Often the innovations turned out as good explanation for individuals substances,
but applied to the whole data set various counterexamples occurred. This experience should
be a warning. More than 16 alerts (cf. figure 11 and the discussion text) are supported by
only one substance and particularly for those – but also for the other preliminary alerts –
more data are necessary for confirmation and validation, also to reduce overfitting to the
structural alert model.171 On the contrary, if all substances with insufficient similarity to
other compounds would have been excluded beforehand, which would be one way to en-
gage the problem of the heterogeneous data, many insights found during this thesis would
not have been gained and heterogeneous data sets will be part of the reality that risk as-
sessors encounter. Therefore, it is of prime importance that preliminary alerts have to fit
into the mechanistic knowledge (of skin sensitisation) to ensure causation (instead of mere
correlation). However, even though mechanistic considerations are given follow-up inves-
tigations are necessary to further consolidate the preliminary alerts. Hence, the proposed
mechanisms in this thesis function as starting point and orientation for further research.172
Likewise, the used alert reliability classification should not be left without critical questions:
why are just these four reliability classes derived? Are 5 substances rely indicating a high
(sic!) performance? Is a performance > 60% high? More work on this should be conducted
in future studies. We need rational and well-discussed criteria at which point an alert is
171Overfitting for a knowledge-based model is a tricky term. Knowledge is never complete and, thus, an overfitted
model just represents our incomplete knowledge base to which the model is adapted. Evidently, the model
can change if new knowledge emerges. In this case it is important to mark how certain the rules of the
structural alert model are, i.e. whether the alerts obtained a high or elevated, low, preliminary or theoretical
performance (which could also have diminished the alarms about alert of Alves et al., 2016).
172Further, in spite of having developed a very “fine-grained” model already several sensitising compounds are
still left for which no hypothesis could be generated and not all of them can have false animal test results.
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includable into structural alert models. This would define a strategy to avoid oversensitivity
of alerts (Alves et al., 2016) without relying on QSAR models or other assessment tools. Of
course, another important way to ensure the reliability of structural alerts is regarding their
domain of applicability (utilising e.g. the method of Ku¨hne et al., 2009).173
Additionally, reactivity calculations (deriving the chemotype of compounds) and measure-
ments (e.g. reaction with glutathion) can be an ample tool for an enhanced discrimination
of active and non-active compounds. An example for skin sensitisation is demonstrated in
Ouyang et al. (2014), though this may be data set specific as discussed in Annex E.6. Suit-
able targets for further research in this regard are in particular moderately performing alerts
with a sufficient number of substances.174,175 These type of calculations are also useful to
reach beyond the binary classification of sensitisers and estimate potency as demonstrated
for the Michael acceptor and SNAr domain (Roberts et al., 2011; Enoch and Roberts, 2013;
Roberts and Aptula, 2014; for other endpoints than skin sensitisation see also: Schwo¨bel
et al., 2010; Wondrousch et al., 2010; Mulliner et al., 2011) as well as other reactivity
domains for which QMMs or relationships to chemoassays were developed (Roberts and
Williams, 1982; Roberts and Basketter, 2000; Roberts et al., 2006, 2007b, 2017b,a; and
internal data of the UFZ working group of ecological chemistry).
Excepted from direct chemotype calculations are pre/pro-alerts and it is of interest to de-
rive how large this group is to evaluate its actual impact. This is also important for risk
assessors, because the assessment of pre/pro-sensitisers likely differs from that of directly
reactive compounds with respect to precautionary and mitigation measures taken. For in-
stance, if a compound has to be activated by autoxidation than reducing air contact is of
prime importance for its handling. Within this data set about 33% of the sensitisers are
pre/pro-electrophiles, which is true for both animal test systems (for details the reader is
referred to Annex E.3). This fits well to older reports (e.g. Patlewicz et al., 2013a), which
lack calculation details, and a recent investigation, which is based on a subset of the data of
this thesis (Patlewicz et al., 2016). Thus, albeit the majority (two third) of sensitisers can be
predicted directly by their immanent electrophilicity, at least one third of all active compounds
will be missed if a metabolic or abiotic activation is not taken into account underlining that it
is important to consider them in future research.
Of course, differences between the domains of reactivity exists concerning the fractions
of pre/pro-compounds, which are further analysed in Annex E.3 and E.4 alongside with the
potency of the sensitisers (for an overview of the overall performance/predictivity of the do-
mains for a non-active/active discrimination see also Annex F.4 table 64). To give a short
173This was ignored by Alves et al. (2016) and an example for the importance is given in the beginning of the
discussion section.
174However, moderately performing alerts make up only a small proportion of the alerts of this thesis and exe-
cuting chemotype calculations for preliminary alerts (which are most of the new implementations) with e.g. 3
sensitisers and 1 non-sensitiser has limited discriminatory use. The same is true for calculations for high or
elevated performance alerts based on many substances with just one counterexample (e.g. Michael acceptor
aldehydes).
175It should be mentioned that chemotype calculations were performed during this thesis (in another project),
which were able to obtain an enhanced discrimination, proving the value of those calculations – although
concrete methodological details have to be criticised. Still, improved statistics were also reached via a more
detailed structural description of the particular alerts, which is partly based on reactivity considerations, such
as the exclusion of weakly reactive Michael acceptors.
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summary on potency in the reactivity domains, on the one hand risk assessors should
be more concerned if acylating agents, pre/pro-Michael acceptors (in particular pre/pro-
quinones) or SNAr reactants are detected, because these domains contain predominantly
strong sensitisers (GHS potency category 1A). On the other hand, for (pre/pro-)Schiff bases
as well as pre/pro-SN2 compounds primarily moderate (or weak) sensitisers are observed.
Concluding remarks. Future research will not only include pre/pro-alerts, but as outlined
several times in the discussion section, this work laid down the foundations for various po-
tential investigations regarding the verification of the mechanism of specific structural alerts
that are newly proposed in this thesis. Moreover, to cope with the problem of a low TNF (of
structural alert models in general) a two-step approach was introduced including a screening
and two high resolution models; the latter are adjusted to the available animal data and the
former comprises general reactivity alerts. This approach brings to light further candidates
for subsequent investigations, i.e. alerts with difference in the screening and high resolution
approach. For some of those a discrepancy between reactivity and actual sensitisation (e.g.
weakly reactive Michael acceptors or SNAr reactants) becomes apparent fuelling further re-
search. The same is true for the proposed pre/pro-alerts based on metabolic considerations
derived from mutagenicity or extended literature knowledge (e.g. formalines, furans, thio-
phenes, thiazoles, morpholines, piperazines). All of those hit some sensitisers, but also sev-
eral non-sensitisers are found and, thus, more data are needed to improve those alerts from
screening to high resolution level. Often the metabolic alerts failed because the structural el-
ements were embedded in larger structures (cf. Annex E.10), which probably influence the
metabolism. Therefore, molecular complexity should be regarded in future investigations.
Also, further data on the differences between mutagenicity and skin metabolism (as well as
special features of mice and guinea pig metabolism) would be helpful.
Obviously, the alerts can provide often only a starting point in the space of structural knowl-
edge due to the limited statistical power of particular alerts with few supporting substances.
In case the new alerts and in particular the theoretical alerts can be underpinned with new
data this verifies (a) the value of the developed model and (b) the value of the approach
to engage also substances classes for which no statistically solid database is available, but
which can be explained mechanistically. This kind of detailed treatment in the manner of
detailed alerts was born out of the necessity to analyse the structurally heterogeneous data
set (see also Annex D.9) without excluding structurally unique substances beforehand, be-
cause heterogeneity is a likely situation engaged in the regulatory practice (which often has
not the luck of analysing homologue series). The generation of further data will finally have
to clarify whether the detailed treatment lead to a distinctively overfitted model or offered real
improvements.
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8. Consensus Modelling
8.1. Introduction
Consensus modelling and the related ideas of integrated testing strategies (ITS) and in-
tegrated approaches to testing and assessment (IATA) became very popular recently (e.g.
Jaworska and Hoffmann, 2010; Hartung et al., 2013; Nendza et al., 2013; Rorije et al., 2013;
Lombardo et al., 2014b,a; van der Veen et al., 2014; Patlewicz et al., 2014b; Tollefsen et al.,
2014; Rovida et al., 2015; Urbisch et al., 2015; Roberts and Patlewicz, 2017). Their pop-
ularity stems from the intuition that more information about a substance leads to a more
robust conclusion regarding its toxic potential.176 This is possible, if either a surplus of in-
formation is available for a given endpoint (as explained below) or other information, such
as physicochemical properties or results from other toxicity testing, reinforce the regulatory
interpretation of the results. For example, the mechanistic basis for enhanced acute aquatic
toxicity and skin sensitisation is similar (cf. correlation analysis), thus positive classifications
for both endpoints lead to a more coherent picture than dissimilar classifications.177 More-
over, the combination of different methods can lead to the compensation of uncertainties of
the individual methods lowering the probability of prediction errors (Leontaridou et al., 2016).
In the practice of regulatory risk assessment the fortunate case can occur that results
of more than one test system are available for a given compound under assessment with
regard to one toxicological endpoint. If this is the case, it seems plausible that a combined
assessment of the experimental outcomes leads to a more robust conclusion regarding the
toxic potential of the compound to be assessed. For instance, it is reasonable to assume that
a compound, which has a similar classification according to its LLNA and its GPT results, is
more likely to be a (non-)sensitiser than a different compound, for which both test systems
disagree with each other.178 In the latter case the classification is not evident. The suspicion
arises that the conduction of one of the animal assays was flawed (e.g. due to impurities
or improper handling of the animals) or one of both tests is not adequate for the compound
under assessment (e.g. the compound is out of the domain of applicability). Furthermore,
the possibility that the true result is in between both tests seems also plausible, because the
compound is, for example just a very weak sensitiser and its borderline toxicity is interpreted
unequal in both tests due to different cut-off criteria.
To handle this and also to handle more complex situations with results from more than two
test systems available, often a “weight-of-evidence” (WoE) approach is applied in regulatory
toxicology. This means the available evidence (test results) is weighted according to certain
assessment criteria. In particular, it is useful if data from an individual test are considered
insufficient to draw a robust conclusion, but concordant data form several sources may be
176Another reason is that one simple test system, e.g. in cell cultures or as chemoassay, often does not com-
pletely resemble the complex processes of animal toxicity testing. However, whether a complete simulation
of an AOP is necessary for a robust assessment remains to be determined and depends, likely, on the as-
sessed endpoint. For skin sensitisation addressing some or even just one key event is considered to be
sufficient (e.g. Roberts and Aptula, 2008; Roberts and Patlewicz, 2017).
177Evidently, the respective applicability domains and test system specific differences have to be minded.
178This line of argumentation can be repeated for results from other endpoints, which have a similar mechanistic
basis.
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able to do so (Ellison et al., 2010). However, the term and application of WoE was criticised
intensely in the recent literature (Linkov et al., 2015), because WoE is supposed to be used
in a vague manner with little scientific use (NRC, 2014). It was already pointed out by Weed
(2005) that there is a lack of a clear definition of WoE, it can be applied in multiple ways,
there is a lack of consensus about how the evidence is weighted and, furthermore, what kind
of qualitative as well as quantitative measures are used. The review of Weed (2005) was
taken up by Linkov et al. (2009, 2015), who developed a WoE taxonomy. They clarify that
the criticism concerning WoE is related to the “colloquial WoE use” and, because it is un-
avoidable to weight the existing evidence, the development of a generalisable, quantitative,
and transparent method is desirable. Thus, critical questions are: What evidence is used?
How much does it weight? And which method of weighting is applied? Furthermore, they
suggest that a systematic application is possible, for example by using different methodolo-
gies based on Bayesian statistics. Also in this thesis such an approach is followed, as it
allows the expression of uncertainty and confidence about the prediction (e.g. which data
of two opposing test results is more reliable, cf. discussion). These are important points
to consider in ITS development (Jaworska and Hoffmann, 2010) and form a way forward to
an evidence-based toxicology as Bayesian statistics allow the inclusion of prior knowledge
such as prevalence data (Hoffmann and Hartung, 2006).
In this regard, what is important for forming a scientific consensus? If for instance the
LLNA and GPTs give always the same result, than an additional testing in the vice versa
animal test system leads to no further insights.179,180 This observation can be translated
to the information gain due to a combination of different in silico toxicological methods or
algorithms, respectively. For those the information gain is optimised if the methods are
sufficiently dissimilar from each other. Otherwise, the application of a second algorithm in
addition to the first in silico model has no significant scientific value. This can be further
illustrated by the trivial extreme case that e.g. a structural alert model is applied twice,
where obviously no information gain is obtained. Therefore, a parallel usage of two or more
computational methods requires that the chosen in silico approaches are methodological
independent as much as possible (cf. Bo¨hnhardt et al., 2010; Yu et al., 2010, 2011; Ku¨hne
et al., 2013). 181
Given these preconditions are fulfilled, the question arises how the overall consensus
model is assessed and how it is interpreted. Normally, if a model is correct in about 90%
of all predictions, i.e. in 90 out of 100 cases (90% concordance with respect to a binary
classification scheme), this value is attributable on average for all substances within the
domain of applicability of that model (where the domain of applicability, of cause, has to be
179However, this argument neglects the biological variability within tests. If it is taken info account also two tests
with the same (!) system can give nevertheless valuable results.
180Which is one reasoning behind the fact that for substances which have GPT results available no further LLNA
has to be conducted according to current legislation such as REACH. However, the scientific evidence for
this similar treatment is likely to be outdated as seen in the correlation analysis, section 4.
181This is one point of criticism, which can be applied to Ellison et al. (2010), who build a consensus on an adap-
tive fuzzy partition method and 3 structural alert models. Although these models differ to a certain degree
(simulation of skin metabolism or inclusion of bioavailability rules), the information gain should be expected
to be lower in comparison to a combination of totally different methods. Similar criticism can be applied to
Verheyen et al. (2017), who combined different in silico models without checking their independence.
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determined separately). However, if two models make predictions which are correct with
a probability of 90% in each, it is not intuitively clear how these individual probabilities are
combined to an overall prediction. In particular problems arise if the predictions of both
models contradict each other and a conclusion in the consensus model has to be drawn
with regard to the predicted (toxicological) endpoint. The choice seems easy if one model is
correct in 90% of all cases and the other in just 60%, but if both model have good statistics
the decision becomes less obvious. To solve this problem Bayesian statics can be consulted,
which give suggestions for the overall conclusion that can be derived from to the combination
of individual models.
Bayesian statistics are a popular tool in medicine and based on the notion that toxico-
logical assays can be treated similar as medical diagnostic tests (Hoffmann and Hartung,
2005, 2006; Guzelian et al., 2005). Different models based on Bayesian statics have been
published already, also with regard to skin sensitisation (e.g. Jaworska et al., 2011, 2013,
2015; Gosling et al., 2013; Rorije et al., 2013; Pirone et al., 2014; Leontaridou et al., 2016;
Fitzpatrick and Patlewicz, 2017). They are based on simple (Rorije et al., 2013) as well as
comprehensive (Jaworska et al., 2015 and before) combinations and they combine a range
of different in vivo tests, in vitro assays, in silico models, and bioavailability parameters.
The more complex models resemble AOP-based ITS structures182 that are embedded in a
Bayesian network (Jaworska et al., 2011, 2013, 2015; Pirone et al., 2014; Fitzpatrick and
Patlewicz, 2017). This network is a graphical representation of the probabilistic relationship
between variables of interest and a target property. It is able to condense complex infor-
mation to a probabilistic conclusion regarding the property of interest. Commercial tools
are marketed to facilitate the construction of Bayesian networks,183 but also implementa-
tions in the open-source statistical programming language R are available (Pirone et al.,
2014). However, with increasing complexity of the model the comprehensibility of the deci-
sions becomes more opaque for non-expert users, which in turn may lead to a decreased
transparency and interpretability of the model by them.184 For this reason simpler, more
comprehensible methods, e.g. developed under the OSIRIS project (Buist et al., 2013; Ror-
ije et al., 2013; Tluczkiewicz et al., 2013; Vermeire et al., 2013), are preferred in this thesis.
8.2. Methods
Bayesian basics. To combine the results of the read-across exercise with the structural
alerts in a comprehensible way, an approach was used based on weight-of-evidence (WoE)
factors (cf. Aldenberg and Jaworska, 2010; Jaworska et al., 2010; and in particular the
supplemental material of Rorije et al., 2013; those references are the major sources for the
following paragraphs and are not always marked explicitly). These are a straightforward
182It has to be noted that the combined parameters may not necessarily follow the AOP order or cover all key
events to give optimal results (Leontaridou et al., 2016). This is in line with the argument that only one key
event (the MIE, protein binding) is important for skin sensitisation assessment and that the current in vitro
tests all model this key event to a certain degree, which makes them successful and not the modelling of the
proposed other key events (Roberts and Aptula, 2008; Roberts and Patlewicz, 2017).
183For example, BayesiaLab is used by Jaworska et al. (2011).
184This may, in fact, be an unjustified accusation, because sometimes reality is complex. However, if simpler
means are available we should strife to use them according to Occams Razor.
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application of Bayesian statistics (also coined inverse statistics) and these are based on the
observation that a hypothesis we have about a particular problem is influenced by our prior
knowledge of that problem. Mathematically expressed Bayes’ rule dating back to 1763185 is:
Pr(H|E) = Pr(E|H) · Pr(H)
Pr(E)
(11)
Therein the | denotes a conditional probability, meaning the facts before the | have a
certain probability given the fact after | is fulfilled. Thus, this equation means: the posterior
probability Pr(H|E) that a hypothesis H is true given the evidence E is available depends
on the inherent likelihood Pr(E|H) of the hypothesis, which is the probability of observing
the evidence E given the hypothesis H. The likelihood is multiplied by the prior probability
Pr(H) of the hypothesis H and likelihood and prior probability are divided by the overall
probability Pr(E). The latter is the same for all hypotheses and can be calculated according
to the law of total probability (cf. supplementary material in Rorije et al., 2013):
Pr(E) = Pr(E|H) · Pr(H) + Pr(E|¬H) · Pr(¬H) (12)
Where ¬ H denotes the logical negation of the hypothesis H. However, as Pr(E) is just a
normalisation constant (cf. Aldenberg and Jaworska, 2010), we can write down Bayes’ rule
in its brief version:
Pr(H|E) ∝ Pr(E|H) · Pr(H) (13)
This means: posterior probability is likelihood (or available evidence) times prior prob-
ability (or short prior). The importance of the latter cannot be emphasised enough. The
prior is the fundamental difference between Bayesian statistics and classical statistical test-
ing.186 The prior as last missing part of equation 13 has to be chosen by the researcher.
Its choice depends on the fact if prior knowledge (about the distribution of the target prop-
erty) is available or not. In case it is an informative prior can be selected. For example, in
medicine the prevalence of an analysed disease would be an informative prior, as it informs
us about the distribution of the disease within the population. If such a value can be derived
for skin sensitisation will be part of the discussion section (and Annex F.6). In the vice versa
case (no prior information), an uninformative or reference prior is applied (also to model our
185Even though it is called Bayes’ rule or theorem not only Thomas Bayes, who proved a special case of this
theorem, is associated with this theory, but also people such as Pierre-Simon Laplace played an impor-
tant role in its development. A brief introduction to the history of Bayesian statistics can be found in the
wikipedia: https://en.wikipedia.org/wiki/History of statistics#Bayesian statistics and a more detailed version
in McGrayne (2011). In this thesis mostly Bayes’ rule will be used, not Bayes’ theorem, for the reasons
explained in Rorije et al. (2013) (supplemental material).
186The classic approaches are often regarded as frequentist statistics or maximum-likelihood estimations, be-
cause they choose the parameter for an estimate, which is most likely to explain the observed values as-
suming a particular distribution. They are only concerned with the likelihood term of the equation, i.e. the
question: if a given (null) hypothesis is true, what is the probability that the data experienced are observed.
Often this kind of testing (in form of p-values or intervals) is interpreted by researchers as how probable it is
to find the true value, i.e. the probability that the true value is resting in its 95%-confidence interval is 95%.
However, this is not the case (Clark, 2014). The conclusion of classical statistics is how likely it is that we
find the true value in case we repeat the experiment, i.e. if we repeat the experiment 100 times and calculate
the confidence interval each time, 95% of those intervals will cover the true value (Clark, 2014). The popular
interpretation of the probability of finding the true value is the posterior probability. Therefore, the Bayesian
approach is much more intuitive in its interpretation.
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indifference about a particular result). For uninformative priors different choices exist, but
normally uniform distributions are assumed. In binary classification, such as sensitising or
not, the uniform discrete (uninformative prior) distribution would be a fifty-fifty (0.5,0.5) prior
(cf. supplementary material of Rorije et al., 2013).
Relationsship to Cooper statistics. The statistical tools which were used throughout
this thesis are connected to probabilities (Pepe, 2003). Given our Hypothesis H is if a toxi-
cological endpoint S (for sensitisation estimated by the LLNA or GPTs) is positive/negative
and our evidence E is a particular (in silico) test result T , we can write e.g. Pr(H|E) as
Pr(S|T ) and, therefore equation 11, 12, and 13 become:
Pr(S|T ) = Pr(T |S) · Pr(S)
Pr(T )
(14)
Pr(T ) = Pr(T |S) · Pr(S) + Pr(T |¬S) · Pr(¬S) (15)
Pr(T |S) ∝ Pr(S|T ) · Pr(T ) (16)
Furthermore, when we denote a positive (test) result with a “+” and a negative one with
a “−”, then we can express the statistical parameters (sensitivity or true positive fraction,
TPF ; specificity or true negative fraction, TNF ; positive predictive value, PPV ; negative
predictive value, NPV )187 of section 4 in the following way (Pepe, 2003; Aldenberg and
Jaworska, 2010; Rorije et al., 2013):
TPF = Se = Pr(T+|S+) (17)
TNF = Sp = Pr(T−|S−) (18)
PPV = Pr(S+|T+) (19)
NPV = Pr(S−|T−) (20)
Of course we can also express the inverse or complementary values (false positive frac-
tion, FPF , and false negative fraction, FNF ) as:188
FNF = 1− TPF = Pr(T−|S+) (21)
FPF = 1− TNF = Pr(T+|S−) (22)
With the separation into positive and negative test results equation 14 becomes:
Pr(S+|T+) = Pr(T
+|S+) · Pr(S+)
Pr(T+)
= PPV
Pr(S−|T+) = Pr(T
+|S−) · Pr(S−)
Pr(T+)
⎫⎪⎪⎬⎪⎪⎭ (23)
187With the terminology introduced in this section it should be mentioned that the TPF and TNF are maximum-
likelihood estimates.
188As a side note: combining TPF and FPF yields the receiver operator curve, ROC, which is often used in
medical evaluation and is visualised as a plot of the true positives over the false positives (Pepe, 2003; Rorije
et al., 2013).
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Pr(S+|T−) = Pr(T
−|S+) · Pr(S+)
Pr(T−)
Pr(S−|T−) = Pr(T
−|S−) · Pr(S−)
Pr(T−)
= NPV
⎫⎪⎪⎬⎪⎪⎭ (24)
Assuming a uniform discrete prior distribution (0.5,0.5), the equations for PPV and NPV
can be simplified (for a full discussion of this derivation cf. supplemental material in Rorije
et al., 2013):
PPV = Pr(S+|T+) = TPF
TPF + 1− TNF (25)
NPV = Pr(S−|T−) = TNF
1− TPF + TNF (26)
In line with this simplification the following set of equations can be derived (from equation
25 and 26) by replacing TPF and TNF as well as their inverse values 1−TPF and 1−TNF
by the corresponding probability expressions:
Pr(S+|T+) = Pr(T
+|S+)
Pr(T+|S+) + Pr(T+|S−)
Pr(S−|T+) = Pr(T
−|S+)
Pr(T+|S+) + Pr(T+|S−)
⎫⎪⎪⎬⎪⎪⎭ (27)
Pr(S+|T−) = Pr(S
+|T−)
Pr(T−|S+) + Pr(T−|S−)
Pr(S−|T−) = Pr(S
−|T−)
Pr(T−|S+) + Pr(T−|S−)
⎫⎪⎪⎬⎪⎪⎭ (28)
Analytical WoE. The last equations can be used to construct an analytical measure for
WoE decisions. Neglecting the positive or negative outcome of the (in silico) tests, we can
write Bayes’ rule as:
Pr(S+|T ) = Pr(T |S
+) · Pr(S+)
Pr(T )
Pr(S−|T ) = Pr(T |S
−) · Pr(S−)
Pr(T )
⎫⎪⎪⎬⎪⎪⎭ (29)
This equation system for unspecified test results is usable to conceive an odds189 version
of Bayes’ rule via dividing the first equation by the second:
OddspostT =
Pr(S+|T )
Pr(S−|T ) =
Pr(T |S+) · Pr(S+)
Pr(T |S−) · Pr(S−) =
Pr(S+)
Pr(S−)
· Pr(T |S
+)
Pr(T |S−) (30)
Where the second part of the last expression is the so-called diagnostic likelihood ratio
Pr(T |S+)/Pr(T |S−), a measure which is used in medicine statistics (cf. Pepe, 2003). The
first part of the last expression in equation system 30 are pre-test odds:
Oddspre =
Pr(S+)
Pr(S−)
(31)
189Not to be confused with the odds ratio (OR) often applied in epidemiology, which is the division of one odds
value with its counter value. It compares the two odds to derive the strength of an association.
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If the pre-test odds become one (as in case of a uniform prior) the diagnostic likelihood
ratio gets equals to the post-test odds. Odds values are interpreted in the following way:
Depending on the direction you are looking, odds can be in favor of or against a particular
hypothesis.190 If they are 4:1 in favor of, the associated probabilities of equation 31 are
distributed as (0.8,0.2). If they are 4:1 against, the associate probability values take the form
(0.2,0.8). Thus, one value is four times higher than the other. It has to be noted that due
to the usage of odds the binary variable with two associated probabilities (that sum up to
1) is cut down to one single value as illustrated by equation 30, but a back-calculation from
odds to probabilities remains always possible (Aldenberg and Jaworska, 2010; Rorije et al.,
2013). Finally, with the odds values at hand, a last operation can be conducted via taking
the logarithm, which leaves us with WoE values:191
WoE = 10 · log10(Odds) ≈ 4.343 · ln(Odds) (32)
In contrast to odds, which are combined through multiplication, WoE values are additive,
a feature which will be used below. They are measured in deciban (db), a unit originally
conceived by Alan Turing in analogy to decibel, and they are a pragmatic expression for
evidence (Good, 1985; Jaworska et al., 2010; Aldenberg and Jaworska, 2010). For instance,
the WoE takes the value of approximately 1 db in case the odds for a particular event are 5:4
in favor of the event (10·log10(5/4) = 0.9691 db). This means that WoE values between +1 db
and -1 db stand for an evidence that is (regulatory) not high enough to support a hypothesis.
To get more acquainted with the WoE values table 17 can be consulted (originally presented
in Rorije et al., 2013).
Table 17: Analytical WoE values and their corresponding probabilities (Rorije et al., 2013)
Probability (%) WoE+ WoE−
50 0.00 0.00
60 1.76 -1.76
70 3.68 -3.68
80 6.02 -6.02
90 9.54 -9.54
95 12.79 -12.79
100 ∞ -∞
WoE+ denotes the evidence for a positive endpoint results, WoE− the evidence for a negative endpoint
result. They are calculated according to equation 32.
Note that for a probility distribution of 50% (0.5,0.5), i.e. an uninformative prior, the ana-
lytical WoE is equal to zero, indicating a conclusion in neither direction is possible. For the
sake of completeness, the WoE form of Bayes’ rule can be written as:
190In our case by convention the positive endpoint value is in the numerator and the negative one in the denomi-
nator, which facilitates the interpretation, cf. supplemental material in Rorije et al. (2013).
191Also other measures based on odds are available, such as Bayes factors, i.e. the ratio of the posterior odds
to the prior odds (Good, 1985; Linkov et al., 2015; Jaworska et al., 2015).
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WoEpost
T+
=WoEpre +WoEtestT+ (33)
WoEpost
T+
=WoEpre +WoEtestT+ (34)
Where the superscripts pre and post denote the probability of the analysed endpoint being
positive before and after the conduction of a test. In case of an uniform discrete distribution
(0.5,0.5), i.e. an uninformative prior, the WoEpre becomes zero:
WoEpre = 10 · log10(Oddspre) = 10 · log10
(
Pr(S+)
Pr(S−)
)
= 10 · log10
(
0.5
0.5
)
= 0 (35)
The WoE expression of Bayes’ rule is the basis for the combination of several tests, for
which a more thorough discussion is given in Aldenberg and Jaworska (2010) or the sup-
plementary material of Rorije et al. (2013). In short, for two independent tests the combined
evidence as WoEpostT1,T2 with the tests being either both positive (+,+), having contradicting
evidence (+,−)(−,+), or both being negative (−,−) is:
WoEpost
T+1 ,T
+
2
=WoEpre +WoEtest
T+1
+WoEtest
T+2
WoEpost
T+1 ,T
−
2
=WoEpre +WoEtest
T+1
+WoEtest
T−2
WoEpost
T−1 ,T
+
2
=WoEpre +WoEtest
T−1
+WoEtest
T+2
WoEpost
T−1 ,T
−
2
=WoEpre +WoEtest
T−1
+WoEtest
T−2
⎫⎪⎪⎪⎪⎪⎪⎪⎬⎪⎪⎪⎪⎪⎪⎪⎭
(36)
The combination of more than two tests is possible in the same manner with a more
complex summation system. In fact, even extensive Bayesian networks can be derived
(such as in Jaworska et al., 2011, 2013, 2015; Pirone et al., 2014). It should be noted that if
one test is very good in finding sensitisers (high sensitivity/TPF ), it can overrule the negative
outcome of a second test if the latter is not as suitable for detecting non-sensitisers, because
the WoE value of the former will probably be higher than the WoE value of the second test
(for a deeper discussion cf. Aldenberg and Jaworska, 2010).
8.3. Results
Statistical independence as modelling prerequisite. First of all, as outlined, it is impor-
tant for a consensus modelling approach that the used methods are independent from each
other. This is definitively the case from a methodological perspective for the applied read-
across and structural alerts (and would also be for the bioavailability cut-offs if they would
have been found), but their independence has to be further verified statistically. This was
introduced by the UFZ working group of ecological chemistry for several endpoints, such
as rate constants of OH radical reactions with organic substances, (Bo¨hnhardt et al., 2010),
pK a dissociation constants (Yu et al., 2010, 2011), or aquatic toxicity (Ku¨hne et al., 2013). To
prove the independence the intercorrelation r2 between the prediction errors of two models
is calculated. For instance, in Ku¨hne et al. (2013) the r2 of the prediction errors of ECOSAR
and a Kow-based read-across model is low with 0.28 reflecting the independence of the
models. In case, a correlation between the prediction errors would have been observed this
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is a sign for the dependence of the used submodels and, thus, the consensus modelling
results in improved statistics which are higher than the true improvements obtained. In the
previous publications of the UFZ working group of ecological chemistry quantitative param-
eters were modelled. In contrast, this thesis is concerned with a binary classification and,
thus, previous approaches cannot be taken directly. However, an analogue measure of error
for a binary model is given with the false positive and negative classifications. Hence, both
were extracted from the read-across and the structural alert submodel results and compared
to each other, to determine if both models exhibit common false predictions or not. This is
listed in table 18.
Table 18: False positive and negative predictions via read-across and structural alerts for
LLNA and GPT data in comparison
LLNA RX FP LLNA RX FN
no yes total no yes total
SA FP no 0a 140 140 SA
FN
no 0a 108 108
yes 28 48 76 yes 44 31 75
total 28 188 216 total 44 139 183
cc 22% cc 17%
GPT RX FP GPT RX FN
no yes total no yes total
SA FP no 0a 71 71 SA
FN
no 0a 130 130
yes 58 30 88 yes 9 18 27
total 58 101 159 total 9 148 157
cc 19% cc 11%
a = The table lists the false predictions of the models (false positive or negative, FP or FN ) for a given
test system (LLNA or GPT). It is asked if a particular prediction is false (yes) or not (no) in the respective
model, leading to the false predictions in the structural alerts only (e.g. fp SA yes, FP RX no), in the
read-across only (e.g. FP SA no, FP RX yes) or in both (e.g. FP SA yes, FP RX yes). Afterwards the
concordance/agreement (cc) between the (false) predictions is calculated by dividing the false predictions
that are made by both models (e.g. FP SA yes, FP RX yes) by all false predictions (e.g. all FP ) for a
particular animal test. The predictions “SA no, RX no” have been eliminated from the analyses, because
being neither a false positive nor a false negative prediction in one of the models denotes a correct prediction
by both models. However, in line with previous analysis of the UFZ working group of ecological chemistry
(Bo¨hnhardt et al., 2010; Yu et al., 2010, 2011; Ku¨hne et al., 2013) the test for independence should concern
the prediction errors of the applied models, which are in this case only the fp or fn, and not the correct
predictions.
In table 18 the concordances (as measure for the agreement) between the false posi-
tive and negative predictions of both submodels are reported.192 If the models exhibit a
statistical dependency this would result in high concordance values, meaning they give er-
roneous predictions for the same set of compounds. In contrast, table 18 demonstrates that
192It has to be mentioned at this point that compounds with an unclear structural alert prediction (opposing
screening and high performance model results) were excluded from this analysis. This may influence the re-
sults as sets of similar molecules are excluded, which may also cause trouble for the read-across predictions.
Therefore, the analysis was repeated incorporating those data, which is delineated in Annex F.1.
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the agreement between the read-across and structural alert (false) predictions is low with
concordances of approximately 10-20%. Therefore, both models are independent and can
be combined in a consensus model. Note, besides, that table 18 also reflects the inferior
performance of the read-across, because the false predictions are in general – and often
substantially – higher in numbers than for the thoroughly optimised structural alerts.
Consensus modelling with weight-of-evidence values. All necessary conditions set
the consensus modelling can be undertaken utilising read-across and structural alert pre-
dictions to forecast LLNA and GPT results. First of all, table 19 illustrates how the combined
predictions turn out to be in the context of WoE factors as derived in the methods section.
Table 19 does not show the WoE factors for the read-across and the structural alerts in-
dividually (which can be found in Annex F.2). Instead, the more important combined WoE
factors are displayed in column 3 with an indication in column 1 and 2 which predictions of
the read-across and structural alert model were combined. In the subsequent columns 4
and 5 the combined WoE factors are used to backcalculate the associated probabilities (via
the respective odds, cf. Annex F.3). The final column shows the suggested prediction of this
Bayesian-based analysis. An example for the calculations is given in Annex F.3.
Table 19: Consensus prediction of read-across and structural alerts (uninformative prior)
LLNA data
SA RX WoE Pr(S+) Pr(S-) Prediction
+ + 9.74 90% 10% +
+ − 2.41 64% 36% o (+)
− + -5.50 22% 78% o (−)
− − -12.83 5% 95% −
GPT data
SA RX WoE Pr(S+) Pr(S-) Prediction
+ + 13.07 95% 5% +
+ − 4.64 74% 26% o (+)
− + -4.18 28% 72% o (−)
− − -12.61 5% 95% −
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of hitting a non-sensitiser,
Prediction: + = sensitisier. − = non-sensitiser, o = not decidable with (+) = trend towards sensitiser and (−)
trend towards non-sensitiser. Calculations took place with regard to equation 32 and 31. An example for the
derivation of the values is given in Annex F.3.
In general, the consensus modelling lead to similar overall conclusions for both animal
testing systems. As to be expected a positive result in both, read-across and structural alert
submodel (=concordant case), leads to the prediction of the respective compound being a
sensitiser with a high associated probability (90% and 95% in the LLNA and GPT, respec-
tively). The inverse is true if both submodel results are negative. Also in this case a high
probability (of forecasting a non-sensitiser) is achieved (95% in both animal protocols). It
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is to point out that the concordant prediction probability of non-sensitisers is the same for
both, LLNA and GPT, whereas the concordant prediction of sensitisers is better in the GPT
than the LLNA. Otherwise, for conflicting structural alert and read-across results (which fol-
low the prediction direction of the structural alerts) the prediction of sensitisers is superior in
the GPT, but for non-sensitisers the prediction is slightly better in the LLNA. The superior-
ity is expressed by larger WoE values for the respective animal test system and is, in turn,
transferred to larger probability value differences.
As mentioned, conflicting read-across and structural alert predictions tend towards the
direction of the structural alerts (bracketed conclusion in the final column of table 19). This
is in line with previous investigations and the independence assessment of both submodels,
from which it is known that the thoroughly calibrated structural alerts give the better overall
performance (with the slight disadvantage of bearing a substance loss due to the exclusion
of substances with opposing screening and high performance results). However, this simple
consensus heuristic (superiority of the alerts for conflicting prediction) was not used for the
final decision concerning the consensus modelling exercise, but compounds with conflicting
read-across and the structural alert predictions were excluded from the subsequent model
evaluation. More data or further tests (e.g. chemoassays) have to be conducted for a robust
decision – one example will be presented in the discussion section.
To understand the decision to exclude conflicting submodel predictions the reader has to
focus on the numerical probability values. Although, one probability value is always larger
than the other the distance between Pr(+) and Pr(-) differs for the scenarios at hand. It is
(expectedly) smaller for the concordant read-across and structural alert combinations than
the conflicting ones. The interesting question is, if the distance is sufficiently large in the con-
flicting scenarios to conclude that a particular target substance is a (non-)sensitiser with all
regulatory consequences that this decision bears – in particular if the model of this thesis is
applied to support regulatory decision making. For this no guidelines or other decision tools
exist currently. Nevertheless, the distances of the associated probabilities of the conflicting
read-across and structural alert predictions in the LLNA (64% vs 36% and 22% vs 78% for
active vs non-active) and the GPT (74% vs 26% and 28% vs 72%) seem not large enough
from the perspective of the author of this thesis for a robust decision. To get a sufficiently
robust prediction at least (!) a value of 90% probability is suggested. A discussion within
the regulatory community is required to develop a sophisticated guidance for risk assessors.
Evidently, this suggestion is context specific and may vary depending on the endpoint under
prediction as well as direction of the prediction. Ultimately, users of the final implementation
of the consensus model should be informed about the direction of the prediction (with the
associated probability) to undertake precautionary measures.
With this results available, the final statistics can be obtained for the combined read-
across and structural alert consensus model, where only results are counted that exhibited
concordant forecasts in both submodels. Conflicting results are excluded beforehand and it
is interesting to observed how big the actual substance loss due to this procedure is. For
this the reader is referred to table 20.
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Table 20: Statistics of combined read-across and structural alert predictions
Model name TNF TPF NPV PPV cc N %
LLNA RX 0.60 0.77 0.67 0.72 0.70 1085 100%
LLNA SA 0.82 0.88 0.82 0.88 0.85 1004 92%
LLNA RX+SA 0.82 0.93 0.88 0.90 0.89 726 67%
GPT RX 0.84 0.54 0.79 0.64 0.74 971 100%
GPT SA 0.84 0.91 0.95 0.75 0.86 849 87%
GPT RX+SA 0.93 0.90 0.96 0.84 0.92 616 63%
RX = read-across, SA = structural alerts, RX+SA = read-across and structural alert submodels combined
according to the explanations given in the text (conflicting predictions excluded), TNF = true negative
fraction (specificity), TPF = true positive fraction (sensitivity), NPV = negative predictive value, PPV =
positive predictive value, cc = concordance, N = number of compounds, % = percentage of the overall data
set.
As can be seen from table 20, nearly all193 statistical parameters were improved after con-
sensus modelling obtaining an increase in concordance of 4-5% for the animal test systems.
The major advances have been made for the prediction of non-sensitisers in the LLNA (6%-
points increase in NPV ) and the prediction of sensitisers in the GPT (9%-points incease in
PPV ). Obviously, already good parameters such as the high NPV of the structural alerts
for the GPT did not rise significantly.
However, this rise of statistical performance comes with the drawback of a decreased
number of predictable substances and, as corollary, likely a smaller domain of applicability of
the model. In the structural alert model already 6-12% of the compounds had been excluded
– because of conflicting results in the screening and high resolution structural alert model –
and this is further increased to a final exclusion of one third (1/3) of the analysed molecules
for both animal trial data sets. It was tried to re-include substances in subsequent modelling
exercise (e.g. via a decision tree) without a significant loss of statistical performance, but the
performance could not be increased beyond the values of the pure structural alert predictions
(cf. Annex F.4). Thus, the statistics are final: the developed consensus model is able to
predict two third (2/3) of the data with a good concordance of about 0.90. For the majority of
the remaining substances the structural alert model proved to be superior with a moderate
concordance of approximately 0.85.
8.4. Discussion
Despite the fact that Bayesian skin sensitisation prediction models already exist, the devel-
opment of a consensus model which entangles methods that refer closely to the chemical
structure (structural alerts and the automatic ACF-based read-across) has not been under-
taken thus far. By modelling skin sensitisation with methods closely related to the structure
of a target compound a criticism of Roberts and Patlewicz (2014) is addressed, which states
that the current Bayesian approaches do not use insights from chemistry and read-across
193The exception being the TPF for the GPT, where the structural alert model is better. This is likely caused by
the low value of the read-across.
137
approaches to the fullest possible extent. Although, the current model is likely not using “the
fullest possible extent”, too,194 it is closer to the chemical knowledge than previous Bayesian
networks. As both methods model primarily the key step of haptenation (taking into account
metabolism in a theoretical manner), other AOP parts which are often used in an ITS-based
consensus model are neglected. However, this is sensible, because the bioavailability anal-
ysis showed that for a binary classification no physicochemical threshold values can be de-
rived. Additionally, neglecting or less weighting bioavailability is in accordance with (recent)
literature (Roberts and Aptula, 2008; Roberts et al., 2013; Jaworska et al., 2015; Alves et al.,
2015; Fitzpatrick et al., 2016b,a; Roberts and Patlewicz, 2017), which suggests that other
parameters than reactivity (based on chemical structure information) are not necessary for
estimating the skin sensitisation potential.
Variation of the prior. Including prevalence or prior information into predictive consider-
ations is thought to be a valuable tool for more robust risk assessment as also proposed in
discussions about evidence-based toxicology (Hoffmann and Hartung, 2005, 2006; Rorije
et al., 2013). This can easily be achieved with the undertaken Bayesian approach. For this
the prior information’s weight-of-evidence is (re)introduced to the model. As outlined in the
methods section, the prior was initially defined as an uninformative prior with a uniform dis-
crete distribution (0.5,0.5) leading to a WoEpre-value of zero. However, if other distributions
are applied, this will change the prior’s WoE value and, thus, modify the final conclusions of
the model. The same is true for presently published Bayesian networks on skin sensitisation,
which will also depend on the prior knowledge/distribution of the data they are modelled on
(e.g. Jaworska et al., 2015).
In case of this study, the inclusion can be executed by utilising the distribution between
active and non-active substances in the respective animal data sets.195 According to the
data base (cf. section 3) there are 57% sensitisers vs. 43% non-sensitisers in the LLNA,
while the GPTs (GPMT+Buehler combined) exhibit values of 35% active vs. 65% non-
active compounds (thus, having to a negative bias). Applying the distribution of the LLNA
(0.57,0.43) and the GPT (0.35,0.65) data to formula 31 and 32 WoEpre values of 1.22 db
and -2.69 db, respectively, are obtained. These have to be added or subtracted from the
WoEpost values in the results section (therein denoted just as WoE without pre or post
because no other than the test evidences are considered) to incorporate the prior evidence.
The prior-modified results are given in table 21.
Interestingly, the differences to the uninformative prior case are small.196 Concordant
predictions of both submodels result in high associated probability values, while conflicting
predictions lead to less secure overall predictions. As to be expected, by applying the cho-
sen priors the prediction probabilities are shifted towards the “bias” (cf. correlation analysis)
of the test systems. In case of the LLNA the WoE values increase and, thus, the prediction
194For example, the model developed in this thesis predicts activity vs. non-activity, but is not able to give potency
suggestion, which is possible for at least some domains of reactivity according to literature. A preliminary
attempt towards introducing a differentiation into mechanistic domains is documented in Annex F.4.
195A prerequisite is, of course, that the collected data represent the distribution of the whole applicability domain
of the model properly. In this regard it has to be mentioned that the LLNA data are possibly biased as
explained in the read-across discussion section.
196Obviously, in case more extreme prior values are chosen the differences to the uninformative prior case
increase. An example for this is given in Annex F.6.
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Table 21: Consensus prediction of read-across and structural alerts with prior
LLNA data, prior = (0.57,0.43)
SA RX WoEpost Pr(S+) Pr(S-) Prediction
+ + 10.96 93% 7% +
+ − 3.63 70% 30% o (+)
− + -4.27 27% 73% o (−)
− − -11.61 6% 94% −
GPT data, prior = (0.35,0.65)
SA RX WoEpost Pr(S+) Pr(S-) Prediction
+ + 10.14 91% 9% +
+ − 2.25 63% 37% o (+)
− + -7.11 16% 84% o (−)
− − -15.00 3% 97% −
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of hitting a non-sensitiser,
Prediction: + = sensitisiers, − = non-sensitiser, o = not decidable with (+) = trend towards sensitiser and
(−) trend towards non-sensitiser. Calculations took place with regard to equation 32 and 31 (and the prior’s
WoE was substracted/added to the WoE beforehand).
of sensitisers (first two lines in LLNA table 21) is associated with a higher probability as com-
pared to the uninformative prior case (LLNA table 19), while the prediction of non-sensitisers
(last two lines in LLNA table 21) becomes less certain. This is turned upside down for the
GPT, for which the WoE values decrease. The resulting final probability values show that by
considering the distribution the prediction of sensitisers is less uncertain in the LLNA, while
the prediction of non-sensitisers is associated with a higher probability in the GPT. This is
true for both, the concordant and the conflicting submodel predictions, and stands in contrast
to the previous results.197 The application of the prior lead to a reversion in the rank order of
prediction security. This means where formerly the GPT was predicted more securely, now
the LLNA prediction is superior for sensitisers, while it is inferior for non-sensitisers (which
is in line with the knowledge gained in the correlation analysis and put into the prior).
However, the uncertain results (with conflicting structural alert and read-across predic-
tions) are still not above the suggested probability threshold fo 0.9 and, hence, more infor-
mation is needed. This can stem either from other alternative testing systems (chemoassays
etc.), non-testing approaches (full regulatory read-across) or in case information in another
animal test is available it can stem from the complementary test organism (e.g. LLNA if a
GPT shall be predicted). The latter case would result in a “test-across” with animal testing
results and requires a correlation analysis between the testing systems. This has been con-
ducted in this thesis for the skin sensitisation testing in mice (LLNA) and guinea pigs (GPT)
197Where the GPT had superior statistics for sensitisers and the LLNA for non-sensitisers in case of conflicting
predictions. If concordant read-across and structural alert results were available there was no difference for
non-sensitisers and the GPT (!) had a larger prediction probability for sensitisers.
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and by using the associated values from the correlation analysis their mutual WoEpost values
can be calculated. Those values can be added to the results already at hand as delineated
in the next section. Moreover, also information from mutagenicity or acute aquatic toxicity
can be used, but for those a) a more detailed correlation analysis would be necessary and
b) the uncertainties of an endpoint-to-endpoint extrapolation have to be taken into account
– wherefore a solid framework should be developed.
Table 22: Consensus prediction of read-across and structural alerts and animal data with
prior
LLNA data, prior = (0.57,0.43)
SA RX GPT WoEpost Pr(S+) Pr(S-) Prediction
+ + + 17.59 98% 2% +
+ + − 6.41 81% 19% o (+)
+ − + 10.25 91% 9% +
+ − − -0.92 45% 55% o (−)
− + + 2.35 63% 37% o (+)
− − + -4.99 24% 76% o (−)
− + − -8.83 12% 88% o (−)
− − − -16.16 2% 98% −
GPT data, prior = (0.35,0.65)
SA RX LLNA WoEpost Pr(S+) Pr(S-) Prediction
+ + + 13.51 96% 4% +
+ + − 2.30 63% 37% o (−)
+ − + 5.62 78% 22% o (+)
+ − − -5.60 22% 78% o (−)
− + + -3.74 30% 70% o (−)
− − + -11.63 6% 94% −
− + − -14.95 3% 97% −
− − − -22.85 0.5% 99.5% −
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of hitting a non-sensitiser,
Prediction: + = sensitisiers, - = non-sensitiser, o = not decideable with (+) = trend towards sensitiser and
(-) trend towards non-sensitiser. Calculations took place with regard to equation 32 and 31 (and the prior’s
WoE was substracted/added to the WoE beforehand).
Inclusion of further submodels and data. Updating the WoEpost values with further
knowledge is a major strength of the Bayesian consensus model and a simple exercise. As
the correlation (and the other statistical performance parameters) between the LLNA and
the GPT are known (cf. correlation analysis), their WoE contribution for predicting the vice
versa animal test system can be readily calculated. The respective values are reported in
Annex F.2. In case this information is taken into account, different from the exercises above,
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not 4 but 9 combined cases have to be considered as listed in table 22 (similar tables are re-
ported for an uninformative prior in Annex F.5 and the prevalence-based prior in Annex F.6).
As more methods enter the scene the table will obviously get more complex and unclear until
finally its depiction in form of a table is not sensible anymore as for comprehensive Bayesian
networks (e.g. Jaworska et al., 2011, 2013, 2015).
Table 22 demonstrates that existing animal data are a valuable addition, which can reduce
the need for further (animal) testing.198 In general, in case all data are concordant (both in
silico models as well as the animal test give the same result) very high probability values
for the prediction of sensitisers as well as non-sensitisers are archived for both animal test
systems (96-99.5%). In the LLNA normally the presence or absence of a structural alert
and concordant animal data (GPT) are sufficient to give a firm conclusion regarding the
LLNA result. However, this is not the case if read-across and structural alerts or read-across
and GPT are in accordance (and stand in contrast to the third data source). Then, no
certain conclusion can be drawn. The prediction of the GPT behaves differently. As to be
excepted, in those the prediction of a non-sensitiser is much easier, because the absence of
structural alerts as well as one other negative test (read-across or LLNA) are sufficient for a
confident prediction (where a negative LLNA is slightly preferred according to the numbers).
In contrast, the prediction of compounds active in the GPT is harder. No combination of two
models can be used to draw a sufficiently safe conclusion in case one other negative model
is available. Thus, the model behaviour for sensitisers and non-sensitisers is symmetrical in
the LLNA but asymmetrical in the GPT, which again reflects the prior knowledge about the
distribution of active and non-active compounds in the different animal protocols.199
Concluding remarks. The last mentioned point is a good transition for a general con-
clusion concerning the developed consensus model. Its regulatory value will depend on a
discussion how much probability of finding a sensitiser or non-sensitiser is enough for a de-
cision in the context of a regulatory risk assessment. Although, this is primarily a subject
for policy makers and regulators, a suggestion developed by (other) scientists is helpful as
starting point for a discussion. The 90% probability suggested in this thesis is a first pro-
posal for skin sensitisation. Other endpoints evidently might have a lower threshold to take
action. For instance, it is conceivable that the threshold probability at which a chemical is
considered non-carcinogenic is lower than for less severe endpoints such as skin sensitisa-
tion. This underpins one strength of the Bayesian approach: a numerical probability for the
prediction is given enabling more precise decisions and even judge if no decision is better
than a flawed one, because too much uncertainty is contained within the available evidence
(and, for example, the associated uncertainty is higher for more complex endpoints, Schultz
et al., 2015).
198Given the prerequisite the in silico methods are consulted. To be exact, also the current regulation stipulates
that only one animal test is conducted and LLNA and GPT can substitute each other. However, this is not
sensible as shown in the correlation analysis. Further information is necessary and two readily available in
silico approach may already be enough. Though, including further evidence besides animal testing is not
enforced in current regulation and is a necessary step to implement the knowledge of this thesis. Further-
more, a clarification of how to weight evidence is needed as already pointed out in the literature (Weed, 2005;
Linkov et al., 2009, 2015). Using this transparent and simple scheme is one way.
199There was a larger discrepancy between the number of sensitisers and non-sensitiser in the GPT in compari-
son to the LLNA.
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One possible advance from this simple scheme with two in silico approaches and possibly
one animal test (if data are at hand) can obviously be the improvement via the inclusion of
further methods/endpoints, e.g. other biological data or the often mentioned chemoassays,
which should – in line with current read-across proposals – be substantiated by mechanistic
associations (Tollefsen et al., 2014; Schultz et al., 2015; Teubner and Landsiedel, 2015; Ball
et al., 2016; Hartung, 2016). Moreover, broadening the model to a full Bayesian network is
possible (references given above). However, care should be taken in not increasing the com-
plexity too much, because this can lead to models which will be less understandable to cur-
rent risk assessors and, thus, may have limited practical value due to a limited acceptance.
Furthermore, respecting Occams Razor/the principle of Parsimony less complex models are
preferred in general – as long as they have a similar statistical performance as solid com-
plexer approaches. In this manner, if complexer Bayesian networks are constructed or more
methods are included in the current scheme, it has to be shown and discussed what the
made improvements are and why they are worthwhile.
Finally, it has to be pointed out that the current animal tests are reference tests and not
“gold standards” (Jaworska and Hoffmann, 2010; Hartung, 2010). In this situation it is for-
tunate that human data are available for skin sensitisation, which can interrelate the animal
references with the actual prediction goal (human health). With those data we can calculate
the performance of the reference (as done in the correlation analysis section). However, as
much more animal data are available, the current model was optimised towards them taking
into account their limitations, or domain of applicability, wherever possible. This is important,
because the outlined Bayesian weight-of-evidence is a powerful framework, but present risk
assessment still relies heavily on animal data. Hence, to facilitate the acceptability of this al-
ternative approach, even before a sophisticated amount of human data is available, it seems
useful for strategic reasons to predict the (possibly limited) animal assays (as also done
by Rorije et al., 2013). In addition, there has always to be a weighting for human health
endpoints between the uncertainty resulting from using (large) animal data bases (or other
approaches respectively) and the uncertainty emerging from (possibly too few) human data.
This is important, because available human data for other endpoints are scarce and a focus
on human data may result in models, for which the data set is too small for a readily reg-
ulatory application. In this manner the flexibility of the Bayesian WoE approach has to be
emphasised: if we have prior information available (not necessarily human data, but for a
specific endpoint), we can introduce it. If not, we can leave it out and make an uninformative
prior prediction, which will lead to the best available prediction for the case of incomplete
knowledge.
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9. Validation
Eventually, the overall model with all its parts was validated according to the OECD princi-
ples of QSAR validation. The results of this exercise are shown in table 23. The full reason-
ing behind the answers to the validation questions is reported in Annex G. The majority of
the principles is fulfilled, if applicable. The exception are some points such as making the
compiled skin sensitisation data public, which will happen in the near future. Moreover, an
independent reproduction of the results with a validation data set is missing. However, also
this is not unobtainable as this (external) validation exercise can be executed readily upon
the availability of further data (e.g. more animal test results of the ECHA dissemination site).
Table 23: Compliance of the developed skin sensitisation model with the OECD principles
on QSAR validation (OECD, 2004, 2007).
Principle Subquestion Judgement
1. Defined endpoint 1.1 Scientific purpose? Fulfilled
1.2 Regulatory need? Fulfilled
1.3 Experimental conditions? Fulfilled
1.4 Units of measurement? Not applicable
2. Defined algorithm 2.1 SAR substructures defined? Fulfilled
2.2 QSAR equation defined? Fulfilled
3. Domain of applicability 3.1 Groups of chemicals excluded? Fulfilled
3.2 Modulating effects? Fulfilled
3.3 Ranges of variable excluded? Fulfilled
3.4 Distributions? Not applicable
4. Internal performance 4.1 Details on training data? Not yet fulfilled
4.2 Data processing? Fulfilled
4.3 Explanation descriptor selection? Fulfilled, if applicable
4.4 Statistical methods used? Fulfilled, if applicable
4.5 Goodness-of-fit? Fulfilled
4.6 Cross-validation and/or sampling? Not yet fulfilled /
not applicable
4.7 Quality of training set/variability? Not applicable
4. Predictivity 4.8 Reproducibility of the model? Not yet fulfilled /
not applicable
4.8 Independent validation set? Not yet fulfilled
5. Mechanistic 5.1 Underlying molecular events? Fulfilled
interpretation 5.2 Known mechanism? Fulfilled
5.3 Literature references? Fulfilled
5.4 A priori/posterior indication? Fulfilled
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10. Concluding Outlook
Initial conclusions have been given in the discussion sections of each chapter, in particular
in the concluding remarks at the end. Here an overall generalised view is presented. For
more specific research proposals the reader is referred to the respective discussion. Firstly,
the compiled large evaluated database can be used as new reference data set in future
research. Still, it can be enhanced by further data, e.g. from the European chemicals
agency, which should be subject to the same selection process as applied during this thesis
to ensure the consistence of the data set. This enrichment is of high importance as several
shortcomings observed in this thesis might be solved with a larger data set (in particular the
performance of the read-across), but enlargement should not be considered as panacea.
Nevertheless, a database update is helpful for advancing the correlation analysis. New
data, in particular new high quality human data (e.g. Api et al., 2017), can clarify if the current
findings are data set specific or generalisable as portrayed in this thesis. Future work also
concerns the skin sensitisation and acute aquatic toxicity correlation analysis. Only an initial
agreement between both was demonstrated and follow-up research has to show for which
substance classes and mechanistic domains endpoint specific differences arise. Likewise,
subsequent studies have to demonstrate (a) if or how structural knowledge can be included
to obtain a better agreement (also regarding a better discrimination between active and non-
active molecules) between the toxicological and ecotoxicological effect and (b) whether the
correlation can be exploited in form of a mutual consensus prediction for both endpoints.
Finally, quantitative instead of categorical investigations are needed and the influence of
hydrophobicity has to be analysed further as it is a prime difference between both endpoints
(in particular with respect to its influence onto the skin sensitisation reactivity domains).
The last parameter is a good transition to the bioavailability investigations. The gained
insights should be transferred to the skin sensitisation AOP, e.g. the low discriminatory
power that can be drawn from physicochemical properties as well as differences to skin irri-
tation. Furthermore, studies are required to verify the preliminary 400 Da threshold for the
potency of compounds and if this can be exploited in mechanistic modelling. The same is
true for other parameters that influence the potency (and are subject to current investiga-
tions of the UFZ working group of ecological chemistry). However, the most significant step
forward would be the identification of the exact target proteins of sensitiser in the skin, to
map out their dermal location and to clarify if hard and soft electrophiles attack in different
skin areas (as suggested), which currently explains their different behaviour regarding the
hydrophobicity (and, thus, the chemoavailability). Otherwise, more data on the volatility (and
decreased solubility) are needed to examine if these can function as better explanations than
hydrophobicity with respect to the potency of a substance – in particular for other compound
classes apart from the already known effects on Michael acceptors and 1-bromoalkanes.
Finally, more human data have to prove whether the suspected influence of bioavailability in
humans, which have a more advanced skin barrier than animals, is true or not.
Obviously, the statistics of the applied read-across showed that it is far from complete,
probably also regarding further presently unimplemented influences of the ACF definition.
Particular advances surmise more domain-based investigations (beyond the approaches un-
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dertaken in the Annexes of this thesis) as well as operating at a larger (more homogeneous)
set of data. However, if the latter are not available strategies in read-across have to be found
to cope with structurally heterogeneous data sets. This can concern the inclusion of further
data into the read-across, e.g. bio- and chemoassay results (as suggested by other recent
investigations) and also physicochemical data.
The structural alerts suffer from a similar problem. They are based on expert-knowledge,
which in itself depends on the data and evidence available. More (well-described and high
quality) data should lead to more insights and as many of the alerts are preliminary, the inclu-
sion of further data as well as investigations specifically targeting preliminary structural alerts
can support the proposed alerts mechanistically (as well as statistically if new animal data
emerge). Good candidates for follow-up investigations are the low performing alerts either
because their reactivity is weak (and, thus, false negatives are seen in the animal tests) or
they comprise metabolic alerts referring to mutagenicity. With respect to the last class more
metabolic data regarding both endpoints in the test species should be collected. Finally, also
the alerts with discrepancies between the LLNA and the GPT should be studied further, e.g.
salicylates or tertiary amines (for which a different metabolic profile is suggested), to clarify if
these alerts detect (human) false positive due to the oversensitivity of the LLNA. Ultimately,
this will lead to a verification or falsification of the (preliminary) advances made and will re-
veal if the theoretical mechanistic considerations are robust or if the alerts are overfitted with
respect to the data at hand. Likewise, a discussion should take place concerning the local
validity of the alerts, i.e. which statistical (and mechanistic) performance of individual alerts
including the number of compounds is sufficient to support regulatory decisions.
Lastly, also regarding the consensus modelling more data are useful. These should tar-
get particularly new LLNA results, because the collected test outcomes are likely biased
towards sensitisers in the present data set, which directly influences the prior applied in the
Bayesian analysis (which in turn modifies the weight-of-evidence factors and, thus, the pre-
diction probabilities). Furthermore, the inclusion of data from e.g. mutagenicity as well as
aquatic toxicity will be interesting to fuel across-endpoint predictions for toxicological effects
based on the same mechanistic principles. For this also more detailed analyses concerning
the compound classes or reactivity domains, respectively, are needed to include more chem-
ical knowledge into this approach. Moreover, the next step for the consensus model is its
routine use in regulatory risk assessment to discover weaknesses in the regulatory practise
(also for more complex endpoints such as developmental toxicity). In this respect a discus-
sion is needed on the acceptable probability, i.e. which prediction probability of a particular
compound is regarded as regulatory relevant. Finally, concerning the general strategy for
regulatorily implementing the consensus model it should be considered to support animal
skin sensitisation testing first and extend this implementation subsequently to human skin
sensitisation to eventually replace animal testing. With this the prediction of animal data
functions as bridge, which can be substituted in the long run. Consequently, because skin
sensitisation is a well-advanced endpoint underpinned by many research efforts, it should be
demonstrated whether or how the combined consensus modelling comprising read-across
and structural alerts can also be applied to other endpoints with less knowledge is available.
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A. Annex Introduction
A.1. Regulatory relevant animal test systems
The historic test animals of choice for skin sensitisation testing are guinea pigs. Many dif-
ferent assays exist (reviewed in Andersen and Maibach 1985) with the ﬁrst test being pre-
sented by Landsteiner back in the 1930s (Landsteiner and Jacobs, 1935, 1936; Basketter
et al., 2008). Despite a plethora of guinea pigs tests (GPTs) being available, only assays
with concrete regulatory relevance shall be portrayed in this Annex.
The ﬁrst of those was presented in 1965 and is still regulatory accepted200 until today
(ECHA, 2014a). The test conceived by Buehler comprises the application of a test sub-
stance in an appropriate vehicle (e.g. corn oil) onto the shaved skin of guinea pigs (Buehler,
1965; OECD, 1992). Normally, 20 test animals and 10 control animals are used (with a
vehicle control receiving the vehicle without the test substance).201 The approach has two
phases. The ﬁrst is an induction phase in which the substance is applied topically with an
occlusive patch202 upon one shaved ﬂank of the test animals for 6 hours and the procedure
is repeated at the same ﬂank two more times with a one week interval. In all these appli-
cations the highest dose causing a mild irritation should be used.203 After the induction a
subsequent topical exposure to the same substance occurs in the challenge phase. Therein,
the maximum non-irritant dose204 of the test substance is applied under an occlusive patch
upon the shaved previously untreated ﬂank of the guinea pigs followed by a waiting time.
After 6 hours the patch is removed and after an additional time of 24 hours the cutaneous
reaction of the animal skin is read out by experts (normally a toxicological pathologist, ide-
ally in a blind reading of test and control animals) with a second reading after 48 hours after
patch removal. A re-challenge for clariﬁcation of the results obtained can be conducted, if
necessary. For further details the reader is referred to the literature section (Robinson et al.,
1990; OECD, 1992).
A further development of the Buehler test was conceived by Magnusson and Kligman
(1969) to enhance the sensitivity towards weak allergens and was coined guinea pig max-
imisation test (GPMT; which is also still regulatory accepted, ECHA 2014a). Its enhanced
sensitivity was subsequently proven (Frankild et al., 2000), but this might be biased due
to the susceptibility of the Buehler test to technical variation (Basketter and Kimber, 2007).
Anyhow, the GPMT consists also of two phases and has the same procedure for the chal-
lenge, but a revised induction phase was introduced. Instead of the dermal application of
200Guinea pig tests (GPTs) are not preferred and only newly conducted under speciﬁc circumstances. The term
“accepted” regards in particular older tests, which were already carried out.
201For both of the presented guinea pig tests (Buehler and GPMT) also reduced versions using lower numbers
of animals (10 in the test groups and 5 in the control) are proposed (OECD, 1992). However, this bears
implications for their statistical reliability and interpretability.
202Occlusion is thought to increase the bioavailability (cf. Basketter and Safford, 2016, or the biovailability section
of this thesis for further references).
203Skin irritation is important as it triggers immune reactions, meaning it induces the recruitment of further (in-
ﬂammatory) cellular signalling pathways that likely enhance the detectability of weak sensitisers (Kligman,
1966; Martin, 2016).
204The highest non-irritant dose is used, because irritation would also lead to a reddening of the skin but is
caused by another immunological process than sensitisation.
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the substance three intradermal injections in the neck region are given to the guinea pigs at
the start of the test with (1) the test substance alone (suspended in an appropriate vehicle),
(2) Freud’s complete adjuvant alone205 and (3) the test substance and Freud’s complete
adjuvant in an emulsion. A week later the occlusive topical application is conducted at one
ﬂank of the test animals (for 48 hours). If the substance is a non-irritant, a pretreatment
of the guinea pigs is carried out with sodium lauryl sulphate (SLS), which provokes a mild
inﬂammatory/irritant local reaction and enhances the possibility to detect (weak) sensitisers
(Kligman, 1966; Alenius et al., 2008; Basketter and Safford, 2016). At least the use of an
injection bears important implications for the bioavailability of the test substances, because
the cutaneous barrier is circumvented in the induction phase. Additionally, the introduction
of an irritant pre-treatment will lead to an increase in bioavailability as laid down in the main
section of this thesis (bioavailability discussion). Eventually, the challenge and read-out pro-
cedure is the same as in the Buehler test. For further details, such as when to conduct a
re-challenge, the reader is again referred to the literature section (OECD, 1992; Schlede
and Eppler, 1995; Frankild et al., 1996; Basketter et al., 2008).
Although being in use for a long time, guinea pig tests have never been formally vali-
dated (Basketter et al., 2008) and many drawbacks of the GPT are closely related to their
design206 (Cockshott et al., 2006). For this reason, a new test emerged in 1989, the local
lymph node assay (LLNA; Kimber and Weisenberger, 1989). First the test was proposed
as screening procedure only, but over time the test became more and more popular and,
thus, the emphasis of testing moved from guinea pig to mice. The testing in mice has not
only the advantage that the immune system of mice is better researched (OECD, 1992),
but also from an animal welfare perspective the LLNA is beneﬁcial (i.e. reduced pain and
distress as well as a lesser number of animals used). Furthermore, a robust interlaboratory
reproducibility of the LLNA was demonstrated in national and international trials (Loveless
et al., 1996; Kimber et al., 2002b, 2011) and, ﬁnally, the LLNA was formally validated by the
(american) Interagency Coordinating Committee on the Validation of Alternative Methods
(ICCVAM; Dean et al. 2001; Basketter et al. 2007a; ICCVAM 2011). Also, an extensive com-
parison to human and GPT data took place (Kimber et al., 2002b; Cockshott et al., 2006;
ICCVAM, 2011), which is delineated to a more comprehensive degree in the correlation
analysis chapter of this thesis. Nevertheless, the LLNA is not an exact replica of the GPTs.
Hence, test system speciﬁc differences arise, in particular with respect to erroneous results
for certain substance groups (cf. correlation analysis).
The differences between the GPT and the LLNA emerge already in the strategy of how
skin sensitisation assessment takes place. While the former tests focus on expert read-outs
of the challenge phase and, thus, regard the outcome of the whole process of ACD, the lat-
ter animal trial investigates the induction phase more closely, which renders it also a faster
assessment method. With respect to the LLNA testing protocol, ﬁrst pre-screening tests are
conducted (a) to determine the vehicle wherein the maximal solubility of the test substance
205An adjuvant is a mixture which enhances the immune reaction of an organism.
206As mentioned in the main section: uncertainties in determining appropriate induction and challenge doses,
animal welfare concerns, subjectivity of the read-out, as well as difﬁculties in assessing the relative potency
of a substance with GP(M)T data leading to equivocal decision about the classiﬁcation of the substance.
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is reached and (b) to assess its irritant potential – in case irritation is observed the maximum
non-irritant dose should be used, as irritants are proposed to give false positive results in
the LLNA (cf. also correlation analysis of this thesis). After the pre-tests, the substance is
applied topically in an appropriate vehicle (cf. OECD 2010) onto the ear of the mice. In
addition, an application of the vehicle alone is tested to establish a negative control group
– furthermore positive controls should be conducted regularly. Importantly, in contrast to
the guinea pig tests this exposure is not occlusive. The application is repeated on the two
consecutive days. On the sixth day of the experiment the animals (typically a number of
4 for each dose group) are humanely killed and the auricular lymph nodes are extracted.
According to the original protocol a marker solution of 3H-methyl thymidine is given before-
hand to enable the detection of lymph node cell proliferation. It is determined via scintillation
analyses of a cell suspension of the extracted lymph nodes.207 Due to comparison with the
control group a stimulation index (SI)208 can be derived and in case a SI is calculated that is
3 times above the control value the substance is regarded as sensitiser. However, besides
scintillation, which works with radioactivity, other methods of measuring the lymph node cell
proliferation are available (cf. Mehling et al. 2012; Kolle et al. 2012) and also other means
of determining if a substance is a sensitiser are at hand (e.g. a conﬁdence limit based ap-
proach, Hothorn and Vohr 2010). According to the standard protocol one negative control
and three testing groups with decreasing doses should be used, but it was demonstrated
that a reduced version using the highest dose group only is also applicable (primarily used
to conﬁrm negative predictions of skin sensitisation, Kimber et al. 2006; Angers-Loustau
et al. 2011; Ezendam et al. 2013).
Thus, the normal result of the LLNA is the stimulation index (SI) of three dose groups, rep-
resenting the degree of lymph node cell proliferation in comparison to the control. In case the
SI exceeds a value of 3 the tested substance is considered to be a sensitiser. This threshold
value was ﬁrst chosen arbitrarily and later justiﬁed by an analysis of Basketter et al. (1999a)
– showing a value of 3.6 would lead to an optimal sensitiser/non-sensitiser distinction and
the value of 3 being a conservative approximation. As the SI is a quantitative outcome it pro-
vides an important improvement over the qualitative or at maximum semi-quantitative mea-
surements (percentage of sensitised animals) of the guinea pig tests, because it enables risk
assessors to rank skin sensitisers accurately according to their potency. For this purpose,
the EC3 value – representing the concentration at which the sensitiser would presumably in-
duce a threefold lymph node cell proliferation – can be derived from a dose-response curve.
The following formula is applied (Basketter et al., 1999c):
EC3 = c+
(3− d)
(b− d) · (a− c) (37)
Where a/c are the concentrations above/under a SI of 3 and b/d are the respective SI
values. The accuracy of the EC3 value obviously depends on the strictness and quality of
the dose-response relationship. Overall, this value is reproducible and its variability is esti-
207Pooled for all mice of a speciﬁc dose group, but also an individual analysis is possible for each animal.
2083H-methyl thymidine incorporation observed in the test group divided by 3H-methyl thymidine incorporation
observed in the control group.
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mated to be within a factor of 2-5 (Basketter and Cadby, 2004; Jowsey et al., 2008; Roberts
et al., 2016a) – which is in the same range as e.g. physicochemical properties considering
the lower value (Roberts et al., 2016a). This variability translates to a rate of misassign-
ment of (GHS) potency categories for substance of approximately 10-15%, it is more stable
for stronger sensitisers, and increases if different vehicles are deployed (Hoffmann, 2015;
Dumont et al., 2016).209 Finally, it correlates well with human potency data (Schneider and
Akkan, 2004; Basketter et al., 2007a, 2008; ICCVAM, 2011; Api et al., 2014). However, not
only an interpolation as given above is possible, but also an extrapolation of the EC3 can be
conducted if all SI are above the limit value of 3:
EC3ex = 2 exp
(
log2(c) +
(3− d)
(b− d) · [log2(a)− log2(c)]
)
(38)
The meaning of the variables is the same as in equation 37, with a and c being the two
lowest test concentrations (above 3) from the dose-response curve. Albeit, for a reliable
extrapolation the experimental values have to fulﬁll certain conditions, in particular an unam-
biguous dose-response relationship should be observed and ideally the lowest concentration
should be not too far away from 3 (Gerberick et al., 2007; Ryan et al., 2007). In recent years
it was demonstrated that also the EC3 derivation/extrapolation with only one dose group (D)
and the respective stimulation index (SI) is possible using a probit equation (cf. Roberts
2015a for details), although this is not regulatory accepted at the moment.
logEC3Probit =
Pr78.5(2)− Pr78.5(SI− 1) + 0.87 log(D)
0.87
(39)
This probit-based EC3 value is interesting, because it enables the derivation of EC3 val-
ues from data of the reduced LLNA (Kimber et al., 2006; Ezendam et al., 2013). Regardless
of which method was used for their calculation, the derived EC3 values allow a ranking of
sensitisers with the stronger sensitisers possessing a low EC3 value and the weak sensitis-
ers exhibiting high values. The EC3 value is (normally) expressed in weight percent (w/v%),
which can lead to hardly comparable results for substances with a high molar weight (e.g.
above 500 Da) in contrast to substances with low molecular weight, because a solution of
the same weight percent of the latter contains more molecules than the former (see below
equation 40 for an example). Thus, the potency of low molecular weight sensitisers is over-
estimated and the potency of high molecular weight sensitisers is underestimated. To solve
this shortcoming and facilitate (quantitative) model development a corrected EC3, termed
pEC3, can be calculated according to the following formula (cf. Roberts 2011), with MW
being the molecular weight of the respective compound:
pEC3 = −logEC3
MW
= log
MW
EC3
(40)
Therein the p-preﬁx is similar to the pH value, which is a negative decade logarithm. Ap-
plying mathematical rules for logarithms, the minus can be remove by inverting the fraction
in the logarithm. As the EC3 is now in the denominator, substances with a larger EC3 re-
209The two mentioned analyses are also important because they demonstrate that in the best case LLNA classi-
ﬁcations should be based on several test data to compensate for the test variability (Casati, 2017).
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sults (weaker sensitisers) have a lower pEC3 values. To give an instructive example, both,
formaldehyde and 4-pentyl-benzenamine have an EC3 of approximately 0.99 (for formalde-
hyde this is the median of 22 EC3 values, 4-pentyl-benzenamine is based on one test only),
but the former molecule is much lighter (molecular weights are 30 Da and 163 Da, respec-
tively) and, thus, a formaldehyde solution of the same weight percentage contains more
sensitising molecules. For this reason calculating the pEC3 leads to differing potency with
values of 1.48 and 2.20. Therefore, the potency of 4-pentyl-benzenamine should be re-
garded as stronger from a molecular perspective.
Albeit providing a quantitative outcome, most regulatory decision making with respect to
the LLNA, for example the globally harmonised system (GHS), is based on categorisation.
There are different classiﬁcation schemes (for an overview cf. Loveless et al., 2010) available
of which the two most popular for the LLNA are depicted in table 24.
Table 24: LLNA classiﬁcation schemes
ECETOC GHS
EC3 [%] Category EC3 [%] Category
> 100 N > 100 N
 10 – <100 W
 1 – <10 M > 2 M
 0.1 – <1 S > 0.2 –  2 S
 0.1 E  0.2 E
Category abbreviations: N = non-sensitiser, W = weak, M = moderate, S = strong, E = extreme sensi-
tiser; classiﬁcation schemes as delineated by ECETOC (ECETOC, 2003; Kimber et al., 2003) and other
references (Gerberick et al., 2007) or in the GHS (cf. Basketter et al. 2005).
Comparing both schemes it is noted that the ECETOC classiﬁcation seems more intuitive,
because is separates the space of EC3 values into logarithmically equal units. The GHS
classiﬁcation in turn is more conservative, starting to consider sensitisers as e.g. strong at
slightly higher EC3 values than the ECETOC scale. For instance, a substance with an EC3
of 1.5% would be a moderate ECETOC sensitiser, but is categorised as strong according to
GHS. Eventually, the GHS scheme comprises fewer classes, which likely lowers the amount
of discordant results if more than one test is considered (Dumont et al., 2016).
In spite of being not intuitive,210 categorisation facilitates decision making and is also
possible for the older guinea pig test. Hence, a comparison of the categorisation between
the different animal test systems becomes possible – at least if both are based on the GHS
classiﬁcation scheme. However, it was never demonstrated if the proposed classiﬁcation
schemes lead to similar categories/classes for the same substance (which is analysed in
Annex B.2-B.4 of this thesis). Similar to the LLNA, also for the GPT different categorisation
proposals exist, whereof the most important (the GHS scheme) is depicted in table 25. It is
very similar to the ECETOC scheme listed in Kimber et al. (2003), which uses the topical
(!) exposure and adds an additional category of weak sensitisers for compounds with a test
concentration above 10%.
210Using a semi-quantitative categorisation instead of the more information rich quantitative value alone.
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Table 25: GPT classiﬁcation schemes
GPMT (GHS) Buehler (GHS)
ind. conc. Incidence ind. conc. Incidence
30-60% 60% 15-60% 60%
> 1 M M > 20 M M
> 0.1 –  1 M S > 0.2 – < 20 M S
 0.1 S E  0.2 S E
Category abbreviations: M = moderate, S = strong, E = extreme sensitiser; ind. conc. = applied induction
concentration (topical in the Buehler test, intradermal in GPMT), GHS classiﬁcation scheme as delineated
in Basketter2005.
Finally, several older classiﬁcation proposals have been distributed, e.g. by Magnusson
and Kligman (1969), which just included the number of sensitised animals but not the ap-
plied dose of the test substance. Due to the narrow focus on the responding animals these
previous classiﬁcation schemes might be not robust enough for regulatory standards today.
This is, because a substance which gives a strong sensitising effect at a small dose (e.g.
0.01% w/v) would be classiﬁed into the same category as a substance which sensitises the
same amount of animals, but was applied in much higher doses (e.g. 20% w/v). Evidently,
two very different compounds from a potency perspective would be grouped together and,
therefore, it was rejected to use this scheme for this thesis. The listed GHS categorisation
is more advanced in comparison as it takes the dose into account. In addition, because
also the LLNA GHS categories are based on concentrations in weight percent (and not the
number of reacting animals) the GHS scheme seems to be most suited for an inter-test
comparison. However, despite having a molecular measurement of potency available for the
LLNA (pEC3), there is no such value (or categorisation) based on the (molecular) concen-
tration for the GPT. Nevertheless, as the read-out of the GPT is based on expert judgment
and not on a quantitative measurement it is questionable if a calculation of the (molecular)
concentration would lead to a big improvement. Furthermore, for an inter-test comparison
similar results should be achieved by using molecular or weight percent concentrations, be-
cause the majority of chemicals in the data base are in the range of a low molecular weight
(cf. bioavailability analysis).
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B. Annex Correlation Analyses
B.1. Analysis for a discrimination between GPMT and Buehler test instead of
a combined assessment
As described in the main text a detailed analysis between GPMT, Buehler test, and LLNA
was rejected for the sake of complexity reduction. Nevertheless, a justiﬁcation for this ap-
proach has to be given. In this regard table 26 and 27 show the relationship between the
GPMT and the Buehler test.
Table 26: Contingency Table GPMT vs. Buehler
GPMT (reference test)
Model Model prediction Non-Sensitiser Sensitiser Total
Buehler test Non-Sensitiser 30 12 42
Sensitiser 4 29 33
Total 34 41 75
Table 27: Statistics of the Buehler test as predictor for GPMT results
Model TNF TPF NPV PPV CC
Buehler 0.88 0.71 0.71 0.88 0.79
TNF = true negative fraction (speciﬁcity), TPF = true positive fraction (sensitivity), NPV = negative pre-
dictive value, PPV = positive predictive value, cc = concordance
At the ﬁrst glance the correlation between the Buehler test and the GPMT is low with
a concordance of 0.79. This is mainly attributable to the high number of false negative
predictions (12) by the Buehler test (if the later developed GMPT is taken as gold standard
or reference test) in the context of a small overall data set (75). This is also observable in the
detailed statistics, which offer nearly good values for the parameters inﬂuences by the few
false positive predictions (TNF and PPV , both 0.88) while the statistics of the parameters
affected by the false negatives (TPF and NPV , both 0.71) are worse. This direction of
bias is not surprising given the fact that the GPMT was developed to be the more sensitive
animal testing protocol and should detect also weak sensitisers which might be missed
by the Buehler test (Basketter and Kimber, 2007). Thus, this results reﬂect the greater
sensitivity of the GPTM, whereas the Buehler test provides superior means for detecting
non-sensitisers (Basketter and Kimber, 2007) – and in fact its detection of non-sensitisers
(TNF in table 27) is larger than the detection of sensitisers.
Astonishingly, this result contradicts the ﬁndings of Luechtefeld et al. (2016a), who ob-
served a signiﬁcantly higher concordance between both tests (92%) on the basis of a larger
data set (364 chemicals). This was as high as the self-consistency of these tests.211 As
211Meaning compounds for which two (or more) Buehler test or GPMT, respectively, were conducted are as-
sessed regarding the question if these tests produced the same result. This was true to an extent of 95% for
the Buehler test (344 chemicals) and 93% for the GPMT (624 chemicals).
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these results are based on a threefold larger data collection they are deemed more reliable
and the ﬁnding of signiﬁcant discrepancies between the Buehler test and the GPMT appears
to be data set speciﬁc. Nonetheless, because the GPMT is the more sensitive test according
to literature (Basketter and Kimber, 2007), in case discordant results emerge (in particular a
negative Buehler test and a positive GPMT) the results of the GPMT should be relied upon.
To further analyse the impact of a combined data set of GPTs, table 28 and 29 depict the
correlations between the LLNA and the Buehler test, the LLNA and the GPMT, as well as
the LLNA and the combined GPT approach separately.
Table 28: Contingency Table LLNA vs. GPMT vs. Buehler vs. GPT
LLNA
Model Model Prediction Non-Sensitiser Sensitiser Total
Buehler Non-Sensitiser 14 10 24
Sensitiser 4 30 34
Total 18 40 58
GPMT Non-Sensitiser 52 42 94
Sensitiser 9 98 107
Total 61 140 201
GPT Non-Sensitiser 61 44 105
Sensitiser 11 104 115
Total 72 148 220
Table 29: Statistics of LLNA vs. GPMT vs. Buehler vs. GPT
Modell TNF TPF NPV PPV CC
Buehler 0.78 0.75 0.58 0.88 0.76
GPMT 0.85 0.70 0.55 0.92 0.75
GPT 0.85 0.70 0.58 0.90 0.75
TNF = true negative fraction (speciﬁcity), TPF = true positive fraction (sensitivity), NPV = negative pre-
dictive value, PPV = positive predictive value, cc = concordance
Inquiring the statistical performance parameters shows that all guinea pig approaches
predict the LLNA results with a nearly identical overall concordance (0.75). Also, the total
number of false negative predictions is always higher than the number of false positives and
the other statistical quality criteria are similar (a deviation of maximally 0.05-points). The only
exception is the detection of non-sensitisers (TNF ) which is approximately 0.07-points lower
in the Buehler only assessment. In contrast, the detection of sensitisers (TPF ) is higher in
the Buehler evaluation in comparison to the other two approaches. This would imply that the
Buehler is better at detecting sensitisers which is very astonishing (!) given the fact that it
should be the less sensitive test according to the statements that the GPMT are speciﬁcally
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developed to constitute the more sensitive testing protocol. Again, this should be attributed
to the small Buehler data compilation. To prove the shortcomings of the collected Buehler
tests a deeper analyses the statistical details of the Luechtefeld et al. (2016a) data set (or
other larger data compilations) is suggested. In the latter data base, both tests (GPMT
and Buehler) exhibit the same concordance towards the LLNA (0.77 based on 403 and 212
chemicals, respectively), but more detailed statistical performance parameters are missing
and could bring further clariﬁcation.
Overall, the combined approach obtains – as to be expected – an average value which
is in between the Buehler test and the GPMT results, shifted towards the GPMT as more
data from this test system are available. Thus, a combination equalises the primarily small
differences between both guinea pig protocols – particularly for the detection parameters
TNF /TPF (and less for the predictive parameters NPV /PPV ). As the Buehler test and
the GPMT do not differ signiﬁcantly enough on a broad scale, it was decided to use the
combined assessment (GMPT data enriched with Buehler tests) to establish a greater data
base for more sophisticated conclusion from a statistical perspective and to use the compiled
data to a maximum extend.212
Finally, table 30 lists the concordances from this analysis in comparison to the data of
Luechtefeld et al. (2016a). As explained before, the ﬁndings for the Buehler test vs. the
LLNA and the GPMT vs. the LLNA are approximately the same, but there is a signiﬁcant gap
between the concordances of the Buehler test vs. the GPMT. As the analysis of Luechtefeld
et al. (2016a) were based on a greater data set their value is deemed more reliable. Though,
a more detailed analysis should be conducted – including an evaluation e.g. if this data set
is a subset of the Luechtefeld et al. (2016a) data (most Buehler data are from the ECHA
dissemination site) and if not which data of both data sets are in agreement with each other
(as intersection) and how (or if) both data sets can beneﬁt/enhance each other.
Table 30: Concordance of LLNA vs. GPMT vs. Buehler for Luechtefeld et al. (2016a) and
this analysis
Test Concordance GPMT Concordance LLNA
Luechtefeld et al. (2016a)
Buehler 0.92 0.77
GPMT 0.77
This analysis
Buehler 0.79 0.76
GPMT 0.75
212As mentioned it would be interesting to analyse whether the data of Luechtefeld et al. (2016a) lead to the
same conclusions – indifference concerning the Buehler test and the GPMT as LLNA predictors.
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B.2. Potency analysis for LLNA, GPMT, and Buehler test categorisation – a
more detailed discussion
In the following section the potency categorisations of the three animal test systems are
compared in detail. A summary of the derived rules is given in Annex B.3. Furthermore,
an even more comprehensive (compound to compound) investigation is given in Annex B.4
(original version of this disseration).213
Buehler vs GPMT. A good start for the potency analysis are the Buehler test and the
GPMT, as both are conducted in the same test organism (guinea pigs). Thus, the main
differences should be due to methodological inﬂuences, not the animal species chosen. 73
substances are classiﬁable according to the GHS-system in both animal tests (cf table 31).
Table 31: GHS potency Classiﬁcation GPMT vs. Buehler
GPMT
Uncl. Cat 1B Cat 1A Total
Uncl. 30 7 5 42
Buehler Cat 1B 3 8 6 17
Cat 1A 0 4 10 14
Total 33 19 21 73
Spearman r2 0.625
Of the 73 substances 48 are classiﬁed in the same category in both test systems (which
results in a Spearman r2 of 0.625). 30 non-sensitisers and 28 sensitisers were identiﬁed
by the GPMT as well as the Buehler test (neglecting the potency category). Assuming
that the measured sensitising effect in the respective test is correct, 3 substances were
classiﬁed false negative in the GPMT and 12 (7+5) false negative with the Buehler method.
Looking into the details reveals that the 3 presumably false negative classiﬁcations of the
GPMT, except for 1 case, are in fact sensitisers and the misclassiﬁcations are due to special
circumstances (Annex B.4). In case of the Buehler test false negatives for 3 substances
explanations for the misclassiﬁcation are at hand: 1 is a borderline negative classiﬁcation, 1
further had to be rejected due to systemic toxicity, and 1 substance seems to be classiﬁed
false positive in the GPMT due to irritation problems (Annex B.4). This leaves 9 substances,
which are not detected by the Buehler protocol, but in the GPMT (and 4 of them are also
positive in the LLNA). This clearly indicates that the GPMT is the more sensitive testing
protocol. The ﬁnding is not surprising, because it was also seen in the binary analysis,
the GPMT is generally accepted as the more sensitive test (Basketter et al., 2005; Basketter
and Kimber, 2007), and the GPMT was optimised towards detecting contact allergens via the
introduction of enhancing factors, like an intradermal induction phase as well as the addition
of Freuds complete adjuvants (Magnusson and Kligman, 1969). However, as pointed out
by Basketter and Kimber (2007) the sensitivity differences may be primarily attributable to
213Note, individual substance data of this thesis will be distributed via ChemProp. Interested readers are advised
to please contact the UFZ working group of ecological chemistry for more information.
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the susceptibility of Buehler tests to technical variation as well as its initial insufﬁciently
precise description. Overall the Buehler test should be regarded as sufﬁciently sensitive for
regulatory classiﬁcation if conducted properly (Basketter and Kimber, 2007).
A similar line of reasoning may explain why some of the 6 substances are classiﬁed into a
higher GHS category (1A instead of 1B) in the GPMT in comparison to the Buehler test. For
three of them the LLNA also suggests a classiﬁcation into the category 1A, while one other
should be counted as moderate (1B) sensitiser according to its LLNA results. Investigating
into the details reveals the following facts (originally more deeply analysed in Annex B.4):
For 2 of the substances (formaldehyde, 2-hydroxyethyl acrylate), where the categorisation
was 1A in the LLNA and the GPMT, but 1B in the Buehler, clear indications are seen that the
GPMT is more sensitive than the Buehler method, since more animals were sensitised. The
other substance with this kind of difference was not evaluable, because of missing informa-
tion for the GPMT. One substance, which was classiﬁed as 1B in the LLNA and the Buehler
test but 1A in the GPMT, is a borderline cases (in all three test systems) and the application
of the precautionary principle for the GPMT(s) lead to the more severe classiﬁcation. The
last two substances exhibit no clarifying LLNA results. While in one case the differences in
the classiﬁcation may probably be rationalised by the used concentrations for the other left
substance no explanation for the discrepancies was found.
Four substances are predicted to be a strong sensitiser due to their Buehler results, but
lead to only moderate reactions in the GPMT. In 3 cases (Annex B.4) a too high dose in the
GPMT (above 5% w/w) prohibited a classiﬁcation as strong sensitiser. This means that the
compounds could still be classiﬁed into the more severe 1A category, in case a retesting
(which is considered unethical) of the substances at a lower dose results in high numbers
of sensitised animals. Last, 1 compound is left, which has a borderline classiﬁcation in the
Buehler test and is probably classiﬁed too high in this test
As a side note, with regard to substance classes and reactivity domains, there is no
class or domain which behaves particularly different in one of the guinea pig test systems.
The commonalities and the differences are distributed equally among them. However, the
amount of substances is too low from a statistical perspective to derive sophisticated con-
clusions on this topic.
Summary. Overall both test systems obtained the same classiﬁcation for most of
the compounds. In case of differing outcomes these can be rationalised by several lines of
reasoning. Leaving out the borderline classiﬁcations (3) and substances where the GPMT
concentration was too high (4), the correlation regarding the potency is moderate. A mod-
erate or strong categorisation in one test will give quite the same in the other system,
given that the concentration in the GPMT is low enough to classify a compound as strong
sensitiser. But, this conclusion should be substantiated with more results and care
should be taken in case of borderline outcomes. Furthermore, the ﬁndings indicate
that the GPMT is more sensitive in comparison to the Buehler test, because it detected
more sensitisers and in one case (formaldehyde) lead to higher numbers of sensitised ani-
mals, which in turn is associated with a more severe classiﬁcation.
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Buehler vs LLNA. Next, the correlations in potency between the Buehler test and the LLNA
are examined. The respective data are depicted in table 32.
Table 32: GHS potency Classiﬁcation LLNA vs. Buehler
LLNA (reference test)
Model Prediction Uncl. Cat 1B Cat 1A Total
Uncl. 15 8 2 25
Buehler Cat 1B 4 8 7 19
Cat 1A 0 3 10 13
Total 19 19 19 57
Spearman r2 0.637
For 33 out of 57 chemicals the same category was obtained (resulting in a Spearman r2
of 0.637). However, in a binary matter for 15 non-sensitisers and 29 sensitisers (43 out of 57
chemicals) both tests gave the same results, a fact which indicates that a classiﬁcation into
active and non-active compounds is in greater accordance than the potency categorisation.
In the cases where the Buehler test identiﬁed a sensitising compound, whereas the LLNA
did not, 3 out of the 4 substances were false positives in the Buehler (see also Basketter and
Kimber 2010) and the last (butan-2-one oxime) is probably false negative in the LLNA (see
Annex B.4 and the main text – correlation analysis – for details). In the vice versa situation
the numbers alone demonstrate that the LLNA is more accurate than the Buehler method or
even too sensitive, as the former assay identiﬁed 10 more sensitisers. Of those 6 are clearly
false negative in the Buehler protocol (taking into account their reaction chemistry besides
other factors, Annex B.4). In addition to that, 2 further compounds exhibited borderline neg-
ative results in the Buehler test. Finally, 1 substance was found for which a clear suggestion
which test is right could not be made and the last (1) chemical is probably false positive in
the LLNA.
Concerning the potency categorisation, 3 substances are classiﬁed in a higher class (1A
instead of 1B), if the Buehler protocol is executed. But, backed up by the 3 respective GPMT
results, at least 2 of the classiﬁcations are due the use of the precautionary principle or
a borderline situation in the Buehler results (Annex B.4). This leaves only 1 substances
(ethylenediamine) which reacts more sensitive in the guinea pig tests.
Turning the perspective, 7 compounds possessed a stronger sensitising effect according
to the LLNA (compared to the Buehler test). In 3 of those cases also the GPMT classiﬁed
the compound as more hazardous, which reinforces the LLNA results. Of the remaining
chemicals 1 of the 4 left exhibited borderline 1B results in the Buehler method, while the last
3 are deﬁnitely classiﬁed too weak (as 1B) by the Buehler protocol.
Summary. Overall, these results mean that the separation into active vs. non-active
compounds is quite similar in both test systems, but the LLNA is more sensitive with
the Buehler test having several false negative results. However, if a chemical is cate-
gorised as 1A via the Buehler method, it is likely that it will exhibit a strong sensitising
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effect in the LLNA, too. But, importantly, this is neither true for the vice versa case (when
a LLNA gives a 1A as categorisation than the Buehler results is not necessarily 1A) nor for
a moderate classiﬁcation according to the Buehler test, as the predicted 1B Buehler sen-
sitisers are classiﬁed moderate as well as strong in the LLNA. Also a 1B categorisation in
the LLNA gives no clear suggestions what the result in the Buehler test looks like. It has
to be mentioned that the numerical basis of this analysis is quite low from a statistical
perspective and, therefore, these interpretation should be taken with care.
LLNA vs GPMT. Last, the most important step of the correlation analysis shall follow: the
combined examination of the GPMT and the LLNA. The importance is not only due to the
fact that both test systems have the most results for the analysed chemicals, but they are
also historically considered to be the most sensitive testing procedures for assessing skin
sensitisation (Basketter et al., 2005). The categorisation is depicted in table 33.
Table 33: GHS potency Classiﬁcation LLNA vs. GPMT
LLNA (reference test)
Model Prediction Uncl. Cat 1B Cat 1A Total
Uncl. 52 34 8 94
GPMT Cat 1B 6 31 10 47
Cat 1A 3 25 29 57
Total 61 90 47 198
Spearman r2 0.535
Out of the 198 substances, which were analysed in both test systems, 113 were classiﬁed
into the same category (giving a Spearman r2 of 0.531). Looking at the active vs. non-active
dichotomy, 52 substances were classiﬁed as deﬁnite non-sensitisers, whereas 95 sensitisers
were unearthed. Alone the fact that 9 vs. 42 (LLNA vs GPMT) possible false negatives
became apparent in the data, shows that the LLNA is likely more sensitive than the GPMT
or even too sensitive as some literature sources claim (Vohr and Ahr, 2005; see also main
text of this thesis). An in-depth analysis (Annex B.4) revealed that of the 9 presumably
false negatives in the LLNA, 4 in fact were GPMT false positives, whereas 4 were classiﬁed
correctly by the GPMT. Whether the 1 left substance was false positive or false negative,
remains an open question (Annex B.4). From the other point of view, where the LLNA stated
a compound should be a sensitiser and the GPMT in contrast did not, the data set contains
13 deﬁnite, 5 probable and 6 borderline false negatives for the GPMT (Annex B.4). Of the
remaining compounds 15 deﬁnite and 1 likely false positives (LLNA) are included (some
are also discussed in the main text of this thesis as well as Kreiling et al. 2008, and Ball
et al. 2011). Lastly, 2 substance are left, where the situation was not fully decidable. Taken
together in 22 cases the LLNA was correct, whereas the GPMT obtained for 16 substances
more accurate results. In this scenario reaction chemistry is useful for discriminating the
results, as shown in the main section of this thesis.
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All of the 4 LLNA false negatives exhibited features encoding for electrophilicity (primarily
from the (pre/pro-)Schiff base reactivity domain) which further substantiates this ﬁnding. The
number of LLNA false positives (16) can be decreased if special substances classes like un-
saturated hydrocarbons, surfactants, and irritative substances are excluded (11 chemicals),
which is well-known in the literature (Kreiling et al. 2008, and Ball et al. 2011). In addition
to that, 2 acids and 2 unsuspicious compounds from a chemists point of view – isopropyl
myristate (a simple ester) and heptan-1-ol (a simple alcohol) – are mysteriously positive in
the LLNA, which should fuel further investigations. Apart from that, the main class which
is classiﬁed (borderline) false negative in the GPMT (22 substances) are classical (pre/pro-
)Michael acceptors (α,β-unsaturated compounds). This is not surprising as they are the
most populated group of sensitisers in this data set and exhibit often only weak reactivity.
10 sensitisers were classiﬁed more severe in the LLNA in comparison to the GPMT. Fol-
lowing the in-depth data analysis, 3 cases seem to exhibit borderline classiﬁcation differ-
ences (or the other guinea pig test, the Buehler test, found a greater sensitising potential),
whereas at least 2 substances reacted deﬁnitely more sensitive in the LLNA. The stronger
LLNA reaction is as well true for 1 additional substance, which was also underclassiﬁed in
the Buehler test. Moreover, for 2 compounds the high test concentration in the GPMT prohib-
ited a classiﬁcation as 1A, but the reaction of the animals (percentage) was strong enough
– a retesting at lower concentration could resolve the discrepancies. For the remaining 2
compounds no solid conclusion is possible due to missing information.
Turning the perspective, 25 substances seemed to be underclassiﬁed in the LLNA or over-
classiﬁed in the GPMT, respectively. Of those, 7 compounds exhibited deﬁnite classiﬁcation
differences between the LLNA and the GPMT, 6 borderline results were seen (or results with
inconsistencies between several test of one and the same test system) and for 9 substances
the classiﬁcation differences could not be further investigated due to missing information in
the original data source. Lastly, for 3 compounds no further decision could be made.
Summary. As concluding remarks, it has to be said that even after subtraction of the known
false positive substances the LLNA is better suited for detecting sensitisers, but may be
too sensitive. Nonetheless, the GPMT was able to ﬁnd 4 sensitisers that were (presumably)
false negative in the LLNA (and primarily belonged to the Schiff base domain). Care should
be taken, when translating potency from one test to the other. It is only possible to say
that a strong sensitiser in the LLNA will also show a strong potential in the GPMT. This
is not true for moderate (1B) sensitisers in the LLNA which contain no information for
the GPMT, because they could be characterised as non-sensitisers, classiﬁed into category
1B or classed into category 1A with quite equally likelihood. Vice versa, a strong result in
the GPMT does not contain information for the LLNA categorisation, whereas a moderate
GPMT result is likely to be moderate in the LLNA, too. In other words, if the LLNA cate-
gorisation is correct, the GPMT is not able to discriminate precisely enough between
strong and moderate sensitisers, since it tends to predict the more severe class.
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B.3. Comparing summary of the potency analysis and derivable rules
As expected the ﬁndings suggest that the classiﬁcation in the different GPT (Buehler and
GPMT) leads to the same conclusions, given that the concentration in the GPMT is low
enough to classify a compound as strong sensitiser. However, the data base (27 sensitiser
in both systems) is too small for sophisticated suggestions. The conclusion is different for
the LLNA-GPT comparisons. On the one side, if a chemical is categorised as strong via the
Buehler method, it is likely that it will exhibit a strong sensitising effect in the LLNA, too, but
not vice versa. Furthermore, a moderate Buehler sensitiser is not usable to deduce its LLNA
potency (moderate Buehler sensitiser are classiﬁed moderate as well as strong in the LLNA).
Also for this comparison the number of used compounds (29 sensitiser in both systems) is
too low to propose robust general rules. On the other side, the LLNA GPMT comparison
has a different proﬁle. It is possible to conclude that strong sensitisers in the LLNA will also
exhibit a strong potential in the GPMT, but not vice versa. The last fact can be emphasised
as the GPMT not being able to discriminate precisely enough between strong and moderate
sensitisers, because it tends to give more severe predictions. For moderate sensitisers a
GPMT 1B → LLNA 1B translation is possible. But, turning the point of view, if a sensitiser
is moderate in the LLNA it can be categorised in any potency class. This suggests that
the category of moderate (or weak) LLNA sensitisers may be of little use in the regulatory
practice. One reason for this is likely that the LLNA is too sensitive, i.e. it misidentiﬁes
non-sensitisers as active. A further factor, experienced by other working groups, is that the
distribution of potency in GPMT is polarised towards the extremes (Cronin and Basketter,
1994; Basketter et al., 2001a). Again, a broadening of the data base should be made to
substantiate the ﬁndings. Moreover, the inherent variability of the tests (Hoffmann, 2015;
Dumont et al., 2016; Luechtefeld et al., 2016a) should be taken into account in follow-up
investigations. However, from the 95 sensitiser in both systems the following heuristics for
the translations of the potency classes (according to the GHS system) to the respective other
test systems can be derived:
1. GPMT 1B → LLNA 1B
2. LLNA 1A → GMPT 1A
B.4. In depth individual compound potency analysis
This Annex originally listed a detailed analysis of every compound with disconcordant an-
imal test results and possible reasons for the classiﬁcation differences. For any questions
regarding individual data please contact the UFZ working group of ecological chemistry.
B.5. Compounds with disconcordant LLNA, GPT, and human results
This Annex originally listed the disconcordant LLNA, GPT, and human results on an individ-
ual compound level. For any questions regarding individual substance data please contact
the UFZ working group of ecological chemistry.
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B.6. Details on the comparison between aquatic toxicity and sensitisation
Table 34: Statistics of sensitisation vs. aquatic toxicity
LLNA data
Organism Data TNF TPF NPV PPV cc N %
Fish all vs all 0.65 0.42 0.50 0.57 0.53 108 100
WW vs. all 0.78 0.60 0.73 0.67 0.70 71 66
WW vs T-0.25 0.69 0.69 0.76 0.61 0.69 71 66
WW vs T-0.5 0.74 0.78 0.83 0.67 0.75 57 53
D. magna all vs all 0.62 0.42 0.49 0.56 0.52 62 100
WW vs. all 0.62 0.53 0.67 0.48 0.58 48 77
WW vs T-0.25 0.65 0.64 0.69 0.60 0.65 31 50
WW vs T-0.5 0.68 0.56 0.68 0.56 0.63 38 61
T. pyriformis all vs all 0.83 0.44 0.57 0.74 0.62 135 100
WW vs. all 0.82 0.57 0.72 0.71 0.72 109 81
WW vs T-0.25 0.86 0.69 0.78 0.80 0.79 66 49
WW vs T-0.5 0.86 0.63 0.76 0.77 0.76 89 66
GPT data
Organism Data TNF TPF NPV PPV cc N %
Fish all vs all 0.75 0.54 0.75 0.54 0.68 130 100
all vs T-0.25 0.81 0.63 0.80 0.64 0.74 113 87
all vs T-0.5 0.82 0.70 0.83 0.68 0.77 93 72
D. magna all vs all 0.77 0.64 0.81 0.58 0.73 84 100
all vs T-0.25 0.79 0.67 0.84 0.58 0.75 68 81
all vs T-0.5 0.82 0.81 0.91 0.65 0.81 54 64
T. pyriformis all vs all 0.86 0.42 0.73 0.62 0.70 141 100
all vs T-0.25 0.87 0.41 0.76 0.60 0.72 115 82
all vs T-0.5 0.85 0.50 0.82 0.55 0.76 82 58
Used data as follows: all = all data used, WW = weak sensitisers in the LLNA were excluded, T-0.25/T-0.5 =
chemicals with values within a grey area were excluded, with 0.25 meaning an grey area of 0.75-1.25 and
0.5 denoting a range of 0.5-1.5, compounds above the grey area were treated as excess toxic and below
were considered as narcotic. TNF etc. as in other tables.
Table 35: Number of (non-)sensitisers in comparison to aquatic data
Fish D. magna T. pyriformis
Result LLNA GPT LLNA GPT LLNA GPT Zhang (2015)
Sensitiser 57 46 33 28 74 51 41
Non-sensitier 51 84 29 56 66 96 13
With regard to the work of Zhang (2015) it is interesting to compare the number of sensitisers vs. non-
sensitiser in the different data sets, which are listed in this table.
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C. Annex Bioavailability
C.1. Basic equations of modelling skin permeation processes
In general, entering the deeper skin compartment such as the dermis or deep parts of
the epidermis is governed by the process of diffusion (passive movement of molecules)
and several partitioning steps across different zones of hydrophilicity, which constitute the
permeation through the varying skin layers (Guy and Potts, 1993). To describe diffusion
processes Fick’s ﬁrst law is used:
Jm = Kp · csat (41)
Therein, Jm is the maximum rate of diffusion that is calculated as the product of a com-
pound speciﬁc permeability coefﬁcient Kp and the its saturation concentration in water csat.
As the latter can often easily be measured the prime target of permeability estimation meth-
ods is Kp. It can be determined as the product of the target chemicals diffusion coefﬁcient
D times the stratum corneum water partition coefﬁcient Kscw divided by the diffusion path
length h (e.g. Guy and Potts 1993):
Kp = D · Kscw
h
(42)
As the main barrier is the stratum corneum, the coefﬁcients and the path length are often
indexed with an SC (e.g. in Basketter et al. 2007c). The latter equation can be approximated
via substituting the stratum corneum water partition coefﬁcient by the octanol-water partition
coefﬁcient Kow and relate the diffusion coefﬁcient to the molecular weight of a compound
(Potts and Guy, 1992; Guy and Potts, 1993; Guy, 2010). Using multiple regression the
following expression (also called Potts and Guy equation) is obtained:
Kp = −2.74 + 0.71 logKow − 0.0061MW (43)
This well-known and simple equation is still useful today and gives comparable estimates
to more complex models (Wilschut et al., 1995; Fitzpatrick et al., 2004; Lian et al., 2008).
However, the use of the log Kow is criticised as being “a poor chemical model for the unique
architecture of the skin” (Abraham and Martins, 2004), which encodes only polar terms
(Geinoz et al., 2004) and, thus, more sophisticated models based on linear free/solvation
energy relationships (LFER/LSER) have to be considered (Abraham et al., 1990; Abraham,
1993; Platts et al., 1999; Abraham et al., 2004; Abraham and Martins, 2004; Arey et al.,
2005). The latter of which utilise the fact that the partitioning behaviour of a chemical is
governed by intermolecular solute-solvent interactions that are deﬁned by three main fac-
tors, namely Van-der-Waals interactions, hydrogen-bonding, and entropic considerations.
Ultimately, the following equation is used (often called Abraham equation; see papers of the
above mentioned working group):
SP = c+ eE + sS + aA+ bB + lL (or vV ) (44)
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Therein several properties are used to derive a solute property SP in a series of solvents.
Generally, capital letters denote independent variables, which are parameters of molecular
properties. Smaller case letters are their respective ﬁtted coefﬁcients – which are referred as
phase parameters or system constants – and are derived by multiple regression. In detail,
E is the excess molar refraction (the molar refraction of the solute minus the molar refrac-
tion of an alkane of equivalent volume, Platts et al. 1999) and S the polarisability (combined
with the dipolarity), which both estimate the polar as well as Van-der-Waals interactions. A
and B denote hydrogen bond acidity and basicity and, thus, constitute hydrogen bonding.
Its importance has been pointed out on several occasions (e.g. Moss et al. 2002; Geinoz
et al. 2004). The latter variable is either the Hexadecan-Air-Partition-Coefﬁcient L or the
Characteristic Volume V both of which model molecular size. It is used to introduce entropy
to the equation, because forming a cavity for a new molecule (e.g. bromophenol) in a sol-
vent (e.g. water) is associated with the break of solvent-solvent bonds, a process which is
energy extensive and leads to a reorganisation of the solvent molecules round the cavity
(Abraham et al., 1990, 2004). The breakage of the highly ordered network of e.g. hydrogen
bonds is linked to an increase in entropy and is subsequently (partly) compensated when
solute–solvent interactions are set up (Abraham et al., 2004).
C.2. DSS investigations
Calculations. The exclusion rules as stated in Gerner et al. (2004b) were taken to investi-
gate if they can also function as limit values for skin sensitisation and, thus, have a general
nature. In this regard only the rules meaningful for this research question were used, which
means that the rules for the eye and for skin corrosion were excluded (because the former
is a totally different target organ and the latter effect does not necessary include substances
that penetrate the skin barrier, but also accounts for substances that destroy it; further-
more, most of the rules are the same as or quite similar to those for skin irritation). The
exclusion rules apply not in every case for every substance, but several of them were de-
velop for speciﬁc compound classes. These are the groups C, CHal, CN, CNHal and CNS,
corresponding to chemicals with the composition: CxHyOz; CxHyOzXa (X = F, Cl, Br, or I);
CxHyNbOz; CxHyNbOzXa (X = F, Cl, Br, or I); CxHyNbOzSc. The following properties are used
for the exclusion rules and were calculated as stated below:
Moleculare weight: The ChemProp (v 6.5, 2016) module for molecular weight (MW) was
used. It simply takes the weights of the individual atoms from the structure under investiga-
tion and sums them together to give the overall weight of the corresponding compound.
Octanol-water partition coefﬁcient: log Kow values were calculated via a consensus mod-
elling method implemented in ChemProp (v 6.5, 2016) and not yet described in the literature.
It forms a consensus by deriving the mean of the results of the 4-8 individualKow-calculation
methods. In addition, the KOWWIN module of the Epi Suite was utilised for estimation of
the log Kow, because it proved to be a reliable method according to literature (Schu¨u¨rmann
et al., 2007). The latter model comprises a simple fragment method, where the molecule
is divided into different fragments (atoms or larger functional group) and the corresponding
values for all fragments are added up to obtain the ﬁnal result. Both approaches lead to
C2
similar overall conclusions,214 albeit the histograms of the ChemProp consensus is shifted
towards higher log Kow values for water soluble substances (cf. Annex C.3). For table 36
the ChemProp calculation results were taken.215 The results produced by the Epi Suite can
be found in table 37.
Water solubility: A consensus model developed by Ku¨hne et al. (2006) and implemented
in ChemProp (v 6.5, 2016) was used for the estimation of the water solubility Sw. It con-
siders seven different methods not requiring a melting point. The consensus decision is
driven by the lowest average error for the most similiar compound of a data set with known
estimation errors, where the structural similarity is calculated by structure comparison via
atom-centered fragments (cf. read-across chapter of the main section of this thesis).
Lipid solubility: Lipid solibility is hard to obtain, thus it was approximated by octanol solu-
bility. Since the Kow (Co/Cw) can also be derived from So/Sw, the octanol solubility can be
calculated from the Kow and the water solubility via:
Kow = So/Sw <=> So = So ·Kow <=> logSo = logSw + logKow (45)
Melting point: First of all, it should be borne in mind that estimations of melting points are
heavily error prone (Lyman, 1985; Reid et al., 1987), which is still true for calculations today
(Ebert, 2016, personal communication). For this reason two models were tested to compen-
sate for errors arising from the utilisation of individual methods. The ﬁrst is the MPBPVP
module of the Epi Suite and the second an (UFZ-)internal ChemProp module (v 6.5, 2016).
The latter operates by calculating the melting point via the methods of Marrero and Gani
(2001), Constantinou and Gani (1994), and Joback and Reid (1987). In case no result is
given by the ﬁrst method, a calculation according to the second method is performed and if
this fails too the last method is applied. All methods rely on group contribution approaches
(for details cf. ChemProp method description or the respective references).
An older approach of the last method (Joback, 1982) is used by the MPBPVP module
(with additional groups as well as melting point correction factors for speciﬁc structures).
MPBPVP additionally applies a second method, which simply relates the melting point (Tm)
to the boiling point (T b) via: Tm = 0.5839 · T b (Gold and Ogle 1969; Lyman 1985; the boiling
point can be estimated by a modiﬁed Stein and Brown, 1994, method). After the calcula-
tion MPBPVP suggests a melting point based on the two individual estimates and several
heuristics, which are explained in detail in the Epi Suite handbook. Due to overestimations
a cut-off value at 350°C is included, which means every substance above that cut-off is
reduced to 350°C. Similar to the Kow calculations the ChemProp results were taken for ta-
ble 36, because they utilised more advanced methods. Still, both approaches lead to the
same conclusions (the respective Epi Suite results can be found in table 37).
214They correlate to a high degree with Pearson r=0,961, r2=0,924.
215This is not without argument. The observed log Kow shift is important for the Gerner classiﬁcation rules,
whereof one general rule operates with a log Kow threshold of -3.1. As the consensus approach calculated
only 5 values to be below this cut-off and the Epi Suite has 23 substances for which the threshold applies,
the latter could be chosen for the sake of data richness. In the end, the result is nearly the same – even
numerically, cf. table 37.
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Vapour pressure: Also for the vapour pressure (P v) estimation models from both pro-
grams (Epi Suite and ChemProp, v 6.5, 2016) were applied. From the several modules of
ChemProp the modiﬁed Grain method (Antoine based) was chosen, which applies a set of
thermodynamic equations developed by Antoine (Grain, 1990) that use the boiling point for
the P v prediction (cf. the respective module in ChemProp or Grain, 1990). In case no boiling
point is given beforehand, it is estimated by the software before the P v calculation is done.
The selection was driven by the fact that Patlewicz et al. (2014c) presented good results
using the Antoine-Grain-method.
The Epi Suite utilises in its MPBPVP module the same method for gases and liquids as
well as a modiﬁed Grain method (Lyman, 1985), which is also applicable to solids. After
the calculation a consensus of both methods is formed, where the latter method is used for
solids and an average of the Antoine and modiﬁed Grain method is computed for liquids
and gases. For hydrocarbons and halogenated compounds also a method elaborated by
Mackay (Lyman, 1985) can be applied in the Epi Suite, but is not used in the in the MPBPVP
suggestion. Overall, the MPBPVP approach gives moderately conﬁdent results and is rec-
ommend for the estimation of the P v estimations at present as explained in Schu¨u¨rmann
et al. (2007) and was therefore selected for table 36 – as before, the results of the other
method (Antoine-Grain-method with ChemProp, v 6.5, 2016) can be found in table 37 and
lead to the same overall conclusion.
Statistics. The most reasonable statistical parameter for the exclusion rules is the neg-
ative predictive value, NPV (Rorije and Hulzebos, 2005). It is calculated as stated in sec-
tion 4. For recapitulation:
NPV =
TN
TN + FN
(46)
Where TN is the number of true negative and FN the number of false negative classiﬁ-
cations.
Results. Table 36 shows the results of the simple application of the exclusion rules for
skin irritation (former risk phrase R38) to the different skin sensitisation data. Gerner et al.
(2004b) were able to exclude skin irritating effects for a sophisticated amount of substances
(typically between 50 and 300, cf. Walker et al. 2005) with an extreme NPV (100%, except
some cases, where the limit values were overruled by other factors such as hydrolysis or
organic salts releasing strong acids or bases). In contrast, in none of the investigated skin
sensitisation data sets only non-sensitisers belonged to the substances below/above the
threshold. Thus, the NPV was below the ideal 100% and typically values between 50% and
75% were obtained – which is not acceptable for a regulatory application. Moreover, the
performance of the cut-offs did normally not change signiﬁcant by discriminating between
LLNA and GPT to allow a regulatory application and is nearly identical for several rules in
both animal test systems. Rules with a sufﬁciently high NPV for further consideration (90%)
were the MW > 380 Da cut-off for CNHal compounds in the LLNA and the log Sw < -4
threshold for the CN group in the GPT. However, they are applicable just for few compounds
(below 30), which renders them rather uncertain from a statistical perspective (the DSS-rules
C4
classiﬁed more data points correctly, approximately 50 more compounds on average).216
This is generalisable for other rules, because most thresholds suffered from the shortcoming
of targeting few substances (often below 30). The exceptions are the limit values for the
melting point, where normally more than 50 substances were above the cut-off. In addition,
it should be mentioned that also Rorije and Hulzebos (2005) criticised some of the DSS
rules, e.g. for lipid solubility for exhibiting a limited data base and, hence, a limited statistical
sophistication.
Discussion. The DSS is not without criticism. As stated in the main section, recent inves-
tigations (Mehmed et al., 2014, poster presentation) found high numbers of false negative
classiﬁcations by utilising a different data set, which leads to the proposal that the observed
rules are data set speciﬁc. Furthermore depends the NPV (and also PPV , cf. Pepe, 2003)
on the distribution of positive and negative test results, what might have a detrimental inﬂu-
ence on the developed rule system (cf. main section). More criticism concerning the DSS
is found in the ECB validation report by Rorije and Hulzebos (2005). Their detailed point of
concern comprises the following core conclusions:
• the cut-offs for the melting point are chosen in a non-conservative manner;
• one log Kow rule should be removed (log Kow < 0.5 for CNS substances);
• the molecular weight threshold for the classes CN and CNHal should be combined to
form a more solid statistical basis;
• the lipid solubility as a parameter has limited value (due to the fact that it is measured
just in few cases);
• the vapour pressure rules are based on inconclusive data.
Rorije and Hulzebos (2005) gave advice how these shortcomings can be revised, i.e. a
more consistent way of setting cut-off values, which lead either to the removal of particular
rules or the reﬁnement their threshold values. Also these improved rules were analysed, but
obtained similar results (cf. table 38). Furthermore, in the ECB report (Rorije and Hulze-
bos, 2005) it is recommended to use other subclasses than proposed in the DSS, because
these are not based on mechanistic considerations. This was taken into account during the
exploratory investigations of potential new limit values (cf. Annex C.5). In conclusion, the
original exclusion rules are not appropriate to rule out bioavailability in skin sensitisation and,
hence, exclusion rules for skin penetration are deemed at least endpoint speciﬁc.
216For this average value the results given in Walker et al. (2005) were compared to the non-sensitisers – i.e.
the correctly negatively classiﬁed substances – from the merged LLNA and GPT data set. The amount of
the non-sensitisers was subtracted from the amount of the non-irritants for each rule and the results were
averaged over all rules.
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Table 36: Results for the DSS rules applied to skin sensitisation
Class DSS rulea Borderb merged datac LLNA GPT
TN /all d NPV d TN /all NPV TN /all NPV
Melting point
All Tm > 200°C - 104/139 75% 51/71 72% 62/86 72%
C Tm > 55°C - 153/268 57% 69/164 42% 105/155 68%
CN Tm > 180°C - 78/107 73% 36/53 68% 51/70 73%
CNS Tm > 120°C - 42/73 58% 18/30 60% 24/46 52%
Octanol-water partition
All log Kow < -3.1 > -5 4/5 80% 1/2 50% 3/4 75%
CNS log Kow < 0.5 > -5 27/48 56% 12/22 55% 18/31 58%
CN log Kow > 5.5 < 8.2 20/26 77% 6/9 67% 15/18 83%
CNHal log Kow > 3.8 < 8.2 20/31 65% 17/28 61% 7/9 78%
Molecular weight
CN MW > 540 Da - 18/24 75% 8/12 67% 11/15 73%
CNHal MW > 380 Da - 22/27 81% 19/21 90% 6/9 67%
CHal MW > 370 Da - 10/13 77% 6/8 75% 4/5 80%
Water solubility
CN Sw < 0.0001 g/L log Sw 40/53 75% 16/27 59% 26/29 90%
(log Sw < -4) > -9.7
CNHal Sw < 0.001 g/L log Sw 21/33 64% 19/30 63% 9/12 75%
(log Sw < -3) > -9.7
Lipid solubility
CN So < 0.4 g/kg log So 68/112 61% 31/55 56% 39/63 62%
(log So < -0.4) > -3
CNHal So < 4 g/kg log So 42/84 50% 29/65 45% 16/25 64%
(log So < 0.6) > -3
Vapour pressuree
C P v < 0.0001 Pa Log P v 45/73 62% 21/44 48% 25/40 63%
(log P v < -4) > -10
a = Only skin irritation (former risk phrase R38).
b = No border of reliability is given in the orginal exclusion rules. This was included, because calcuted
physicochemical properties behind a certain range are deemed unreliable. For example, to best knowledge
of the UFZ working groups on ecological chemistry it is not possible to reliably measure a log Kow above
8.2. The values reﬂect the UFZ working groups experience with the different physicochemical parameters.
c = The number of all tests does not add up additively (LLNA + GPMT + Buehler = all), because several
substances were tested in more than one test system.
d = NPV = Negative predictive value in percentage; TN = number of correct/true negative classiﬁcations;
all = TN+FN ; FN = number of false negative classiﬁcations.
e = The results are based on the respective ChemProp v 6.5 calculations, except for vapour pressure. See
above for the reasoning of the selection.
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Table 37: Results for the DSS rules applied to skin sensitisation with Epi Suite calculations
Class DSS rulea Borderb merged datac LLNA GPT
TN /all d NPV d TN /all NPV TN /all NPV
Melting pointe
All Tm > 200°C - 210/281 75% 113/157 72% 112/149 75%
C Tm > 55°C - 153/278 55% 66/168 39% 105/156 67%
CN Tm > 180°C - 114/156 73% 56/82 68% 68/91 75%
CNS Tm > 120°C - 72/131 55% 36/67 54% 36/70 51%
Octanol-water partitione
All log Kow < -3.1 > -5 18/23 78% 6/9 67% 14/17 82%
CNS log Kow < 0.5 > -5 43/75 57% 17/30 57% 29/51 57%
CN log Kow > 5.5 < 8.2 17/28 61% 7/15 47% 12/17 71%
CNHal log Kow > 3.8 < 8.2 22/37 59% 17/31 55% 7/10 70%
Lipid solubilitye
CN So < 0.4 g/kg log So 37/52 71% 18/29 62% 21/30 70%
(log So < -0.4) > -3
CNHal So < 4 g/kg log So 15/27 56% 13/22 59% 5/10 50%
(log So < 0.6) > -3
Vapour pressure
C P v < 0.0001 Pa Log P v 6/15 40% 5/13 38% 2/6 33%
(log P v < -4) > -10
a = Only skin irritation (former risk phrase R38).
b = No border of reliability is given in the orginal exclusion rules. This was included, because calcuted
physicochemical properties behind a certain range are deemed unreliable. For example, to best knowledge
of the UFZ working groups on ecological chemistry it is not possible to reliably measure a log Kow above
8.2. The values reﬂect the UFZ working groups experience with the different physicochemical parameters.
c = The number of all tests does not add up additively (LLNA + GPMT + Buehler = all), because several
substances were tested in more than one test system.
d = NPV = Negative predictive value in percentage; TN = number of correct/true negative classiﬁcations;
all = TN+FN ; FN = number of false negative classiﬁcations.
e = These are based on the respective Epi Suite calculations. Molecular weight, water solubility, and vapour
pressure are the respective ChemProp v 6.5 results (the ﬁrst two are not shown here, cf. main text). See
above for the reasoning of the method selection.
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Table 38: Results for the DSS rules with the updates of Rorije and Hulzebos, 2005
Class modiﬁed DSS rulea safety rangeb merged datac LLNA GPT
TN /all d NPV d TN /all NPV TN /all NPV
Melting pointe
All Tm > 430°C 380 – 480°C 5/7 71% 5/6 83% 2/5 40%
C Tm > 285°C 171 – 399°C 1/1 100% 0/0 0% 1/1 100%
CN Tm > 240°C 213 – 267°C 36/43 84% 18/24 75% 24/28 86%
CNS Tm > 430°C 421 – 439°C 0/1 0% 0/1 0% 0/1 0%
Octanol-water partitione
All log Kow < -3.1 -2.92 – -3.28 4/5 80% 1/2 50% 3/4 74%
CNS excluded
CN log Kow > 5.4 5.13 – 5.67 20/26 77% 6/9 67% 15/18 83%
CNHal log Kow > 3.7 3.64 – 3.77 21/34 62% 18/30 60% 7/10 70%
Molecular weighte
CN MW > 539 Da 526 – 552 Da 18/24 75% 8/12 67% 11/15 73%
CNHal MW > 375 Da 374 – 376 Da 25/30 83% 21/23 91% 7/10 70%
CHal MW > 368 Da 359 – 377 Da 10/14 71% 6/9 67% 4/5 80%
Water solubilitye
CN combined with CNHal
CNHal Sw < 0.002 g/L log Sw 57/75 76% 32/47 68% 31/36 86%
(+CN) (log Sw < -3.7) -3.4 – -4
Lipid solubilitye
limited data base, no reﬁnement
Vapour pressure
C P v < 0.0001 Pa no range 45/73 62% 21/44 48% 25/40 63%
(log P v < -4)
a = Only skin irritation (former risk phrase R38). The modiﬁed rules for the melting point are much stricter
than in the original DSS. Other rules have changed just slightly. More details can be found in Rorije and
Hulzebos, 2005.
b = This range was given by Rorije and Hulzebos, 2005, to account for uncertainty in the physicochemical
data. Large ranges indicate a high uncertainty in the given data base for the decision criteria. For the
upper and lower value the calculations were repeated seperately (data not shown), which lead to the same
conclusions. The reliability border (see main text) was also applied during these investigations.
c = The number of all tests does not add up additively (LLNA + GPMT + Buehler = all), because several
substances were tested in more than one test system.
d = NPV = Negative predictive value in percentage; TN = number of correct/true negative classiﬁcations;
all = TN+FN ; FN = number of false negative classiﬁcations.
e = These are based on the respective ChemProp 6.5 calculations, except vapour pressure. See above for
the selection.
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C.3. Exploratory Analysis of Physiocochemical Properties for the Derivation
of New Limit Values – principal investigations
Documenting all exploratory investigations of the bioavailability exercises is disencouraged
in this Annex, because several results repeat themselves and the generated graphics would
comprise a large amount of pages/paper (about 150). For this reasons the following Annex
lists different exemplary results. Besides the reported histograms in the main section several
additional physicochemical properties were analysed regarding their function to discriminate
between sensitisers and non-sensitisers. The following properties were analysed:
• Moleculare weight MW,
• Octanol-water partition coefﬁcient Kow (two models tested),
• Water solubility Sw,
• Lipid solubility as So (see above),
• Melting point Tm,
• Vapour pressure P v,
• Henry’s Law Constant as Kaw, and
• Octanol-air partition coefﬁcient Koa.
While molecular weight is an estimate of molecular size (e.g. Potts and Guy, 1992), Kow,
Sw, and So are representations of the partitioning process between different skin layers as
well as the vehicle in which the sensitiser is applied. Melting point is a property highly de-
pendent on hydrogen bonding and, thus, offers insights for partitioning processes, albeit the
reasons for its usefulness have never been addressed sufﬁciently (Moss et al., 2002). The
last three properties, P v,Kaw, andKoa, model the volatility of a particular compound from its
own phase or water or octanol, respectively (with the Koa performing best for discriminatory
purpose in a recent publication; Schu¨u¨rmann et al. 2016). However, also other parameters
can be applied, for example molecular size can also be modelled differently e.g. as L or V .
Molecular size plays an important role for partitioning and, thus, is included in LSER resp.
Abraham parameters together with other signiﬁcant properties such as the hydrophobicity
and hydrogen bonding (Abraham and Martins 2004, cf. also Annex C.1). As these parame-
ters give a more accurate representation of partitioning processes as compared to using just
the Kow or Sw, they were also inspected (and calculated by the method Platts et al. 1999).
These parameters are:
• Excess molar refraction E,
• Polarisability S,
• Hydrogen Bond Acidity A,
• Hydrogen Bond Basicity B,
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• Characteristic Volume V , as well as
• the Hexadecan-Air-Partition-Coefﬁcient L.
For all of these parameters staked histograms were constructed using SPSS Statistics
22. Afterwards, a visual inspection took place, if extreme intervals (very large or very small
values, respectively) of those properties are primarily populated by non-sensitisers. This
was not the case for the merged data set. For each of the physicochemical parameters an
exemplary histogram is shown in the ﬁgures 68-85.
Further investigations. Because the correlation analyses showed that LLNA and GPT
correlate to a much lesser degree than currently expected, for all parameters the analyses
were repeated using LLNA or GPT data only. Most of the staked histograms looked similar217
as the graphics for the merged data and they looked also similar between the two animal
test systems, which is exemplarily depicted for MW, Kow, Sw, and P v in ﬁgure 86-93. The
ﬁrst two have been selected, because they are calculable for (nearly) all compounds and
illustrate that both look similar for the LLNA and the GPT. However, the LLNA has more
sensitisers incorporated in its data set in contrast to the GPT, where the amount of non-
sensitisers is higher (cf. section data analysis of the main text). For this reason the statistical
requirements for a GPT cut-off are higher than for a LLNA limit value. This is important for
water solubility Sw for which a possible GPT cut-off can be set at -7 (up to -12, where
the predictions are already barely reliable). This would form a exclusion rule that is able
to identify approximately 30 non-sensitisers (and no additional sensitisers). However, as
the GPT tends to give (false) negative results this was judged to be not powerful enough
from a statistical perspective. Additionally, in the LLNA substances beyond this threshold
are reported which induce sensitisation and currently no differences in mice and guinea pig
skin are known (at least to the author of this thesis), which could explain the differences.
The last property, vapour pressure P v, is included, because it has been reported to explain
differences between the LLNA and other testing systems in a recent publication (Patlewicz
et al., 2014c). The expectation would be to derive a threshold for highly volatile compounds
beyond which no sensitisation is seen. Still, this is not observed and the LLNA histogram
has a similar shape in comparison to the GPT as depicted in ﬁgure 92 and 93.
Combination of several parameters. Because none of these trials was successful it
was investigated, if a combination of two properties is sufﬁcient to derive (more complex)
exclusion rules. An example for the investigated three dimension histograms is given in
ﬁgure 94. However, this had to be rejected due to statistical performance problems – only
few compounds could be excluded (normally below 20, which would be only about 2%,
assuming 1000 substances, of the overall data). The histogram shows further that also the
separation in strong and moderate sensitisers leads to no further insights.
As ﬁnal combined measure a multivariate discrimination analysis was conducted via util-
ising SPSS Statistics Version 22. However, this obtained no conﬁdent results, either. The
respective discrimination is shown in table 39-41.
217Not in absolute terms, but primarily with respect to the drawn conclusions.
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Figure 68: Distribution MW (merged LLNA and GPT data; raw SPSS output without post-
processing)
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Figure 69: Distribution Sw (ChemProp) (merged LLNA and GPT data; raw SPSS output with-
out post-processing)
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log Kow (ChemProp - consensus modelling with 4 methods)
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Figure 70: Distribution Kow (ChemProp-Konsensus) (merged LLNA and GPT data; raw
SPSS output without post-processing)
log Kow (Epi Suite)
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Figure 71: DistributionKow (Epi Suite) (merged LLNA and GPT data; raw SPSS output with-
out post-processing)
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Figure 72: Distribution So (ChemProp for Kow) (merged LLNA and GPT data; raw SPSS
output without post-processing)
Lipid Solubility So (approx. with Sw and Kow; Kow via EPISUITE)
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Figure 73: Distribution So (Epi Suite for Kow) (merged LLNA and GPT data; raw SPSS out-
put without post-processing)
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Figure 74: Distribution Tm (ChemProp) (merged LLNA and GPT data; raw SPSS output
without post-processing)
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Figure 75: Distribution Tm (Epi Suite) (merged LLNA and GPT data; raw SPSS output with-
out post-processing)
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Figure 76: Distribution P v (ChemProp, Antoine) (merged LLNA and GPT data; raw SPSS
output without post-processing)
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Figure 77: Distribution P v (Epi Suite) (merged LLNA and GPT data; raw SPSS output with-
out post-processing)
C15
log Kaw (ChemProp, unpublished method)
5.04.03.02.01.0.0-1.0-2.0-3.0-4.0-5.0-6.0-7.0-8.0-9.0-10.0-11.0-12.0-13.0-14.0-15.0-16.0
Fr
eq
ue
nc
y
120.0
100.0
80.0
60.0
40.0
20.0
0.0
2
1
0
Overall_class_worst
0
Mean =-5.8535
Std. Dev. =3.85196
N = 898
1
Mean =-4.6239
Std. Dev. =3.54539
N = 463
2
Mean =-6.6514
Std. Dev. =3.71465
N = 287
Figure 78: Distribution Kaw (merged LLNA and GPT data; raw SPSS output without post-
processing)
log Koa (ChemProp)
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Figure 79: Distribution Koa (merged LLNA and GPT data; raw SPSS output without post-
processing)
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Figure 80: Distribution E (merged LLNA and GPT data; raw SPSS output without post-
processing)
Polarisability S (Platts et al. as implemented in ChemProp)
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Figure 81: Distribution S (merged LLNA and GPT data; raw SPSS output without post-
processing)
C17
H-bond Acidity A (Platts et al. as implemented in ChemProp)
4.54.03.53.02.52.01.51.0.5.0
Fr
eq
ue
nc
y
1,000.0
800.0
600.0
400.0
200.0
0.0
2
1
0
Overall_class_worst
0
Mean =.3834
Std. Dev. = .47475
N = 1,025
1
Mean =.2056
Std. Dev. = .32797
N = 488
2
Mean =.2935
Std. Dev. = .38639
N = 294
Figure 82: Distribution A (merged LLNA and GPT data; raw SPSS output without post-
processing)
H-bond Basicity in Water B (Platts et al. as implemented in ChemProp)
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Figure 83: Distribution B (merged LLNA and GPT data; raw SPSS output without post-
processing)
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Figure 84: Distribution V (merged LLNA and GPT data; raw SPSS output without post-
processing)
Ostwald Solubility L (Platts et al. as implemented in ChemProp)
30.025.020.015.010.05.0.0
Fr
eq
ue
nc
y
300.0
200.0
100.0
0.0
2
1
0
Overall_class_worst
0
Mean = 8.8305
Std. Dev. = 5.59594
N = 992
1
Mean = 7.4962
Std. Dev. = 3.46183
N = 480
2
Mean = 7.3738
Std. Dev. = 2.85431
N = 291
Figure 85: Distribution L (merged LLNA and GPT data; raw SPSS output without post-
processing)
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Figure 86: Distribution MW (LLNA data only; raw SPSS output without post-processing)
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Figure 87: Distribution MW (GPT data only; raw SPSS output without post-processing)
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Figure 88: Distribution Kow (LLNA data only; raw SPSS output without post-processing)
log Kow (ChemProp - consensus modelling with 4 methods)
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Figure 89: Distribution Kow (GPT data only; raw SPSS output without post-processing)
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Figure 90: Distribution Sw (LLNA data only; raw SPSS output without post-processing)
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Figure 91: Distribution Sw (GPT data only; raw SPSS output without post-processing)
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Figure 92: Distribution P v (LLNA data only; raw SPSS output without post-processing)
Vapour Pressure log Pv (Epi Suite)
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Figure 93: Distribution P v (GPT data only; raw SPSS output without post-processing)
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Figure 94: 3D-histogramm of MW and Kow (merged LLNA and GPT data set; processed
SPSS output)
Table 39: Classiﬁcation function coefﬁcients
Sensitiser
Property no yes
MW 0.024 0.023
log Kow -0.708 -0.560
log Sw 3.392 3.366
Tm -0.018 -0.017
log P v 4.856 4.884
log Kaw 0.287 0.285
log Koa 1.402 1.434
E 5.968 7.234
S 4.208 4.184
A 10.428 9.482
B -5.024 -4.898
L 1.937 1.690
V 14.468 14.847
constant -25.465 -25.636
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Table 40: Contingency for the linear discriminant analysis (LDA) with several physicochemi-
cal properties
Activity
Non-Sensitiser Sensitiser Total
LDA Non-Sensitiser 463 260 723
Sensitiser 285 413 698
Total 748 673 1421
Table 41: Statistics for the linear discriminant analysis (LDA) with several physicochemical
properties
Statistical Evaluation
Concordance Category Sensitivity Predictivity
LDA 0.616 Non-Sensitiser 0.619 0.640
Sensitiser 0.614 0.592
C.4. Exploratory Analysis of Physiocochemical Properties for the Derivation
of New Limit Values – additional investigations using R instead of SPSS
for generating non-stacked histogramms and density functions
The inspection of staked histograms offers the advantage that the stacks do not hide each
other in comparison to a histogram where the column are placed before each other. This
occurs, for instance, if the strong sensitisers are in front of the moderate sensitisers and the
non-sensitisers, but the strong sensitisers comprise a greater amount of substances. How-
ever, the staked histograms also exhibit the disadvantage of not representing the distribution
of the stacks adequately, because in this visualisation it is hard to tell, if the distribution of
the highest stack is the same as for the lower ones or if it just appears that way, because the
lower stacks inﬂuence the height of the whole column. Therefore, non-staked histograms
were investigated (computed with R, Version 3.2.0, on RStudio Version 0.99.441), which is
shown for the examples of MW, Kow, Sw, and P v in ﬁgure 95, 97, 99, and 101. In addition,
because the frequency values in histograms are given in absolute amounts and this can hide
an uncommonly high occurrence of small amounts,218 the respective density functions of the
distributions have been analysed, which are normalised with overall amount of (strong and
moderate) sensitisers and non-sensitisers for the respective categories. They are depicted
in ﬁgure 96, 98, 100, and 102.
218For instance, in case above a molecular weight of 500 Da 15 sensitisers and 100 non-sensitisers are observed,
than this in itself seems not to be a signiﬁcant ﬁnding. However, if this is contrasted by an amount of 100
sensitisers vs. 1000 non-sensitisers below a molecular weight of 500 Da, than there is an increase of
5% for the higher molecular masses, which means the percentage of sensitisers is increased for heavier
compounds.
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Figure 95: Distribution MW (merged LLNA and GPT data; non-stacked (!) histogram; by R)
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Figure 96: Distribution MW (merged LLNA and GPT data; density function; by R)
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Figure 97: Distribution Kow (merged LLNA and GPT data; non-stacked (!) histogram; by R)
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Figure 98: Distribution Kow (merged LLNA and GPT data; density function; by R)
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Figure 99: Distribution Sw (merged LLNA and GPT data; non-stacked (!) histogram; by R)
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Figure 100: Distribution Sw (merged LLNA and GPT data; density function computed by R)
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Vapour pressure log Pv (Epi Suite)
−12 −11 −10 −9 −8 −7 −6 −5 −4 −3 −2 −1 0 1 2 3 4 5 6
0
10
20
30
40
50
60
Fr
eq
ue
nc
y
GHS Category
1A
1B
Uncl.
Figure 101: Distribution P v (merged LLNA and GPT data; non-stacked (!) histogram com-
puted by R)
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Figure 102: Distribution P v (merged LLNA and GPT data; density function computed by R)
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C.5. Exploratory Analysis of Physiocochemical Properties for the Derivation
of New Limit Values – further investigations for speciﬁc substance
groups
After the principle analyses an even ﬁner approach was conducted. For this, the data were
divided into different subgroups. First of all, the classiﬁcation scheme of Gerner (C, CHal CN,
CNHal, CS) and, in addition, the skin sensitisation reactivity domains were analysed (Aptula
et al., 2005) whether they are useful tools for a discrimination or not. In this regard it has to
be considered that the reactivity domains are constructed to contain sensitising compounds
and, therefore, it is in particular interesting to investigate whether the non-sensitisers (!)
which belong to those domains are in the range of extreme physicochemical values. The
latter would indicate that bioavailability is an explanation for their deviating behaviour (non-
sensitisers in reactivity domains). The two categorised approaches were explored for all
of the above given parameters including a differentiation between merged data, LLNA, and
GPT. As all of the constructed histograms219 would expand the number of pages of this A
nnex to an unreasonable extend and bear no further insight, twelve selected examples are
shown below (ﬁgure 103-114). They were taken up, because they are either interesting from
a theoretical perspective or represent the most promising candidates for cut-off criteria (and,
lastly, it was decided to show something of everything).
The ﬁrst (ﬁgure 103) depicts the lipid solubility So for compounds of the composition CHON
(cf. Annex C.2). It is visible that a possible cut-off could be drawn at -0.75. However, this
would only exclude few substances (25 of 497, with two being sensitisers in the GPT and
non-sensitisers in the LLNA), which is unsatisfactory from a statistical perspective. This was
also a shortcoming of some of the original DSS rules (e.g. on lipid solubility for the groups of
CHON and CHONHal based on 56 and 29 chemicals) as pointed out by Rorije and Hulzebos
(2005) during the validation. The issue of too few data points is a reoccurring drawback. It is
also true for the second example (Ostwald solubility L for CHO compounds, ﬁgure 104) and
even more signiﬁcant for the two following instances (ﬁgure 105 and 106, Sw for CHONHal
and MW for CHONS). In general, the categories CHONS, CHONHal, and CHOHal were
populated with fewer substances in comparison to the other classes conceived for the DSS,
a problem which increased via restricting the data to one animal test system. Speaking of
this, the last two selected histograms (ﬁgure 107 and 108) show the groups according to
Gerner for the individual animal systems. The ﬁrst presents the vapour pressure P v in the
context of CHO compounds tested in the LLNA and the second depicts the MW for the same
compound group in the GPT. It is observable that there is no improvement in the LLNA, but
a possible cut-off at 400 Da for the GPT. Again, this occurs (coincidently) together with a
low amount of substances for which the threshold applies (20), which is not sophisticated
enough from a statistical viewpoint – taking also into account that the GPT tend to give
(false) negative results. In general, it was observed that the composition of the compounds
seemed to have more impact than the concrete physicochemical properties chosen, e.g. in
219420 histograms had to be shown. This is calculated as: 14 physicochemical parameters times 3 data sets
(merged, LLNA, GPT) times 5 categories for the Gerner scheme plus the same amount from the 5 reactivity
domains. As two histograms ﬁt onto one page, this would make approximately 210 pages.
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the group CHON also the Sw, the polarisability S, and excess molar refraction E offered the
possibility of deriving limit values (but all with too few data, mostly below 30) for the merged
data, for which (nearly) the same substances would be excluded as for So (cf. beginning of
this paragraph). Notably, at least Sw and So correlate to a signiﬁcant degree, which is also
true for their relationsship with S and E. The same is true in the CHO category, where L
and MW were the most promising candidates for limit values.
Concerning the reactive domains, ﬁgure 109 and 110 show two examples for the merged
data set. In the ﬁrst, it is visible that for the Ac domain most sensitisers group below 500 Da.
However, also above 500 Da two sensitisers are observed and no clear cut-off is possible
(further the substances above 500 Da would be too few from a statistical viewpoint). In the
second histogram the Koa is depicted for SN2 electrophiles. In this case a limit value of
2.5 would be conceivable, but also here the number of substances to which the threshold
applies is too low. The initial examples are followed by three ﬁgures (111-113) that analyse
different typically meaningful parameters in the LLNA. The ﬁrst two examine the log Kow as
discriminatory variable for SB as well as SN2 electrophiles. In both groups the Kow plays
(at least partly) a role in deriving the potency of compounds belonging to that domain (see
main text or Aptula and Roberts 2006; Roberts et al. 2006, 2007d,b). Still, the with respect
of functioning as cut-off value the Kow was not useful. The same applies to the last LLNA
example. In ﬁgure 113 a histogram is shown regarding MA and their respective log Koa
value. Although internal investigations (Bo¨hme, 2016, personal communication) propose
that the Koa is a suitable tool in the assessment of MA potency values in the LLNA, it is
not usable to discriminate between sensitisers and non-sensitisers. The examples conclude
with a negative example of the MA domain in GPTs (ﬁgure 114), where the log Kow is not
useful for discriminating between active and non-active substances.
In brief, even the reactivity domains are no useful categorisation tools to facilitate the
derivation of limit values. These investigations suggest that albeit some physicochemical
properties are appropriate tools in potency assessment they are not strong enough to rule
out a sensitising effect.
Lipid Solubility So (approx. with Sw and Kow; Kow via ChemProp
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Figure 103: Distribution So for the CHON group (merged LLNA and GPT data; raw SPSS
output without post-processing)
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Ostwald Solubility L (Platts et al. as implemented in ChemProp)
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Figure 104: Distribution L for the CHO group (merged LLNA and GPT data; raw SPSS out-
put without post-processing)
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Figure 105: Distribution Sw for the CHONHal group (merged LLNA and GPT data; raw SPSS
output without post-processing)
Molecular Weight (Parent, ChemProp)
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Figure 106: Distribution MW for the CHONS group (merged LLNA and GPT data; raw SPSS
output without post-processing)
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Vapour Pressure log Pv (Epi Suite)
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Figure 107: Distribution P v for the CHO group (LLNA data only; raw SPSS output without
post-processing)
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Figure 108: Distribution MW for the CHO group (GPT data only; raw SPSS output without
post-processing)
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Figure 109: Distribution MW for the Ac-domain (merged LLNA and GPT data; raw SPSS
output without post-processing)
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log Koa (ChemProp)
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Figure 110: Distribution Koa for the SN2-domain (merged LLNA and GPT data; raw SPSS
output without post-processing)
log Kow (ChemProp - consensus modelling with 4 methods)
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Figure 111: Distribution Kow for the SB-domain (LLNA data only; raw SPSS output without
post-processing)
log Kow (ChemProp - consensus modelling with 4 methods)
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Figure 112: Distribution Kow for the SN2-domain (LLNA data only; raw SPSS output without
post-processing)
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log Koa (ChemProp)
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Figure 113: Distribution Koa for the MA-domain (LLNA data only; raw SPSS output without
post-processing)
log Kow (ChemProp - consensus modelling with 4 methods)
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Figure 114: Distribution Kow for the MA-domain (GPT data only; raw SPSS output without
post-processing)
C.6. Short thought on bioavailability and the dermal sensitisation threshold
A further brief thought should be given to a potential dermal sensitisation threshold (DST,
Safford 2008). There is growing evidence for the usefulness of such a threshold (Keller
et al., 2009; Safford et al., 2011) and in case this is veriﬁed further the question arises how
it is justiﬁable. At the ﬁrst glance, one explanation would be bioavailability considerations
stating that the amount of a substance entering the viable dermis is not high enough, if
the concentration is below such a threshold of sensitisation. However, there is no ample
evidence for this argument and if the current ﬁndings are conﬁrmed further, they indicate
that the role of bioavailability is negligible. Therefore, the more rational explanation would
be a difference in reactivity and if a ﬁxed amount of a substance always enters the deeper
skin (e.g. via shunt pathways) this leads to the corollary that the suspected threshold is
only lower for more reactive substances, where a smaller amount is necessary to induce
sensitisation. Hence, it is reasonable that recently rules have been developed for which
reactive substances a DST should not be applied (Safford et al., 2015; Roberts et al., 2015).
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However, as there are differences between human and animal skin this may account to the
animal trials but not to humans (cf. bioavailability main part of this thesis for a more detailed
discussion on animal-human-differences).
C.7. Molecular Weight as Inﬂuence on Potency – all data sets
Table 42: GHS potency categorisation and molecular weight – all data
GHS Class MW > 400 MW < 400
No. of compounds % of compounds No. of compounds % of compounds
merged data
Cat 1A 4 2% 292 18%
Cat 1B 26 14% 463 28%
Unclassiﬁed 152 84% 879 54%
All 182 1634
LLNA
Cat 1A 2 2% 178 18%
Cat 1B 21 23% 398 41%
Unclassiﬁed 70 75% 405 41%
All 93 981
GPT
Cat 1A 2 2% 165 19%
Cat 1B 8 8% 142 16%
Unclassiﬁed 92 90% 564 65%
All 102 913
As can be seen in table 42 there is no marked difference between the animal test sys-
tems assessed separately and the merged data (at least for Cat 1A). This implies that the
observed potency reduction above 400 Da can be regarded as general rule. In both ani-
mal tests the number of strong sensitisers decreases signiﬁcantly if the value of 400 Da is
transgressed. Mind further the test system differences already observed in the correlation
analyses: The number of non-sensitisers is much higher in the GPT (even 90% above 400
Da), while the LLNA has more moderate sensitisers included.
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C.8. Volatility as Inﬂuence on Potency (as proposed by Patlewicz et al., 2014c)
This Annex addresses the pragmatically chosen log P v cut-off reported in Patlewicz et al.
(2014c) and a short overview of the data shall be given. For any questions regarding individ-
ual substance data please contact the UFZ working group of ecological chemistry. Patlewicz
et al. (2014c) used the Epi Suite Antoine calculation method for their publication. Repeated
log P v calculations were conducted with the Epi Suite (to stick as much as possible to their
ﬁnding) and the data at hand. However, as the initial results were based on the Epi Suite
consensus for log P v (Antoine and modiﬁed Grain method), the results from the Antoine
method were added, to show that they do not differ signiﬁcantly from the consensus method
of the Epi Suite and lead to the same conclusions. Thereafter, the collected data were anal-
ysed for substances, which have a log P v > 2 and are tested in more than one animal test
system. Based on these data 8 substances above the pragmatical threshold were classiﬁed
in the same sensitising category in the two test systems, 6 were probably underclassiﬁed
by the LLNA and for 4 the LLNA was more conservative than the guinea pig tests. Hence,
we have 6 substances supporting the potency limit value and 12 against it (neglecting the
strength of reactivity of those compounds). Furthermore, the sensitisers with discordant re-
sults were analysed, for which the LLNA would be underpredictive compared to the GPMT
(or the GPMT overpredictive). Given that volatility is a good explanation for the differences
between the test systems, one would expect a great amount of these compounds to be
highly volatile, but as many as 20 out of 23 substances had a log P v below 2. Therefore,
most of the discrepancies could not be explained by the pragmatically chosen cut-off.
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D. Annex Read-across
D.1. ACF-Deﬁnitions – points to consider
In this public version of the dissertation this section is reduced, as the current state of read-
across skin sensitisation research is preliminary. All publicly already available read-across
parts are documented in ChemProp as well as several publications of the UFZ working group
of ecological chemistry (cf. main section). New parts will be subsequentially distributed. For
detailed information regarding the scope of different ACF-deﬁnitions as well as possibilities
of current read-across implementations please contact the UFZ working group of ecological
chemistry or consult the ChemProp read-across manual.
One point to be considered, which was mentioned in the main section of the thesis and
already published e.g. in Schu¨u¨rmann et al. (2011), is that the outcomes of the read-across
based on different ACF deﬁnitions can be combined to compensate individual weaknesses.
In particular, one drawback of the ﬁrst-order ACF is their short length and, thus, by deﬁnition
not taking into account structural features farther away from the centre. One example for
this problem is given in Annex D.2. This can be compensated by including second-order
ACF, which in turn may already be to speciﬁc for an assessment leading to a signiﬁcantly
decreased domain of applicability of the ﬁnal model (Schu¨u¨rmann et al., 2011). For this
reason a combination of both is sensible to circumvent their individual drawbacks. Their
read-across results can be mixed as given in the following equation (Schu¨u¨rmann et al.,
2011):
RA1+2 = (1− a)RX1 + a RX2 (47)
Where the combined outcome RA1+2 is calculated by adding up the read-across results
from the ﬁrst-order ACF RX1 and the selected local reference set by second-order ACF
RX2, while both are multiplied by a weighting factor a.220
D.2. Illustrative read-across case study
This case study is to illustrate characteristics of the ACF-based read-across approach (with
the default ACF-deﬁnition). It goes not (!) beyond knowledge already available for the UFZ
working group of ecological chemistry, but functions as an application example to enhance
understanding. The respective data are given in ﬁgure/table 43.
First of all, all of the detected compounds221 look similar to the target compound atranol
from a chemist perspective: they exhibit either an aromatic aldehyde function (plus one
hydroxy group) or two hydroxy groups besides a methyl group, all adjacent to the aromatic
ring system. All compounds exhibit a moderate to good degree of resemblance to atranol
with similarity values from 0.74 to 0.87 and the compounds with the higher similarity match in
activity to the well-known sensitising effect of atranol. The overall assessment would classify
220Typically the weighting factor is ﬁtted to the data by applying the solver-function of MS excel.
221Six instead of 5 compounds are reported by ChemProp, because the last two have the same similarity value
and, hence, no preference for one of both can be made. In fact also the higher similarity compounds (2-3)
have the same Dice similarity.
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No. Name Similarity Sensitiser?
1 Chloroatranol 0.86957 1 (Yes)
2 4-methylcatechol 0.81695 1 (Yes)
3 2-methylresorcinol 0.81695 1 (Yes)
4 3-methylcatechol 0.81695 1 (Yes)
5 Vanillin (3-methoxy-4-hydroxybenzaldehyde) 0.74126 0 (No)
6 Isovanillin (3-hydroxy-4-methoxybenzaldehyde) 0.74126 0 (No)
Table 43: Nearest neighbours of atranol with respect to default ﬁrst-order ACF
atranol as a sensitiser with a weighted mean of 0.69. This means it will be considered a
sensitiser unless a moderate exclusion criterion (moderate grey area for the binary prediction
interval) is applied. Moreover, adding a similarity threshold of 0.8 would cut off the non-
sensitisers and lead to a weighted mean of 1.222 Pushing the similarity threshold further
to 0.9 leaves us with no similar compounds, which illustrates the (drastically) decreased
applicability domain of a high threshold.
However, also shortcomings of the chosen ACF approach become apparent. For exam-
ple, the default ﬁrst-order ACF are not able to discriminate between the ortho, meta, and
para position (which is already described in literature, see e.g. Dimitrov and Mekenyan,
2010; Schu¨u¨rmann et al., 2011) – in this case of the hydroxy group. Nevertheless, this
is important from a mechanistic perspective, because the hydrogen of the ortho OH-group
is able to activate the aromatic aldehyde function via hydrogen bonding. For this reason,
atranol and chloratranol are strong sensitisers, while the other aromatic aldehydes (vanillin
and isovanillin) are considered to be non-sensitisers or sometimes very weak sensitisers
222Which is also a good example for the fact that a similarity threshold is able to push the prediction for a particular
compound out of a grey area.
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(Patlewicz et al., 2001; Roberts et al., 2006; Natsch et al., 2012; Roberts and Aptula, 2015).
In addition to that, the located methylcatechol and methylresorcinol compounds are sensi-
tisers, but their mechanism of action is different from atranol, because the former resemble
pre/pro-Michael systems (e.g. Aptula et al., 2005, cf. structural alerts – section 7 – for more
information) whereas the latter is directly sensitising via Schiff base formation. Overcoming
this downside requires to discriminate between ortho, meta, and para substituents accu-
rately, which is possible with knowledge of the UFZ working group of ecological chemistry.
The last point refers to using second-order ACFs or (partly) including the hydrogen atoms
of the neighbours of the central atom (e.g. suggested by Schu¨u¨rmann et al., 2011), though
both did not lead to a signiﬁcant increase in statistical performance in this thesis (cf. An-
nex D.4). One possible explanation can be derived from the case study. Therein, (coinci-
dentally) also the nearest neighbours belonging to other mechanistic domains had the same
activity as the target compound and, thus, cancelled out the inﬂuence of the two further aro-
matic aldehydes which are mechanistically closer to atranol (subtracting the activating effect
of the ortho hydroxy group). In the end, it is possible that also in other cases the neighbours
of other domains inﬂuenced the results. Hence, the missing performance improvement by
introducing second-order ACF is data set speciﬁc – which is in line with the suggestion that
the data set might be too heterogeneous.
D.3. Application of the similarity threshold and the grey area to the best
performing models with respect to the merged LLNA and GPT data
This section summarises further results for the standard ACF-deﬁnition of the best perform-
ing models with 5 nearest neighbours for the merged LLNA and GPT data with respect to the
similarity threshold and the grey area approach. The outcomes are illustrated in table 44.
As expected, both parameters, the similarity threshold and the grey area (regarding the bi-
nary prediction interval), inﬂuence the statistical performance to a signiﬁcant degree. With an
increasing similarity threshold applied, the statistical performance increases from a concor-
dance of 0.71 to a maximum of 0.81 (threshold 0.9), albeit there is a 80% loss of compounds
which can be predicted. This means the domain of applicability decreases drastically (for
the analysed skin sensitisation data), in case an enhancement in predictivity shall be reach
via a similarity threshold. The same is observed for the application of the grey area ap-
proach. The statistical performance increases with rising rigorousness of the grey area. The
concordance rises from 0.71 to a maximum of 0.85 with the downside of a lower number of
predictable compounds. Note that the loss of compounds is not as severe as for the similarity
threshold for the most rigorous applications. With a similarity threshold of 0.9 the compound
loss is 80% while the decrease of compounds predicted for the grey area within the interval
of 0.1-0.9 is 73% (even with a higher concordance). These results are attributable to other
ACF-deﬁnitions, too (cf. Annex D.4).
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Table 44: Read-across results for the similarity threshold and grey area (merged data, de-
fault deﬁnition)
Model name TNF TPF NPV PPV cc N %
1A500 0.75 0.67 0.73 0.7 0.71 1867 100
1A570 0.76 0.72 0.75 0.73 0.74 1443 77
1A580 0.79 0.79 0.79 0.79 0.78 968 52
1A590 0.83 0.83 0.82 0.83 0.81 372 20
1A5 0.5 0.75 0.67 0.73 0.70 0.71 1867 100
1A5 0.3 0.81 0.70 0.77 0.75 0.76 1149 62
1A5 0.2 0.83 0.75 0.80 0.79 0.79 916 49
1A5 0.1 0.88 0.81 0.85 0.85 0.85 502 27
TNF = true negative fraction (speciﬁcity), TPF = true positive fraction (sensitivity), NPV = negative predic-
tive value, PPV = positive predictive value, cc = concordance, N = number of compounds, % = percentage
of the overall data set
Model names are derived as follow: ﬁrst number is the ACF-order, the letter the ACF-deﬁnition used, the
next number the number of used similar compounds (5). If the latter is followed by two numbers, these
indicate a similarity threshold, if applied (with 00 for no threshold; the same is true if no two numbers follow).
For instance 1A570: at least a similarity of 0.7 is necessary for a compound to be taken into account, while
the model uses the ﬁrst-order ACF deﬁnition A (standard approach) with an amount of 5 similar compounds
for read across. However, if the middle number is follow by a 0.X, this indicates the grey area applied
as 1 − 0.X for the sensitiser interval and 0 + 0.X for the non-sensitiser interval, meaning a symmetrical
exclusion area (grey zone) around 0.5 is formed for unclear predictions.
D.4. Full read-across results for the merged data set
Originally, this Annex documented the full range of read-across outcomes – not only a se-
lection of the best performing models. Interested readers are advised to please contact the
UFZ working group of ecological chemistry for more information on the other models. For a
condensed and narrative version the reader is referred to the main section of this thesis (as
well as Annex D.3). Still, a short overview of the investigations shall be given.
In summary, surprisingly the standard ACF deﬁnition performs as good as a large range
of modiﬁcations for the ACF decomposition. Although different modiﬁcations improve the
read-across slightly, they do not increase the overall model performance with 3 or 5 nearest
neighbours. This counts for ﬁrst and second-order ACF as well. Furthermore, a combination
of both, ﬁrst and second-order ACF, was evaluated with respect to the question if they give
better results than an evaluation of ﬁrst or second-order ACF alone, which was demonstrated
in previous studies e.g. for aquatic toxicity (Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013).
Again the merely slight improvements point out to the robustness of the default/generic read-
across model when used to assess skin sensitisation data. Interestingly, reading across 3
compounds lead to a lesser substance loss than using 5 compounds in the extreme values
of the grey area approach , but at the same time the 3 neighbour read-across showed only
a minor increase in statistical performance. Moreover, no synergistic effects were observed
between the non-standard ACF deﬁnitions and applying a similarity threshold or a grey area
approach (including combined models consisting of ﬁrst and second-order ACF ). Thus, for
the sake of simplicity the generic/standard approach should be applied for ACF-based skin
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sensitisation read-across – at least with respect to the merged data. Lastly, with respect to
the compounds excluded (substance loss) via introducing a similarity threshold, the second
order ACF performed worse than the ﬁrst order ACF, which is expected, because the former
deﬁne more speciﬁc fragments and, thus, fewer compounds match the similarity criteria, i.e.
fewer substances obtain high Dice similarity values.
D.5. Full read-across results for the LLNA- and GPT-subset
As before, interested readers are advised to please contact the UFZ working group of eco-
logical chemistry for more information with respect to the ACF-based read-across. Still, a
short overview shall be given.
In summary, with the results of the correlation analysis available, the assumption that
LLNA and GPT lead to the same results concerning the sensitisation potential of a tar-
get compound is not valid anymore. Therefore, the read-across exercise was repeated for
the animal systems separately, but due to time constraints only the default ACF deﬁnition
was retested (with different numbers of nearest neighbours and different depth of the ACF).
Although it can not be excluded that for the individual animal assays the ACF deﬁnition be-
comes important again (in contrast to the merged data), indications (!) for the inﬂuence of
the ACF deﬁnition should have been seen for the merged data, too, which was not the case.
In addition to the number of nearest neighbours and the depth, the evaluations regarding
the similarity threshold and the grey area were repeated (in particular because they showed
the strongest effect on the merged data). The approach with ﬁrst order ACF and reading
across 5 compounds proved to be slightly superior and is, thus, discussed in detail in the
main section of this thesis. The differences between the individual test read-across and
reading across the merged data set are explained further in the end of this Annex.
Moreover, a combination of ﬁrst and second order ACF was analysed in greater detail
by combining models with and without similarity threshold. None of the approaches ob-
tained signiﬁcantly better results than the standard ﬁrst order ACF read-across with 5 near-
est neighbours: in case the concordance was better the number of predicted compounds
was decreased; no model was found which had a higher concordance for the same number
of compounds in comparison to the standard approach.
As last binary variation an optimised approach was tested by applying unsymmetrical
intervals for the grey area method as mentioned in the read-across discussion of section of
this thesis. However, this was only slightly better than previous models regarding the number
of predicted compounds (examples are given in table 45 and 46).
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Table 45: Read-across for LLNA-data with asymmetrical grey area
Model name TNF TPF NPV PPV cc N %
1A5 0.2 0.65 0.91 0.83 0.79 0.80 532 49
1A5 0.3-0.8 0.77 0.69 0.84 0.79 0.78 591 55
1A3 0.2 0.65 0.90 0.82 0.79 0.80 476 44
1A3 0.3-0.8 0.81 0.70 0.87 0.79 0.80 522 48
TNF = true negative fraction (speciﬁcity), TPF = true positive fraction
(sensitivity), NPV = negative predictive value, PPV = positive predictive
value, cc = concordance, N = number of compounds, % = percentage of
the overall data set models 1A5 0.2 and 1A3 0.2 are listed for comparison
(meaning as explained in table 44), applied grey area is indicated as range,
e.g. 1A5 0.3-0.8 has a grey area from 0.3 to 0.8.
Table 46: Read-across for GPT-data with asymmetrical grey area
Model name TNF TPF NPV PPV cc N %
1A5 0.2 0.92 0.63 0.86 0.78 0.84 557 56
1A5 0.2-0.7 0.89 0.69 0.86 0.74 0.82 603 60
1A3 0.2 0.92 0.67 0.87 0.77 0.85 532 53
1A3 0.15-0.7 0.90 0.71 0.87 0.77 0.84 553 55
1A3 0.35 0.78 0.68 0.82 0.62 0.74 1000 100
1A3 0.35 ± 0.05 0.76 0.78 0.86 0.65 0.77 777 78
1A3 0.35 ± 0.1 0.76 0.80 0.87 0.65 0.77 742 74
1A3 0.35 ± 0.2 0.77 0.79 0.87 0.66 0.78 689 69
1A3 0.15-0.7 0.90 0.71 0.87 0.77 0.84 553 55
1A3 0.25-0.75 0.91 0.68 0.87 0.76 0.84 534 53
1A3 0.15-0.7 0.91 0.69 0.87 0.77 0.84 575 58
TNF = true negative fraction (speciﬁcity), TPF = true positive fraction (sensitivity),
NPV = negative predictive value, PPV = positive predictive value, cc = concor-
dance, N = number of compounds, % = percentage of the overall data set, models
1A5 0.2 and 1A3 0.2 are listed for comparison (meaning as explained in table 44),
applied grey area is either indicated as range, e.g. 1A3 0.15-0.7 has a grey area
from 0.15 to 0.7 or as deviation from a cut-off, e.g. 1A3 0.35 ± 0.05 has a cut-off a
0.35 (above would indicate a sensitiser) with a grey area from 0.3-0.4.
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Comparison: merged, LLNA, and GPT data performance. Finally, the performance
for all data sets shall be compared brieﬂy (cf. table 47). The general trends are the same
for assessment of the merged data and the LLNA/GPT data only. All three show increasing
statistical performance with the application of the similarity threshold or the grey area, where
the latter leads to a lower overall substance loss for the strictest applications.223 Moreover,
the substance loss and the concordance are nearly the same in numbers for differentiated
LLNA and non-differentiated (merged) data. However, an in-depth analysis of the statistical
parameters reveals that the differentiation leads to a distinct increase in performance for the
positive statistical measures (TPF , PPV ) and a performance decrease for their negative
counterparts (TNF , NPV ). The decrease in speciﬁcity (TNF ) is the most severe with a
difference of approximately 10-20%-points in the extreme cases. Furthermore, the varia-
tion of the speciﬁcity/sensitivity (TNF /TPF ), which stand for the recognition power of the
model, is larger in comparison to the predictive values (NPV , PPV ). These results stand
in contrast to the GPT-only read-across exercise. Therein, the inverse results are obtained
– a sharp increase in the performance of the negative statistical parameters (TNF , NPV )
and a marked decrease of the positive values (TPF , PPV ) with about 5-10%-points for
most of the parameters. This clearly reﬂects the data distribution of the active vs. non-active
compounds as well as the bias of the different animal test system (towards positive results
for the LLNA and towards negative results for the GPT, which is discussed more deeply in
the main section of this thesis).
223This is important as concordance and substance loss (which is indicative of the domain of applicability of
the model) are both important parameters. A model which is extremely reliable (100% concordance), but
applicable to just 10 substances, is of limited use in routine toxicological assessment.
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Table 47: Read-across results for the similarity threshold and grey area (merged, LLNA and
GPT data, default deﬁnition)
Model name TNF TPF NPV PPV cc N %
Merged data:
1A500 0.75 0.67 0.73 0.7 0.71 1867 100
1A570 0.76 0.72 0.75 0.73 0.74 1443 77
1A580 0.79 0.79 0.79 0.79 0.78 968 52
1A590 0.83 0.83 0.82 0.83 0.81 372 20
1A5 0.5 0.75 0.67 0.73 0.70 0.71 1867 100
1A5 0.3 0.81 0.70 0.77 0.75 0.76 1149 62
1A5 0.2 0.83 0.75 0.80 0.79 0.79 916 49
1A5 0.1 0.88 0.81 0.85 0.85 0.85 502 27
LLNA:
1A500 0.59 0.79 0.68 0.72 0.70 1081 100
1A570 0.61 0.81 0.67 0.77 0.73 769 71
1A580 0.66 0.84 0.70 0.81 0.77 505 47
1A590 0.74 0.88 0.76 0.86 0.83 187 17
1A5 0.5 0.59 0.79 0.68 0.72 0.70 1081 100
1A5 0.3 0.63 0.86 0.77 0.77 0.77 660 61
1A5 0.2 0.65 0.91 0.83 0.79 0.80 532 49
1A5 0.1 0.64 0.94 0.86 0.81 0.83 293 27
GPT:
1A500 0.84 0.57 0.78 0.65 0.74 1000 100
1A570 0.86 0.67 0.82 0.72 0.79 728 73
1A580 0.84 0.77 0.85 0.75 0.81 487 49
1A590 0.88 0.77 0.87 0.79 0.84 166 17
1A5 0.5 0.84 0.57 0.78 0.65 0.74 1000 100
1A5 0.3 0.90 0.61 0.83 0.74 0.81 687 69
1A5 0.2 0.92 0.63 0.86 0.78 0.84 557 56
1A5 0.1 0.96 0.65 0.89 0.83 0.88 362 36
TNF = true negative fraction (speciﬁcity), TPF = true positive fraction (sensitivity), NPV = negative predic-
tive value, PPV = positive predictive value, cc = concordance, N = number of compounds, % = percentage
of the overall data set
Model names are derived as follow: ﬁrst number is the ACF-order, the letter the ACF-deﬁnition used, the
next number the number of used similar compounds (5). If the latter is followed by two numbers, these
indicate a similarity threshold, if applied (with 00 for no threshold; the same is true if no two numbers follow).
For instance 1A570: at least a similarity of 0.7 is necessary for a compound to be taken into account, while
the model uses the ﬁrst-order ACF deﬁnition A (standard approach) with an amount of 5 similar compounds
for read across. However, if the middle number is follow by a 0.X, this indicates the grey area applied
as 1 − 0.X for the sensitiser interval and 0 + 0.X for the non-sensitiser interval, meaning a symmetrical
exclusion area (grey zone) around 0.5 is formed for unclear predictions.
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D.6. Weighting of fragments with reactive features
As outlined in the main text of the thesis additional ACF models were constructed, which
weight the created ACF with expert knowledge gained during the structural alert exercise
to differentiate between fragments with active (chemical reactive) features and non-active
(non-reactive) substructures. For those the following methods were applied: (1) an ACF
set was created from the compounds with alerts and used for read-across, (2) within this
set all ACF which are not associated with reactive features were excluded and this further
reduced ACF set was applied in the read-across exercise, (3) all fragments of (1) were
weighted with expert judgement according to their inﬂuence on reactivity (with a weight
of 0.5 for no inﬂuence, and weights of 0.65, 0.75, 0.85, and 1 with increasing degree of
inﬂuence/evidence of the fragment being part of (pre/pro)-electrophilic compounds). Due to
their time intensive development the last two approaches were tested for the LLNA read-
across only. The results for the LLNA can be found in table 48. As can be seen from this
table none of the results performed better than the default approach and more work has to
be conducted to carve out if this approach is useful for further developments.
Table 48: Results for the read-across aligned to known structural alerts
Model name TNF TPF NPV PPV cc N %
1A500 0.60 0.77 0.67 0.72 0.70 1085 100
RXSA1L 0.49 0.76 0.61 0.66 0.64 1080 99
RXSA2L 0.61 0.77 0.68 0.72 0.70 1083 99
RXSA3L 0.61 0.77 0.67 0.72 0.70 1085 100
RXSA1L = ACF of sensitisers only for the LLNA, RXSA2L = ACF of sensi-
tisers without ACF common in sensitisers and non-sensitisers for the LLNA,
RXSA3L = ACF weighted according to expert knowledge (from the structural
alert exercise)
D.7. Semiquantitative prediction of the GHS categories
As before, interested readers are advised to please contact the UFZ working group of eco-
logical chemistry for more information with respect to the ACF-based read-across. In brief,
the following results were obtained: Another important investigation was if the application
of the ACF-based read-across to the LLNA or the GPT data is not only possible in a binary
manner, but allows for a semiquantitative classiﬁcation as stipulated by the globally har-
monised system (GHS). This is principally possible if further measures such as a minimum
similarity or a grey area are implemented (Spearman’s rank r2 of up to 0.66 were reached),
but these theoretical instruments introduce the same problem as for the binary read-across
– a high loss of predicted substances – and the results are far from a regulatorily acceptable
performance. The collection and utilisation of a more appropriate data set is advised. As
stated, the current models are not reliable enough for a regulatory risk assessment.
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D.8. Quantitative read-across for pEC3 values in the LLNA
As before, interested readers are advised to please contact the UFZ working group of eco-
logical chemistry for more information with respect to the ACF-based read-across. In brief,
the following results were obtained: For the LLNA quantitative data are available. Therefore,
quantitative read-across models were constructed based on different ACF deﬁnitions for an
overall LLNA data set in order to predict the pEC3 values of the target compounds. More-
over, the concept of reactivity domains offers the ability to assess the quantitative data in a
reﬁned manner by just evaluating the compounds belonging to a speciﬁc domain. As at the
time being the advanced structural alert model was not available, the alerts of Enoch et al.
(2008a) were used for a (rough) assignment to the respective domain (pre/pro-electrophiles
were included). None of them obtained a statistical performance, which is sufﬁcient enough
for regulatory risk assessment. Note that also for this exercise normally the different ACF
deﬁnitions gave quite similar results. However, it should be mentioned that models (with
the inclusion of a similarity threshold) for SN2 compounds had the highest correlation coefﬁ-
cients (above 0.5) – but were not good enough for regulatory assessment. This is based on
the fact that homologue series are among the SN2 data and, hence, the structural variety is
not as large as for other reactivity domains. This further underlines the importance of having
a structurally homogeneous data set available in order to obtain a good read-across, as also
reported by Van Leeuwen et al. (2009).
Read-across is endpoint speciﬁc (cf. main text). This explains (partly) why the generic
quantitative ACF approach is successful for the sufﬁciently large data sets of aquatic toxicity
(692 compounds, Schu¨u¨rmann et al., 2011; 1365 compounds, Ku¨hne et al., 2013), but not
for the smaller LLNA data collection. Although the latter contains 1090 compounds in total
several of those had to be excluded for quantitative analysis, because the non-sensitisers
have no associated quantitative outcome.224 The exclusion of the non-sensitisers leads to a
halved quantitative skin sensitisation data set with 572 sensitisers, which have EC3 values
available. Thus, the ﬁnal data set is smaller than for the aquatic toxicity investigations.
Further, the reduction of predictable compounds with increasing similarity threshold is less
severe for the aquatic endpoints. A compound loss of approximately 65% is observed for a
threshold of 0.9 or 0.87 for ﬁsh or daphnia, respectively (Schu¨u¨rmann et al., 2011; Ku¨hne
et al., 2013), whereas for skin sensitisation the same threshold is associated with a loss
of 81% compounds for the quantitative read-across. Again, this suggests the used skin
sensitisation data (sub)set is too heterogeneous for a sophisticated ACF-based read-across.
224In contrast to aquatic toxicity where the non-active compounds exhibit a baseline toxicity value and can nor-
mally be used. This is in particular true if the prediction is concerning the LC50 – as in Schu¨u¨rmann et al.
(2011) and Ku¨hne et al. (2013). But also in case the toxicity enhancement (Te) is considered – as in Ku¨hne
et al. (2013) – every compound has a corresponding Te value. Even for purely baseline toxic compounds a
log Te can be reported, e.g. 0 for compounds for which the calculated narcosis value and the experimental
log LC50 are the same. In skin sensitisation on the contrary there is a cut-off beyond which no values are
measured. To point this out: It is not sensible to derive an EC3 beyond 100% (because no substance can
be applied in, for example, a 150-weight-percentage solution). This would be similar to an aquatic toxicity
testing in which LC50 values above a particular threshold (e.g. -1) are not considered at all.
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D.9. Assessment of the structural heterogeneity of the data set using ACF
To estimate the heterogeneity of a data set a tool in ChemProp (6.5, 2016) is available to
quantify the structural ACF diversity. This is the calculation of the ACF similarity of one
particular compound in comparison to the ACF of the whole data set. The results can be
found in table 49.
Table 49: Heterogeneity of the data sets
ACF similaritya
Data set average max min average of the lowest-10% Nc
LLNA all 0.25 0.40 0.062 0.14 1081
LLNA 0.9b 0.32 0.46 0.075 0.18 187
GPT all 0.24 0.43 0.068 0.13 1000
GPT 0.9b 0.33 0.50 0.114 0.19 166
a = meaning the ACF similarity of one particular compound in comparison to the whole data set. b = only
compounds which have structurally close neighbours with a minimum similarity of 0.9 are taken into account
to construct a more homogeneous data set as reference. c = N is the number of compounds included in the
respective data set.
For the data at hand the mean similarity to each other is 0.25/0.24 (LLNA/GPT, respec-
tively), with a maximum similarity of 0.40/0.46 and a minimum similarity of 0.062/0.068. The
lowest 10% of the substances (10% percentile) had a mean similarity of 0.14/0.13. How-
ever, to be meaningful this values have to be compared to other data. No reference data
sets for structural heterogeneity are available.225 Hence, to give an estimate of the val-
ues of a quite homogeneous data set, the calculations were repeated for compounds that
have neighbours which are beyond a similarity threshold of 0.9. This should obtain at data
set, which has a much lower heterogeneity than the full read-across data. The respec-
tive mean, maximum, and minimum similarity values obtained are 0.32/0.33, 0.46/0.50, and
0.075/0.114 (LLNA/GPT, respectively). The mean similarity of the 10%-lowest percentile
was 0.18/0.19. As to be expected (due to the construction process), the similarity values
for the more homogeneous data sets are larger by about 0.07 for the mean and maximum
similarity. Still, also this reported values seem to be low. This is explainable by the fact that
although homologue series of substances are included in the more homogeneous data sets
the similarity between two different homologue series does not have to be high, because
they can substantially differ with regard to other structural features (which is higher valued if
logarithmic counting is applied as in this thesis). Overall, there is no guidance what (mean)
similarity/heterogeneity is necessary for a good model development data set – which will
certainly depend on other variables such as the endpoint or mechanism under evaluation.
Thus, further discussion within the scientiﬁc community is indicated.
225At least not to the best knowledge of the author of this thesis.
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E. Annex Structural Alerts
E.1. Critical discussion of structural alerts development methods and
proposed drawbacks
As stated in the main part of the thesis, structural alert development can be divided into two
principle strategies (Raies and Bajic, 2016): ﬁrstly, expert-based and, secondly, algorithm-
based rules. The former rules are conceived by the formalisation of the knowledge of human
experts for a particular ﬁeld of toxicology. For example, the reactivity domain based works of
Aptula and Roberts (Aptula et al., 2005; Aptula and Roberts, 2006) or the software package
Derek for Windows (DfW; Barratt et al. 1994; Zinke et al. 2002) as well as several structural
alert implementations in ChemProp (v 6.5, 2016) take this approach. As they are conceived
by human reasoning they are understandable by and explainable to other experts and are,
thus, transparent. Nevertheless, the expert focus is also a possible drawback, because the
alerts are limited to the expert’s knowledge which could be incomplete or biased (Raies
and Bajic, 2016). However, this in fact is also true for machine-derived rules if their training
set is limited. Furthermore, knowledge itself is never complete but subject to scientiﬁc de-
velopments. Another issue to consider (also envisaged during this thesis) is that updating
expert-driven rule bases is laborious and requires a detailed literature analysis (Raies and
Bajic, 2016).
The second, algorithm-based approaches utilise computer programs (or QSARs, Alves
et al. 2016) for the automatic and statistic-based correlation of structural elements with par-
ticular toxicological endpoints (Raies and Bajic, 2016). They use probabilistic methods to
determine if certain substructural features are associated with toxic or non-toxic effects. By
this procedure alerts can be inferred which are not part of an experts knowledge canon.
Importantly,226 because the rules are based on probabilistic correlations this means they
may not resemble a causal relationship (correlation is important for causality but not equal!)
and, therefore, can derive rules which lack any mechanistic underpinning. Hence, like other
statistical QSARs they are exposed to the criticism of being to speciﬁc for the data sets
they are based on. Moreover, they may lead to incorrect mechanistic conclusions as shown
in Roberts et al. (2007a). Eventually, errors in structure translate directly to errors in the
model (as stated in Ball et al. 2016, for QSARs in general), which may be detected if expert
supervision is applied.
Generally, structural alerts have been subject to criticism in two recent reviews (Raies and
Bajic, 2016; Alves et al., 2016) and at least some arguments should be addressed in this
thesis. Raies and Bajic (2016) state that structural alerts “do not provide insight into the
biological pathways of toxicity”. This is just partly correct. Of course, structural alerts do not
bring to light the complete AOP of a toxicological effect – also because the AOP should be
independent of a concrete chemical. But if they are based on mechanistic principles, they do
very well offer insights into key steps of biological pathways such as the molecular initiating
event (e.g. the domain-based models for covalent protein binding, which is important in skin
sensitisation; Aptula et al. 2005; Aptula and Roberts 2006) and provide important rationales
226And unfortunately not mentioned by Raies and Bajic (2016)
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to explain outliers such as deviations from the baseline toxicity observed in acute aquatic
toxicity (Lipnick, 1991). Furthermore, in skin sensitisation the knowledge-based derivation
of the reactivity domains (which depend on expert-based rules) guides which electrophile-
nucleophile interactions are possibly encountered during haptenation – i.e. if cystein or lysin
or other amino acid residues are the primary target – and subsequently they determine
which further (Q)SAR models should be applied (cf. hard and soft electrophiles, Annex E.2)
to model the molecular initiating event properly. Therefore, structural alerts do not provide
insight into the whole AOP cascade, but can at least a priori deﬁne what exact key event
will be observed (if they are mechanism-based), which will likely affect further downstream
events.
Further fundamental criticism on structural alerts is given by Alves et al. (2016). The
authors propose that blind reliance on structural alerts leads to oversensitivity, because the
alerts are biased towards predicting compounds as active. Additionally, they state that alerts
are normally embedded into a more complex molecular structures, which affects if the hit
structural element is active or not. As solution to improve the performance of their collection
of negative examples Alves et al. (2016) suggest using a combination of QSAR models and
structural alerts. In this combination the structural alerts function as screening hypothesis
and the QSAR methods are applied to conﬁrm the signiﬁcance of structural alerts as well as
give more accurate predictions.227
However, as demonstrated in this thesis this is not the only possible way of reﬁnement
and even within the concept of structural alerts as well as the development of models based
on structural features more degrees of freedom exists. For instance, it is valid to point out
that structural alerts should often be perceived as hypothesis and not strict alarming signals
(Alves et al., 2016), but to judge if the occurrence of a particular alert is signiﬁcant (and, thus,
constituents more than a mere hypothesis) the concept of alert reliability (Mekenyan et al.,
2014; Patlewicz et al., 2014c) can be consulted. Unfortunately, the reliability of particular
alerts is not typically addressed in the literature and, therefore, was also neglected in the
analysis of Alves et al. (2016).
Concerning the other fundamental criticism, the second point (alerts are embedded into
more complex molecules) is deﬁnitely valid. In other literature this is covered by the term
chemotype, which is the inclusion of further structural or (physicochemical) features into
the structural alert to calculate their effect on properties such as reactivity. Furthermore, it is
well-known from chemistry that masking a reactive centre by additional substituents attached
to it (termed steric hindrance) can lead to the deactivation of formerly active groups. Also
the complex interactions of the ortho, meta, and para position at aromatic ring systems have
been discussed in the context of chemistry before (e.g. Hammett constants) and are well-
regarded important key consideration in the developed of structural models (e.g. the QMM-
based SNAr reactivity predictions by Roberts and Aptula 2014, the SNAr alerts by Enoch
et al. 2012a and Enoch et al. 2013 or the QSARs and structural considerations for Schiff
base formation of aromatic aldehydes, Roberts et al. 2006; Natsch et al. 2012; Roberts and
Aptula 2015). As outlined, the point that structural alerts may oversimplify complex structural
227Unnoticed by Alves et al. (2016) this can been considered as a machine-based analogue to the reactivity
domain based predictions discussed by Roberts et al. (2007a).
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interactions seems principally correct, but this does not mean that more complex models are
always better. As pointed out by Teubner and Landsiedel (2015) it should be considered that
the inclusion of general molecular descriptors can dilute the relevant information (reactive
group available) with molecular features of less relevance and it is crucial to know in which
case structural information alone (e.g. in form of structural alerts) is sufﬁcient and in which
case structural similarity fails to be a correct measure.
However, the criticism of Alves et al. (2016) that structural alert should not be used blindly
and encompass a signiﬁcant positive bias is judged more critical. Every model or test may
lead to false results if used blindly. Even for long-established tests, such as the Ames mu-
tagenicity assay, it has to be checked if they were conducted properly, if the results are
reasonable, and if the preconditions for their application are fulﬁlled, e.g. if the test sub-
stance is within the domain of applicability. The same accounts for structural alerts and
from this perspective it seems trivial to criticise a blind reliance on structural alerts as being
prone to error. In addition, it appears biased to calculate a domain of applicability for QSAR
models, but ignore this for structural alerts (as done in Alves et al. 2016). Structural alerts
have in fact a domain of applicability, too, based on the data set which was used for their
derivation – and can be calculated e.g. by the method of Ku¨hne et al. (2009). However, to
be fair, in most alert models the domain of applicability is not included per se, what explains
the ﬁnding of the positive bias given in Alves et al. (2016).
Lastly, one substantial fear concerning structural alerts is that the list of structural alerts
is incomplete (Raies and Bajic, 2016). However, as indicated in the beginning of this Annex
knowledge itself is never complete but subject to scientiﬁc developments. Therefore, it is
natural that structural alert models evolve over time and subsequently include more rules in
case new knowledge becomes available. This missing knowledge would probably not have
been discovered with other data driven model development approaches, either.
E.2. Hard and soft electrophiles in the context of toxicological endpoints
The terms hard and soft electrophiles and nucleophiles originate from the hard and soft
acids and bases (HSAB) concept of Pearson (Pearson, 1963). Therein the terms denote
chemical characteristics of the molecules/ions: Hard species typically contain high charge
states, are small, and weakly polarisable, whereas soft ones are generally large, strongly
polarisable, and exhibit low charge states (Riedel, 2004). In general, Pearson wanted to
explain why particular molecules react preferably with each other. He found that hard acids
prefer to react with hard bases and soft acids react faster and form stronger bonds with
soft bases, which explains several favoured salt formations in inorganic chemistry. However,
while being a useful explanatory tool in inorganic chemistry, its universal applicability in
organic chemistry is questioned by recently (Mayr et al., 2011; Slawik et al., 2017).
Still, the hard and soft differentiation is important for mechanistically linking skin sensitisa-
tion to other endpoints. For example, mutagenicity (Mekenyan et al., 2010) and respiratory
sensitisation228 (Enoch et al., 2011; Mekenyan et al., 2014) are more concerned with hard
228Due to the oxidative environment the prime target nucleophile is lysin and not cystein, which is less prelavent
in the free thiol/thiolate form (but as disulphide) in the lung in comparison to the skin (Enoch et al., 2011).
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nucleophilic targets of the human body, whereas skin sensitisation broadens the possible in-
teraction sites to soft nucleophiles as well. Of the introduced reactivity domains the acylation
and Schiff base formation are typically counted as hard electrophile-nucleophile interactions
(Aptula and Roberts, 2006; Mekenyan et al., 2014; Patlewicz et al., 2015a), while Michael
acceptors (Schultz et al., 2006; Bo¨hme et al., 2009, 2010) and SNAr reactants (Roberts
et al., 2008) are normally treated as soft electrophiles. SN2 compounds span over the whole
range of hard and soft electrophiles (Aptula and Roberts, 2006). However, as already noted
by Aptula and Roberts (2006) the differentiation may be not that strict and reactions of hard
with soft compounds are possible. This is likewise observed in several investigations of the
working group of ecological chemistry (Bo¨hme, 2016, personal communication) as recently
demonstrated in a publication with Michael acceptors (Slawik et al., 2017). As a last note,
this classiﬁcation scheme is important for bioavailability and quantitative reactivity consider-
ations (see section 5 for an in-depth discussion), because for hard electrophiles partitioning
processes modelled by the log Kow are proposed to play a role (cf. Roberts et al. 2006,
2007b; Patlewicz et al. 2015a), whereas in the soft (sub)domains this is not the case – their
skin sensitisation potential can be described by reactivity alone (cf. Enoch and Roberts,
2013; Roberts and Aptula, 2014).
E.3. Calculation of the fraction of pre/pro-reactive compounds
To calculate the fraction of pre/pro-reactive compounds utilising the developed structural
alerts, ﬁrst it was determined if an alert of a particular domain (at the screening level) ﬁred
for a given target compound and furthermore whether this alert is directly reactive or if a
(metabolic or abiotic) activation is necessary to yield the ultimate electrophile. Thereafter,
the fraction of pre/pre-alerts was calculated according to:
fpre/pro =
#SApre/pro
#SAdirect +#SApre/pro
(48)
With #SAdirect being the number of substances with directly reactive structural features
and #SApre/pro being the number compound with pre/pro-alerts. The result separated into
the reactivity domains and animal test systems are reported in table 50.
The overall fraction of pre/pro-sensitiser (taking all domains together) was approximately
1/3 of all detected compounds. Furthermore, it is interesting to note that the Michael ac-
ceptors had a very high fraction of pre/pro-reactive compounds (in particular due to the high
number of pre/pro-quinones and related structures), while other domains such as the acylat-
ing agents had very low numbers or even no pre/pro-alerts are known as in case of the SNAr
reactants. Lastly, the SN2 reactants and Schiff bases seemed to differ between the animal
test systems regarding their pre/pro-fractions with the pre/pro-SN2 reactants predominantly
found in the LLNA. The pre/pro-Schiff bases were observed to a greater extend in the GPT.
At least in the SN2 case this is due to the different testing protocols, because – as explained
on several occasions in the main text – the pre/pro-SN2 alerts often refer to substances
needing air oxygen for activation, which is less available in the occlusively conducted GPT.
However, the difference between the (pre/pro-)Schiff bases is not explainable by this and for
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Table 50: Fraction of pre/pro-alerts (all data)
Domain LLNA GPT
#SAdirect #SApre/pro fpre/pro #SAdirect #SApre/pro fpre/pro
Ac 58 3 5% 79 3 4%
MA 104 118 53% 76 88 54%
SB 98 52 35% 41 62 60%
SN2 174 68 28% 98 21 18%
SNAr 34 - - 13 - -
Speciala 13 34 72% 7 28 80%
sum 507 241 32% 340 174 34%
a = It is not sure if it is useful to compare the special alerts directly, as they comprise a different set of
mechanisms. The alert for para halo phenols, annilines, and toluenes can even be group as pre/pre and
directly reactive alert (was pre/pro in the applied scheme and is the largest group of the special alert; cf.
Annex E.9).
them it is suspected that the observed discrepancy is due to the data collection, because
many of the collected aldehydes (directly reactive Schiff bases, e.g. from Gerberick et al.
2005, and Natsch et al., 2012, amongst others) are just tested in the LLNA and not in the
GPT.
As the screening model was used for the determination of (pre/pro-)reactive structures
and this model is prone to false positive predictions (cf. main text of this thesis), it was
decided to re-calculate the ﬁndings. During the re-calculation only sensitisers were used,
leaving out non-sensitiser with a hit structural alert in order to prevent that the false positive
(non-sensitiser) lead to biased results. For instance, it is conceivable that the fraction of
pre/pro-alerts can fall signiﬁcantly, in case the inclusion of directly reactive alerts with low
performance (many false positives) leads to the detection of a disproportional high number
of compounds with screening (direct) structural alerts. An concrete example for this would
be weakly reactive Michael acceptors which do not lead to sensitisation in the animal tests.
They bear reactive features, but are in fact non-sensitisers and would not have been included
if only sensitisers were counted. Thus, the number of compounds with directly reactive alerts
rises and and leads to a decrease of the fraction of pre/pro-alerts. Evidently, also the vice
versa case is conceivable. The results for the calculations in which only sensitisers were
used are given in table 51.
However, as can be seen by comparing table 50 and 51 only slight differences in the
trends229 became apparent if the non-sensitisers are not taken into account with deviations
of 1-8%-points in the domains. For the overall fraction nearly no changes were observed.
Hence, it is concluded that the fraction of pre/pro-reactive compounds within the given data
set is about 1/3 of all potential sensitisers. This value is stable over both animal test systems,
which assures its reliability.
229The fraction of pre/pro-sensitisers differs for the reactivity domains with the Michael acceptors having a dispro-
portionally high fraction of pre/pro-reactive compounds (predominantly due to the many pre/pro-quinones)
and the acylating agent exhibiting very few pre/pro-reactive compounds. Test system difference were further
observed (as expected) for the (pre/pro-)SN2 reactants and the (pre/pro-)Schiff bases.
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Table 51: Fraction of pre/pro-alerts (only sensitiser)
Domain LLNA GPT
#SAdirect #SApre/pro fpre/pro #SAdirect #SApre/pro fpre/pro
Ac 50 2 4% 63 1 2%
MA 78 104 57% 47 63 57%
SB 70 36 34% 29 31 52%
SN2 136 59 30% 53 10 16%
SNAr 28 - - 4 - -
Speciala 12 30 71% 4 17 81%
sum 397 201 34% 216 105 33%
a = It is not sure if it is useful to compare the special alerts directly, as they comprise a different set of
mechanisms. The alert for para halo phenols, annilines, and toluenes can even be group as pre/pre and
directly reactive alert (was pre/pro in the applied scheme and is the largest group of the special alert; cf.
Annex E.9).
E.4. Category (GHS) distribution of sensitiser separated by reactivity
domains
Introduction. In case a risk assessor is confronted with a particular target compound be-
longing to a given reactivity domain, the question arises if the domain membership alone
is sufﬁcient to indicate the potency of the target compound, which in turn would bear fur-
ther implications for the risk assessment of the particular chemical (e.g. additional safety
measure have to be applied for strong sensitisers). In order to analyse if speciﬁc domains
are populated by an increased number of strong sensitisers, ﬁrst a baseline value has to be
established, meaning how much strong/moderate sensitiser are included in the data set in
general. This is reported in table 52 together with the percentages of strong and moder-
ate sensitisers (GHS classiﬁcation scheme) within the reactivity domains plus an indication
whether this is above or below the expected baseline value (column trend). It has to be
stated that the domain-based numbers are from an older analysis and some later updates of
the structural alert model have not been included. However, the overall result and the trends
should be the same.
Domain based results. Of the sensitisers included in the data base on average 70%
were located in the GHS Category 1B (short Cat 1B; moderate sensitisers) and 30% in GHS
Category 1A (short Cat 1A; strong sensitisers) in the LLNA and 47% in Cat B and 53% in Cat
1A in the GPT, respectively.230 In case the categorisation in a particular domain differs from
this baseline, it can be deduced if predominantly strong or moderate sensitisers are found
within that domain. To cope with noise in the data an arbitrary threshold of ± 5%-points was
set, below/above which a deviation becomes relevant.
Although (epidemiological) frequency of sensitisation and potency of sensitiser run not in
parallel and not every strong sensitiser is a alarming signal (Basketter and Kimber, 2014),
risk assessors are in general more interested in strong than moderate sensitisers, because
230Only sensitisers are included for which a categorisation was possible (N = 600 LLNA, N = 317 GPT; the GPT
number is low because the data set contains much more non-sensitisers).
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Table 52: Category (GHS) distribution of sensitiser separated by reactivity domains
Domain* LLNA GPT
N Cat 1B Cat 1A Trend N Cat 1B Cat 1A Trend
Baseline** 70% 30% 47% 53%
Ac 48 48% 52% ↑ 59 17% 83% ↑
pAc 1 100% 0% ↓ 1 100% 0% ↓
MA 76 68% 32% – 46 57% 43% ↓
pMA 101 54% 46% ↑ 58 40% 60% ↑
SB 68 79% 21% ↓ 28 46% 54% –
pSB 34 77% 23% ↓ 31 61% 39% ↓
SN2 136 69% 31% – 51 49% 51% –
pSN2 60 83% 17% ↓ 11 100% 0% ↓
SNAr 24 42% 58% ↑ 4 50% 50% –
Special 32 75% 25% – 20 55% 45% ↓
* = for all domains the screening model was used (to target the highest possible number of sensitisers;
non-sensitisers are ignored anyway), ** = all sensitisers of the data set irrespective the fact whether they
have an alert or not, ↑ = deviation of more than 5% towards the higher category, ↓ = deviation of more than
5% towards the lower category, – = deviation of ± 5%
the former pose a greater hazard and, thus, need likely a stricter regulation. Hence, it is
interesting to note that those occur with a higher than expected frequency/percentage in the
acylation domain and for pre/pro-Michael acceptors in both animal test systems. Further, the
smallest domain (SNAr reactants) shows an increased percentage in the LLNA, but not in the
GPT, although the number of cases in the latter is statistically not reliable. On the contrary,
a lower number of strong sensitisers (and, thus, more moderately sensitising compounds)
is observed in the Schiff base domain (just LLNA), for the special cases (just GPT) as well
as for pre/pro-Schiff bases and pre/pro-SN2 reactants (for both in both animal test systems).
In the remaining domains no deviations from the average where detected. Therefore, from
a GHS potency category perspective risk assessors should raise their awareness if com-
pounds with acylating features, pre/pro-Michael systems or SNAr structural alerts occur. For
(pre/pro-)Schiff bases as well as pre/pro-SN2 compounds the level of alertness should be
lower.
In depth analysis of the domains. Complementary to the general overview an in depth
analysis of the domains is possible, in particular to address the questions: Is a particular
alert responsible for the tendency in the domain or is the trend observed over the complete
domain? Contradict some alerts the trend of the domain? For this only alerts with a sufﬁcient
number of compounds (5 sensitiser) where evaluated. However, in most domains the
majority of the alerts (if enough substances where available) followed the general trend. A
short list of additional ﬁndings and observations is given:
• Acylating agents: no substance type (alert) seemed to be specially interesting for risk
assessment beyond the domain-based assessment with the exception of the iso(thio)-
cyanates, which are (nearly) exclusively strong sensitisers.
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• Michael acceptors: the distribution between strong and moderate sensitisers ﬁts to the
reaction chemistry of the alerts (quinones > aldehydes > ketones > esters, with ”>” =
”more reactive than”; also α-substitution decreases the reactivity and, thus, less strong
sensitisers are found), with the exception of the aldehydes which, strangely, had more
moderate sensitisers in comparison to e.g. the ketones.
• pre/pro-Michael acceptors: nothing special to report (all alerts ﬁt to the general trends).
• Schiff bases: nothing special to report (all alerts ﬁt to the general trends). Interestingly,
the GPT seemed to be more susceptible to this domain (more strong sensitisers, most
obvious for the collected aldehyde data), which should be investigated further because
the LLNA normally is deemed the more sensitive test. As noted for the pre/pro-alert
analysis in Annex E.3 only very few aldehydes are included in the GPT data set and
more GPT results concerning this substance class should be collected.
• pre/pro-Schiff bases: most alerts ﬁt to the general trends. The exception are the
pre/pro-glyoxals which have a marked LLNA-GPT-discrepancy (100% moderate in the
LLNA and 40% to 60% moderate to strong sensitisers in the GPT, respectively) and hit
exceptionally many strong sensitisers in the GPT. This may indeed be data set speciﬁc
– as also noted for the pre/pro-alert analysis in Annex E.3.
• SN2 reactants: most alerts ﬁt to the general results, whereby the alerts for SN2 substi-
tution at an sp3-carbon include nearly exclusively moderate sensitisers if only halogens
are investigated (but SN2 compounds with non-halogen leaving groups can be strong).
Furthermore, the epoxide (just LLNA) and sulphur-SN2 subalerts seem to hit dispro-
portionately many strong sensitisers.
• pre/pro-SN2 reactants: exhibit a lower than baseline percentage of strong sensitisers
in both animal test systems. In the GPT even 100% are moderate sensitiser, which ﬁts
to the fact that many false positives are observed for this domain for this test system.
Therefore, it is probably sensible to exclude pre/pro-SN2 reactants as GPT alerts. Evi-
dently, these alerts do not function good in the GPT, because (air-oxygen) activation is
needed for most of them and GPT are conducted occlusively.
• SNAr reactants: nothing special to report (all alerts ﬁt to the general trends). Of course,
it is noted that the GPT alerts just hit very few compounds and are therefore statistically
not reliable.
• Special cases: nothing special to report (all alerts ﬁt to the general trends). However,
most alerts had a low number of categorisable compounds (N < 5).
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E.5. Discrimination of primary and secondary haloalkanes based on
physicochemical parameters
In literature a biphasic potency distribution of primary and secondary haloalkanes is re-
ported. This has been described to depend either on the log Kow partition coefﬁcient
(Roberts et al., 2007b) or volatility loss of short-chain compounds in combination with solubil-
ity problems for long-chain compounds (Siegel et al., 2009). To test if one parameter related
to these hypotheses is applicable as exclusion criterion for this speciﬁc substance groups
the collected skin sensitisation data was screened for primary and secondary haloalkanes
and the relevant physicochemical parameters were calculated. Furthermore, substances
with similar alerts, e.g. α-activated haloalkanes, were excluded because of their enhanced
reactivity. The results for the analysed optimal cut-off values are depicted in table 53.
Table 53: Discrimination of primary and secondary haloalkanes based on physicochemical
parameters
LLNA GPT
Cl Br I Cl Br I
no cut-off 5/12a 19/25 5/8 1/12 2/4 0/1
Kow > X
b 4/5 18/21 5/7 0/2 2/3 0/0
Koa > Y 3/5 17/21 5/6 0/4 2/4 0/0
P v < Z 3/5 16/20 5/6 1/4 2/4 0/0
a = sensitiser/all compounds hit, b = optimal values in the visual inspection were X = 3.5, 2.5, 2.5 (Cl, Br, I),
Y = 6.2, 4, 4.5 (Cl, Br, I), Z = 1, 2, 2 (Cl, Br, I)
The application of limit values lead to small improvements for all of the (primary and sec-
ondary) haloalkanes in comparison to the no-cut-off scenario.231 Although the difference
is small (often just one substance), using the log Kow was superior to the volatility-related
parameter (Koa and P v) for chloro- and bromoalkanes, but not for iodoalkanes, which is
marked in table 53 above. For the sake of this very slight superiority the Kow was chosen
as discriminatory value, but – as already stated in the main section of this thesis – this is a
preliminary ﬁnding, which has to be re-investigated for upcoming models in case new data
for this substance groups become available.
231As a side note: the data show also the increased SN2 reactivity for haloalkanes with high atomic number
(bromo- and iodoalkanes) for which less false positive classiﬁcations are observed than for chloroalkanes
(which are less reactive). Therefore, the cut-off values for chloroalkanes and the other two groups differ
more than between bromo- and iodoalkanes.
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This Annex originally listed the full range of individual substance results with respect to
the bioavailability thresholds of primary and secondary haloalkanes. For any questions re-
garding the individual substance data please contact the UFZ working group of ecological
chemistry. Nevertheless, a short overview of the data shall be given.
Analysing the non-sensitisers with structural alerts for (primary and secondary) haloalka-
nes in detail the following conclusions become apparent: Firstly, as the differences be-
tween the volatility classiﬁcation and the Kow-based cut-off are small it is interesting to
note that ﬁve of remaining false classiﬁcations (non-sensitisers predicted to be active in
the animal assays) are shared by all of the models, which is true for 1-bromononane, 1-
bromohexadecane – only GPT negative, but positive in the LLNA –, and 1-iodooctadecane
as well as the more complex 3-[4-[(6-bromohexyl)oxy]-butyl]benzene-sulfonamide and N-[2-
benzyloxy-5-(2-bromo-1-hydroxy-ethyl)-phenyl]-formamide. At least the last two structures
are suspected to exhibit erroneous results in the QSAR calculations of their physicochem-
ical properties, which is indicated by the their extreme values (Koa > 10 and P v < −4).
The remaining three compounds either provide strange animal testing results in context of
their nearest neighbours (e.g 1-bromonoctane and 1-bromodecane are positive in the LLNA
whereas 1-bromononane is negative) or can have solubility issues as proposed by Siegel
et al. (2009) (1-bromohexadecane, 1-iodooctadecane). Secondly, a group of substances is
correctly excluded by all physicochemical-based cut-off rules (N = 12), indicating a gener-
ally disadvantageous physicochemical property proﬁle for all of them leading to a reduced
bioavailability. Albeit, for several of these substances it should be noted that it is strange
that the volatility-based limit values are also successful for predicting negative results in the
occluded GPT. Finally, eight compounds contradict the volatility-based threshold while being
discriminated correctly by the log Kow (where at least four compounds of those were tested
in a GPT, where volatility is negligible anyway). Turning this view upside down, only two
counterexamples are better predicted by the volatility parameters than the Kow. Hence, with
respect to this data base, it is better to chose the Kow-based rules, because they have less
counterexamples than the discrimination by volatility. Still, this has to be underpinned by
further analysis and is considered preliminary.
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E.6. Investigating the possibility of using the EHOMO for discriminating
sensitising and non-sensitising anilines and phenols
Presently, the sensitising potential of anilines and phenols is hard to estimate conﬁdently.
Therefore, it is interesting that Ouyang et al. (2014) report a differentiation of those com-
pounds into sensitisers and non-sensitisers utilising quantum chemical calculations of the
EHOMO-values – with the additional constraint that compounds with related alerts (e.g. or-
tho/para hydroquinones, aminophenols, and benzenediamines) are excluded beforehand.232
To investigate whether this is speciﬁc for their data set or a general rule, the calculations
were (successfully) repeated (with the help of Dominik Wondrousch) for the respective com-
pounds of this data collection. This Annex originally listed the full range of individual sub-
stance results with respect to the EHOMO-values of anilines and phenols. For any questions
regarding the individual substance data please contact the UFZ working group of ecological
chemistry. Nevertheless, a short overview of the data shall be given.
Ouyang et al. (2014) derived an equation for the discrimination into active and non-active
compounds with a threshold of 0.5 (compounds with values above this threshold are positive,
below negative), which lead to a perfect (!) split of their data. All data, which are also
belonging to the data set of Ouyang et al. (2014), could be classiﬁed correctly with the
derived values with the exception of benzocaine. This is because benzocaine is classiﬁed
negative in the data set of Ouyang et al. (2014) and is categorised as sensitiser according
to the collected data of the data set of this thesis. In fact, there is a speciﬁc publication
(Basketter et al., 1995) for this, which discussed this compound in detail and comes to the
conclusion that it is a sensitiser.
However, the inclusion of new data showed that several compounds (at least 59 out of
140) are miss-classiﬁed and, therefore, this rule seems not to be of a general nature. The
respective statistics are shown in table 54 for the whole data set. Furthermore, statistics of
additionally restricted data sets were added in which compounds were excluded for which an
additional structural alert was derived during the course of this thesis. Of all of these results
the predictions are not convincing enough to establish the EHOMO-based rule of Ouyang
et al. (2014) as general principle for anilines and phenols. Additional research is necessary
to shown to which compounds the ﬁndings apply and which substances in the data set of
this thesis are outside of the domain of applicability of the model of Ouyang et al. (2014).233
232To not dilute this results with insights gathered during the course of this thesis it was tried to exclude for this
analysis only substances with alerts known at the time point of the publication of Ouyang et al. (2014).
233In fact, it was also tried to regard the structural applicability domain derived from the data set of Ouyang et al.
(2014). However, only few (4) additional substances were left after the calculations. Furthermore, it is to add
that the substances used in this thesis are often much complexer.
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Table 54: Statistics of using the EHOMO for discriminating sensitising and non-sensitising ani-
lines and phenols
Data set TNF TPF NPV PPV cc Na
LLNA all 0.64 0.48 0.64 0.48 0.57 75
LLNA restricted 0.64 0.63 0.89 0.26 0.64 47
GPT all 0.61 0.40 0.72 0.29 0.55 71
GPT restricted 0.53 0.44 0.81 0.17 0.51 49
a = Meaning of the abbreviations is the same as used in the main text (cf. tables there)
E.7. Hierachical classiﬁcation scheme for reactivity-based structural alerts
Introduction During the course of this work it became clear that the current deﬁnition of
structural alerts might be not sufﬁcient to describe the research results properly. This was
based on one simple question: how many alerts are included in the model? It turned out that
this question was heterogeneously answered in previous publications from a structural point
of view. For example, Michael acceptors (α,β-unsaturated compounds with an electron with-
drawing group attached) are listed as separate alerts for the different electron withdrawing
groups (carbonyl, nitro etc.), whereas compounds reacting according to a SNAr mechanism
are grouped together as one single alert without listing the relevant structural elements sep-
arately (e.g. activation of the aromatic system via nitro groups, carbonyl functions, and
halogen atoms is treated similar).234 Both views are in compliance with the deﬁnition of
structural alerts as substructural indicators for a certain effect. However, in the ﬁrst case a
list of substance groups is given, while in the second the general concept (SNAr reactivity)
is relevant, leading to an unequal handling of both cases.
To reconcile both views, to provide a uniﬁed counting rationale for alerts, and to generate a
clearer language for speaking about (reactivity-based) structural alerts, the reasoning behind
them was reconsidered and a unifying concept was conceived. However, as the developed
concept is not chemically intuitive (e.g. the valence rule for chemical structures is not
regarded properly for heteroatoms) and the concept is probably to broad for a sophis-
ticated application, more thoughts are needed. In consequence, with respect to the
given arguments there was dissent in the working group of ecological chemistry, if
the concept is sensible applicable. Anyhow, the concept is still included in this thesis
as it provides means to sort the developed structural alerts (also those from litera-
ture) and in particular the Annex E.8 and E.9 rely on it. The following section gives an
introduction to the developed concept.
The developed hierarchical structural alert classiﬁcation scheme consists of the terms
“alert class”, “alert” and “subalert” as deﬁned below. The terms are based on the fact that in
234Of course, this is reasonable for illustrative reasons. In case each alert for SNAr compounds would be listed
separately a combinatoric explosion occurs. This can be easily demonstrated: a SNAr compound has nor-
mally one leaving group and two activation groups in the ortho and para position. For the sake of simplicity
the leaving group shall be all four halogen atoms and the activation groups shall be nitro, sulfones, and ke-
tones. Even with such few groups, we end up with 4x3x3=48 different alerts. As many different activation
and leaving groups can be conceived we readily end up with hundreds of alerts, if we spell them out.
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reactive toxicology the structural elements, which are important for electrophile-nucleophile-
interactions, can be grouped according to their function as shown in ﬁgure 115.
Figure 115: General electrophile-nucleophile-interaction with the involved structural compo-
nents (primarily non-pre/pro-alerts; some components may be missing, e.g. in
case of a Michael addition there is no leaving group).
Where A = attacked atom (with difference between e.g. sp2 and sp carbon, in case non-
carbon atoms are attacked the valances may be different); X = leaving group or substituted
atom/ structure; Q = electron withdrawing or activating group (or groups which will become
such); Y = wildcard for different groups/atoms, which should to be there, but have no speciﬁc
function; R = other residues (mainly C and H). These groups may become very speciﬁc for
a given alert. From this point of view the following levels of detail can be considered for a
given set of structural alerts:
• Reactivity Domain: similar reaction mechanism as in the framework of Aptula and
Roberts (2006).
• Alert class (=subdomain): reﬁned inspection of the reaction mechanisms (more gen-
eralised version of Enoch and Cronin, 2010; Enoch et al., 2011).
• Alert: speciﬁcation of the core structure, i.e. the attacked atom/structure A (the nucle-
ophilic centre of the molecule, including different orbital hybridisation states), speciﬁ-
cation of rings (number of atoms as well as position and number of heteroatoms), and
distances to activating/leaving groups (for example one carbon atom away or two).
• Subalert: speciﬁcation of electron withdrawing groups Q, the leaving group X, as well
as further necessary atoms Y.
• Subsubalert: further speciﬁcation of modifying structural elements (e.g. carbon at
α-position weakens reactivity of Michael acceptors; mostly speciﬁcations of R ), not
always needed.
• Chemotype: inclusion of further information not only based on connectivity (additional
dimension, e.g. Yang et al., 2015).
This hierarchical concept235 can be further extended if e.g. different modes/mechanisms of
action (such as baseline narcosis vs. excess toxicity in acute aquatic toxicity) are taken into
account, which is not necessary for skin sensitisation, where the common mechanism of ac-
tion is protein binding. Moreover, the scheme is primarily developed for directly/intrinsically
reactive compounds but can be applied to pre/pro-electrophile as well, where the emerging
reactive structure is the starting point for classiﬁcation. For instance, all features that can be
235Which can be considered as analogy to the different hierarchical levels of biological organisation and may
utilise the nomenclature of taxonomy, in case further levels of detail are added.
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metabolised to aldehydes are counted as pre/pre-aldehyde alert, which makes sense from
a mechanistic perspective. However, as observed later this gives rise to a legion of (partly)
very different structures being grouped together as (sub)alerts. More considerations for
pre/pro-alerts are necessary and an additional level between alerts and subalerts is helpful
for orientation.236 Five examples for this approach and its implications are given in table 55
(all reactive without activation beforehand).
Table 55: Examples for the different hierarchical alert levels
Level Alert class Alert Subalert Subsubalert Singular
Substances
Description Mechanism/
Subdomain
Attacked
atom/
structure A
Leaving/
modifying
group X/Q/Y
Additional
contraints
(often speci-
ﬁcations of R)
Example A Simple SN2 SN2 at sp3 C Bromalkane Bromalkane
at primary C
1-Bromo-
hexane
Example B α,β-un-
saturated
compound
with activating
group
α,β-un-
saturated
double-bond
with activating
group
α,β-un-
saturated
Esters
α,β-un-
saturated
Esters with C
in α-Position
Ethylmeth-
acrylate
Example C SNAr at
(non-hetero)
aromatic
systems
SNAr at
(strong)
activated
aromatic
systems
Dinitro-
aromats with
Cl leaving
group
No tert-butyl
ortho to Cl
Dinitrochloro-
benzene
(DNCB)
Example D Iso(thio)-
cyanate-type
acylation
Iso(thio)-
cyanates
Isocyanates Isocyanates
at aliphatic
carbon
Butyl-
isocyanate
Example E Ring opening
acylation
(thio)lactones
and lactams
β-lactams – Penicillin
Descriptive
Predictive
Within table 55 the lines “descriptive” and “predictive” illustrate that within this hierarchical
scheme opposing trends exists for these features.237 If we deﬁne the structure of an alert
very concrete, our model becomes very descriptive for the given data (it is able to describe
them properly), but ﬁnally we end up with a model where the alerts consist of individual sub-
236For instance, formaldehyde releasers are grouped together mechanistically with amines as well as allyl al-
cohols with blocked β-Carbon into one alert, because all are aldehyde precursors. However, as the ﬁrst
speciﬁcally emit formaldehyde, all formaldehyde subalerts may be grouped together into a “subalert-class”
and, thus, be separated from the other two subalerts, which can also give rise to longer chain aldehydes.
237A colleague noted that this looks in fact like the uncertainty relationship of quantum mechanics. We cannot
get one property without neglecting the other. This may be a bit presumptuous, but is in principle correct.
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stances and each sensitiser composes its own alert, which in turn means that the developed
model is not very predictive (it cannot predict the effect of new compounds, because it is not
generalised). In contrast to this, if we deﬁne the structural alerts in our model very loose (e.g.
every leaving group of the chemical universe is possible), the model gains the ability to pre-
dict a whole range of new compounds, which were not included in the training set, but it may
be not speciﬁc enough to describe each special case properly. For instance, at the aliphatic
carbon iodide is likely a better leaving group than ﬂuoride (SN2 under biological/aqueous
conditions) and given the fact that only good leaving groups evoke a sensitising effect in
reality the range of included leaving groups for this reactivity domain may be limited, which
is true as alkyl ﬂuorides are basically non-sensitisers. Thus, not all compounds for which a
SN2 reaction is theoretically possible are sensitisers, but a certain reactivity barrier has to be
overcome, which could be calculated via chemotyping the compounds. In conclusion, to be
both descriptive and predictive structural alerts need to be speciﬁc enough to discriminate
the data at hand accurately and have to be wide enough to enable the prediction of new
compounds. They should be as precise as necessary and as broad as possible. Eventually,
Occams Razor should be obeyed by not developing unnecessary complex alert models, but
with a sufﬁcient degree of complexity to model sensitisation adequately.
Results. The following paragraphs give a numerical overview of the hierarchical model.
Table 56 summarises the alert numbers broken down into the respective reactivity domains.
Table 56: Number of alerts in the developed model sorted by reactivity domains
Domain Alert Alerts Subalerts Subalerts
classes (with theoretical) (without theoretical)
Ac 3 11 65 22
pAc 2 2–5* 25 5
MA 4 7 95 19
pMA 5 8–10* 82 61
SB 2 3 22 12
pSB 2 3–15* 27 19
SN2 6 11 172** 46
pSN2 3 3–7* 32 24
SNAR 1 7 2934** 23
pSNAr 0 0 0 0
special 5 7 15 7
p-special 2 4 15 10
Ac = acylating agents, MA = Michael acceptors, SB = Schiff base formers, SN2 and SNAr = substances able
to undergo SN2 and SNAr reactions, special = not in any of the listed domains, preﬁx p = pre/pro-alerts. * =
For pre/pro-alerts the ﬁrst number indicates the alerts and the second the subalert classes, if they are taken
into account, cf. main text. Counting was based on the table in Annex E.8 and E.9 **combinatoric explosion
due to different leaving + activating group for one SN2 alert and all SNAr alerts, cf. main text.
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16 alert classes were derived from the collected skin sensitisation data for directly reactive
chemicals, which are depicted in ﬁgure 116. In addition, 12 pre/pro-reactive alert classes
were described as well as 7 special cases which do not ﬁt completely into the established
reactivity domains and are described in the discussion section of the main part of this thesis
in detail. The grouping of the pre/pro-alerts into classes is based, as explained, on the
structure of the emerging reactive metabolites. Thus, the pre/pro-alert classes correspond
to the directly reactive alert classes with 5 alert classes having no pre/pro-alerts currently.
These are ring-opening acylating agents, SNvinyl and SNpropargyl-compounds, chemicals
which can undergo an intramolecular ring formation (SN2 due to β activation) as well as all
SNAr electrophiles. Of the 28 alert and pre/pro-alert classes 20 were already described in
the literature review of Enoch et al. (2011) (without naming them alert classes). However, a
different grouping of alerts into classes took place in this work (cf. table in Annex E.8).238
Overall, 8 previously not described classes (1 direct and 7 pre/pro) have been described –
leaving aside the special cases.
Figure 116: Reactive-toxic alert classes (direct, without pre/pro-alerts).
238As a side note that quinones are not merged with compounds that carry an activated double bond, is due to
the fact that quinones are in addition to their Michael reactivity able to redox cycle and their overall reactivity
is often higher than of “normal” Michael acceptors.
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Going one level of detail deeper in addition to the comprehensive literature skin sensitisa-
tion and protein binding structural alert schemes (Enoch et al., 2008a, 2011) approximately
29 alerts were derived (special cases alerts included). Together with the literature model the
constructed alert system consists of 39 alerts and 16 pre/pro-alerts. Notably, grouping of dif-
ferent pre/pro-subalerts into one full alert leads to the integration of very different structures
into one alert. This is often counter-intuitive, but stems from the fact that all these structures
are metabolised to an electrophilic compound which can be assigned to one of the described
directly reactive alerts. A good example for this are the pre/pro-Schiff bases (cf. table in An-
nex E.8), where (primary, secondary, and tertiary) amines and α,β-unsaturated alcohols
(with blocked β-Carbon) are grouped together into one pre/pro-alert. This is not meaningful
if the structures are compared directly, but from a mechanistic perspective it is. However,
for further orientation a level between alerts and subalerts can be added in particular for the
pre/pro-electrophiles, leading to 44 alerts and 37 pre/pro-alerts.
At the even deeper level of subalerts, 3303 subalerts for directly reactive substances and
181 pre/pro-subalerts have been included in the model. Mind that these may have been
described as separate alerts previously, because the terminology developed in this thesis
was lacking. For example, the model of Enoch et al. (2011) incorporates approximately
150 subalerts (leaving aside the SNAr reactants) while the current model has 378 subalerts
(again without SNAr reactants as well as one SN2 alert, cf. next sentences). It becomes
apparent that spelled out as subalerts some alerts consists of many subparts while others
change only slightly. For instance, the alert “isocyanates and related” has (only) 4 subalerts
(of which 1 is theoretical) – cf. Annex E.8. On the other side, in particular the SNAr subalerts
become very high in numbers (2601) due to their 3 interchangeable substructures (one
leaving group and two activating groups at the aromatic system) which give rise to a great
number of different combinations; in fact this subalerts nearly count individual substances,
but are still modiﬁable at the ring positions that are not occupied by the leaving/activating
groups. The second major contribution to the overwhelmingly high number of subalerts
are α-activated haloalkanes and related (with 2 interchangeable substructures: one leaving
group and one activating group) which have 172 subalerts.
Discussion. The way we talk about a particular topic reﬂects and shapes our perception,
thinking, and reality of this topic. Right now the way we talk about structural alerts is simple.
They are routinely related as substructural fragments of a molecule, which are responsible
for a particular (toxicological) effect. This is a working deﬁnition, which leaves room for inter-
pretation. However, as structural alert models become more and more complex (or detailed)
this deﬁnition may become problematic, because it becomes too inaccurate to obtain a suf-
ﬁcient model description. To engage this problem the above delineated hierarchical scheme
was conceived. It is particularly helpful for navigating through the developed structural alert
model and is able to clarify model strengths and weaknesses with a greater degree of pre-
cision (e.g. is a whole alert class erroneous or is the problem at the subalert level) than
utilising the common structural alert deﬁnition. However, it can also support structural alert
models in the statistical evaluation.
E17
The latter fact is important with a look to the skin sensitisation data set at hand. Unlike
other data sets which consists of carefully chosen homologue series and chemically closely
related compounds (e.g. the Tetrahymena data set of the correlation analysis, cf section 4.4),
it comprises a set of structurally heterogeneous substances as already diagnosed during the
read-across exercise.239 This means that for several compounds structurally close neigh-
bours are missing and, thus, the derivation of structural alerts with high statistical conﬁdence
(alert reliability 1) is not possible for these compounds. Still, even if only the derivation of
preliminary alerts is possible these may be grouped together to an alert class for which suf-
ﬁcient substances may exist. An example is the cyclopropenone alert (cf. Annex E.8 and
E.9, Alert 13A), which in itself is backed up by just one substance, but becomes reliable if
the whole class of ring opening acylation reactions is considered (cf. Annex E.8 and E.9,
Alert class 13). The support from a statistical perspective is even more true for the subalerts,
which are legion and whereof several would be just preliminary alerts, but if they are grouped
together mechanistically into full alerts their reliability increases.240 This is exempliﬁed by
succinimidyl carbonates (cf. Annex E.8 and E.9, Alert 11A(15-16)), which are a preliminary
subalert but can be integrated to a reliable full alert (acid halogenids and related, cf. Annex
E.8 and E.9, Alert 11A). However, this may fail in the case of very unique structures such
as the bis(dimethyl-amino)methylene alert (cf. Annex E.8 and E.9, Alert 67A). Nevertheless,
it is important that the related subalerts, alerts, and alert classes are mechanistically sim-
ilar to ensure the soundness of this expert-driven classiﬁcation (which is indeed similar to
mechanism-based read-across).
239And also the problems seen in the read-across development may be attributed to this heterogeneity, as (quan-
titative) read-across works best for homologue series for compounds (Van Leeuwen et al., 2009).
240Of course, this is not completely new, since experts grouped alerts or subalerts together before (e.g.
Mekenyan et al., 2014), but no overall explicit scheme for this process was available, besides referring to
(implicit) expert knowledge.
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E.8 Developed structural alert model 
The following Annex summarises the developed structural alert model with all its alarming 
features. It goes beyond the main text – which focusses on the new developments – and also 
lists the already available partly well-known literature alerts. The table gives a structure as 
well as chemical names to reduce the ambiguity of the description. Furthermore, several 
literature references are listed in the last column. These concern literature regarding the 
respective fragment(s) in general and include not necessarily only skin sensitisation 
publications. However, the list is not exhausting and should be considered just a starting 
point for further investigations. 
In addition a nomenclature for the alerts was developed to facilitate the navigation within the 
model. It is based on the classification scheme elaborated in Annex E.7. For example 
“42B(1-3)” means the following: 4 = domain, 42 = alert class, 42B = alert, 42B(1-3) = 
subalert 1 to 3; in case a second (small) letter appears behind the capital letter (as in 
42Bc(1-3)), the second letter denotes the “subalert-class”, i.e. the level between alert and 
subalert, which is at times useful to subdivide the structurally heterogeneous pre/pro-alerts. 
This can lead to different groupings, as can be seen for several pre/pro-alerts. 
Moreover, some of the used abbreviations shall be explained beforehand: C = an aliphatic 
carbon, Car = an aromatic carbon, Ph = phenyl ring, NN and NNN include all types of bonds 
between the Ns, e.g. N-N, N=N, N#N, because these can vary for the same molecule 
depending on the structural data base consulted. As a note of caution, (also expressed in the 
main text) concerning the usage of the word thiol and thion: normally, just the term thio-
esters (or thio-sulphonates, respectively) is applied in chemistry. However, in this thesis 
differentiation is taken for the sake of a precise language (following a suggestion in 
Wikipedia), because the substitution of an oxygen atom with an sulphur atom within an ester 
(or sulphonate) could refer to two different compounds, if just the syllable thio is added. The 
first is a substitution of a “=O” (e.g. carbonyl) group with an “=S” (referred here commonly as 
thion) and the second a replacement of “-OR” (e.g. ether bond, alcohol) with an “-SR” 
(referred here commonly as thiol). Eventually, uncommon subalerts are depicted separately, 
but belong to an alert (or uncommon alert and families/classes, respectively), as can be seen 
from the above delineated nomenclature. For instance, succinimidyl esters and carbonates 
are a subalert of “acid halogenids and related”, but are portrayed separately due to their 
unique structure. 
Lastly, a (grey) color coding was introduced to differentiate new alerts*, new theoretical 
alerts*, the well-known literature alerts (no coloration), and theoretical alerts. 
*if a star* is added this means the alert is not totally new, but has been described (partly) in 
literature (which is not necessary skin sensitisation literature, but can be an alert for a related 
endpoint that also concerns electrophilic compounds).  
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ID Alert 
(or Alert class) 
Subalert 
(X, Y, Q specified) 
further comment/constraints 
(R specified) 
References 
1 Ac Domain   1, 2 
11 
 
Direct acylation 
   
11A (a,b) 
(1-14) 
 
a) acid halogenids, carbamyl halogenids, 
acid azides, noncylic anhydrids, acid 
peroxides O/S-phenyl esters, alkyl thiol 
esters,  
 
b) salicylates, (activated) aromatic 
carbonates  
 
 
 
 
c) thion esters, alkyl dithio esters 
a) Y = O, X = F, Cl, Br, I,  
NNN, OC(=O)R, OOR, O-Ph, 
S-Ph, SC 
 
 
 
 
 
b) Y = O, X= Ph with ortho 
OH, O-Ph 
 
 
 
 
c) Y = S, X = OR, SR 
a) R = C or Car, H, -N(C)C 
(carbamyl or -OC, only for X = 
halogen), or second X (e.g. Cl in 
Phosgen). In case of OPh, para 
CH3 and Carboxy-groups lead to 
deactivation (ref. in Annex E.9) 
 
 
 
b) R = OC; in case of carbonates 
an activating group (N(=O)O, 
S(=O)(=O)OR, C(=O)OR) has to 
be attached to the ring. 
 
c) R = C or Car 
(CS2 is not included, as it has a 
thiol tautomere – SN2) 
2, 3, 4, 5, 6, 
7, 8, 9, 10, 
11, 12, 13, 
93, 100 
11A 
(15-16) 
 
succinimidyl esters and carbonates 
 
R = C, O 
Also Tetrafluorophenyl (TFP) 
Esters and Sulphodichlorophenol 
(SDP) Esters  are addable 
9 
11B 
(1-6) 
 
sulphurous acid halogenids + acid azides 
X = F, Cl, Br, I, and NNN R = C or Car, OC or OCar 2, 4, 9, 10, 
93 
11C 
(1-6) 
 
X = F, Cl, Br, I, and NNN  
Y = O, S 
R = C or Car 2, 10, 93 
0 E30 
 
phosphorous acid halogenids + acid azides 
12 
 
Isocyanate Type 
   
12A 
(1-4)  
a) iso(thio)cyanates, carbodiimides and  
b) ketenes 
 
a) X = N-C, O, S  
 
b) X = O 
 
a) R = N(-C) (if  X = O and S), N-C 
(if  X = N-C) 
b) R= CR2 
Also HNCNH (cyanamide) is 
included, which has a diimide 
tautomere. 
3, 4, 5, 8, 10, 
12, 14, 15, 
93, 100 
12B 
 
dithiocarbonimidic acid esters 
X = S-C  R= N-C 4, 10 
 
 
 
13 
 
Ring opening acylation 
   
13A 
(1-2) 
 
cyclopropenones and -thiones 
X = C 
 
Y = O, S 
 
 10 
13B 
(1-6) 
and 
43B 
(1-4) 
 
(thio)lactones, lactams 
X = O, S, N 
 
Y = O, S 
 
 3, 4, 5, 6, 8, 
10,16 
13C 
(1-12) 
2
1
 
X = O, S 
 
Y1 = O, S 
 
Y2 = N, C or Car 
In case of Y2 = Car, the C between 
Y2 and C=Y1 should not contain a 
big residue (e.g. Ph), otherwise 
steric hindrance occurs. 
1, 8, 10, 17, 
18,  
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(az)lactones 
13D 
(1-4) 
2
1
 
6-ring azlactones and related* 
X = O 
 
Y1= O, S 
 
Y2 = C, N 
 
R = C or Car  
13E 
(1-2) 
 
 dihydropyranones, dihydrocoumarins* and 
related 
X = O 
 
Y= O, S 
 
R = H, C or Car 1, 6 
 
13F 
(1-6) 
 
cyclic anhydrides 
X = O, S (but not N!) 
 
Y= O, S, C (only one Y) 
 
R = C or Car  1, 6, 8, 10, 
14 
P1 Pre/pro-Ac Domain   19, 20 
P11Aa 
(1-6) 
 
1,1-dihaloalkanes* 
X = Cl, Br, I R = C or Car 
 
 
19, 20 
P11Aa 
(7-15)  
 
1,1,1-tri- and tetra-haloalkanes* 
X = Cl, Br, I R = C (not Car! cf. below), X 
(subalert 16-27 if tetra is counted 
additionally). 
Listed as different from P11Aa1-6 
for metabolic reasons. Only 
tetrachloromethane for tetra in the 
data set. 
21 
P12Aa  
(1) 
1
2
 
isocyanate releasers*  
thiazolidinediones* 
 19, 20 
22 E32 
 
P12Aa 
(2) 
 
 
formamides* 
R = C or Car 
 
19, 20 
P12Aa 
(3) 
 
sulphonylureas* 
R = C or Car 
 
19, 20 
P12Ab 
(4) 
and  
P31A 
(5) 
 
benzylamines* 
  19, 20 
P12Ac 
(5) 
+
 
Isonitriles 
 R = any non H atom  
2 MA Domain   2, 11, 22, 23, 
24, 25, 26, 
27 
21 
2
1  
Polarised-alkenes 
   
21A 
(1-20) 
1
2
 
Michael alkenes: aldehydes, ketones, 
carboxylic acids, (thio(n))esters, amides, 
nitro, nitroso, cyano, oximes, sulphates, 
sulphonates, sulphone, sulphinyl,  2-
pyridine*, 4-pyridine*, pyrimidines, triazins 
 
Q = C(=O)H, C(=O)C, 
C(=O)OH, C(=O)OC, 
C(=O)SC, C(=S)OC, 
C(=O)NH2, N(=O)O, N=O, 
C#N, N=OR, 
OS(=O)(=O)OR, 
S(=O)(=O)OR, S(=O)(=O)R, 
S(=O)R, 2-pyridine, 4-
pyridine, pyrimidines (2, 4 
and 2,6), triazins. 
R = H, C or Car 
 
In case of Michael esters (and 
ketones) R1 should not be a C 
(reactivity is too weak) – 
subsubalert level (cf. Böhme et al., 
2010 or Blaschke et al., 2011). 
2, 3, 4, 8, 10, 
14,15, 23, 
24, 25, 28, 
29, 30, 31, 
32, 33, 34, 
35, 91, 93, 
96, 97, 100 
23
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22 
 
Polarised-alkynes 
   
22A 
(1-20)  
Michael alkines: aldehydes, ketones, 
carboxylic acids, (thio(n))esters, amides, 
nitro, nitroso, cyano, oximes, sulphates, 
sulphonates, sulphone, sulphinyl, 2-
pyridine*, 4-pyridine*, pyrimidines, triazins 
Q = C(=O)H, C(=O)C, 
C(=O)OH, C(=O)OC, 
C(=O)SC, C(=S)OC, 
C(=O)NH2, N(=O)O, N=O, 
C#N, N=OR, 
OS(=O)(=O)OR, 
S(=O)(=O)OR, S(=O)(=O)R, 
S(=O)R, 2-pyridine , 4-
pyridine, pyrimidines(2,4 and 
2,6), triazins 
R = H, C or Car 2, 8, 10, 100 
 
23 
2
1
 
Quinones-and-quinone-type 
   
23A (or 
Aa) 
(1-12) 
1
2  
para-quinones, quinone-imines, quinone-
di-imines, quinone-methides, imine-
methides, pyranones and N-related 
compounds* 
a) Q1 = C(=O) 
Q2 = C(=O), C(=N), O, N, C( 
=CH2), C(CH2CH=CH2)  
 
b) Q1 = C(=N) 
Q2 = C(=O), C(=N), O, N, C( 
=CH2), C(CH2CH=CH2)  
 
  2, 3, 4, 5, 8, 
10, 14, 36, 
100 
23B (or 
Ab) 
(1-12) 
1
2
 
ortho-quinones, quinone-imines, quinone-
di-imines, quinone-methides, imine-
methides ,pyranones and N-related 
compounds 
a) Q1 = C(=O) 
Q2 = C(=O), C(=N), O, N, C( 
=CH2), C(CH2CH=CH2)  
 
b) Q1 = C(=N) 
Q2 = C(=O), C(=N), O, N, C( 
=CH2), C(CH2CH=CH2)  
 
  2, 4, 5, 8, 
10, 14, 27, 
100 
24 other MA compounds    
24A 
(1-10) 
 
acid imides and related 
Q = C(=O), C(=S), S(=O)=O, 
S(=O) 
R = H, C 5, 10 
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24B 
(1-10) 
azocarbonamides and related 
Q = C(=O), C(=S), S(=O)=O, 
S(=O) 
R = H, C 
 
10 
 
 
 
 
24C 
(1) 
 
3-Methyl-4Phenyl-1,2,5-thiadiazol* 
 MA, special case 8, 15 
 
P2 Pre/pro-MA Domain    
P21-22-24 Pre-polarised-alkenes/alkynes    
P21Aa 
(1-4) 
1
2
 
allyl alcohols, allyl amines, allyl methoxy 
ethers, allyl sulphurous acid esters 
Q = COH, CNH2, COCH3, 
COS(=O)OR 
 
R = H, C or Car 
 
In fact the activation mechanism 
for COS(=O)OR may be a 
hydrolysis, whereas the others are 
likely to be metabolically activated. 
4, 8, 10, 15, 
31, 37, 100 
 
P21Ab 
(5) 
sulphone-sulphates 
  10 
P21Ac 
(6-7) 
 
furans*, thiophens* 
Q = O, S  19, 20 
P22Aa 
(1-4)  propargyl alcohols, propargyl amines, 
propargyl methoxy ethers, propargyl 
sulphurous acid esters 
 
Q = COH, CNH2, COCH3, 
COS(=O)OR 
R = H, C or Car 
In fact the activation mechanism 
for COS(=O)OR may be a 
hydrolysis, whereas the others are 
likely to be metabolically activated. 
8, 14, 100 
P23 Pre/pro-quinones and quinone-type     
25
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P23Aa 
(1-21) 
2
1
 
para-hydroquinones,aminophenols, 
benzenediamines, pre/pro-quinone-
methides and related compounds 
a) Q1: NH2 
Q2: NH2, NHR, NR2, N=N 
 
b) Q1: OH 
Q2: NH2, NHR, OH, OCH3, 
OCH2CH3, CH3, 
CH=CHCH3,  CH2CH=CH2 
N=N-Ph , N(=O)O, Ph, 
C=CPh  
c) Q1: OCH3 
Q2: CH=CHCH3, 
CH2CH=CH2 
 
 
 
 
d) Q1: N(=O)O  
Q2: NR2, NHR, NH2  
(ortho-nitro-N-(N-)alky-
anilines) 
R = C 
 
 
 
 
 
 
 
c) Q2 = CH2CH=H2C: no OCH3 
ortho to OCH3  
for Q1 = OCH3 no aldehyde or 
C#N should be attached to the 
aromatic system as they alter the 
metabolism (they are metabolised 
to carboxylic acids, which 
competes/replaces the O-
dealkylation of the methoxy-group). 
 
d) R = C (not Car, not CH3, not in 
ring), both R=C is only allowed in 
screening; hard to differentiate 
from other alerts, in particular 
substances with ortho quinone 
alerts.  
1, 2, 4 , 5, 7,  
8, 10, 15, 17, 
38, 39, 40, 
41, 93, 100 
P23Ac 
(22) 
 
 
 e) Q1: NR2 
Q2: H 
 
N-N-alkyl-anilines* 
R = C (not Car, not carbonyl, not 
part of a ring) 
 
P23Ac = hydroxylation (OH) in 
para necessary 
4, 7,14 
P23Ac 
(23) 
 
 
phenothiazine 
R= C, H 42, 43 
26 E36 
 
P23Ac 
(24-25) 
 
  
 
one Y = NHR, NH 
para N-diaromatic diamines 
R = C 
Further substituents at the Ring 
system at which both NHR are 
attached seem to have a negative 
influence on the quinone formation, 
thus only H is allowed currently. 
44 
P23Ba 
(1-21) 
2
1
 
ortho-hydroquinones,aminophenols, 
benzenediamines, pre/pro-quinone-
methides and related compounds 
a) Q1: NH2 
Q2: NH2, NHR, NR2, N=N 
 
b) Q1: OH 
Q2: NH2, NHR, OH, OCH3, 
OCH2CH3, CH3, 
CH=CHCH3, CH2CH=CH2 
N=N-Ph, N(=O)O 
 
 
 
c) Q1: OCH3 
Q2: CH=CHCH3, 
CH2CH=CH2 
methylene-dioxyphenyls* 
tetrahydro-quinoxaline 
d) Q1: N(=O)O 
Q2: NR2, NHR, NH2 
ortho-nitro-N-(N-)alky-
anilines 
R = C 
 
 
b) Q2: N=N-Ph: the aromatic 
system should not be a naphtyl-
ring. further for OCH3 no aldehyde 
or C#N should be attached to the 
aromatic system as they alter the 
metabolism (they are metabolised 
to carboxylic acids, which 
competes/replaces the O-
dealkylation of the methoxy-group). 
 
c) for Q1 = OCH3 and methylene-
dioxyphenyls no aldehyde or C#N 
should be attached to the aromatic 
system as they alter the 
metabolism (they are metabolised 
to carboxylic acids, which 
competes/replaces the O-
dealkylation of the methoxy-group). 
 
 
 
 
 
 
 
 
d) R = C (not Car, not CH3, not in 
ring), both R=C is only allowed in 
screening. (several NH2 
substances also include other 
pre/pro-MA alerts) 
1, 2, 4, 5, 7, 
8, 10, 19, 20, 
31, 39, 93, 
100 
27
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P23Bc 
(22-23) 
 One Y = NHR 
Evt. if para = H 
  
ortho N-diaromatic diamines 
R =  H, C 
Further substituents at the Ring 
system at which both NHR are 
attached seem to have a negative 
influence on the quinone formation, 
thus only H is allowed currently. 
44 
P23C 
(1-3) 
2
1
 
meta-hydroquinones,aminophenols, 
benzenediamines 
a) Q1: NH2 
Q2: NH2 
 
b) Q1: OH 
Q2: NH2, OH 
 6, 8, 99 
P24+P25 naphtyl-type + indols    
P24Da 
(1-3) 
2
1
 
1-naphtols, 1-naphtylamines 
Q = NH2 
 
Q = OH 
 
Q = OH* 
 
 
R1, R2 = H 
 
R1, R2 = H 
 
R1 = CH3, R2 = H (quinone 
methide, special case) 
8, 17 
 
P24Ea 
(1-3) 
 
2-naphtols, 2-naphtylamines 
Q = NH2 
 
Q = OH 
 
Q = OH 
 
 
R = H 
 
R = H 
 
R = CH3 (quinone methide, special 
case) 
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P25A 
(1-5) 
2
2
1
1
 
6-alkoxyindoles, 5-alkoxyindoles*,  
3-methylindoles* 
a) Y1=any, Y2=OH, OCH3 
 
b) Y1=OH, OCH3, Y2=H 
 
c) Y1=H, Y2=H 
a) R1= H, R2 =H 
 
b) R1= H, R2 = C 
 
c) R1= CH3, R2 =H 
 
 
19, 20 
 
 
 
 
 
 
 
3 SB Domain   1, 2, 6, 47, 
48, 45 
31 
 
Monocarbonyls and related 
   
31Aa 
(1-4) 
 
aldehydes, thioaldehydes, imines, Michael 
aldehydes with blocked b-carbon 
a) X = O, S, NC R = C (not Car), in case of X=O 
also Michael aldehydes with 
blocked b-carbon are included 
(=subalert 4). 
 
Sugars should be excluded. 
1, 2, 3, 4, 5, 
8, 10, 14, 16, 
37, 39, 46, 
47, 49, 50, 
51, 52, 93, 
95, 100 
31Ab 
(5-7) 
 b) 
1
3
2
 
aromatic aldehydes and 
related 
X = O, S, NC 
Y1 = H, F, Cl, Br, I, OH, 
OCH3 
Y2 = H, F, Cl, Br, I, OH, 
OCH3, N(=O)O, N=O, 
N+(C)(C)C, S(=O)O, 
OS(=O)O, C#N, C(=O)C, 
C(=O)O 
Y3 = H, F, Cl, Br, I, OH, 
OCH3, N(=O)O, N=O, 
N+(C)(C)C, S(=O)O, 
OS(=O)O, C#N, C(=O)C, 
C(=O)O 
R = Car 
 
 
 
 
 
 
 
Whether a concrete chemical is a 
sensitiser or not depends on the 
Hammett values of the Ys, which 
influence the activity of the 
aldehyde group. An ortho OH 
enhances the reactivity strongly 
due to hydrogen bonding. 
However, the Hammett values are 
no ultimate predictive tool for 
sensitisation  as can be seen in the 
data of Natsch et al., 2012. 
2, 7, 8, 45, 
47, 48, 49, 
53, 54, 95 
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32 
 
Activated (Di)Carbonyls 
 
  
32A 
(1-12) 
 
1,2-diketones and other alpha activated 
ketones 
Q = C(=O)C, C(=O)OH, 
C(=O)OC, N(=O)O, N=O, 
N+(C)(C)C, S(=O)O, 
OS(=O)O, C#N, P=O, S=O, 
C(=O)NR2 
R = C, Car 
Q = C(=O)NR2  is possible if R and 
R2 are ortho Car of the same 
aromatic system, i.e. isatin:
 
1, 2, 4, 8, 11, 
15, 53, 93, 
100 
32Ba (or 
B) 
(1-2) 
 
1,3-diketones and other beta activated 
ketones 
Q = C(=O)CR, C(=O)OR* R = (H), C 
R = Car: reactivity is significantly 
reduced as in aromatic aldehydes. 
However, R = Car can be used for 
screening purpose. Also C(=O)OR 
is just a screening alert. 
Other activating groups for Q are 
not yet included. 1,3-diketones 
may constitute a special case due 
to hydrogen-bonding between both 
carbonyl-groups (cf. 32C). The 
depicted α-CH is acidic. 
1, 2, 4, 8, 10 
16, 93, 100 
32Bb (or 
C) 
(3) 
 
tautomeres of 1,3-diketones 
 R = (H), C 
 
27 
P3 Pre/pro-SB Domain    
P31 Pre/pro mono aldehydes    
P31Aa 
(1) 
 
allyl alcohol with blocked b C 
  8, 10, 39, 50, 
51 
0 E40 
 
P31Ab 
(2) 
 
ortho-hydroxy-benylalcohols 
 
 Probably extendable to other 31A 
substances. 
 
P31Ac 
(3-5) 
1
2  
primary, secondary and tertiary amines 
X1  = H, CH3, CH2CH3 
X2  = H, CH3, CH2CH3 
 
R = C, H 
 
 
1, 4, 5, 7, 8, 
10, 39, 93 
P12A 
(4) 
and  
P31Ad 
(6) 
 
benzylamines* 
  11, 19, 20 
P31Ae 
(7-8) 
  
ethanolamines , ethylenediamines 
X = NH2, OH 
 
R = C (not Car) 10 
P31Af 
(9-11) 
 
 
morpholines*, piperizines* 
X = NR, O, S 
 
R = H, C or Car 
 
5, 10 
P31Ag Formaldehyde-Releaser   4, 14, 10, 55, 
56 
P31Ag 
(12) 
exP34A 
3
1
2  
N-methylol derivatives and related such as 
alpha-hydroxy-ureas (R1 = C(=O)N) 
 R1, R2, R3  = H, C 
R1 and R2 as well as R2 and R3 
may be part of a ring (e.g. cyclic 
urea derivates and oxazolidine). 
Also alpha-hydroxy-urea related 
compounds are included (e.g.) 
 
31
E41 
 
P31Ag 
(13) 
exP34B  
(1) 
2
1
 
cyclic urea derivates, such as 
imidazolidinyl urea and hydantoin 
Y1 = C=O 
Y2 = CH2, C(C) (C) 
 
Y1= CH2 
Y2 = CH2 
  
P31Ag 
(14) 
exP34B  
(2) 
 
cyanuric acids 
   
P31Ag 
(15) 
exP34C 
 
poly-tert-amine ring systems 
 R is normally part of at least one 
ring but often more than one (e.g. 
Adamatane), R = CHx  
 
P31Ag 
(16) 
exP34D 
2
1
 
halo-nitro-dioxanes* and halo-nitro-diols* 
 Y = H, C or F,Cl, Br, I 
R1, R2 = H, C 
 
(R1 and R2 may constitute a ring 
system as in 5-Bromo-5-nitro-1,3-
dioxan) 
4 
P31Ag  
(17-18) 
exP34E 
(1-2) 
benzylhemiformal and related* 
 R = H, CCar  
P31Ag  
(19-22) 
exP34F 
(1-4) 
 
lactonitrile*, anilinoacetonitrile*, 
cyanomethyl acetate* 
X = OH 
 
X = NHPh, OC(=O)CH3 
R = CH3 
 
R = H 
14 
 
 
 
32 E42 
 
P32 Pre/pro-Diketones    
P32Aa 
(1) 
  
thiazole* 
 R = any 19, 20 
P32Ab 
(2-3) 
 
1,2-diamine and related 
Y = NH2, =O R = H, C or Car 98 
P32Ba 
(1-2) 
 
1,3-diamines and related 
Y = NH2, =O R = H, C or Car 
 
98 
4 SN2 Domain   1, 2 
41 
 
Leaving group at activated sp3 carbon 
(alpha activation) 
   
41Aa 
(1-78) 
 
 
alpha activated halogen alkanes, alkyl 
sulphate, alkyl sulphonate, and azide 
compounds 
X = Cl, Br, I, NNN,, 
OS(=O)(=O)OC or Car, 
OS(=O)(=O)C or Car 
Q = C=C, C#C, Ph, C(=O)C, 
C(=S)C*, C(=O)O, C(=S)O, 
C(=O)N, C(=S)N, OC, 
OC(=O)O, N(=O)O*, C#N* 
R = C, H 3, 5, 6, 7, 10, 
11, 14, 15, 
26, 49, 93, 
100 
41Ab 
(79-81) 
X = acetate 
allyl, propargyl and benzyl 
acetates 
Q = C=C, C#C, Ph 
More activating groups may be 
added if further data become 
available. 
7, 8, 10, 15 
 
33
E43 
 
41Ac 
 (82) 
X = phenolate 
phenoxyacetic acids and its 
esters 
R = C, H 
More activating groups may be 
added (instead of the ester) if 
further data become available. 
 
42 
 
SNVinyl (Leaving group at sp2 carbon) 
   
42A 
(1-7) 
 
alkenes with halogen, azide, alkyl sulphate, 
and alkyl sulphonate leaving group 
X = Cl, Br, I, NNN, 
OS(=O)(=O)OC or Car, 
OS(=O)(=O)C or Car 
R = C 8, 10, 15 
 
43 
 
SN propargyl (Leaving group at sp 
carbon) 
   
43A 
(1-7)  
alkynes with halogen, azide, alkyl sulphate, 
and alkyl sulphonate leaving group 
X = Cl, Br, I, NNN, 
OS(=O)(=O)OC or Car, 
OS(=O)(=O)C or Car 
 
  
 
 
 
 
44 
 
Strained ring systems 
   
44Aa 
(1-3) 
  
epoxides, aziridines and sulphuranes 
X = O, S, N  3, 4, 5, 8, 10, 
14, 16, 30, 
37, 39, 51, 
52, 57, 58 , 
59, 60, 61, 
62, 63, 64, 
65, 93, 94, 
100 
34 E44 
 
13B(Ab) 
(1-6) 
and 
44B 
(1-4) 
 
(thio)lactones 
X = O, S 
Y = O, S 
 3, 10, 16, 
100 
45 
 
Intramolecular ring form (beta 
activation) 
 Could also be counted as P44A  
45Aa 
(1-9) 
 
1,2-dihalogens 
X = Cl, Br, I  10 
45B(Ab) 
(1-12) 
2
1
 
S,N-Mustards, β-halo-ether and β-halo-
alcohols 
X1 = Cl, Br, I 
X2 = N, S, OH, OC 
 
Beta halo ether are often not 
reactive*, if R = CCX1 than the 
substance is a Mustard.  
 
3, 10, 7 
14 
46 
 
Direct Leaving 
Leaving group at sp3 carbon 
(alkylation),  nitrogen, 
sulphur (also SH included, 
which is rather an oxidation 
than SN2), halogen, and 
metal atom 
  
 
 
46A 
(1-8)  
primary alkanes with halogen, azide alkyl 
sulphate and alkyl sulphonate leaving 
group 
X = Cl, Br, I, NNN, 
OS(=O)(=O)OC or Car, 
OS(=O)(=O)C or Car 
 
Also alkyl-(thio)phosphonate 
(CP(=O)(OC)OC) and alkyl-
(thio)phosphate (OP(=O)(OC)OC) 
are reactive, but sensitisation  is 
not verified within the data set. 
Probably the Serin specific 
reaction does not lead to 
sensitisation  (wrong target) 
In case of halogenalkanes the Kow 
has shown to be important for 
reactivity. Thus the following 
thresholds should be applied: log 
Kow > 3.5 (Cl) log Kow > 2.5 (Br) log 
Kow > 2.5 (I) (preliminary, other 
explanations exist, cf. Siegel et al. 
2009) 
2, 3, 4, 5, 6. 
7, 8, 10, 49, 
67, 66, 68, 
92, 93 
35
E45 
 
46B 
(1-2) 
 
2
1
 
N-nitroso-compounds 
X = N=O 
Y1 = C or H 
Y2 = C(=O)N, C(=N)N 
 
 
 6, 8, 10, 11, 
14, 16, 69 
46B 
(3-4) 
2
1
 
N-acyloxy-N-acetylphenyls, N-acyloxy-N-
alkoxyamides 
X = OC(=O)C  
a) Y1 = C(=O)C, Y2 = Ph 
  
b) Y1 = C(=O)N, Y2 = OCH3 
Proposed in Enoch et al., 2011, but 
in the referred paper DNA toxicity 
of this compounds is analysed. No 
data are available to prove 
sensitisation. 
 
 
10 
 
 
   
46Ca 
(1-9)  
thiols 
2
1  
associated subalerts: thiol acids,thiol 
carbamate, thiol carbonates, (thiol-thiol) 
dithiocarbonates, dithio acids, dithio 
carbamates (thioacids), (thion, thiol) 
dithiocarbonates, trithiocarbonates 
 
 
 
 
 
 
 
Y1 = C, N, O, S 
Y2 = O, S 
R = CH2, P  
 
 
3, 10, 34, 68, 
93 
46Cb 
(10-17)  
disulphides, sulphoxides-of-disulphides, 
thiosulphonates (= sulphones of 
disulphides), thiosulphates, sulphenyl-
halides, thiocyanates 
X = SR, S(=O)C, 
S(=O)(=O)C, S(=O)(=O)OC,  
Cl, Br, I, C#N 
R = any 3, 4, 10, 34 
46Cb 
(18) 
 
 
thio-phthalimines 
R = H, C  
36 E46 
 
46Cb 
(19-20) 
 
 
isothiazol-3-ones, 
isothiazolin-3-ones 
Isothiazol-3-ones: unsaturated 
ring, isothiazolin-3-ones: saturated 
ring 
1, 4, 5, 6, 8, 
10, 53 
46Cc 
(21) 
 
aromatic-sulphonic-acids 
 Alert according to Enoch et al., 
2011 and Gerner et al., 2004, 
however no actual adduct 
formation was investigated. 
5, 10 
46Cd 
(22-23) 
21  
thions with H-donor – as thiols tautomeres 
associated subalerts: thiourea, dithio 
carbamates (thioesters), thion carbamates 
 
 
 
 
Y1 = NH 
Y2 = N, S, O 
 
Also CS2 is included, which has a 
thiol tautomere 
4, 100 
46Cd 
(24-26) 
 
mercaptobenzothiazols 
Y = H*, S*, N For mercaptobenzothiazol also the 
thion tautomere should be 
considered: 
 
6, 8, 70 
 
46D-G 
(1-2) 
Hal
 
Hal = F, Cl, Br, I 
N-halo-sulphonamides, N-halo-imides 
X = NS(=O)(=O)R  
Hal
 
 
 
or  
 
 
R = C or Car 
 
Both depicted groups are better 
leaving groups than the halogen 
atoms. However, this should be 
tested e.g. via crossreaction 
studies. 
4, 10 
 
37
E47 
 
X = N(C(=O)R)C(=O)R 
Hal  
46H 
(1-4) 
 
 
organometal compounds 
A = metal such as: Sb, Hg, 
Pb 
X = Cl, Br, I, SR 
 
R = C 3 
P4 Pre/pro-SN2 Domain    
P44     
P44Aa 
(1-2) 
polyaromatic hydrocarbons 
a)  
b)
 
H are necessary for activation to 
epoxides (or hydroquinones as 
discussed in Enoch et al., 2011) 
OH should also be possible 
6, 8, 10, 39 
 
 
activated double bonds (see below) 
   
38 E48 
 
P44Ab  
(or B) 
(3-8) 
 
vinyl benzenes, 2-pyridine, 4-pyridine 
pyrimidine, triazine 
Q = Ph, 2-pyridine, 4-
pyridine, pyrimidine (2,4 and 
2,6), triazine 
 
R = C (not Car), H 
Y = Nar or Car 
10, 15, 39 
P44Ab  
(or B) 
(9-11) 
  
 
(pre/pro)-Michael acceptor 
with blocked β-carbon* 
Q = C(=O)R1 or C(OH) 
R = C or Car, R1 = H, C or Car 
 
(also Michael acceptor aldehydes 
are included, but they react as 
Schiff bases, too, cf. Wu et al., 
2010) 
4, 6, 37, 39, 
50, 51, 52, 
71, 73, 74 
P44Ab  
(or B) 
(12) 
 
 
α,β unsaturated oximes* 
R = C or Car 
 
At least one H has to be at the 
double bond. 
30, 31, 39, 
61, 72 
P44Ab  
(or B) 
(13) 
 
 
 
peonile 
  
P44Ab  
(or B) 
(14) 
 
 
methoxy alkenes 
COC=C, double bond is not part of 
a ring. 
 
 
 
double bonds in terpenes 
Y = H or C(R2)H   
39
E49 
 
P44Ac  
(or C) 
(15) 
 
double bond in terpenes* 
R = alkyl  31, 37, 50, 
51, 59, 60, 
62, 72, 71, 
74 
P44Ac 
(or C) 
(16-19) 
 
6-Ring with at least one double bond as 
specified in subalerts 
double bond in terpenes* 
 
R = alkyl; conjugation should 
enhance the potential for 
autoxidation (Karlberg et al., 2008) 
52, 59, 60, 
74, 75, 94 
 
 
unsaturated ring systems 
   
P44Ad 
(or D) 
(20) 
 
 
simple unsaturated ring 
systems, with at least 7 
atoms 
 
The ring has to be at least 7 atoms 
long, including the DB and no 
further activating groups (e.g. 
carbonyl) should be near the DB. 
7, 94 
0 E50 
 
P44Ad 
(or D) 
(21) 
 
 
dibenzazepineand related 
Y = O, S, N 
  
P44Ad 
(or D) 
(22-23) 
 
bicyclo hexenes 
 
 
  
P44Ad 
(or C/D) 
(6/5) 
(24) 
 
2,5-dihydrofuran 
R  = H, C, e.g. cassis 94 
P44Ad 
(or C/D) 
(7/6) 
(25) 
 
octahydronaphthalene, 
e.g. bosivelone 94, 95 
P46     
P46Ca 
(1-6) 
 
thiophosphate esters* 
Y = O, S After hydrolysis a free SH-group 
becomes available. Thiophosphate 
esters differ in this regard from 
phosphate esters, which are 
primarily not sensitizing (in this 
data set). 
 
P46Cb 
(7) 
 
silyl thioethers 
 
 
 R = O, C or Car  
41
E51 
 
5 SNAr Domain   1, 2, 6 
51 
 
Activated (hetero)aromatic systems 
 Q can be in ring (heteroaromatic) 
or as C-Q be attached to the ring 
 
51A 
(or Aa) 
(1-2601) 
 
ortho-para activated aromatic systems 
X = F, Cl, Br, I, 
S(=O)(=O)OR, C#N, N=NR, 
mesylates, tosylates 
 
Q = F, Cl, Br, I, N(=O)O, 
N=O, N+(C)(C)C, 
S(=O)(=O)C, S(=O)(=O)N, 
S(=O)=O, S(=O)(=O)O; C#N, 
C(F)(F)F, C=O, C(=O)C, 
C(=O)OC, C(=O)OH 
Screening: X = all, Q = all 
Special case*: Car-I+-Car  
 
High performance: at least one 
strong activating group and one 
other (strong = N(=O)O, N=O, 
N(C)(C)C, S(=O)(=O)C, 
S(=O)(=O)N, S(=O)=O, 
S(=O)(=O)O; C#N, C(F)(F)F; 
moderate=C(=O)OH, C(=O)OC, 
C(=O)C,C=O), weak: F, Cl, Br, I) 
 
An ortho-ortho-activation is also 
conceivable, however, only one 
additional non-sensitiser is found if 
this is applied (-> screening only). 
3, 4, 5, 8, 10, 
11, 26, 76,  
77, 78, 79, 
93, 100 
51B  
(or Ab)  
(1-41) 
 
para activated aromatic systems 
a) X = F, Br, I 
 
Q = N(=O)O, N=O,  
N+(C)(C)C, S(=O)(=O)C, 
S(=O)(=O)N, S(=O)=O, 
S(=O)(=O)O; C#N, C(F)(F)F, 
C=O, C(=O)C, C(=O)OC,  
C(=O)OH 
 
b) X = Cl 
 
Q = N(=O)O, C(F)(F)F 
In case of the aromatic system Cl 
is a much worser leaving group 
than the other halogens (Böhme, 
2016, personal communication) 
Screening alert only, due to too 
few substances and knowledge 
gaps. 
 
42 E52 
 
51 
 
Activated hetero-aromatic systems 
 Q can be in ring (heteroaromatic) 
or as C-Q be attached to the ring 
 
51C-F 
(or Acdef) 
(1-288) 
 
activated heteroaromatic systems 
X = F, Cl, Br, I, 
S(=O)(=O)OR, C#N, 
mesylates, tosylates 
 
Q = F, Cl, Br, I , N(=O)O, 
N=O, N+(C)(C)C, 
S(=O)(=O)C, S(=O)(=O)N, 
S(=O)=O, S(=O)(=O)O; C#N, 
C(F)(F)F, C=O, C(=O)C, 
C(=O)OC,  C(=O)OH 
Screening: X = all, Q = all 
 
Pyridines with strong activating 
group 
 
High performance: only 
pyrimidines, triazines 
 
Also the respective ortho ortho 
molecules are conceivable, but do 
not add additional value to the 
model (-> screening only) 
4, 5, 6, 8, 10, 
80 
51G  
(or Ag)  
(1-4)  
 
 
halo imidazoles, including halo-purines 
 
 
X = F, Cl, Br, I 
 
halo purine 
100 
6 No classical domain/ mechanism    
61A 
(or Aa) 
 
t-butyl hydroperoxides 
  Hydroperox. 
discussed: 
50 62, 71, 
74, 81, 82, 
83, 84, 85, 
93, 94 
43
E53 
 
61B 
(or Ab) 
 
alpha aromatic (hydro)peroxides 
 R = benzyl, H  
61C 
(or Ac) 
 
ring peroxides 
 Screening only, cf. Annex E.10  
62A 
(1-9) 
 
aromatic 1,1,1-trihalogen-compounds* 
X = Cl, Br, I SN2 possible, but SN1 also 
plausible. 
86 
 
63A 
(or Aa) 
(1-9) 
2
1
 
para halo phenols, annilines and toluenes 
Y1 = Cl, Br, I 
 
Y2 = OH, CH3, NH2 
 6, 12, 87, 88 
63B 
(or Ab) 
(1) 
 
meta NH2 pyridines 
Y = NH2 Investigations have to be made, if 
also other Y are possible, but were 
negative. 
 
63C 
(or Ac) 
(1) 
 
ortho NH2 pyridines 
Y = NH2 Investigations have to be made, if 
also other Y are possible, but were 
negative. 
 
44 E54 
 
64A 
(1-4) 
 
2,2,6,6-tetramethylpiperidines and 8-
azabicyclo[3.2.1]octanes as nitroxide 
radical precursors* 
Y = C, O, H R = any 
Also 
 
89 
65A 
 
phospines and related compounds 
 R  = C or Car, O, S 89 
90 
66A 
 
Clotrimazole* 
 R= Ph 17, 89 
67A 
 
bis(dimethyl-amino)methylenes 
 R = any non H atom  
 
45
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E.9 Performance of the Individual (Sub)Alerts 
Meaning of the used colors:  domain, alert class, alert, subalert; test system difference,  
screening alert only,  performance modification for the line above (in HR model)
Alert ID/Name LLNAa GPTa Alert 
Reliabilityb 
(Mekenyan
2014) 
Comments 
(a,b – see end of table) 
1 Acylation 
Screening 
40/48 
(83%) 
56/60 
(93%) 
  
1 Acylation  
HR both 
38/42 
(90%) 
53/55 
(96%) 
 With performance 
modifications 
1 Acylation  
HR for LLNA 
46/50 
(92%) 
56/70 
(80%) 
 With salicylates and cyclic 
anhydrides 
11 28/36 47/59   
11A 26/34 45/58   
a-F   4  
a-Cl 9/10 4/4 1  
a-Br   4  
a-I   4  
     
a-NNN   4  
a-OC(=O)R   4  
a-OOR 4/5 4/6 1  
a-O-Ph 6/11 25/27 1 2 or  
a-O-Ph performance 
modification for HR 
 4/5 22/22 1 Exclusion of O-Ph-Acetates 
and compounds with para 
OH/OC and carboxy-groups 
(cf. Roberts et al. 2007b) 
a-S-Ph   4  
a-SC 1/2 1/1 3  
b-Ph with ortho OH 4/4 0/8 3 Probablec LLNA-GPT-
difference 
b-O-Ph 1/1 7/7 1 Activating groups at phenyl 
important. (cf. Roberts et al. 
 2007b)
c-O 0/0 1/1 3  
c-S 0/0 3/3 3  
b-O-Succ 3/3 0/0 3 Succinimidyl esters and 
carbonates, two with other 
alerts, thus only one 
completely new 
c-TFP   4 TFP-esters 
c-SDP   4 
 
SDP-esters 
11B 2/2 2/2 3  
a-F   4  
a-Cl 2/2 2/2 3  
a-Br   4  
a-I   4  
47 E57 
 
     
a-NNN   4  
11C 1/1 0/0 3 Y = O,  none with Y = S 
a-F   4  
a-Cl 1/1 0/0 3  
a-Br   4  
a-I   4  
     
a-NNN   4  
12 5/5 13/15   
12A 5/5 13/15 1  
a-NC 1/1 1/2 3  
a-O 3/3 10/11 1  
a-S 1/1 2/2 3  
b-O   4  
12B   4  
X = S-C   4  
13 20/21 7/11   
13A 1/1 0/0 3  
Y = O 1/1 0/0 3  
Y = S   4  
13B 3/4 2/2 3 Y = O, none with Y = S 
lactams 2/3 2/2 3  
lactones 1/1 0/0 3  
thiolactams/-ones   4  
13C 10/10 1/1 1 X,Y1 = O, none with X,Y1 = S 
 
Y2 = N 8/8 1/1 1  
Y2 = Car 2/2 0/0 3 The C between Y2 and C=Y1 
should not contain a big 
residue (e.g. Ph) otherwise 
steric hindrance occurs 
(negative GPT data). 
Y2 = C   4  
13D 1/1 0/0 3 Y1 = O, none with Y1 = S 
Y2 = N 1/1 0/0 3  
Y2 = C   4  
13E 1/1 0/0 3 Y = O, none with Y = S 
13F 4/4 3/7 3  or 2 Probable LLNA-GPT-
difference 
Y1 = O, none with Y1 = S 
X = O 4/4 3/7 3  or 2  
X = S   4  
P1 Pre/pro-
Acylation 
Screening 
4/5 
 (80%) 
2/5 (30%)   
P1 Pre/pro-
Acylation  
HR 
3/3 
(100%) 
0/0 (0%)   
 
 
48
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P11A 2/2 1/3 3  
P11A1-6   4  
P11A7-15 1/1 1/3   
R = C 0/0 1/3 3 1,1,1-tri-haloalkanes 
 
Only X = Cl in data base, 
positive result is a complex 
substance. Should be used for 
screening only until further 
evidence is available. 
  
R = X 1/1 0/0 3 1,1,1-1- tetra-haloalkanes 
Only X = Cl in data base. 
  
P12A 2/3 1/3 3  
P12Aa1   4  
P12Aa2 1/2 1/3 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
P12Aa3   4  
P12Ab4   4  
P12Ac5 1/1 0/0 3  
2 Michael 
acceptors 
Screening 
76/101 
(75%) 
 47/75 
(63%) 
  
2 Michael 
acceptors HR for 
LLNA 
68/75 
(91%) 
32/47 
(68%) 
 With performance 
modifications, e.g. without 
methyacrylates. 
2 Michael 
acceptors  HR for 
GPT 
60/66 
(91%) 
30/39 
(77%) 
 taking out ketones with 
alkylated alpha C. 
21A 71/96 40/67 1  
Q = C(=O)H 17/18 4/5 1  
Q = C(=O)C 23/26 5/13 1  or 2  
Q = C(=O)C, 
performance 
modification for HR 
GPT 
15/17 3/5  Without alkyl at alpha C 
Q = C(=O)OH 1/5 2/4 2 Low performance and only 
weak reactivity from a 
chemical perspective. Should 
be used for screening only 
until further evidence is 
available. 
Q = C(=O)OC 22/31 26/40 1  
Q = C(=O)OC, 
performance 
modification for HR 
both 
16/19 16/21 1 Without alkyl at alpha C 
(methacrylates) 
Q = C(=O)SC 0/1 0/0 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
Q = C(=S)OC   4  
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Q = C(=O)NH2 2/8 2/3 2 Low performance and only 
weak reactivity from a 
chemical perspective. Should 
be used for screening only 
until further evidence is 
available. 
Q = N(=O)O   4  
Q = N=O   4  
Q = C#N 0/2 1/1 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
Q = N=OR 4/4 0/0 3  
Q = OS(=O)(=O)OR   4  
Q = S(=O)(=O)OR 1/1 0/0 3  
Q = S(=O)(=O)R 1/1 0/0 3  
Q = S(=O)R   4  
Q = 2-Pyridine    4  
Q = 4-Pyridine 1/1 0/0 3  
Q = Pyrimidine   4  
Q = Triazine   4  
22A 2/2 0/0 3  
Q = C(=O)H   4  
Q = C(=O)C   4  
Q = C(=O)OH   4  
Q = C(=O)OC 2/2 0/0 3  
Q = C(=O)SC   4  
Q = C(=S)OC   4  
Q = C(=O)NH2   4  
Q = N(=O)O   4  
Q = N=O   4  
Q = C#N   4  
Q = N=OR   4  
Q = OS(=O)(=O)OR   4  
Q = S(=O)(=O)OR   4  
Q = S(=O)(=O)R   4  
Q = S(=O)R   4  
Q = 2-Pyridine    4  
Q = 4-Pyridine   4  
Q = Pyrimidines   4  
Q = Triazins   4  
23 2/2 4/4   
23A 2/2 4/4 3  
Q1 = C(=O) 
Q2 = C(=O) 
1/1 2/2 3  
Q1 = C(=O) 
Q2 = C(=N) 
  4  
Q1 = C(=O) 
Q2 = O 
0/0 1/1 3  
Q1 = C(=O)   4  
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Q2 = N 
Q1 = C(=O) 
Q2 = C(=C) 
0/0 1/1 3  
Q1 = C(=O) 
Q2 C(CH2CH=CH2 
  4  
Q1 = C(=N) 
Q2 = C(=O) 
  4  
Q1 = C(=N) 
Q2 = C(=N) 
1/1 0/0 3  
Q1 = C(=N) 
Q2 = O 
  4  
Q1 = C(=N) 
Q2 = N 
  4  
Q1 = C(=N) 
Q2 = C(=C) 
  4  
Q1 = C(=N) 
Q2 C(CH2CH=CH2 
  4  
23B   4  
Q1 = C(=O) 
Q2 = C(=O) 
  4  
Q1 = C(=O) 
Q2 = C(=N) 
  4  
Q1 = C(=O) 
Q2 = O 
  4  
Q1 = C(=O) 
Q2 = N 
  4  
Q1 = C(=O) 
Q2 = C(=C) 
  4  
Q1 = C(=O) 
Q2 C(CH2CH=CH2 
  4  
Q1 = C(=N) 
Q2 = C(=O) 
  4  
Q1 = C(=N) 
Q2 = C(=N) 
  4  
Q1 = C(=N) 
Q2 = O 
  4  
Q1 = C(=N) 
Q2 = N 
  4  
Q1 = C(=N) 
Q2 = C(=C) 
  4  
Q1 = C(=N) 
Q2 C(CH2CH=CH2 
  4  
24 2/2 1/2   
24A 1/1 1/1 3  
Q = C(=O) 1/1 1/1 3  
Q = S(=O)   4  
Q = S(=O)(=O)   4  
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24B 0/0 0/1 3  
Q = C(=O) 0/0 0/1 3 R was just H 
 
Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
Q = S(=O)   4  
Q = S(=O)(=O)   4  
24C 1/1 0/0 3  
24C1 1/1 0/0 3  
P2 Pre/pro-Michael 
acceptors 
Screening 
103/116 
(89%) 
63/87 
(72%) 
  
P2 Pre/pro-Michael 
acceptors HR both 
100/101 
(91%) 
61/79 
(77%) 
  
P21 6/9 4/10 1   or 2  
P21A 6/9 4/10 1   or 2  
a-Q = COH 2/2 2/4 3  
a-Q = CNH2     
a-Q = CH2OCH3 1/1 0/0 3  
a-Q = COS(=O)OR     
b-sulphone-sulphate 0/0 1/4 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
c-furans 2/4 0/1 3 Alert is derived from metabolic 
activation of mutagens and 
should be used for screening 
only until further evidence is 
available. 
c-thiophens 1/2 1/1 3 Alert is derived from metabolic 
activation of mutagens and 
should be used for screening 
only until further evidence is 
available. 
P22 1/1 1/2   
P22A 1/1 1/2 3  
Q = COH 1/1 0/1 3  
Q = CNH2   4  
Q = CH2OCH3   4  
Q = COS(=O)OR 0/0 1/1 3  
P23 91/101 52/66 1  
P23A 46/50 36/38 1  
Q1 = NH2  
Q2 = all below 
15/17 11/12   
Q2 = NH2  6/6 5/5 1  
Q2 = NHR 4/6 2/3 1  or 3  
Q2 = NR2 3/3 2/2 3  
Q2 = N=N 2/2 2/2 3  
Q1 = OH 
Q2 = all below 
19/21 14/15   
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Q2 = NH2 3/3 1/2 3  
Q2 = NHR 2/3 3/3 3  
Q2 = OH 2/3 1/1 3  
Q2 = OCH3 0/0 1/1 3  
Q2 = OCH2CH3 0/0 1/1 3  
Q2 = CH3 2/2 4/4 3  
Q2 = CH=CHCH3 5/5 1/1 3  
Q2 = CH2CH=CH2 4/4 1/1 3 All have also ortho-quinone 
alerts 
Q2 = N=N-Ph    4  
Q2 = N(=O)O 4/4 2/2 3  
Q2 = Ph 1/1 0/0 3  
Q2 = C=CPh 0/0 1/1 3  
Q1 = OCH3 
Q2 = all below 
2/2 2/2   
Q2 = NH2   4  
Q2 = CH=CHCH3 1/1 1/1 3  
Q2 = CH2CH=CH2 1/1 1/1 3  
Q1 = N(=O)O 1/2 1/4 3 Very hard to differentiate from 
other, in particular substances 
have ortho quinone alerts 
Q2=  all below     
Q2=  NR2   4  
Q2=  NHR 0/1  1/3 3  
Q2=  NH2  1/1 0/1 3  
Q1 = NR2 2/2 1/1 3  
Q2=  H     
Q2=  H 2/2 1/1 3  
Q =
 
1/1 1/1 3  
Q =
 
1/1 1/1 3  
Q1 = N-Ph 3/4 7/8 1  
Q2=  all below     
NHR 2/3 5/5 1  or 3  
NH2 1/1 2/3 3  
P23B 56/63 22/32 1  
Q1 = NH2  
Q2 = all below 
3/3 2/2   
Q2 = NH2  2/2 1/1 3  
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Q2 = NHR 0/0 1/1 3  
Q2 = NR2   4  
Q2 = N=N 1/1 0/0 3  
Q1 = OH 
Q2 = all below 
39/43 16/21   
Q2 = NH2 5/5 1/1 1  
Q2 = NHR 1/1 1/1 3  
Q2 = OH 11/11 6/8 1  
Q2 = OCH3 11/11 5/5 1  
Q2 = OCH2CH3 1/1 1/1 3  
Q2 = CH3 7/9 2/4 1   or 2  
Q2 = CH=CHCH3   4  
Q2 = CH2CH=CH2   4  
Q2 = N=N-Ph  1/1 0/0 3  
Q2 = N(=O)O 3/4 2/2 3  
Q1 = OCH3 
Q2 = all below 
4/6 2/3   
Q2 = NH2   4  
Q2 = CH=CHCH3   4  
Q2 = CH2CH=CH2   4  
Methylene-
dioxyphenyl 
4/6 1/2 3 1 or Positive substances have 
other alerts (but also one with 
just this group) 
tetrahydro-
quinoxaline 
0/0 1/1 3  
Q1 = N(=O)O 8/10 2/6 1  or 2 Possible LLNA-GPT-
Difference, but just three GPT 
examples, not taken into 
account right now. 
(some substances also include 
 other pre/pro-MA alerts)
Q2=  all below     
Q2=  NR2 1/1 0/1 3  
Q2=  NHR 6/8 1/2 1  or 3  
Q2=  NH2  7/9 2/5 1  or 2 (several substances also 
include other pre/pro-MA 
alerts) 
Q1 = N-Ph 2/2 0/0 3  
Q2=  all below     
NHR 1/1 0/0 3  
NH2 1/1 0/0 3  
P23C 8/8 3/5 1  
Q1 = NH2  
Q2 = NH2 
3/3 0/2 3  
Q1 = OH 
Q2 = NH2 
2/2 2/2 3  
Q1 = OH 
Q2 = OH 
3/3 1/1 3  
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P24 5/6 6/7 1  
P24D 3/4 2/2 3  
Q = NH2 0/0 1/1 3  
Q = OH 2/2 0/0 3  
Q = OH, R = CH3 1/2 1/1 3  
P24E 2/2 4/5 1  
Q = NH2   4  
Q = OH 2/2 4/5 1  
Q = OH, R1 = CH3   4  
P25 2/2 1/2 3  
P25A 2/2 1/2 3  
a) Y1=any, Y2=OH 2/2 1/2 3  
a) Y1=any, 
Y2=OCH3 
  4  
b) Y1=OH, Y2=H   4  
b) Y1=OCH3, Y2=H   4  
c) Y1=H, Y2=H   4  
3 Schiff base 
formers Screening 
70/98 
(71%) 
29/41 
(71%) 
  
3 Schiff base 
formers HR both 
66/77 
(86%) 
24/29 
(79%) 
  
31 44/51 18/22   
31A 44/51 18/22 1  
a-X = O 29/33 16/20 1  
a-X = S   4  
a-X = NC 3/3 0/0 3  
a-X = O (b-blocked 
double bond at R) 
6/6 2/2 1  
31B 6/9 0/0 1  
b-All aromatic 
aldehydes 
9/20 2/6 2 Y1, Y2, Y3 = any 
b-performance 
modification for HR 
(Hammett-values) 
6/9 0/0 1  
32 26/36 9/12   
32A 16/18 3/3 1  
Q = C(=O)C 8/10 1/1 1  
Q = C(=O)OH 2/2 1/1 3  
Q = C(=O)OC 1/1 1/1 3  
Q = N(=O)O   4  
Q = N=O   4  
Q = N+(C)(C)C   4  
Q = S(=O)O   4  
Q = OS(=O)O   4  
Q = C#N   4  
Q = P=O 2/2 0/0 3  
Q = S=O   4  
Q = C(=O)NR2 1/1 1/1 3  
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32B 10/18 6/9 1  or 2  
a-Q = C(=O)C 
 
9/15 3/6 1  or 2  
a-Q = C(=O)C 
performance 
modification for HR 
both 
9/11 0/1 1 Without R = Car at both 
carbonyls and without 
carbonyls as part of a ring. 
a-Q = C(=O)OC 1/6 0/1 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
a-Q = C(=O)OH 0/0 0/0 4 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
b-Tauromere 
(ex32C) 
0/0 3/3 3  
P3 Pre/pro-Schiff 
base formers 
Screening 
30/46 
(65%) 
29/52 
(56%) 
  
P3 Pre/pro-Schiff 
base formers HR 
both 
26/31 
(84%) 
26/36 
(72%) 
 With performance 
modifications 
P3 Pre/pro-Schiff 
base formers HR 
for LLNA 
32/37 
(86%) 
28/46 
(61%) 
 With performance 
modifications and tertiary 
amines. 
P31 18/23 13/25 1 (with tertiary amines) 
P31A 17/21 
33/44 
13/25 
29/51 
1  
a-allyl alcohols 3/4 1/1 3  
b-ortho-hydroxy-
benzyl-alcohols 
1/2 0/0 3  
c-primary amines 7/10 10/14 1  
c-secondary amines 1/1 0/0 3  
c-tertiary amines 7/7 4/13 1  or 2 With primary amines (allowed 
as additional groups in the 
compounds). Probable LLNA-
GPT difference. 
 6/6 2/10  Without primary amines. 
Probable LLNA-GPT 
difference. 
d-benzyl amines   4  
e-both X: 5/5 9/11 1  
e-X = NH2 4/4 8/9 1  
e-X = OH 2/2 2/3 3  
f-both X: 4/9 6/13  Low performance without 
modifications 
f-X = NR 1/3 5/7 1  
f-performance 
modification for HR 
1/1 5/6 1 R not Car or C(=O) 
 
 
f-X = O 3/6 1/6  Low performance and few 
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substances. Should be used 
for screening only until further 
evidence is available. 
f-Possible 
performance 
modification for HR 
2/3 0/0 3 Only C(=O) as R at N. 
However, only few substances 
left after many exclusions. 
Should be used for screening 
only until further evidence is 
available. 
f-X = S   4  
exP34 8/11 5/11   
g-P34A 4/4 2/4 3  
g-P34B 1/4 0/0   
g-P34B(1) 0/3 0/0 3 For one substance positive 
human data are available (de 
Groot et al., 2010).  Right now 
the alert is used for screening 
only until further evidence is 
available. 
g-P34B(2) 1/1 0/0 3  
g-P34C 3/3 1/1 3  
g-P34D 0/0 1/2 3 Positive human evidence for 
the negative substance 
available (de Groot et al., 
2010). 
g-P34E   4  
g-P34E(1)   4  
g-P34E(2)   4  
g-P34F 0/0 1/4  The alert is derived from 
aquatic toxicity and has a low 
performance. Thus it should be 
used for screening only, until 
further evidence is available. 
g-X = OH  0/0 0/1 3  
g-X = NHPh   4  
g-X = OC(=O)CH3 0/0 1/2 3  
     
P32 2/5 1/5 3  
P32A 2/5 1/5 3  
a-thiazoles 1/4 1/5 3 Alert is derived from metabolic 
activation of mutagens and 
should be used for screening 
only until further evidence is 
available. 
b-Y = NH2 1/1 0/0 3  
b-Y = (=O)   4  
P32B   4  
Y = NH2   4  
Y = (=O)   4  
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4 SN2 Screening 
 
130/164 
(79%) 
54/96 
(56%) 
 With vinyl/benzyl acetates 
4 SN2 HR for LLNA 128/149 
(86%) 
52/82 
(63%) 
 With vinyl/benzyl acetates 
and with performance 
modifications 
4 SN2 HR for GPT 112/132 
(85%) 
45/62 
(73%) 
 Without vinyl/benzyl 
acetates  and thiols and with 
performance modifications 
41 24/28 10/23   
41A 8/9 5/8 1  
a-Q = C=C   4  
a-Q = C#C   4  
a-Q = Ph (X = Cl, Br) 3/3 1/1 3  
a-Q = C(=O)C (X = 
Cl) 
1/1 1/1 3  
a-Q = C(=S)C   4  
a-Q = C(=O)O (X = 
Cl, Br, 
OS(=O)(=O)C) 
1/3 1/1 3 2x ester 2x acid, negative are 
Cl and OS(=O)(=O)C, Br 
positive 
a-Q = C(=S)O   4  
a-Q = C(=O)N (X = 
Cl, SO3) 
2/2 1/2 3  
a-Q = C(=S)N    4  
a-Q = OC   4  
a-Q = OC(=O)O   4  
a-Q = N(=O)O (X = 
Br) 
0/0 1/2 3  
a-Q = C#N (X = Br) 1/1 0/1 3  
41B 11/14 4/13 1 or 2  
b-Q = C=C 6/8 2/8 1  or 2 ProbableLLNA-GPT-
Difference  
b-Q = C#C   4  
b-Q = Ph 5/6 2/4 1  or 3 Possible LLNA-GPT-
Difference 
c-X = phenolate 5/5 1/2 1  or 3  
42 4/5 5/5 1  
42A 4/5 5/5 1  
X = Cl 4/5 4/4 1  
X = Br 0/0 1/1 3  
X =  I   4  
X = NN   4  
X = OS(=O)(=O)OC 
or Car 
  4  
X = OS(=O)(=O)C or 
Car 
  4  
43 1/1 0/0 3  
43A 1/1 0/0 3  
X = Cl   4  
X = Br   4  
X =  I 1/1 0/0 3  
X = NN   4  
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X = OS(=O)(=O)OC 
or Car 
  4  
X = OS(=O)(=O)C or 
Car 
  4  
44 27/32 14/17   
44A 26/31 14/17 1  
X = O 26/31 14/17 1  
X = S   4  
X = N   4  
44B 1/1 0/0 3  
X = O 1/1 0/0 3  
X = S   4  
45 0/6 1/5 2  
45A 0/2 1/3 2  
X = Cl 0/2 0/1 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
X = Br 0/0 1/2 3  
X = I   4  
45B 0/4 0/2 3  
X1 = Cl, Br, I, X2 = N   4  
X2 = Cl, Br, I, X2 = S   4  
X1 = Cl, X2 = OH 0/2 0/2 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
X1 = Br, I, X2 = OH   4  
X1 = Cl, X2 = OC 0/2 0/0 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
X1 = Br, I, X2 = OC   4  
46 81/103 27/53  Without log Kow for 45A 
46A 39/58 5/20 1 or 2 Without log Kow 
X = Cl 5/12 2/13 2 Without Kow Screening only 
(other halogen related alerts 
were excluded beforehand) 
If log Kow > 3.5 4/5 0/2 1  
X = Br 19/25 2/4 1 Without Kow Screening only 
(other halogen related alerts 
were excluded beforehand) 
If log Kow > 2.5 18/21 2/3 1  
X = I 5/8 0/1 1 Without Kow Screening only 
(other halogen related alerts 
were excluded beforehand) 
If log Kow > 2.5 5/7 0/0 1  
     
X = NNN   4  
X = OS(=O)(=O)OC 2/2 0/0 3  
X = CS(=O)(=O)OC 8/12 1/2 1  
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X = PO3 0/1 0/1 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
X = PO4 1/3 3/7 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
46B 3/3 0/0 3  
X = N=O 3/3 0/0 3  
X = OC(=O)C   4  
46C 32/35 17/27 1  
a-Thiols 11/11 5/9   
Thiols 6/6 3/7 1 or 2 Including non C-SH (e.g. P-
SH) 
Possible LLNA-GPT-
Difference. 
Y1 = C, Y2 = O 0/0 1/1 3  
Y1 = N, Y2 = O   4  
Y1 = O, Y2 = O   4  
Y1 = S, Y2 = O   4  
Y1 = C, Y2 = S   4  
Y1 = N, Y2 = S 4/4 1/1 3  
Y1 = O, Y2 = S 1/1 0/0 3  
Y1 = S, Y2 = S   4  
b-Disulphids and 
related 
15/16 8/10   
X = SR 7/8 2/4 1  
X = S(=O)C   4  
X = S(=O)(=O)C   4  
X = S(=O)(=O)OC   4  
X = Cl   4  
X = Br   4  
X = I   4  
X = C#N 3/3 0/0 3  
Thio-Phthalimine 1/1 1/1 3  
Isothiazol-3-ones,  4/4 4/5 1  
Isothiazolin-3-ones   4  
c-Aromatic-
sulphonic-acids 
  4  
Aromatic-sulphonic-
acids 
  4  
d-Thions 6/8 7/10  Including CS2 
Y1 = N, Y2 = N 2/3 3/4 3  
Y1 = S, Y2 = N 2/3 1/1 3  
Y1 = O, Y2 = N   4  
Mercaptobenzothiaz
ols (all  3 together) 
2/2 3/5 3 Negative GPT data are 
positive in human. GPT not 
sensitive enough? 
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46D-G 1/1 1/1 3  
N-halo-
sulphonamides  
1/1 1/1 3 (X = Cl) 
N-halo-imides   4  
46H 5/5 0/1 1  
Sn 5/5 0/1 1  
Hg   4  
Pb   4  
     
P4 Pre/pro-SN2 
Screening 
59/98 
(87%) 
11/21 
(52%) 
  
P4 Pre/pro-SN2  
HR 
59/98 
(87%) 
11/21 
(52%) 
  
P44 57/66 9/18   
P44A-a 3/3 0/0 3 Both alerts have an overlap. 
a) 2/2 0/0 3  
b) 3/3 0/0 4  
P44A-b 22/24 3/7 1  
vinyl phenyls 1/1 0/0 3  
2-pyridine   4  
4-pyridine 1/1 0/0 3  
Pyrimidine   4  
Triazine   4  
Michael acceptor 
aldehydes with 
blocked β-carbon 
5/5 2/2 3  
Michael acceptor 
ketones with blocked 
β-carbon 
3/3 0/3 3 Possible LLNA-GPT-
Difference, but just three GPT 
examples, not taken into 
account right now 
Pre/pro Michael 
acceptor alcohols 
with blocked β-
carbon 
3/4 1/1 3  
Oximes 5/5 0/0 1  
Peonile 2/2 0/1 3  
Methoxy alkenes 2/3 0/0 3  
P44A-c 23/29 4/7 1 or 2  
 
11/13 1/3 1  
 
2/3 1/1 3  
 
3/3 0/0 3  
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5/8 0/0 1  
 
7/8 2/3 1  
 
 
 
 
 
P44A-d 10/12 1/3 1 Possible LLNA-GPT-
Difference, but just three GPT 
examples, not taken into 
account right now. 
unsaturated ring 
systems, with at 
least 7 atoms 
5/5 0/2  3 1 or Possible LLNA-GPT-
Difference, but just two GPT 
examples, not taken into 
account right now. 
Dibenzazepine and 
related 
0/0 1/1 3  
Bicyclo compounds 2/3 0/0 3+3 Two subalerts 
2,5-dihydrofurans 1/1 0/0 3  
Octahydronaphthale
nes 
1/2 0/0 3  
 
P45 2/2 2/3   
P45C 2/2 2/3 3  
(thio)phosphates,  
Y = S 
1/1 1/1 3  
(thio)phosphates,  
Y = O 
0/0 1/2 3  
C-S-Si 1/1 0/0 3  
 
5 SNAr Screening 28/34 
(82%) 
4/13 
(31%) 
 Theoretical alerts not listed. 
For a description see 
corresponding alert table 
5 SNAr HR 22/23 
(96%) 
3/7 (43%)  Theoretical alerts not listed. 
For a description see 
corresponding alert table 
51A Screening: all 
activating groups 
14/16 3/9 1  
51 HR 10/10 2/4 1  
51 HR1  10/10 2/3 1 two strong activating group 
51 HR2 2/2 0/1 3 one very strong activating 
group and one halogen 
51B 4/5 0/0 3 Screening only due to 
uncertain state of knowledge 
(possibly overfitted). 
X = F, I, Br 2/3 0/0 3  
X = Cl 2/2 0/0 3  
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51C-F-Screening: 
all 
9/12 1/4 1  
 
Pyridines 2/5 0/1 3 Low performance and few 
substances. Should be used 
for screening only until further 
evidence is available. 
Pyrimidines 4/4 1/1 1  
Triazines 3/3 0/2 3  
51G 1/1 0/0 3  
X = Cl 1/1 0/0 3  
 
6 special Screening 53/59 
(90%) 
32/50 
(64%) 
  
6 special HR 53/59 
(90%) 
31/47 
(66%) 
  
61 3/3 2/2 3  
     
61A 1/1 1/1 3  
61B 0/0 1/1 3  
61C 2/2 0/0 3  
62A 3/3 0/0 3 X = Cl 
62A 3/3 0/0 3 X = Cl 
63 26/30 14/20   
63A 10/11 7/9 1 Y1 = Cl, Statistic without 
aromatic aldehydes (Schiff 
bases) 
Y2 = OH 7/8 3/4 1 Y1 = Cl, Br (one Br substance) 
Y2 = CH3 1/1 2/2 3 Y1 = Cl 
Y2 = NH2 2/2 2/3 3 Y1 = Cl 
63B 3/3 0/0 3  
63C 2/3 1/2 3  
64A 4/4 3/8 2 or 3  
64A1 
Y = C, O, H all 
included 
1/1 3/8 3 or 2 Possible LLNA-GPT-
Difference, but just one LLNA 
examples, not taken into 
account right now. 
64A4 3/3 0/0 3  
65A 4/5 2/5 1  
66A 1/1 0/0 3  
67A 1/1 0/0 3  
 
  
63 E73 
 
a (number of correctly predicted compounds)/(total number of hits in training set) 
b Mekenyan OG, Patlewicz GY, Kuseva C, Popova I, Mehmed A, Kotov S, Zhechev T, Pavlov T, 
Temelkov S, Roberts DW 2014. A mechanistic approach to modelling respiratory sensitization. Chem. 
Res. Toxicol. 27: 219-239. Excerpt from the relevant section of the paper: 
“The specific reliability thresholdsapplied […] are as follows:  
(1) high performance alert based on performance ≥60%; n ≥5, mechanistic justification availability;  
(2) low performance alert based on performance ≤60%; n ≥5, mechanistic justification availability;  
(3) undetermined alerts based on n < 5 mechanistic justification availability but does not take into 
account the performance; and 
(4) undetermined theoretical alerts based on mechanistic justification of the toxic end-point. 
 
Alert reliability for the alert epoxides, aziridines, and sulphuranes as shown in Table 17 is summarised 
as follows by way of an illustrative example: (1) the number of compounds in the local training set is 6; 
(2) 3 are active as parents (Table 18), and 3 are activated as a result of lung metabolism (Table 19). 
Correctly predicted compounds are as follows: 3 out of 3 respiratory sensitisers are correctly predicted 
as parents; 3 out of 3 respiratory sensitisers are correctly predicted as metabolites; and alert 
performance = (correctly predicted compounds)/(total number of compounds in training set) = 
6/6 = 100 %. (3) Mechanistic justification availability.” 
 
c probable/possible test system difference if n > 5 and performance < 50% in one system, but good in 
the other (defined by M. Hillebrand). 
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E.10. Structures for particular alerts as discussed in the main text
Figure 117: Three new (pro-)Michael acceptors. 1 3-methyl-4-phenyl-1,2,5-thiadiazole-
1,1-dioxide (LLNA+), 2 8-methoxy-1,6-octadiene (LLNA+), 3 2-(4-tert-
butylphenoxy)cyclohexyl prop-2-ynyl sulphite (LLNA+).
Figure 118: 1 4-phenylphenol (LLNA+) and 2 4-hydroxystilbene (GPMT+).
Figure 119: Methylene dioxyphenyls, 1 hydroxyethyl-3,4-methylenedioxyaniline (LLNA+), 2
alpha-methyl-1,3,-benzodioxole-5-propionaldehyde (LLNA+, also SB alert), 3
piperonal (LLNA+, also SB alert), 4 1,3-benzodioxazole-5-sulphonyl chloride
(LLNA+, also SN2 alert), 5 5-[2-(2-butoxyethoxy)ethoxy]methyl-6-propyl-
1,3-benzodioxole (LLNA-), 6 (4S,5R)-1-[(1R,2R,3S)-3-(1,3-benzodioxol-5-
yl)-1-(2-benzyloxy-4-methoxyphenyl)-1-hydroxy-6-propoxy-2-indanoyl]-3,4-
dimethyl-5-phenyl-2-imidazolidinone (LLNA-, stereochemistry not shown),
7 (3r,3as,6ar)-hexahydrofuro-[2,3-b]furan-3-yl [(1s,2r)-3-[(1,3-benzodioxol-
5-ylsulfonyl)(2-methylpropyl)-amino]-2-hydroxy-1-[[4-[(2-methyl-4-thiazolyl)-
methoxy]phenyl]methyl]-propyl]carbamate (LLNA-, stereochemistry not shown).
For metabolism no aldehyde group should be present as these are (likely)
preferred in metabolism as reasoned for other compounds in the main text (e.g.
vanillin).
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Figure 120: Diazo-phenyls in ortho position to hydroxy groups, which are both attached to a
naphthyl-ring. 1 Curry Red (LLNA-), 2 Pigment Red 57 (LLNA equivocal, GPT-),
3 Pigment Red 48 (LLNA-), 4 C.I. Acid Orange 7 (LLNA equivocal, GPT-), 5 Acid
Red 18 (LLNA equivocal, GPT-), 6 C.I. Pigment red 112 (LLNA-, GPT-), 7 1-[(2-
chloro-4-nitrophenyl)diazenyl]-2-naphthol (LLNA-), 8 Basic Brown 16 (LLNA+),
9 Red oil (D&C Red no. 17) (GPT+), 10 N,N’-(2,5-dichloro-1,4-phenylene)-
bis4-[(2,5-dichlorophenyl)diazenyl]-3-hydroxy-2-naphthamide (LLNA-), 11
N,N’-(2-chloro-1,4-phenylene)bis4-[(2,5-dichlorophenyl)diazenyl]-3-hydroxy-
2-naphthamide (LLNA-), 12 diisopropyl 3,3’-[(2,5-dichloro-1,4-phenylene)-
bis[iminocarbonyl(2-hydroxy-3,1-naphthylene)azo]]bis[4-methylbenzoate]
(GPT-).
Figure 121: 1,3-diketone tautomeres. 1 Lawsone (2-hydroxy-1,4-naphthoquinone) (GPT+),
2 dehydroacetate (GPT+), 3 bis[(2Z)-4-oxopent-2-en-2-olate] (GPT+).
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Figure 122: Thiazols. 1 Disperse Blue 106 (LLNA+), 2 1,1-dimethylethyl [(1S)-2-[4-[(2-
methyl-4-thiazolyl) methoxy] phenyl]-1-(2S)-oxiranylethyl]-carbamate (LLNA-,
stereochemistry not shown), 3 ethyl (Z)-alpha-((2-(tert-butoxy)-1,1-dimethyl-
2-oxoethoxy)imino)-2-(tritylamino)thiazol-4-acetate (LLNA-, stereochemistry
not shown), 4 4-nitrophenyl 1,3-thiazol-5-ylmethylcarbonate (GPT+), 5
5-thiazolylmethanol (GPT-), 6 (S)-2-amino-6-propionylamino-4,5,6,7-tetrahydro-
benzothiazole (GPT-, stereochemistry not shown), 7 (S)-2,6-diamino-4,5,6,7-
tetrahydrobenzothiazole (GPT-, stereochemistry not shown), 8 (E)-5-benzyl-1-
(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-N-nitro-1,3,5-triazinan-2-imine (GPT-,
stereochemistry not shown), 9 (3r,3as,6ar)-hexahydrofuro-[2,3-b]furan-3-yl
[(1s,2r)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)-amino]-2-hydroxy-1-
[[4-[(2-methyl-4-thiazolyl)methoxy]phenyl]methyl]-propyl]carbamate (LLNA-,
stereochemistry not shown).
Figure 123: Morpholines. 1 morpholine (GPT-), 2 4-methylmorpholine (GPT-), 3 4,4’-(oxy-
diethane-2,1-diyl)dimorpholine (GPT-), 4 3-(N-morpholino)propanesulfonic acid
(GPT-), 5 4-acetylmorpholine (LLNA+), 6 morpholine-4-carbaldehyde (LLNA+),
7 4-(4-aminophenyl)morpholin-3-one (LLNA-), 8 4-(4-Nitrophenyl)-morpholin-
3-on (LLNA-), 9 1,6-Bis[2,2-dimethyl-3-(N-morpholino)-propylideneamino]-
hexane (LLNA+), 10 hydroxyanthraquinone-aminopropyl methyl morpholinium
methosulfate (GPT+), 11 (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-
methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-
2,5-piperazinedione (LLNA-, stereochemistry not shown), 12 2-benzyl-2-di-
methylamino-4’-morpholinobutyrophenone (GPT-).
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Figure 124: Piperazines. 1 triforine (1,4-bis(2,2,2-trichloro-1-formamidoethyl)piperazine)
(LLNA+), 2 1,4-diazabicyclo [2.2.2]octane (GPT-), 3 N-[4-[4-[4-[[5-
(2,4-diﬂuorophenyl)tetrahydro-5-(1H,-1,2,4-triazol-1-yl-methyl)-furan-3-yl]-
methyloxy]phenyl]-1-piperazinyl]phenyl]-1-[1-ethyl-2-(phenylethoxy)propyl]-
hydrazinecarbonamide (LLNA-), 4 4-[4-[4-[(3R, 5R)[5-(2,4-diﬂuorophenyl)
tetrahydro-5-(1H-1,2,4-triazol-1-yl-methyl)-furan-3-yl]methyloxy]phenyl]-1-
piperazinyl]phenyl-2-[(1S,2S)(1-ethyl-2-phenylmethoxypropyl)]-2,4-dihydro-
3H-triazol-3-one (LLNA equivocal, stereochemistry not shown), 5 (+-)-2,4-di-
hydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-
1,2,4-triazol-3-one (GPT-, stereochemistry not shown), 6 N,N’-bis(2-amino-
ethyl)piperazine (BAPZ) (LLNA+), 7 N-(2-piperazin-1ylethyl)ethylenediamine
(EAPZ) (LLNA+), 8 2,2-bis([3-(4-ethylpiperazin-1-yl)propanoyl]oxymethyl)-
butyl 3-(4-ethylpiperazin-1-yl)propanoate (LLNA+), 9 N-(3-guanidino-4-
methyl-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide (GPT+), 10
N-(4-methyl-3-nitro-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide
(GPT+), 11 (2R,4S)-4-(4-acetyl-1-piperazinyl)-n-(1r)-1-[3,5-bis(triﬂuoro-methyl)-
phenyl]-ethyl-2-(4-ﬂuoro-2-methylphenyl)-n-methyl-1-piperidine-carboxamide
monomethane-sulfonate (LLNA-, stereochemistry not shown).
Figure 125: Phenoxyacetic acids and esters. 1 phenoxyacetic acid (LLNA+), 2 2,4,5-tri-
chlorophenoxyacetic acid (LLNA+), 3 allyl phenoxyacetate (LLNA+), 4 2-ethyl-
hexyl 2,4-dichlorophenoxyacetate (LLNA+), 5 heptan-2-yl [(5-chloroquinolin-8-
yl)oxy]acetate (LLNA+).
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Figure 126: Benzothiazols. 1 2-mercaptobenzothiazole (LLNA+, GPT+), 2 N-(1,3-benzo-
thiazol-2-ylsulfanyl)cyclohexanamine (GPT-, human+), 3 dibenzothiazyl disul-
ﬁde (MBTS) (LLNA+ GPT+), 4 n-tert-butyl-2-benzothiazolesulfenamide (LLNA
equivocal), 5 2-(morpholin-4-ylsulfanyl)-1,3-benzothiazole (LLNA+), 6 n,n-di-
cyclohexyl-2-benzothiazolessulfenamide (GPT-, human+).
Figure 127: Ring peroxides. 1 methylethylketone peroxide trimer (GPT+), 2 dibenzodioxocin
(LLNA+), 3 ascaridole (LLNA+).
Figure 128: 1 1-[bis(dimethylamino)methylene]-1H-benzotriazol-1-ium 3-oxide (LLNA+) and
2 clotrimazole (LLNA+).
Figure 129: Ortho and meta aminopyridines. Ortho: 1 2-amino-5-bromopyridin-3-ol
(LLNA+), 2 2-amino-3-hydroxypyridine (LLNA-, also MA alert conceivable), 3
2,6-diaminopyridine (LLNA+, also MA alert conceivable), 4 amoxanox (GPT+),
5 2,6-diamino-3-((pyridin-3-yl)azo)pyridine (GPT-). Meta: 6 3,5-diamino-2,6-
dimethoxypyridine (LLNA+, GPT equivocal), 7 6-methoxy-2-methylamino-3-
aminopyridine (LLNA+), 8 6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinamine (LLNA+).
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Figure 130: Perﬂuoro compounds. 1 tridecaﬂuorooctyl methacrylate (LLNA-, GPT-, MA
alert), 2 tridecaﬂuorooctyl acrylate (LLNA-, MA alert), 3 nonaﬂuorobutane-1-
sulfonyl ﬂuoride (LLNA-, sulphur SN2 alert), 4 tridecaﬂuorooctan-1-ol (LLNA-
), 5 bis(nonaﬂuorobutyl)phosphinic acid (LLNA-), 6 tetraﬂuoro-2-(heptaﬂuoro-
propoxy)propanoate (LLNA-), 7 nonaﬂuoro-4-(triﬂuoromethyl )-3-pentanone
(GPT-).
Figure 131: Steroids (for all stereochemistry not shown). 1 hydrocortisone (LLNA-
), 2 11,17,21-trihydroxypregna-1,4-diene-3,20-dione (LLNA-), 3 (16-b)-21-
(acetyloxy)-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione (LLNA-), 4
beclomethasone-17-monopropionate (LLNA-), 5 trienol (LLNA-), 6 estr-4-ene-
3,11,17-trione 3-(ethylene dithioketal) 17-(2,2-dimethylpropane-1,3-diyl ketal)
(LLNA-).
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F. Annex Consensus modelling
F.1. Demonstration of model independence with further structural alert
models.
The precondition for consensus modelling is the independence of the used submodels. This
was demonstrated in the main text for the read-across and combined structural alert model.
However, the latter submodel excludes a certain amount of compounds beforehand. There-
fore, it is sensible to check if the independence also holds if not the combined structural
alert model, but the screening and respective high resolution structural alert model are used
(which apply to all compounds, but introduce an additional number of false predictions). It is
important to keep in mind that the screening model bears an error to the positive side, while
the high resolution approaches tends towards more false negative predictions. The results
are depicted in table 57 and 58.
As to be expected the number of false positives goes up in the screening model (from 76
to 140 and 88 to 178 compounds in the LLNA and GPT, respectively), because it is build to
be (over)sensitive. Obviously, some of the false positive predictions are in common with the
read-across and others are not. Overall, an increase in the concordance is observed, which
is barely notable for the GPT (3%-points) and small for the LLNA (7%-points). However,
the overall concordance of 29% in the LLNA is still not high enough to prove a signiﬁcant
agreement.241 In addition, it is noted that the number of false negative predictions does
not change in both animal tests. This is reasonable, because the structural alert screening
approach differs from the combined model with regard to the false positives and not the false
negatives.242
For the high resolution structural alert models it is turned upside down. Because they are
optimised towards giving correct positive predictions (and not correct negative predictions)
the number of false negative rises (from 75 to 91 and 22 to 59 compounds in the LLNA
and GPT, respectively). This is associated with an increase in concordance, which is small
for the LLNA (5%-points) and notable for the GPT (about 10%-points).243 Still, the value of
22% concordance in both is not high enough to cause concern about the structural alert and
read-across model being dependent. Eventually, the conducted high resolution modiﬁca-
tions primarily concern the exclusion of low performing alerts.244 Thus, the number of false
positive stays the same as for the combined structural alert model (cf. main text).
241Further, this test tends to give more (false) positives in general due to its (over)sensitivity.
242This is, because low performing alerts are excluded in the high resolution model and, thus, the respective false
positives do not appear in the combined structural alert approach, while false negatives are left untouched
from the perspective of the screening model.
243In this case it is to note that the GPT tend to give more (false) negatives and, thus, this greater increase is in
line with the observed test system differences.
244Which are associated with false negative predictions and not with false positives.
F1
Table 57: False positive and negative prediction via read-across and structural alerts
(screening model) for LLNA and GPT data in comparison
LLNA RX FP LLNA RX FN
no yes total no yes total
SA
FP
no 0a 115 115 SA
FN
no 0a 108 108
yes 67 73 140 yes 44 31 75
total 67 188 255 total 44 139 183
cc 29% ↑↑ cc 17%
GPT RX FP GPT RX FN
no yes total no yes total
SA
FP
no 0a 51 51 SA
FN
no 0a 130 130
yes 128 50 178 yes 9 18 27
total 128 101 229 total 9 148 157
cc 22% ↑ cc 11%
a = for further explanation consult table 18 of the main text. FP = false positives, FN = false negatives, RX
= read-across, SA = structural alerts, cc = concordance, (↑)↑ = (strong) increase in comparison to main text.
Table 58: False positive and negative prediction via read-across and structural alerts (high-
performance models) for LLNA and GPT data in comparison
LLNA RX FP LLNA RX FN
no yes total no yes total
SA FP no 0a 140 140 SA
FN
no 0a 97 97
yes 28 48 76 yes 49 42 91
total 28 188 216 total 49 139 188
cc 22% cc 22% ↑
GPT RX FP GPT RX FN
no yes total no yes total
SA
FP
no 0a 71 71 SA
FN
no 0a 111 111
yes 58 30 88 yes 22 37 59
total 58 101 159 total 22 148 170
cc 19% cc 22% ↑↑
a = for further explanation consult table 18 of the main text. FP = false positives, FN = false negatives, RX
= read-across, SA = structural alerts, cc = concordance, (↑)↑ = (strong) increase in comparison to main text.
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F.2. WoE values of the individual methods.
As in the main section of this thesis only the WoE values of the combined model are re-
ported, this Annex lists shortly the WoE values of the individual methods – together with
the corresponding sensitivity (TNF ), speciﬁcity (TPF ), and their associated inverse values
(1-TNF = FNF and 1-TPF = FPF , respectively), which were used for the calculations.
All statistical values were taken from the respective result parts of this thesis: the structural
alert (combined) models performance, the read-across ﬁnal performance, and the correla-
tion analysis.
Table 59: WoE values of the individual methods
model+ TPF 1-TNF 10*log(TPF /(1-TNF ))
model− 1-TPF TNF 10*log(TPF /(1-TNF ))
model LLNA+ LLNA− WoE
SA+ 0.880 0.180 6.89
SA− 0.120 0.820 -8.35
RX+ 0.790 0.410 2.85
RX− 0.210 0.590 -4.49
GPT+ 0.703 0.153 6.62
GPT− 0.297 0.847 -4.55
model GPT+ GPT− WoE
SA+ 0.910 0.160 7.55
SA− 0.090 0.840 -9.70
RX+ 0.540 0.160 5.28
RX− 0.460 0.840 -2.62
LLNA+ 0.904 0.416 3.37
LLNA− 0.096 0.584 -7.84
TPF = true positive fraction, TNF = true negative fraction, RX = read-across, SA = structural alerts, + and
− denote positive and negative predictions by the respective model/animal test, WoE = weigt-of-evidence
factor (cf. main text).
F3
F.3. Probability calculation example.
To calculate the associated probabilities given in the main section and the following tables in
Annex F.5 and F.6 from the given WoE values (see above) and their combinations, ﬁrst the
odds is backcalculated according to equation 32. For example, the odds for the SA+ and
RX+ WoE combined (6.89 + 2.85 = 9.74) in the LLNA would be:
WoE = 10 · log10(Odds) <=> Odds = 10WoE/10 = 109.74/10 = 9.42 (49)
As the Odds are deﬁned as fraction of the probabilities and Pr(S−) is equal to 1−Pr(S+)
and vice versa, the following is applied afterwards (eq 31):
Odds =
Pr(S+)
Pr(S−)
=
Pr(S+)
1− Pr(S+) <=> Pr(S
+) =
Odds
1 +Odds
=
9.42
1 + 9.42
= 0.904 (50)
Odds =
Pr(S+)
Pr(S−)
=
1− Pr(S−)
Pr(S−)
<=> Pr(S−) =
1
1 +Odds
=
1
1 + 9.42
= 0.096 (51)
This results in the following table:
Table 60: Bayes calculation example
SA RX WoE odds Pr(S+) Pr(S-) Prediction
+ + 9.74 9.42 0.904 0.096 +
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of hitting a non-sensitiser,
Prediction: + = sensitisiers.
This is shortened in the main text to:
Table 61: Bayes calculation example shortened
SA RX WoE Pr(S+) Pr(S-) Prediction
+ + 9.74 90% 10% +
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, odds = probability ratio, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of
hitting a non-sensitiser, Prediction: + = sensitisier..
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F.4. Further consensus modelling investigations.
Besides the simple consensus decision based on concordant read-across and structural
alerts predictions, two further consensus modelling approaches were developed. Firstly,
it was tried to enhance the domain of applicability of the consensus modelling under the
rationale of a low loss of statistical performance, because certain substances had to be
excluded from the ﬁnal model predictions (thus, lowering its domain of applicability). This
concerns (a) disregarded compounds with contradicting read-across and structural alerts
predictions and (b) compounds excluded beforehand in one of the used approaches.
In case of (a) normally the structural alert model is preferred, because it obtained better
statistics and is concordant with the tendency of the equivocal predictions as can be seen
in table 19 of the main section (for this compare the second and third line of the column SA
with the column prediction; the RX does not reﬂect the overall prediction tendency). Here
no improvement beyond the structural alert model is to be expected as the statistics of the
combined model would be identical with the structural alert model if the better prediction is
taken in case of contradicting read-across and structural alert outcomes (structural alerts
are always the better model and are, thus, taken for every prediction).
However, regarding (b) the structural alert model has excluded several substances as
equivocal (discordant results in the screening and high resolution submodel) and those could
be reintroduced – to broaden the domain of applicability – by utilising the read-across results
in the context of a consensus decision. Moreover, also read-across predictions can obtain
equivocal results in case the grey area approch for the binary prediction interval is applied.
This limits the domain of applicability of the read-across, but possibly these compounds can
be reintroduced via the structural alerts, which may lead to better predictions of problematic
read-across substances. To investigate all of the aspects mentioned for (a) and (b) a decision
tree approach was developed. Therein, the following heuristics are used:
• If read-across and structural alerts are concordant take this result
• If read-across and structural alerts disagree consult the structural alerts
• If the structural alerts give 0.5 (equivocal) as result take the read-across prediction
• If the read-across reports an equivocal (0.5) prediction use the structural alerts instead
(this obviously depends on the grey area applied in the read-across submodel)
The respective statistics are depicted in the tables 62 and 63. Alongside the decision tree
models also the outcomes of the structural alert exercise and the consensus modelling ap-
proach using just concordant results are listed for comparison. As can be seen in the tables,
the statistics of the developed models are approaching the performance of the structural
alert model alone for both animal tests – with respect to the data excluded as well as the
statistics (via decreasing contribution of the read-across). However, none of the decision
trees surpassed the structural alerts performance and no indication is given that it might
even outperform the consensus approach using only concordant results.
F5
Table 62: Advanced consensus models LLNA
Model namea TNF TPF NPV PPV cc N %
L SA alone 0.82 0.88 0.83 0.88 0.86 1015 93%
L Consensus 0.82 0.93 0.88 0.90 0.89 726 67%
L DT RX 0.5 0.79 0.86 0.82 0.84 0.83 1089 100%
L DT RX 0.4-0.6 0.80 0.87 0.82 0.85 0.84 1064 98%
L DT RX 0.3-0.7 0.81 0.87 0.82 0.86 0.84 1047 96%
L DT RX 0.2-0.8 0.81 0.87 0.82 0.87 0.85 1037 95%
L DT RX 0.1-0.9 0.81 0.88 0.83 0.87 0.85 1017 93%
a = meaning of the abbreviations: L = LLNA, SA = structural alerts; DT = decisions tree above as outlined
in the text; RX 0.X-0.Y = read-across with a grey area in between 0.X and 0.Y, thus just compound < 0.X
and > 0.Y are considered, 0.5 means no no grey area. TNF = true negative fraction (speciﬁcity), TPF =
true positive fraction (sensitivity), NPV = negative predictive value, PPV = positive predictive value, cc =
concordance, N = number of compounds, % = percentage of the overall data set.
Table 63: Advanced consensus models GPT
Model namea TNF TPF NPV PPV cc N %
G SA alone 0.84 0.91 0.95 0.75 0.86 850 87%
G Consensus 0.93 0.90 0.96 0.84 0.92 616 63%
G DT RX 0.5 0.83 0.85 0.92 0.71 0.84 971 100%
G DT RX 0.4-0.6 0.83 0.86 0.92 0.72 0.84 947 97%
G DT RX 0.3-0.7 0.84 0.87 0.93 0.73 0.85 922 95%
G DT RX 0.2-0.8 0.84 0.88 0.93 0.74 0.85 903 93%
G DT RX 0.1-0.9 0.84 0.90 0.94 0.75 0.86 872 90%
a = meaning of the abbreviations: G = GPT; SA = structural alerts; DT = decisions tree above as outlined
in the text; RX 0.X-0.Y = read-across with a grey area in between 0.X and 0.Y, thus just compound < 0.X
and > 0.Y are considered, 0.5 means no no grey area. TNF = true negative fraction (speciﬁcity), TPF =
true positive fraction (sensitivity), NPV = negative predictive value, PPV = positive predictive value, cc =
concordance, N = number of compounds, % = percentage of the overall data set.
As second additional approach the applied structural alert model was modiﬁed concerning
its overall prediction, which currently takes place in a binary manner (yes/no). Because the
read-across is more “quantitative” or fuzzy (binary prediction interval value between 0 and
1) it was tried to develop a more fuzzy structural alert model to obtain a combined prediction
via multiplication of both results and and taking the root afterwards:
Prediction =
√
SApred.int. · RXpred.int. (52)
Typically SApred.int. (with pred.int. meaning prediction interval) takes a value of 0 or 1 in the
binary case, which was tested in these analyses, too. To also derive a quantitative (binary
prediction interval) estimate for the structural alerts the well-known reactivity domain classi-
ﬁcation were used in a (pseudo) Bayesian approach: For each alert it was derived to which
reactivity domain it belongs and for this domain the respective statistics were consulted.
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If, for example, alerts for Michael acceptors are giving a correct positive prediction with a
PPV of 0.89 (LLNA), this value was used as SApred.int.. This ensures that the better the
respective domain is performing the higher are the applied values. The used values for the
respective domains are listed in table 64. For the remaining non-sensitisers a value of 0.17
or 0.05 (1−NPV of the combined structural alert model of LLNA or GPT, respectively) was
used. Moreover, as last step, also substances with equivocal predictions were included with
a value of 0.5 for SApred.int. and RXpred.int. (the latter is of course only available as 0.5 if a
grey area binary prediction interval approach is applied).
Table 64: Weighting of reactivity domains (for equation 52)
used value (PPV ) for
Domain Ac pAc MA pMA SB pSB SN2 pSN2 SNAr Special NS
LLNA 0.91 1.00 0.89 0.90 0.86 0.83 0.86 0.87 0.96 0.90 0.17
GPT 0.97 0.50 0.76 0.76 0.83 0.74 0.70 0.48 0.43 0.61 0.05
The statistical performances listed in table 65 and 66 demonstrate several facts, which
are true for both animal test systems. Firstly, putting the equivocal (0.5) structural alert
predictions into the model leads to statistically weaker results than setting equivocal com-
pounds aside. This indicates that they are probably problematic in the read-across as well,
which can also explain why the decision trees including the read-across prediction for these
substances did not obtain signiﬁcantly superior results. Secondly, the simple approach con-
sidering only binary structural alert predictions is not worse than the more complex (pseudo)
Bayesian method, which considers the performance of the reactivity domains. The statistics
are nearly identical for the simple and complex “0.5S out” models – with some minor devia-
tions. Finally, despite the fact that the newly developed approaches obtained models with a
good performance and even better statistics than the pure structural alert model, they were
not able to outperform the original consensus exercise (which considers only concordant
structural alert and read-across predictions). For this the model “0.5S out, 0.4-0.6RX” and
“L Consensus” as well as “0.5S out, 0.3-0.7RX” and “G Consensus” can be compared. Both
of the new approaches excluded a similar number of substances as the original consensus
models but did not exhibit a superior statistical performance. To note a detail on this, in case
of the GPT the detection of non-sensitisers (TNF ) was better in the new model compared
to the model of the main section, but on the contrary the detection of sensitisers (TPF )
decreased tremendously (to 0.59). As TPF and TNF can be seen as antagonists this is
not surprising and the deeper reason is the very low value of 0.05 applied for substances
without structural alerts – leading to more (false) negative predictions in comparison to situ-
ations where a higher value is applied for non-sensitisers. Moreover, this is in line with the
tendency of the GPT to give (false) negative results, which makes hitting a non-sensitiser
randomly more likely than detecting a sensitiser. Thus, the imbalanced detection rate is
rooted in the imbalanced performance of the animal test system.
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Table 65: Advanced consensus models LLNA with weighting
Model namea TNF TPF NPV PPV cc N %
L SA alone 0.82 0.88 0.83 0.88 0.86 1015 93%
L Consensus 0.82 0.93 0.88 0.90 0.89 726 67%
simple 0.5S in, 0.5RX 0.81 0.80 0.76 0.85 0.81 1088 100%
simple 0.5S out, 0.5RX 0.85 0.82 0.76 0.89 0.83 1002 92%
0.5S in, 0.5RX 0.78 0.76 0.82 0.81 0.80 1088 100%
0.5S out, 0.5RX 0.85 0.76 0.89 0.81 0.83 1002 92%
0.5S out, 0.4-0.6RX 0.85 0.86 0.80 0.90 0.85 731 67%
0.5S out, 0.3-0.7RX 0.80 0.93 0.86 0.89 0.88 507 47%
0.5S out, 0.2-0.8RX 0.79 0.95 0.89 0.90 0.89 431 40%
0.5S out, 0.1-0.9RX 0.74 0.93 0.84 0.88 0.87 259 24%
a = meaning of the abbreviations: L = LLNA; simple = structural where used in a binary/trinary fashion (0, 1
or 0, 0.5, 1) for the equation 52, for the models without the simple preﬁx the domain performances (cf. text
and table 64) were used as input for SAquant; 0.5S in/out = structural alerts with unclear result (0.5) where
taken into account or not; 0.X-0.Y RX = read-across with a grey area in between 0.X and 0.Y, thus only
compound with < 0.X and > 0.Y are considered, 0.5 means no grey area. TNF = true negative fraction
(speciﬁcity), TPF = true positive fraction (sensitivity), NPV = negative predictive value, PPV = positive
predictive value, cc = concordance, N = number of compounds, % = percentage of the overall data set
Table 66: Advanced consensus models GPT with weighting
Model namea TNF TPF NPV PPV cc N %
G SA alone 0.84 0.91 0.95 0.75 0.86 850 87%
G Consensus 0.93 0.90 0.96 0.84 0.92 616 63%
simple 0.5S in, 0.5RX 0.88 0.69 0.85 0.75 0.82 971 100%
simple 0.5S out, 0.5RX 0.90 0.72 0.86 0.80 0.84 842 86%
0.5S in, 0.5RX 0.86 0.84 0.71 0.67 0.80 971 100%
0.5S out, 0.5RX 0.91 0.85 0.80 0.68 0.83 842 86%
0.5S out, 0.4-0.6RX 0.93 0.65 0.85 0.82 0.84 721 74%
0.5S out, 0.3-0.7RX 0.96 0.59 0.85 0.87 0.85 587 60%
0.5S out, 0.2-0.8RX 0.97 0.64 0.88 0.88 0.88 477 49%
0.5S out, 0.1-0.9RX 0.98 0.62 0.91 0.90 0.91 330 34%
a = meaning of the abbreviations: G = GPT; simple = structural where used in a binary/trinary fashion (0, 1
or 0, 0.5, 1) for the equation 52, for the models without the simple preﬁx the domain performances (cf. text
and table 64) were used as input for SAquant; 0.5S in/out = structural alerts with unclear result (0.5) where
taken into account or not; 0.X-0.Y RX = read-across with a grey area in between 0.X and 0.Y, thus only
compound with < 0.X and > 0.Y are considered, 0.5 means no grey area. TNF = true negative fraction
(speciﬁcity), TPF = true positive fraction (sensitivity), NPV = negative predictive value, PPV = positive
predictive value, cc = concordance, N = number of compounds, % = percentage of the overall data set
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F.5. Inclusion of further submodels and data: uninformative prior case
In the main section only the inclusion of further data with the informative prior (distribution
of (non-)sensitisers in the test systems taken into account) is listed. For the sake of com-
pleteness and because it is discussed brieﬂy also the uninformative prior case should be
reported, which is done in table 67.
Table 67: Consensus prediction of read-across and structural alerts and one animal model
– uninformative prior case
LLNA data
SA RX GPT WoE odds Pr(S+) Pr(S-) Prediction
+ + + 16.00 39.79 0.975 0.025 +
+ + − 5.10 3.24 0.764 0.236 o (+)
+ − + 8.99 7.92 0.888 0.112 o (++)
+ − − -1.91 0.64 0.392 0.608 o (−)
− + + 1.16 1.31 0.566 0.434 o (+)
− − + -5.85 0.26 0.206 0.794 o (−)
− + − -9.74 0.106 0.096 0.904 −
− − − -16.75 0.0211 0.021 0.979 −
GPT data
SA RX LLNA WoE odds Pr(S+) Pr(S-) Prediction
+ + + 16.20 41.71 0.977 0.023 +
+ + − 4.99 3.16 0.759 0.241 o (+)
+ − + 8.30 6.77 0.871 0.129 o (+)
+ − − -2.91 0.51 0.339 0.661 o (−)
− + + -1.05 0.79 0.440 0.560 o (−)
− − + -8.94 0.13 0.113 0.887 o (− −)
− + − -12.26 0.059 0.056 0.944 −
− − − -20.16 0.0096 0.010 0.990 −
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, odds = probability ratio, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of
hitting a non-sensitiser, Prediction: + = sensitisiers, - = non-sensitiser, o = not decideable with (+) = tendency
to sensitiser and (-) tendency to non-sensitiser. Calculations took place with regard to equation 32 and 31.
An example for the derivation of the values is given in Annex F.3.
F.6. Including the prevalence of sensitiser among industrial chemicals
In medicine the utilised prior information is the prevalence of a particular disease (Hoffmann
and Hartung, 2005, 2006; Rorije et al., 2013). This is also possible for skin sensitisation
as e.g. shown in Leontaridou et al. (2016). However, in this Annex not the epidemiological
prevalence of allergic dermatitis is introduced into the model, but the prevalence of skin sen-
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sitisers among industrial chemicals. This approach disregards the concrete distribution of
the data set at hand (which was included in the main section), but applies the distribution of
sensitisers in the chemical universe approximated by the frequency among registered indus-
trial chemicals. With this an estimation is possible what impact chemicals have that lie be-
yond the current applicability domain of the model, which is based on the presently available
data. Obviously, this disregards the applicability domain and can be seen as ﬂawed model
usage. However, non-expert users may use the model inadequately on a chemistry-blind
basis (for example, Alves et al., 2016, disregarded the applicability domain of their analysed
structural alert models) and, thus, it is interesting to assess if the model makes good predic-
tions even beyond its applicability domain – which should not be regarded as prerequisite
for a good model, but as useful feature.245 Furthermore, the data set distribution-based prior
of the main section could be biased for the collected data (which is not improbable in case
of the LLNA, where some of the included data collections focussed on positive test results)
and also from this perspective a broadened assessment is sensible.
In the literature different estimates for the skin sensitiser prevalence exist. Among them
are 20% based on the ELINCS lists classiﬁcations (Safford, 2008), 20% based on fragrance
ingredients in the IFRA/RIFM dataset (Keller et al., 2009) as well as 28% for a mix of dif-
ferent test systems or 33-36% for the LLNA data only (the last two number are from the
new chemicals database at the ECB, Angers-Loustau et al., 2011). These numbers ﬁt to
the recent ﬁnding of Luechtefeld et al. (2016a), who observed a prevalence of positive skin
sensitisation testings of about 21% among the REACH registration data (as GHS hazards re-
ported in substance dossiers with different tests). Although a differentiation between LLNA
and GPT should be undertaken – as shown in the correlation analysis of this thesis and
Angers-Loustau et al. (2011) – and their individual prevalences should be used for further
calculations (leading possibly to different results), the value of Luechtefeld et al. (2016a)
was taken as most accurate estimate for both in the further calculations, because it is based
on the largest data set. Moreover, as it is the lowest value and farest away from the be-
fore used 50% (uninformative prior) it will have the highest impact. Applying this value
(0.21,0.79) to formula 31 and 32 a WoEpre-value of -5.75 db is calculated, meaning this
amount of evidence has to be subtracted from the WoEpost-values in the results section.
The prevalence-modiﬁed results are shown in table 68.
As to be expected, the overall pattern of the predictions exhibits a more negative trend for
both animal test system.246 This is because according to the prevalence information more
non-sensitisers exist in the chemical universe and, thus, they make up a greater proportion
of the prior distribution. This in turn causes the decrease of the WoEpost-values (subtraction
of WoEpre) and the associated probabilities are shifted towards higher values for the non-
sensitiser predictions (Pr(S-)). Obviously, this is sensible because it is much more likely to
hit a non-sensitiser by default with any prediction according to the prevalence and for this
reason accurately predicting a sensitiser should be harder.
245In the optimum case chemical insights are applied by experts to predictions of new chemicals and reduce
possible uncertainties (Roberts and Patlewicz, 2017).
246Meaning: from the formerly uncertain prediction with a negative trend (row 3) a second certain negative
prediction emerges, the formerly uncertain prediction with a positive trend gets a negative trend (row 2), and
the formerly certain positive prediction is now associated with more uncertainty (row 1).
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Table 68: Consensus prediction of read-across and structural alerts with a prevalence/prior
of (0.21,0.79)
LLNA data
SA RX WoE odds Pr(S+) Pr(S-) Prediction
+ + 3.93 2.47 0.712 0.288 o (+)
+ − -3.08 0.493 0.330 0.670 o (−)
− + -10.91 0.0811 0.075 0.925 −
− − -17.92 0.0162 0.016 0.984 −
GPT data
SA RX WoE odds Pr(S+) Pr(S-) Prediction
+ + 7.08 5.17 0.836 0.164 o (+)
+ − -0.82 0.828 0.453 0.547 o (−)
− + -10.91 0.0961 0.088 0.912 −
− − -17.92 0.0156 0.015 0.985 −
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, odds = probability ratio, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of
hitting a non-sensitiser, Prediction: + = sensitisiers, − = non-sensitiser, o = not decideable with (+) = trend
towards sensitiser and (−) trend towards non-sensitiser. Calculations took place with regard to equation 32
and 31 (and the prior’s WoE was substracted/added to the WoE beforehand).
Interestingly, this prior information is that high that it turns the formerly uncertain negative
prediction into a certain one (with a associated probability of 0.925 in the LLNA and 0.912
in the GPT). Therefore, it is enough for predicting a non-sensitiser if no structural alert is
at hand. Otherwise, a negative read-across result combined with a present structural alert
is not a sufﬁcient condition for a non-sensitiser prediction. Nevertheless and even more
importantly, although both alternative models are positive they give an uncertain result if
the prevalence prior is applied (albeit having a positive trend the result is not sufﬁcient for
a robust decision as deﬁned in the results section of the main text). Therefore, to predict
a sensitiser more information is need. This can stem form different source e.g. other non-
animal test systems or animal data, as further explained in the main section of this thesis.
In this Annex, though, an analysis shall be conducted concerning the prevalence prior and
the updated information by including the vice versa animal test system (cf. table 69).
Table 69 suggest that if the results from one animal test system and the two in silico ap-
proaches are concordant no further animal testing (i.e. a second animal test) is necessary.
This means, if all three predictions are positive than the complementary animal test system
will be very likely positive, too. The same is true for a concordant negative prediction or if two
prediction methods are negative (with the exception of the read-across and the complemen-
tary animal test system; in this case more research is needed, e.g. in form of a improved
read-across).
However, the more troublesome case for regulation is when two predictions are positive
and one is negative. In line with majority vote 2 out of 3 approaches (Bauch et al., 2012;
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Table 69: Consensus prediction of read-across and structural alerts and animal data with a
prevalance/prior of (0.21,0.79)
LLNA data
SA RX GPT WoE odds Pr(S+) Pr(S-) Prediction
+ + + 10.61 11.51 0.920 0.080 +
+ + − -0.56 0.88 0.468 0.532 o (−)
+ − + 3.27 2.13 0.680 0.320 o (+)
+ − − -7.90 0.16 0.140 0.860 o (−)
− + + -4.63 0.34 0.256 0.744 o (−)
− − + -11.96 0.064 0.060 0.940 −
− + − -15.80 0.026 0.026 0.974 −
− − − -23.14 0.0049 0.005 0.995 −
GPT data
SA RX LLNA WoE odds Pr(S+) Pr(S-) Prediction
+ + + 10.45 11.09 0.917 0.083 +
+ + − -0.76 0.84 0.456 0.544 o (−)
+ − + 2.55 1.80 0.643 0.357 o (+)
+ − − -8.66 0.14 0.120 0.880 o (−)
− + + -6.80 0.21 0.173 0.827 o (−)
− − + -14.70 0.034 0.033 0.967 −
− + − -18.01 0.016 0.016 0.984 −
− − − -25.91 0.0026 0.003 0.997 −
SA = structural alert prediction, RX = read-across prediction, WoE = weight-of-evidence factor for the com-
bined prediction, odds = probability ratio, Pr(S+) = probability of hitting a sensitiser, Pr(S-) = probability of
hitting a non-sensitiser, Prediction: + = sensitisiers, - = non-sensitiser, o = not decideable with (+) = trend
towards sensitiser and (-) trend towards non-sensitiser. Calculations took place with regard to equation 32
and 31 (and the prior’s WoE was substracted/added to the WoE beforehand).
Urbisch et al., 2015) one might suspect that two positive results are indicating an effect.
However, with the low given informative prior/prevalence, no combination can overrule the
contradicting negative prediction and knowledge from further tests is needed for clariﬁcation.
Though, this is not that clear for the uninformative prior case (cf. Annex F.5 for the numerical
values) and the distribution-based priors (cf. main text). For instance, in the uninformative
scenario a positive prediction by one animal model as well as a hit structural alert are nearly
enough for a conﬁdent positive prediction in the other animal test system (with a probability
of ﬁnding a sensitiser of 0.888 in the LLNA and 0.871 in the GPT) and it is a matter of
argument if these values are accepted for regulatory decision making. Again, the need for a
stringent weight-of-evidence discussion and implementation in the current guidelines must
be emphasised.
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G. Annex Validation
To validate the ﬁnal model the OECD principles on (Q)SAR validation can be applied (OECD,
2004, 2007). They originated during discussions in Setubal, Portugal (Eriksson et al., 2003;
Jaworska et al., 2003; Cronin et al., 2003a,b), were formalised by the OECD QSAR Work-
ing Group in Paris in 2004, and can be consulted to check the validity of (Q)SAR models.
Each point of the principles shall be discuss brieﬂy for the developed model and a tabularly
summary is given in the main section in table 23 (in analogy to the validation exercise of the
BfR decision support system, Rorije and Hulzebos, 2005). All points address the question:
“Is the following information available for the model?”
1 Deﬁned endpoint
1.1 A clear deﬁnition of the scientiﬁc purpose of the model (i.e. does it make predictions
of a clearly deﬁned physicochemical, biological or environmental endpoint)?
The model developed in this thesis makes predictions for the skin sensitising effect of or-
ganic (and metalorganic) chemicals with respect to their animal test results. Fulﬁlled.
1.2 The potential of the model to address (or partially address) a clearly deﬁned regula-
tory need (i.e. does it make predictions of a speciﬁc endpoint associated with a speciﬁc test
method or test guideline)?
Skin sensitisation is a clearly deﬁned endpoint according to the REACH and other regu-
lations. A (Q)SAR application under REACH is possible according to Annex XI. It is also
important for (GHS) classiﬁcation and labelling according to the CLP regulation. Fulﬁlled.
1.3 Important experimental conditions that affect the measurement and therefore the pre-
diction (e.g. sex, species, temperature, exposure period, protocol)?
The predicted animal assays are either the LLNA (local lymph node assay) or regulatory
accepted GPT (guinea pig maximisation test + Buehler test), which are fully described and
standardised in the respective OECD guideline documents 406 and 429. The model applies
to tests conducted according to these guidelines. Fulﬁlled.
1.4 The units of measurement of the endpoint?
The skin sensitising effect is measured as stimulation index (SI) in the LLNA and as visual
expert read-out in the GPT. Measures of potency are the EC3 values in the LLNA and the
determined percentage of sensitised animals in the GPT (cf. Annex A.1), which in turn lead
to the potency categorisation of the substances. However, the purpose of developed model
in its current state is the binary classiﬁcation without addressing potency. Not applicable.
2 Deﬁned algorithm
2.1 In the case of a SAR, an explicit description of the substructure, including an explicit
identiﬁcation of its substituents?
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All used structural alerts are exactly and explicitly described in Annex E.8 of this thesis. For
some alerts speciﬁc structural features are excluded, which is also stated in Annex E.8. Fur-
thermore, the log Kow-based cut-off values for halogenalkanes are included, too. Lastly, it
is stated in Annex E.9 which alert belongs to the screening model and which is used in the
high resolution predictions. Fulﬁlled.
2.2 In the case of a QSAR, an explicit deﬁnition of the equation, including deﬁnitions of
all descriptors?
Both the read-across and the consensus modelling give quantitative values which are di-
chotomised (binary classiﬁcation) in a consecutive step (possibly with the exclusion of equiv-
ocal results as third category). They do not use classical QSAR regression equations.
The algorithm for the ACF-based automatic read-across is well-described in literature (e.g.
Schu¨u¨rmann et al., 2011; Ku¨hne et al., 2013) and also in the read-across chapter of this
thesis. All of the used parameters are deﬁned. The applied decision supporting consen-
sus approach is based on Bayesian statistics, which is based on well-known mathematical
principles and even the generation of the utilised weight-of-evidence (WoE) values is trans-
parently explained in this thesis as well as in the scientiﬁc literature (e.g. Aldenberg and
Jaworska, 2010; Jaworska et al., 2010; Rorije et al., 2013). A suggestion for an explicit cut-
off at which the WoE value associated probabilities are sufﬁcient for regulatory classiﬁcation
is given and discussed. Fulﬁlled.
3 Domain of applicability
3.1 In the case of a SAR, a description of any limits on its applicability (e.g. inclusion and/or
exclusion rules regarding the chemical classes to which the substructure is applicable)?
Already stated for principle 2.1 (Deﬁned algorithm/description of substructures). Fulﬁlled.
3.2 In the case of a SAR, rules describing the modulatory effects of the substructure’s molec-
ular environment?
During the derivation of the structural alerts potency considerations were included which
stem from the modulating effect of certain substituents. This was the reasoning for exclud-
ing some alerts in the high performance approach (e.g. α-substitution of Michael acceptors
or SNAr reactants which only have weakly activating (halogen) groups), which is listed in
Annex E.8 and E.9. Fulﬁlled.
3.3 In the case of a QSAR, inclusion and/or exclusion rules that deﬁne the following vari-
able ranges for which the QSAR is applicable (i.e. makes reliable estimates): a) descriptor
variables, b) response variables?
The model prediction is binary (yes/no classiﬁcation) for the LLNA and the GPT and is,
thus, not concerned with descriptor/response ranges. However, both animal tests can be
classiﬁed deeper with the EC3 values and percentage of responding animals as response
variable. As the training set covers the whole range of different values from extreme to weak
G2
sensitisers for both animal test systems, the coverage of a great response range is given
and no inclusion or exclusion rules have to be deﬁned.
Furthermore, it should be mentioned that the parts of an applicability domain (Dimitrov et al.,
2005a: physicochemical, structural, mechanistic, metabolic) all can be deﬁned based on the
utilised training set. The physicochemical domain is given by the range of physicochemical
properties as given in the training set. The training set covers the whole range for impor-
tant physicochemical parameters as observed in the bioavailability exercise of this thesis (cf.
also Annex C.3). The structural domain can be derived via the application of the model of
Ku¨hne et al. (2009), which can further be taken to predict if a compound is inside or outside
the structural applicability domain of the model. The mechanistic domain is deﬁned by the
domains of reactivity for skin sensitisation (cf. principle 5.1-5.4), all of which are represented
in the training set. Finally, the metabolic domain is at least partly covered by the structural
alert rules based on metabolism as well as the group of substances with similar structure
found by the read-across, which will exhibit a similar metabolism. However, it cannot be
excluded that speciﬁc metabolic steps are not covered by the model as it does not integrate
the full metabolome of an organism, but the substances with this metabolites are likely to be
outside of the structural applicability domain, too.
Overall, based on training set considerations the model should cover a sophisticated range
of organic compounds with respect to the physicochemical and mechanistic domain. In case
of the structural domain the model of Ku¨hne et al. (2009) is usable to infer if a particular tar-
get compound is within the domain or not. The metabolic domain is at least partly covered.
Fulﬁlled.
3.4 A (graphical) expression of how the descriptor values of the chemicals in the training
set are distributed in relation to the endpoint values predicted by the model?
As the model gives binary predictions a graphical expression of the distribution seems not
sensible. The distribution of positive and negative LLNA and GPT is reported in the data
base chapter of this thesis and is discussed subsequently e.g. in the discussion section of
the read-across chapter. Not applicable.
4 Internal performance and predictivity
Internal performance
4.1 Full details of the training set given, including details of: a) chemical names, b) structural
formulae, c) CAS numbers, d) data for all descriptor variables, e) data for all response vari-
ables, f) an indication of the quality of the training data?
All structural (chemical names, structural formulae, and CAS numbers) and all test com-
pound related results (LLNA: EC3, used vehicle, SI-values, categorisation, and purity – all if
available; GPT: percentage of sensitised animals, induction dose, categorisation, and purity
– all if available) as well as indication of the reliability of the data (if available, an indica-
tion of the Klimisch classiﬁcation and GLP status of the used data is given) are stored in
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an in-house UFZ-data base. The used data will be made available upon publication of the
model.247 Not yet fulﬁlled.
4.2 a) An indication whether the data used to the develop the model were based upon the
processing of raw data (e.g. the averaging of replicate values). b) If yes to a), are the raw
data provided? c) If yes to a), is the data processing method described?
In case a particular substance had multiple data for one test system a consensus was
formed. First of all, the best professional judgment was used to determine if all data are
similarly reliable. If not, the most reliable tests were taken. If yes, the median of the EC3
values was taken for the LLNA and in cases were no EC3 value was available (LLNA with
sensitising and non-sensitising results) it was decided on a case by case basis if the com-
pound is to be considered as sensitiser or not (or if no conclusion can be drawn and the
results are equivocal). In case of multiple GPT the span of the percentage of sensitised ani-
mals plus the range of used concentrations (if available) was listed in the merged test result
(e.g. 20-60% with an induction dose of 0.05-0.2% over 4 GPT), which was the driving force
behind a consensus categorisation. Beside the merged (processed) data, all individual data
are listed separately in the data base. Fulﬁlled.
4.3 An explanation of the approach used to select the descriptors, including: a) the approach
used to select the initial set of descriptors, b) the initial number of descriptors considered, c)
the approach used to select a smaller, ﬁnal set of descriptors from a larger, initial set, d) the
ﬁnal number of descriptors included in the model?
See 4.4 if applicable. Fulﬁlled, if applicable.
4.4 a) A speciﬁcation of the statistical method(s) used to develop the model (including details
of any software packages used). b) If yes to a), an indication whether the model has been
independently conﬁrmed (i.e. that the independent application of the described statistical
method to the training set results in the same model)?
The development of the model was not classically statistics-driven as in typical QSAR meth-
ods and no algorithm was used to determine the best model. Nevertheless, in case of the
structural alerts the use of the alert reliability (Mekenyan et al., 2014; Patlewicz et al., 2014c)
was one of the guiding principles for the differentiation in screening and high performance
alerts. Furthermore, alerts with low or moderate reliability are considered as preliminary.
Therefore, a local validation (Patlewicz et al., 2014a) of the respective alerts took place,
which states if an alert should be treated as fully reliable or if is reliability is decreased.
In case of the read-across out of several models the approach with the best statistical perfor-
mance was taken considering also the likely domain of applicability in form of the substances
in the training set for which the read-across was applicable. However, as explained in the
main section, none of the models seem to be superior and, thus, the standard ACF approach
was applied. Whether a performance enhancement via a restriction of the similarity thresh-
old or the grey area is conducted in the ﬁnal model, has to be decided by the model user.
247If possible in case of the used ECHA data for which legal concerns may exists concerning a publically avail-
ability outside the ECHA dissemination site.
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Lastly, no statistical optimisation via an algorithm was applied for the consensus modelling
via Bayesian statistics-based WoE values. The derivation of a preliminary cut-off for the
WoE-associated probabilities (at 90% probability of a compound being active or non-active)
was based on professional judgment and should be subject to further debate as indicated.
Fulﬁlled, if applicable.
4.5 Basic statistics for the goodness-of-ﬁt of the model to its training set (e.g. r2 values
and standard error of the estimate in the case of regression models)?248
The relevant statistical measures for a binary classiﬁcation model are the Cooper or con-
cordance statistics (Yerushalmy, 1947; Cooper et al., 1979). The associated values (sen-
sitivity, TPF ; speciﬁcity, TNF ; positive and negative predictive value, PPV and NPV ;
concordance, cc) are calculable for all submodels and are moderate to nearly good for the
structural alert and even better for the consensus model. They are barely moderate for the
read-across. In addition, for the structural alerts for each alert the statistical performance is
listed within the framework of the alert reliability approach (Mekenyan et al., 2014; Patlewicz
et al., 2014c) in Annex E.9. Fulﬁlled.
4.6 a) An indication whether cross-validation or resampling was performed. b) If yes to
a), are cross-validated statistics provided, and by which method? c) If yes to a), is the re-
sampling method described?
The read-across is inherently cross validated because it is conducted in a leave-one-out
manner (to exclude the target substance itself, which would have an ACF-based Dice sim-
ilarity of 1). The structural alerts are not determined with an automatic method, thus a
cross-validation is not the right measure. They are based on an expert knowledge approach
and leaving out one data point will not change the model. Not applicable / not yet fulﬁlled.
4.7 An assessment of the internal performance of the model in relation to the quality of
the training set, and/or the known variability in the response?
The model developed in this thesis makes binary predictions and, thus, the variability in the
response can not readily be taken into account as it is outside of the scope of the model,
except in circumstances where the variability would lead to a different binary classiﬁcation.
However, in that case the model would aim to predict probably false (or very uncertain) test-
ing results, which is not sensible. Not applicable .
Predictivity / external validation
4.8 a) An indication whether the model has been validated by using a test set that is in-
dependent of the training set. b) If yes to a), is there an indication of the quality of the data
in the test set?
Neither a split into training and test set data nor an independent test set was consulted for
an external validation. In the beginning of the project it was decided to include all possible
248It has to be mentioned that no formal criterion exists in the OECD QSAR guidelines at which point a model
has a reliable goodness-of-ﬁt, e.g. which r2 is necessary for a good model.
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data, because this signiﬁcantly enhances the probability of ﬁnding similar substances in the
read-across (Ku¨hne et al., 2013). Moreover, the possibility to derive new alerts – and not just
alerts which are already described in literature – is higher in case all available data are taken
into account and in particular important if alerts with a low number of associated substances
(but mechanistic interpretation) are developed, because the chance is given that individual,
but important compounds are excluded during a training-test-set-split of a heterogeneous
data compilation.
During the course of the model development new data became available at the ECHA due
to new registrations after the date of data collection, which could be used for an external
validation. However, although these data would be independent from the used training set,
it is not clear if they would be representative of the data and would fall within the applica-
bility domain of the developed model. This has to be checked, if these data are consulted.
Furthermore, the data should ideally be subject to the same selection process as in this the-
sis, which would include the manual collection with expert judgement concerning the data
reliability. This time intensive procedure is not possible at the end of this thesis due to time
constraints, but might be applied for an external validation exercise afterwards. Not yet ful-
ﬁlled / not applicable
4.9 If an external validation has been performed: a) the number of test structures, b) the
identities of the test structures, c) the approach for selecting the test structures, specify-
ing how the applicability domain of the model is represented by the test set, d) a statistical
analysis of the predictive performance of the model (e.g. including sensitivity, speciﬁcity, and
positive and negative predictivities for classiﬁcation models), e) an indication of quality of the
test data, f) an evaluation of the predictive performance of the model that takes into account
the quality of the training and test sets, and/or the known variability in the response, g) a
comparison of the predictive performance of the model against previously-deﬁned quantita-
tive performance criteria?
No external validation has took place (cf. 4.8). Not yet fulﬁlled.
5 Mechanistic Interpretation, if possible
5.1 In the case of a SAR, a description of the molecular events that underlie the properties
of molecules containing the substructure (e.g. a description of how substructural features
could act as nucleophiles or electrophiles, or form part or all of a receptor-binding region)?
For all structural alerts a mechanism for the electrophile-nucleophile interaction is described
either in literature – cf. Annex E.8 – or in the structural alert discussion section of this thesis.
Fulﬁlled.
5.2 In the case of a QSAR, a physicochemical interpretation of the descriptors that is con-
sistent with a known mechanism of (biological) action?
The read-across identiﬁes the structurally most similar neighbours with which a prediction
concerning the activity of the target compound is formed. This neighbours can be readily
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interpreted with structural chemical knowledge as given in respective discussion section.
The interpretation of the Bayesian WoE values is straightforward, not regarding a physico-
chemical underpinning, but with respect to the relevance of the submodels (structural alerts,
read-across, animal data) driving the consensus decision. Fulﬁlled.
5.3 Literature references that support the (purported) mechanistic basis?
An abundant set of references is available to support reactivity as the most important mecha-
nistic basis of skin sensitisation (e.g. Aptula et al., 2005; Aptula and Roberts, 2006; Roberts
et al., 2007b,d; Roberts and Aptula, 2008; Karlberg et al., 2008; cf. table in Annex E.8 for
more detailed references) and the electrophile-nucleophile interaction is also part of the skin
sensitisation adverse outcome pathway (OECD, 2012a,b). Finally, also for the failure of the
bioavailability model as well as for the consensus modelling several literature references are
cited in the respective chapters. Fulﬁlled.
5.4 An indication whether the mechanistic interpretation of the model was determined a
priori (i.e. before modelling, by ensuring that the initial set of training structures and/or de-
scriptors were selected to ﬁt a pre-deﬁned mechanism of action) or a posteriori (i.e. after the
modelling, by interpretation of the ﬁnal set of training structures and/or descriptors)?
As can be seen in 5.3 the mechanistic justiﬁcation was available in the literature beforehand.
This was the basis for the literature-based structural alerts. The new alerts are expert a pos-
teriori interpretations how the found sensitising structural feature can function in accordance
with the mechanistic basis of electrophile-nucleophile interactions. The interpretation of the
missing inﬂuence of bioavailability took also place a posteriori and it was a priori expected
that bioavailability plays a signiﬁcant role, which was not observed for the data at hand (and
is in accordance with recent literature, cf. bioavailability chapter). Fulﬁlled.
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